data_6nnb_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6nnb _Structure_validation_residue.Date_analyzed 2019-08-16 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 10.3 Cg_exo . . . . . 0 N--CA 1.451 -1.004 0 CA-C-O 121.03 0.346 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.63 -8.59 22.02 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -72.4 155.75 39.8 Favored 'General case' 0 C--O 1.259 1.555 0 C-N-CA 123.124 0.57 . . . . 0.0 111.478 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.39 100.66 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.092 1.357 . . . . 0.0 110.212 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.28 169.22 21.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.946 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -100.48 128.89 46.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.8 m -128.58 141.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.0 93.56 9.39 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 38.0 tt0 -65.18 -53.6 42.41 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.942 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.9 m -148.84 149.29 31.05 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.27 -26.8 66.75 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 7.09 36.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 0.0 111.511 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.73 -44.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.0 110.142 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.44 -152.7 21.32 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.097 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.82 109.11 7.07 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 123.57 0.748 . . . . 0.0 111.062 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.69 176.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -105.82 126.0 51.66 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.501 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.06 178.81 5.33 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.695 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -133.55 131.29 39.56 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.16 120.21 29.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.644 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.7 mp -95.43 -38.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.122 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 9.5 tpp180 . . . . . 0 N--CA 1.392 -3.339 0 CA-C-O 121.629 0.728 . . . . 0.0 110.394 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.9 t . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 121.533 0.683 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.426 HG11 ' CG ' ' A' ' 47' ' ' GLU . 76.7 t -101.89 118.05 48.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.12 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.94 152.91 38.35 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 172.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -137.0 130.56 31.63 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -84.43 170.97 13.0 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -74.03 -4.14 33.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -10.15 59.39 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.53 -5.42 70.36 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.132 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.475 ' HD3' ' OE2' ' A' ' 18' ' ' GLU . 13.6 ptm180 -78.26 125.45 29.37 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 117.281 0.541 . . . . 0.0 111.262 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' CG ' HG11 ' A' ' 39' ' ' VAL . 8.6 tt0 -88.32 146.61 25.21 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.402 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 18.7 p90 -153.76 164.67 37.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 120.843 0.354 . . . . 0.0 110.589 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.9 t -86.9 116.25 24.84 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.213 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . . . -95.59 160.37 14.54 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 54' ' ' GLN . 5.7 mpt_? -136.8 162.42 33.27 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.89 -3.87 38.02 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 121.343 -0.456 . . . . 0.0 113.757 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -96.77 -9.68 28.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.408 0.623 . . . . 0.0 109.63 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.9 mt-30 -113.73 -2.32 13.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.922 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 35.1 t -130.79 135.36 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.962 -172.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -137.39 124.0 21.0 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.207 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.438 ' H ' HD21 ' A' ' 57' ' ' LEU . 1.8 pt? -101.85 115.15 29.91 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.292 35.3 pt . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.446 -1.293 0 N-CA-C 110.974 -0.433 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.36 -9.99 39.03 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -73.32 159.03 33.99 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.87 95.37 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.89 178.33 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.468 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -113.66 126.63 55.47 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 84.7 t -127.17 133.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.8 tt -84.89 91.85 8.13 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.02 -50.49 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.556 -1.657 . . . . 0.0 109.926 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 t -132.96 149.88 52.2 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -18.39 62.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.005 0.431 . . . . 0.0 110.145 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.34 -16.09 29.86 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -104.14 -33.21 8.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.0 110.841 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.1 -158.12 31.35 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -73.31 104.49 4.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.618 0.767 . . . . 0.0 110.532 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.66 163.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.633 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 34.6 ttm180 -79.82 126.46 31.0 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -133.31 160.77 36.34 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.563 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -125.68 124.46 41.18 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.94 118.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -90.37 -42.67 14.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.7 tpp180 . . . . . 1 N--CA 1.378 -4.041 0 CA-C-O 121.537 0.684 . . . . 0.0 109.655 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.42 -1.939 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 31' ' ' ARG . 49.1 t -98.41 111.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.986 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.02 147.1 29.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -129.3 121.47 27.58 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 67.6 m -65.59 157.14 30.6 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.954 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.633 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 45.6 m-20 -65.32 2.88 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.498 0.666 . . . . 0.0 112.62 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' SER . 41.9 mt-30 -87.12 -5.81 58.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.81 9.32 78.13 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 121.8 0.666 . . . . 0.0 111.479 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -95.28 111.81 23.61 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 123.823 0.849 . . . . 0.0 110.522 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -94.95 153.27 17.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -170.9 144.86 2.27 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 123.795 0.684 . . . . 0.0 110.801 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -74.33 95.63 2.71 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.909 0.861 . . . . 0.0 111.535 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.94 159.13 19.12 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -107.02 160.61 15.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.82 2.33 12.83 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -102.69 -9.46 20.03 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.566 0.698 . . . . 0.0 109.14 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.7 mt-30 -100.5 -4.22 29.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.97 133.4 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -137.32 139.91 41.16 Favored 'General case' 0 N--CA 1.391 -3.421 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.85 -171.86 0.24 Allowed 'General case' 0 C--N 1.291 -1.939 0 O-C-N 123.493 0.496 . . . . 0.0 110.489 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 C--N 1.315 -0.913 0 CA-C-O 122.547 1.165 . . . . 0.0 111.714 174.885 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 N--CA 1.439 -1.704 0 N-CA-C 110.828 -0.489 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.58 6.4 35.54 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -73.39 -175.04 1.81 Allowed 'General case' 0 C--O 1.25 1.1 0 C-N-CA 124.823 1.249 . . . . 0.0 110.932 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.55 106.44 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 32.7 m -132.58 176.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.789 0.804 . . . . 0.0 112.273 -168.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 9.7 pttm -113.73 132.96 55.63 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.202 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.34 125.86 71.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.604 0.716 . . . . 0.0 111.873 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' A' ' 23' ' ' GLY . 26.3 tp -88.86 92.83 9.37 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.52 -59.77 3.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.958 0.885 . . . . 0.0 109.814 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.3 m -146.27 156.08 43.11 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -14.91 63.35 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.59 0.71 56.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.737 0.303 . . . . 0.0 111.046 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -129.83 -53.46 1.14 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.26 0.553 . . . . 0.0 109.805 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 17' ' ' LEU . . . 103.06 -172.6 21.69 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.068 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.31 114.51 3.52 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.273 1.029 . . . . 0.0 111.489 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.3 163.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.431 HH11 ' CG ' ' A' ' 43' ' ' ASP . 38.6 ttm105 -79.52 133.75 36.49 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -154.41 172.61 17.45 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.073 0.463 . . . . 0.0 110.845 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -130.73 130.47 43.84 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.4 t -71.03 115.52 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.35 -42.57 15.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 . . . . . 0 N--CA 1.382 -3.868 0 CA-C-O 122.135 0.969 . . . . 0.0 111.137 -179.126 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 49' ' ' THR . 21.6 t . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -107.78 115.94 50.07 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.06 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.5 m -135.29 143.62 36.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' ' 47' ' ' GLU . 36.2 tt0 -130.87 126.9 37.41 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.484 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 46.3 t -77.27 167.69 21.3 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.626 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.431 ' CG ' HH11 ' A' ' 26' ' ' ARG . 5.9 p-10 -76.29 -6.55 51.96 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.281 1.039 . . . . 0.0 110.477 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -84.62 6.79 22.56 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.099 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.49 16.13 75.57 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 122.139 0.855 . . . . 0.0 111.462 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -93.13 98.28 11.21 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.384 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HB2' HE21 ' A' ' 41' ' ' GLN . 3.4 tm-20 -95.57 150.87 19.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -171.39 153.14 3.47 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.011 0.819 . . . . 0.0 111.285 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.2 t -78.76 112.47 15.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.903 0.858 . . . . 0.0 109.44 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.15 177.56 5.54 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.737 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 55' ' ' VAL . 54.6 mtp180 -123.58 146.49 48.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.22 -14.65 57.18 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.941 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.86 -6.2 58.87 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.498 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.0 mt-30 -120.98 14.21 11.47 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.158 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 51' ' ' ARG . 12.6 t -133.39 136.83 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.476 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 5.3 mmm180 -140.11 150.73 44.66 Favored 'General case' 1 N--CA 1.375 -4.205 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.08 178.033 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 91.4 mt -57.97 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 123.191 1.472 . . . . 0.0 111.427 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.423 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 13.3 pt . . . . . 0 C--N 1.255 -3.517 0 O-C-N 120.846 -1.159 . . . . 0.0 112.415 175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.625 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.1 Cg_exo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.46 -6.97 9.12 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.7 158.81 35.61 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.72 0.808 . . . . 0.0 110.367 -177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -127.61 108.8 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 122.635 1.207 . . . . 0.0 111.982 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 28.6 m -134.81 -172.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.643 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -127.66 140.54 52.02 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 27' ' ' ALA . 25.1 m -130.59 146.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.66 112.26 24.77 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -80.21 -71.6 0.45 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.34 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -116.24 139.54 50.25 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.912 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.62 66.01 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 112.325 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 5.5 41.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -127.34 -52.05 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.67 -154.25 18.36 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.45 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -78.21 118.54 20.53 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.206 1.002 . . . . 0.0 111.333 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 163.18 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 18.3 tpp180 -87.6 114.42 24.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -107.77 140.6 40.6 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.943 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -113.31 119.27 37.1 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 49.0 t -69.47 111.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.6 mm -94.3 -33.73 5.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.14 0.495 . . . . 0.0 110.827 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.537 ' NE ' HG22 ' A' ' 39' ' ' VAL . 8.8 ttp180 . . . . . 1 N--CA 1.347 -5.587 0 CA-C-O 122.095 0.95 . . . . 0.0 108.614 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' THR . 60.2 t . . . . . 0 CA--C 1.503 -0.838 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG22 ' NE ' ' A' ' 31' ' ' ARG . 63.1 t -125.05 116.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 119.509 1.049 . . . . 0.0 112.126 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.89 142.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 29.6 tt0 -127.18 108.28 10.76 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.915 0.864 . . . . 0.0 109.008 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 15.6 m -70.82 169.34 14.84 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.856 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -28.26 -58.83 0.12 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 128.552 2.741 . . . . 0.0 114.359 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -59.22 -19.45 45.62 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.173 1.789 . . . . 0.0 112.595 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.1 21.06 23.96 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -172.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -90.43 99.88 12.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.238 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.451 ' CD ' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -91.45 142.9 27.16 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -165.13 176.47 8.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.875 0.734 . . . . 0.0 110.755 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.5 t -96.71 117.51 31.17 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-O 121.638 0.732 . . . . 0.0 110.493 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.53 169.52 10.96 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.899 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.562 ' O ' HG21 ' A' ' 55' ' ' VAL . 24.4 mmt180 -131.41 145.45 51.81 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.35 -34.3 48.13 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 115.253 0.861 . . . . 0.0 115.253 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.2 -0.06 43.41 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 122.149 -0.618 . . . . 0.0 111.739 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -114.46 9.42 16.75 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 51' ' ' ARG . 45.8 t -124.83 139.89 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-O 121.128 0.489 . . . . 0.0 109.882 -174.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -137.66 129.28 28.33 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.02 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 57' ' ' LEU . 4.0 pp -99.6 131.87 45.31 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--O 1.248 1.02 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -172.669 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 13.8 Cg_exo . . . . . 0 N--CA 1.438 -1.764 0 N-CA-C 111.044 -0.406 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.12 -12.83 9.72 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.196 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.16 169.73 14.47 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 122.805 0.442 . . . . 0.0 110.094 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.82 111.57 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.42 0.628 . . . . 0.0 110.691 -173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -131.76 169.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.878 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -111.9 133.18 54.25 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.949 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.34 137.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.419 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.01 93.68 9.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.0 -49.89 66.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.182 -1.826 . . . . 0.0 110.966 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.7 m -147.25 148.05 31.05 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.506 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.17 68.12 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.8 8.74 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.965 0.412 . . . . 0.0 111.211 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.98 -45.21 1.03 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.288 0.566 . . . . 0.0 109.51 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.06 -154.54 21.19 Favored Glycine 0 N--CA 1.423 -2.167 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -72.56 108.14 5.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.863 0.865 . . . . 0.0 110.833 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.58 146.4 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.52 134.64 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.07 166.39 24.93 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.699 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -119.21 142.19 48.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.17 121.5 26.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.9 mm -89.47 -38.99 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.157 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 1 N--CA 1.343 -5.805 0 CA-C-O 121.943 0.877 . . . . 0.0 110.538 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' THR . 2.7 m . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.12 122.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.202 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.75 153.74 35.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.551 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 34.1 tt0 -123.52 123.93 41.71 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.4 t -78.08 170.24 16.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.75 1.86 13.66 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.062 0.934 . . . . 0.0 111.472 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -89.76 0.33 57.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.468 174.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 11.69 84.03 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 99.8 mtt180 -87.74 101.87 14.1 Favored 'General case' 0 N--CA 1.41 -2.427 0 C-N-CA 122.925 0.49 . . . . 0.0 110.24 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 38.0 tt0 -97.51 120.91 38.74 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.85 166.08 28.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.6 t -99.42 132.49 44.72 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.46 156.54 33.87 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.962 0.41 . . . . 0.0 111.005 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.455 ' O ' HG21 ' A' ' 55' ' ' VAL . 46.3 mtp180 -84.68 157.71 21.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.57 8.03 6.09 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-O 121.766 0.648 . . . . 0.0 112.882 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' ARG . 14.2 m120 -103.86 -8.84 19.43 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.93 -0.54 15.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.697 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 51' ' ' ARG . 5.9 t -127.82 138.26 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -139.53 152.36 46.85 Favored 'General case' 1 N--CA 1.377 -4.112 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.89 -169.73 0.5 Allowed 'General case' 0 C--N 1.27 -2.85 0 O-C-N 123.934 0.771 . . . . 0.0 109.817 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 pt . . . . . 0 C--N 1.306 -1.323 0 CA-C-O 122.518 1.152 . . . . 0.0 110.966 174.012 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.7 Cg_exo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.39 0.25 50.3 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.9 159.11 23.74 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 123.064 0.546 . . . . 0.0 110.076 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.03 100.21 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 122.734 1.254 . . . . 0.0 108.603 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.44 177.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.428 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 47.9 pttt -117.94 134.07 55.31 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 40' ' ' VAL . 65.7 t -131.64 130.34 62.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.0 tt -90.86 100.5 13.35 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -66.79 -57.68 6.56 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.698 0.761 . . . . 0.0 110.563 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -147.17 160.59 42.27 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.514 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -25.77 67.52 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.01 7.1 36.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.848 0.356 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.34 -46.4 1.34 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.092 0.473 . . . . 0.0 109.981 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 88.85 -160.87 30.27 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.304 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.45 111.03 10.32 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.474 0.71 . . . . 0.0 111.091 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.39 154.78 4.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 44.7 ttt180 -75.32 136.64 40.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.14 163.5 36.76 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.142 0.972 . . . . 0.0 112.87 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -116.25 119.67 36.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.19 111.16 3.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 41.4 mt -80.36 -45.2 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.389 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.92 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.566 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 3.0 ptp180 . . . . . 1 N--CA 1.343 -5.808 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.961 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.426 -1.668 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.566 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 3.0 m -129.66 138.86 53.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.446 HG22 HG23 ' A' ' 16' ' ' VAL . 35.8 m -133.2 152.93 36.56 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.008 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 57.7 tt0 -116.92 124.45 49.45 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -83.05 173.76 11.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 26' ' ' ARG . 3.1 m-20 -61.04 -16.64 45.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.428 1.091 . . . . 0.0 110.778 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -78.17 1.33 21.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.673 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.71 87.85 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 116.233 -0.44 . . . . 0.0 113.391 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 35.7 ttt-85 -101.24 120.11 39.76 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.542 0.337 . . . . 0.0 111.564 -174.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.9 136.52 34.56 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -145.1 155.94 43.62 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -95.73 137.23 35.1 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.211 0.529 . . . . 0.0 111.358 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 172.39 13.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.4 mtp180 -85.56 160.19 19.7 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.82 -19.44 69.52 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.238 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -86.94 -1.88 58.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.436 0.636 . . . . 0.0 109.819 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.27 2.26 17.61 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 16' ' ' VAL . 38.4 t -125.22 133.02 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 5.9 mmm180 -138.91 140.86 38.48 Favored 'General case' 0 N--CA 1.385 -3.677 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.145 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -176.17 0.08 Allowed 'General case' 0 C--N 1.287 -2.112 0 O-C-N 123.901 0.75 . . . . 0.0 112.42 170.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 58' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.438 -1.026 0 CA-C-O 122.996 1.379 . . . . 0.0 110.157 171.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.598 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 42.3 Cg_exo . . . . . 0 N--CA 1.451 -1.024 0 CA-C-O 121.67 0.613 . . . . 0.0 111.398 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.46 -24.37 3.94 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.813 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -73.42 169.77 16.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.26 132.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -145.28 177.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 124.333 1.053 . . . . 0.0 108.712 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.4 133.87 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -86.1 95.22 9.48 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.51 -59.92 4.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.799 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.2 m -139.1 149.0 44.04 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.25 66.89 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.56 8.03 38.55 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.996 0.427 . . . . 0.0 110.972 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.8 mt -130.02 -46.48 1.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.13 -158.26 20.05 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.346 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -72.41 112.22 8.29 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.965 0.906 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.91 152.28 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -78.19 135.24 37.58 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -143.97 159.24 42.92 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.85 0.833 . . . . 0.0 112.116 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -105.78 133.16 50.95 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.971 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 48.1 t -72.56 111.12 6.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 51.4 mm -91.02 -35.51 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.927 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.339 -6.006 0 CA-C-O 121.814 0.816 . . . . 0.0 108.925 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.244 0.772 0 N-CA-C 102.224 -3.25 . . . . 0.0 102.224 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.24 124.0 59.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 119.173 0.897 . . . . 0.0 108.848 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 29' ' ' VAL . 28.5 m -137.5 155.44 31.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.72 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 35.0 tt0 -121.77 124.22 43.68 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 22.3 t -75.65 171.98 13.38 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -10.99 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.402 1.096 . . . . 0.0 109.785 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -9.88 58.98 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.721 174.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.2 85.28 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.441 -0.409 . . . . 0.0 112.529 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -91.11 125.71 35.98 Favored 'General case' 0 N--CA 1.407 -2.623 0 O-C-N 122.283 -0.54 . . . . 0.0 111.296 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 42.2 tt0 -92.07 134.56 34.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.71 153.57 42.59 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.6 t -113.08 116.78 30.42 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.787 0.803 . . . . 0.0 110.838 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.35 -171.34 1.94 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.968 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -100.98 164.59 11.74 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.86 -8.75 69.2 Favored Glycine 0 C--O 1.216 -1.009 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -85.79 -1.82 57.61 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -118.8 11.2 12.59 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.495 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.26 136.28 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 121.418 0.627 . . . . 0.0 109.336 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -132.72 129.69 39.03 Favored 'General case' 0 N--CA 1.395 -3.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.324 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.67 138.75 37.3 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.759 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.282 37.1 pt . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 126.415 1.886 . . . . 0.0 115.492 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.45 -1.065 0 CA-C-O 121.152 0.397 . . . . 0.0 112.791 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.26 48.51 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.016 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.57 156.77 18.87 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-O 120.964 0.411 . . . . 0.0 110.985 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.5 106.94 21.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 m -123.03 173.31 9.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.97 -170.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -110.34 126.81 54.64 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.074 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.42 HG13 HG21 ' A' ' 55' ' ' VAL . 25.6 m -121.9 144.63 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.35 87.05 3.77 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 171.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -70.32 -42.12 72.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.072 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.7 m -144.44 142.43 30.3 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.681 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.08 67.15 Favored 'General case' 0 C--O 1.21 -0.994 0 C-N-CA 122.851 0.46 . . . . 0.0 112.164 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.02 3.79 47.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.917 0.389 . . . . 0.0 110.959 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -123.42 -44.79 2.11 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.27 -153.35 21.73 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -74.43 107.55 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 123.409 0.684 . . . . 0.0 110.722 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG23 HE22 ' A' ' 44' ' ' GLN . 28.3 m -111.83 171.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.773 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.44 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 41.1 ttm180 -82.35 140.81 33.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.05 170.49 16.56 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.894 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 4.4 ptp180 -131.77 129.39 40.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.81 112.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mt -86.09 -47.31 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.289 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 . . . . . 1 N--CA 1.328 -6.527 0 C-N-CA 117.023 -1.871 . . . . 0.0 114.442 -170.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.478 -1.81 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.608 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 60.2 t -114.45 130.33 68.96 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 121.882 0.849 . . . . 0.0 112.672 -170.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 29.7 m -124.89 159.82 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.583 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.644 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 35.4 tt0 -124.88 116.51 22.34 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.9 m -70.68 163.78 26.39 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.44 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 3.8 m-20 -62.96 -15.12 54.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.969 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.427 HE22 HG23 ' A' ' 25' ' ' VAL . 1.7 mp0 -83.88 2.42 38.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.4 10.42 70.86 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.644 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 4.3 mpt_? -91.44 115.99 28.49 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 118.238 1.019 . . . . 0.0 110.29 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.608 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 31.2 tt0 -93.95 108.21 20.04 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -139.45 166.02 25.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.747 0.308 . . . . 0.0 110.633 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -82.06 136.79 35.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.33 -176.27 3.83 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.466 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 55' ' ' VAL . 62.4 mtm180 -146.09 154.55 41.95 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.46 2.6 5.57 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-O 121.666 0.592 . . . . 0.0 113.219 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -92.78 -20.04 21.15 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.81 -4.2 14.04 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.366 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 51' ' ' ARG . 15.3 t -139.23 140.64 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.433 -3.552 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 5.2 mmm180 -134.82 151.01 50.59 Favored 'General case' 1 N--CA 1.362 -4.866 0 O-C-N 125.301 1.626 . . . . 0.0 107.055 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.8 mt -69.19 -170.43 0.26 Allowed 'General case' 0 C--N 1.278 -2.511 0 O-C-N 124.088 0.867 . . . . 0.0 110.498 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.9 pt . . . . . 0 C--N 1.304 -1.395 0 CA-C-O 122.402 1.096 . . . . 0.0 110.336 171.494 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.6 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 23.0 Cg_exo . . . . . 0 N--CA 1.441 -1.576 0 N-CA-C 111.194 -0.349 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.92 -15.32 12.43 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 156.58 38.76 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.34 109.07 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 57' ' ' LEU . 28.3 m -132.54 -179.68 3.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -112.92 122.29 47.2 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.94 132.74 70.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.1 tt -80.12 98.24 7.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.02 -56.21 18.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.549 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 m -151.09 148.25 28.08 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.92 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 86.17 3.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.335 0.588 . . . . 0.0 109.748 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.43 -43.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.56 -47.16 5.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.337 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 103.38 -143.6 15.78 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.144 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -72.83 114.28 10.8 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.339 1.056 . . . . 0.0 111.061 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.83 164.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.454 HH11 ' CG ' ' A' ' 43' ' ' ASP . 42.6 ttm180 -77.06 131.01 38.17 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.31 136.7 33.51 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.365 0.602 . . . . 0.0 111.192 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HE ' HD11 ' A' ' 30' ' ' ILE . 49.2 ttp180 -108.66 123.95 49.76 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.22 125.17 22.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.7 mm -105.07 -35.93 3.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.289 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.451 ' HE ' HG22 ' A' ' 39' ' ' VAL . 2.1 ttp180 . . . . . 1 N--CA 1.354 -5.272 0 CA-C-O 122.043 0.925 . . . . 0.0 111.836 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.224 -0.263 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.451 HG22 ' HE ' ' A' ' 31' ' ' ARG . 69.8 t -99.63 123.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.926 -170.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.97 149.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -132.34 126.95 34.49 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.1 m -67.91 159.78 29.85 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.454 ' CG ' HH11 ' A' ' 26' ' ' ARG . 6.1 p-10 -66.6 -15.54 63.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.167 0.508 . . . . 0.0 111.667 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -78.66 0.54 26.13 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.612 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.21 65.97 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 170.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -91.23 129.14 37.26 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 118.927 1.364 . . . . 0.0 112.519 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -85.81 141.36 29.7 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.03 171.14 17.32 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -97.48 141.73 30.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.804 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.4 140.93 44.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.611 ' O ' HG21 ' A' ' 55' ' ' VAL . 56.2 mtp180 -113.9 145.83 40.92 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.58 -16.16 54.83 Favored Glycine 0 C--O 1.214 -1.116 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.37 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -88.56 -2.29 58.51 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.46 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.1 mt-30 -126.83 14.9 7.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.573 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 51' ' ' ARG . 31.5 t -129.52 139.73 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 121.724 0.773 . . . . 0.0 110.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -137.19 140.77 42.0 Favored 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' H ' HD22 ' A' ' 57' ' ' LEU . 2.3 pt? -75.92 -153.17 0.04 OUTLIER 'General case' 0 C--N 1.261 -3.252 0 CA-C-O 121.778 0.799 . . . . 0.0 111.505 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt . . . . . 0 C--N 1.293 -1.885 0 CA-C-O 122.656 1.217 . . . . 0.0 112.129 177.604 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.0 Cg_exo . . . . . 0 N--CA 1.444 -1.415 0 N-CA-C 110.624 -0.568 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.39 29.35 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -67.43 150.74 48.51 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.324 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.19 98.2 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 122.842 1.306 . . . . 0.0 111.0 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.64 172.8 9.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.531 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 40.5 pttt -108.13 129.28 55.17 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 33.5 m -129.24 140.62 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.282 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.5 tt -101.31 102.9 13.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -72.17 -68.84 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.057 0.932 . . . . 0.0 109.579 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -128.69 153.67 47.08 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.01 -173.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -19.87 65.58 Favored 'General case' 0 C--O 1.209 -1.036 0 C-N-CA 122.856 0.462 . . . . 0.0 112.084 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.88 2.28 51.89 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.84 0.352 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.27 -44.12 1.9 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.968 0.413 . . . . 0.0 110.284 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 85.79 -156.78 30.44 Favored Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -81.12 112.15 18.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.38 164.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -82.15 137.02 35.06 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.0 146.27 48.89 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' NH1' ' HA ' ' A' ' 43' ' ' ASP . 15.9 mtm180 -113.77 123.59 50.22 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.22 118.31 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.605 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 53.2 mt -85.91 -44.23 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.547 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.025 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 5.4 ptp85 . . . . . 1 N--CA 1.347 -5.592 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.186 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.413 -2.293 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.468 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 74.2 t -91.74 123.92 44.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.525 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.2 150.58 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.475 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -129.17 128.98 44.49 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.3 t -74.78 165.24 25.56 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 10.4 m-20 -65.6 -15.68 62.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -78.8 -2.08 37.85 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.981 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.47 73.17 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.801 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -81.78 104.01 11.86 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.605 0.762 . . . . 0.0 110.604 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -86.89 137.62 32.24 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.97 -177.97 7.02 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.439 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -101.87 119.17 38.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.16 169.85 9.95 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.568 ' O ' HG21 ' A' ' 55' ' ' VAL . 74.3 mtm180 -139.77 158.58 43.86 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.23 0.54 6.17 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.17 -8.46 22.2 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.676 0.751 . . . . 0.0 109.074 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.2 mt-30 -119.61 6.6 11.03 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.703 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.568 HG21 ' O ' ' A' ' 51' ' ' ARG . 23.1 t -127.43 134.99 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.997 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 -174.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 27.4 mmm180 -137.77 136.96 37.77 Favored 'General case' 0 N--CA 1.383 -3.791 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.422 ' H ' HD22 ' A' ' 57' ' ' LEU . 2.5 pt? -72.48 -175.54 1.64 Allowed 'General case' 0 C--N 1.28 -2.453 0 O-C-N 123.537 0.523 . . . . 0.0 110.524 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--N 1.325 -0.475 0 C-N-CA 124.244 1.018 . . . . 0.0 111.121 174.56 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.645 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 33.4 Cg_exo . . . . . 0 C--O 1.244 0.783 0 CA-C-O 122.536 0.974 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' NE ' ' A' ' 28' ' ' ARG . . . -178.97 -22.32 0.03 OUTLIER Glycine 0 C--N 1.267 -3.256 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.427 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.88 123.55 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.63 123.55 52.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.1 169.32 6.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.927 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 58' ' ' ILE . 31.8 mttm -98.15 129.29 44.94 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 23.4 t -127.38 126.23 67.22 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.21 102.34 15.0 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.56 -59.46 2.7 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.88 0.847 . . . . 0.0 109.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -124.37 154.24 40.65 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.617 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.01 -21.13 63.23 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.89 -18.77 33.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.657 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.99 -36.95 9.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.073 0.463 . . . . 0.0 110.753 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.09 -162.17 40.31 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -74.51 112.99 11.25 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.341 0.591 . . . . 0.0 110.494 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.83 146.22 18.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.549 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -78.64 127.28 31.89 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-O 121.282 0.563 . . . . 0.0 110.009 -178.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.72 159.41 41.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.557 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' NE ' ' HA2' ' A' ' 11' ' ' GLY . 61.1 ttt180 -119.06 135.98 54.36 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 51.7 t -63.98 112.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 171.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.645 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.4 mm -97.22 -34.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 . . . . . 1 N--CA 1.344 -5.736 0 CA-C-O 121.81 0.814 . . . . 0.0 110.141 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.517 -0.325 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG13 ' HB ' ' A' ' 30' ' ' ILE . 2.7 t -94.48 132.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -164.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.96 140.47 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -124.88 125.47 44.01 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 m -87.04 173.83 9.05 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.78 -44.06 1.53 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.945 2.098 . . . . 0.0 115.647 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.35 -6.06 43.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.87 10.93 62.35 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.131 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.28 102.05 6.53 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.486 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 22.2 tt0 -84.77 115.19 22.58 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.338 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.74 170.47 15.93 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.878 -0.514 . . . . 0.0 111.527 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.0 m -86.33 137.68 32.4 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.145 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.81 163.37 12.77 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.845 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -140.94 153.74 45.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.95 -17.61 51.79 Favored Glycine 0 N--CA 1.477 1.431 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -87.23 -10.18 53.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.342 0.592 . . . . 0.0 110.219 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.1 mt-30 -110.83 5.99 21.03 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.912 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.2 129.88 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.545 -171.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -132.38 119.07 20.2 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.1 pt? -92.89 88.54 6.22 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 122.003 0.906 . . . . 0.0 112.828 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.487 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 4.4 pt . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.618 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 21.3 Cg_exo . . . . . 0 N--CA 1.44 -1.659 0 CA-C-O 121.423 0.51 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.79 -17.35 10.95 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.319 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 33.4 t0 -63.52 158.85 19.96 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.761 0.825 . . . . 0.0 111.712 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -116.31 107.58 22.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.176 0.59 . . . . 0.0 109.58 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.6 175.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -126.28 139.8 53.03 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 57.7 t -131.17 133.85 62.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.92 -66.29 0.57 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.96 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.8 m -126.63 146.15 50.29 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.898 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -21.43 66.45 Favored 'General case' 0 C--O 1.21 -0.998 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.27 48.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.859 0.362 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.68 -46.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 0.0 109.803 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.29 -158.15 23.59 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.311 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -78.85 112.21 15.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.1 0.56 . . . . 0.0 110.677 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.16 149.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -97.88 123.8 42.02 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.048 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.16 169.22 17.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.156 0.979 . . . . 0.0 113.614 -168.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 22.1 mmt180 -112.6 132.88 54.93 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.903 -1.499 . . . . 0.0 107.438 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 65.9 t -67.56 114.15 4.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 173.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.618 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 44.4 mm -87.17 -40.63 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.596 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.502 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.421 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 1.4 ptp180 . . . . . 1 N--CA 1.338 -6.036 0 CA-C-O 121.984 0.897 . . . . 0.0 110.563 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 49' ' ' THR . 31.0 m . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 11.4 m -126.1 144.42 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.229 1.014 . . . . 0.0 113.523 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.93 141.11 47.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.247 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 34.7 tt0 -106.06 116.97 32.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 8.3 t -80.33 172.16 14.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.134 -175.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -44.39 -37.24 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 127.051 2.14 . . . . 0.0 112.55 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -76.81 0.97 18.74 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.27 -3.77 83.47 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 122.103 0.835 . . . . 0.0 112.125 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -77.61 107.72 10.29 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 124.135 0.974 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.7 tt0 -84.92 114.9 22.47 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -131.58 167.76 18.86 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.428 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.4 t -102.38 145.95 28.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.377 -175.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.85 156.11 48.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.461 -0.896 . . . . 0.0 113.028 -172.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 157.53 16.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.45 -23.26 62.34 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.134 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.79 1.09 54.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.155 0.502 . . . . 0.0 111.107 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.5 mt-30 -104.8 -2.75 24.4 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.37 138.18 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.434 0.635 . . . . 0.0 110.648 -170.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -137.73 126.23 23.51 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.571 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.471 ' H ' HD21 ' A' ' 57' ' ' LEU . 2.5 pt? -94.9 141.39 28.7 Favored 'General case' 0 C--N 1.262 -3.203 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.4 mt . . . . . 0 CA--C 1.547 0.864 0 O-C-N 124.163 0.915 . . . . 0.0 109.117 -174.007 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 CA-C-O 120.944 0.31 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -2.84 56.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -83.82 154.95 23.22 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 122.667 0.387 . . . . 0.0 111.089 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.1 112.7 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 CA-C-O 122.111 0.958 . . . . 0.0 108.631 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 57' ' ' LEU . 35.5 m -128.55 176.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.666 0.745 . . . . 0.0 111.819 -171.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -115.01 129.73 56.78 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 66.5 t -129.44 130.97 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.84 90.61 8.37 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.96 -54.51 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.526 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.1 m -144.22 149.25 36.06 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.477 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.48 -17.44 64.8 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.97 5.46 46.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.88 0.371 . . . . 0.0 110.673 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -130.97 -47.69 1.02 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.177 0.513 . . . . 0.0 109.887 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.84 -156.66 19.72 Favored Glycine 0 N--CA 1.428 -1.85 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.089 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 91.7 m95 -74.03 112.69 10.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.449 0.7 . . . . 0.0 110.765 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.28 152.14 8.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -71.13 131.49 43.65 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' HA ' HH21 ' A' ' 28' ' ' ARG . . . -140.31 169.27 17.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.477 HH22 ' CG ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -128.9 134.12 48.15 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.6 t -75.02 115.82 16.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.8 -43.79 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 . . . . . 1 N--CA 1.347 -5.582 0 CA-C-O 121.868 0.842 . . . . 0.0 110.167 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.499 -1.007 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -103.76 116.1 46.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.732 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 29' ' ' VAL . 31.2 m -127.85 148.76 32.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.027 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 34.4 tt0 -118.38 131.0 56.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.0 t -89.62 174.98 7.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.477 ' CG ' HH22 ' A' ' 28' ' ' ARG . 15.2 m-20 -72.19 -10.08 59.3 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.144 0.973 . . . . 0.0 109.779 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.66 2.43 48.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.074 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.59 0.79 85.32 Favored Glycine 0 CA--C 1.506 -0.474 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.719 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -80.89 111.83 17.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 118.149 0.974 . . . . 0.0 110.973 177.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 36.3 tt0 -96.36 114.22 25.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -139.22 161.81 36.51 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.179 0.514 . . . . 0.0 111.876 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.3 t -91.54 106.27 18.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.422 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.64 161.69 14.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.243 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -80.3 153.11 28.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.19 6.85 6.64 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.148 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.81 -21.94 15.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 46.5 mt-30 -90.8 -12.64 35.8 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.188 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 16' ' ' VAL . 19.1 t -115.88 125.73 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.88 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.564 ' HG3' ' CH2' ' A' ' 24' ' ' TRP . 6.4 mmp_? -133.37 140.84 47.6 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.463 ' HA ' HG11 ' A' ' 14' ' ' VAL . 2.5 pt? -61.34 176.6 0.45 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 124.371 1.044 . . . . 0.0 111.17 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.3 pt . . . . . 0 C--N 1.316 -0.873 0 CA-C-O 122.121 0.962 . . . . 0.0 113.53 177.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.439 -1.691 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.94 1.39 31.91 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.22 153.56 38.01 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.431 0.692 . . . . 0.0 110.22 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 107.25 22.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -133.0 -179.94 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 122.159 0.981 . . . . 0.0 112.42 -168.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 47.8 pttt -123.4 136.25 54.53 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.5 t -125.96 127.19 70.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.117 0.484 . . . . 0.0 110.112 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.406 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.5 tp -85.39 86.73 7.35 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.46 -58.54 4.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.257 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.3 t -129.81 156.4 44.4 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.312 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.61 -13.1 30.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.088 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -107.45 -38.78 5.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 85.35 -172.86 47.56 Favored Glycine 0 N--CA 1.424 -2.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.361 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . 0.416 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 93.0 m95 -62.23 106.9 0.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.45 1.1 . . . . 0.0 111.896 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -99.18 146.63 8.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 32.2 ttm180 -67.65 137.69 55.79 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.19 172.27 16.09 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -136.22 127.68 28.58 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.86 120.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.52 -42.8 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.439 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER . . . . . 1 N--CA 1.343 -5.792 0 CA-C-O 122.564 1.174 . . . . 0.0 111.083 -174.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 33.4 t -103.88 126.24 58.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.398 -172.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.4 146.81 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 32.3 tt0 -114.66 125.58 53.91 Favored 'General case' 0 C--N 1.254 -3.566 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -69.96 166.06 20.42 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 16.9 t70 -57.64 -30.88 65.74 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.854 0.862 . . . . 0.0 111.377 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.03 -5.31 30.29 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.754 1.622 . . . . 0.0 112.484 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.86 68.33 Favored Glycine 0 C--O 1.224 -0.519 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.093 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -82.84 110.35 17.78 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 122.654 0.381 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.0 tt0 -90.34 135.96 33.35 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.733 0.813 . . . . 0.0 109.412 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.57 -175.88 5.38 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -122.18 143.97 49.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.4 -178.14 6.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' ASN . 14.7 mtm180 -106.51 165.83 11.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.484 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.67 28.58 1.81 Allowed Glycine 0 N--CA 1.472 1.08 0 CA-C-O 121.789 0.66 . . . . 0.0 112.545 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.7 m120 -117.17 -16.09 10.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.1 mt-30 -104.56 -2.15 25.55 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.879 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 6.4 t -118.0 140.58 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 11.8 mmm180 -150.43 141.69 23.23 Favored 'General case' 0 N--CA 1.403 -2.781 0 O-C-N 124.672 1.233 . . . . 0.0 110.15 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 97.0 mt -56.84 169.78 0.48 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 124.974 1.421 . . . . 0.0 110.434 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 pt . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 122.153 0.978 . . . . 0.0 111.929 176.053 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.652 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.4 Cg_exo . . . . . 0 N--CA 1.457 -0.652 0 CA-C-O 120.854 0.272 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.71 5.28 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.29 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.5 148.9 44.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.648 0.261 . . . . 0.0 111.35 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.62 116.36 52.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.64 166.68 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 112.598 -169.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -110.95 125.56 53.82 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 168.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.34 133.4 60.14 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.999 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.79 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -82.53 90.79 6.8 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.28 -50.64 67.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.791 -2.004 . . . . 0.0 111.733 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -147.18 144.96 29.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.42 66.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.56 8.07 35.94 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.835 0.35 . . . . 0.0 111.227 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -128.61 -44.77 1.35 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.225 0.535 . . . . 0.0 109.82 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 96.05 -153.69 20.63 Favored Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.01 113.02 9.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.74 0.816 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.6 161.07 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -80.02 131.2 35.74 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.98 173.52 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.152 0.501 . . . . 0.0 110.297 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.14 134.51 36.45 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.24 118.08 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 19.8 mt -107.95 -33.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.079 -172.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 . . . . . 1 N--CA 1.343 -5.788 0 CA-C-O 122.498 1.142 . . . . 0.0 112.443 -170.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t . . . . . 0 CA--C 1.493 -1.248 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG11 ' HG3' ' A' ' 47' ' ' GLU . 16.5 t -106.37 125.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.048 0 CA-C-O 121.723 0.773 . . . . 0.0 113.03 -174.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.62 141.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.44 HE21 ' HA2' ' A' ' 45' ' ' GLY . 53.8 tt0 -125.49 126.76 45.4 Favored 'General case' 0 C--N 1.26 -3.29 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 t -78.67 168.34 19.9 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.85 -4.5 35.22 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.557 0.694 . . . . 0.0 111.37 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -72.81 -17.12 61.59 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.643 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA2' HE21 ' A' ' 41' ' ' GLN . . . 92.55 9.87 61.05 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.749 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.6 104.55 16.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HG3' HG11 ' A' ' 39' ' ' VAL . 21.7 tt0 -80.51 118.53 22.19 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.55 175.42 9.6 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.785 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.9 m -100.08 119.32 38.12 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.97 136.61 48.97 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.334 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 53' ' ' ASN . 51.8 mtp180 -90.79 154.03 19.81 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.65 29.19 0.88 Allowed Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.075 0.819 . . . . 0.0 112.744 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.8 m120 -125.08 -8.55 7.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -116.81 -1.55 12.02 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.133 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 51' ' ' ARG . 22.3 t -124.16 136.21 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 CA-C-O 121.237 0.541 . . . . 0.0 109.864 -171.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -139.14 134.94 33.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.58 -173.02 0.86 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.555 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 C--N 1.307 -1.278 0 CA-C-O 121.893 0.854 . . . . 0.0 113.126 178.355 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 4.3 Cg_exo . . . . . 0 N--CA 1.444 -1.413 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.7 4.55 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.676 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 20.9 m-20 -60.03 125.16 22.57 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.15 103.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 30.1 m -131.32 176.88 7.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.797 -173.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -105.39 123.73 48.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.142 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.79 134.36 66.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -85.9 100.11 11.87 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -73.38 -66.03 0.74 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.6 m -121.41 140.3 52.32 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.219 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.67 66.4 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.33 2.73 53.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -124.74 -44.25 1.96 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 0.0 109.989 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 -151.35 20.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -73.38 108.27 6.15 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.663 0.785 . . . . 0.0 110.761 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.0 m -110.71 165.26 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.649 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -82.02 124.29 29.66 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.25 162.83 34.54 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.546 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 1.6 mpp_? -123.92 136.96 54.67 Favored 'General case' 0 CA--C 1.476 -1.88 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.028 176.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.49 115.08 10.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 57.5 mt -82.94 -41.03 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.384 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.8 ptp85 . . . . . 1 N--CA 1.345 -5.679 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.874 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.424 -1.767 0 CA-C-O 122.048 0.928 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.467 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 88.1 t -92.25 128.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.217 -171.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.29 154.88 31.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -132.89 126.6 32.51 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -71.71 162.16 29.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 124.2 0.937 . . . . 0.0 109.632 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.92 -15.56 13.43 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.66 13.37 10.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.335 -0.228 . . . . 0.0 110.903 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.34 35.78 77.1 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-O 121.373 0.429 . . . . 0.0 113.107 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -113.94 109.22 18.15 Favored 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 122.851 0.46 . . . . 0.0 110.154 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -84.23 140.63 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -154.92 168.78 25.81 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -97.54 125.35 42.19 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.68 167.07 10.03 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.755 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -122.1 153.78 38.23 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.39 -20.24 43.85 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.194 0.838 . . . . 0.0 115.194 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.65 -7.36 52.87 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.027 -0.69 . . . . 0.0 110.939 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -104.6 1.21 29.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.37 133.41 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.914 0 CA-C-O 121.575 0.702 . . . . 0.0 109.403 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 21.5 mmm180 -137.87 135.12 35.86 Favored 'General case' 1 N--CA 1.379 -4.003 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.808 177.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.42 ' H ' HD21 ' A' ' 57' ' ' LEU . 2.5 pt? -70.16 -175.89 1.06 Allowed 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.44 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt . . . . . 0 C--N 1.31 -1.11 0 CA-C-O 122.524 1.154 . . . . 0.0 112.394 175.276 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 6.4 Cg_exo . . . . . 0 N--CA 1.44 -1.626 0 CA-C-O 121.754 0.647 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.68 -16.56 2.64 Favored Glycine 0 N--CA 1.424 -2.138 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.144 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.4 159.23 34.56 Favored 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.235 0.609 . . . . 0.0 109.442 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.97 113.48 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.83 169.18 22.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.611 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -103.18 124.04 47.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 38.3 t -123.38 129.13 74.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -91.39 106.15 18.29 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.99 -69.97 0.41 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.226 1.012 . . . . 0.0 109.324 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.4 m -124.38 147.84 47.96 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 113.789 -1.551 . . . . 0.0 108.991 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.0 -23.36 66.38 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.5 -1.58 57.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.8 0.334 . . . . 0.0 111.518 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.37 -42.0 2.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.282 0.563 . . . . 0.0 109.658 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 -156.72 28.04 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -75.47 109.15 8.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.068 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -107.43 145.24 15.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -84.42 124.91 31.83 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -177.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.16 151.9 51.1 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.359 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -106.64 131.25 54.0 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t -68.41 113.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.0 mt -91.26 -40.58 12.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 121.537 0.684 . . . . 0.0 109.886 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 . . . . . 1 N--CA 1.368 -4.563 0 CA-C-O 122.14 0.972 . . . . 0.0 110.341 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.7 t -109.58 131.47 60.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -166.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.64 149.22 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 113.014 -1.903 . . . . 0.0 106.073 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.24 123.4 38.05 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 m -76.75 168.74 19.57 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.081 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -58.95 -17.41 24.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.831 1.652 . . . . 0.0 111.514 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -83.33 7.72 15.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.394 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.22 42.22 99.72 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -124.09 104.75 9.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.746 -171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -82.67 132.08 35.19 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -151.87 175.6 12.3 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 121.32 -0.152 . . . . 0.0 110.614 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 11.7 t -91.62 143.76 26.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . . . -118.7 146.84 44.41 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.298 0.571 . . . . 0.0 111.192 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.8 mtp-105 -125.24 150.58 46.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.48 -19.47 41.26 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 115.038 0.775 . . . . 0.0 115.038 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.53 -12.6 53.87 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.487 0.66 . . . . 0.0 110.146 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 37.8 mt-30 -114.65 0.18 13.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.092 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 t -127.12 124.52 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.566 0 CA-C-O 121.925 0.869 . . . . 0.0 111.114 -174.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 15.9 mmm180 -132.29 137.11 47.35 Favored 'General case' 1 N--CA 1.368 -4.561 0 CA-C-N 113.831 -1.531 . . . . 0.0 106.935 177.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.0 168.15 0.7 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.548 0.53 . . . . 0.0 111.826 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.443 -0.789 0 CA-C-O 121.601 0.715 . . . . 0.0 110.334 -179.198 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.446 -1.284 0 CA-C-O 121.977 0.741 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.15 -19.0 0.83 Allowed Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.311 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.35 129.22 39.08 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -84.54 114.27 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 57' ' ' LEU . 34.9 m -125.29 173.44 11.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.298 -169.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -119.38 129.1 54.64 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.444 HG11 HG23 ' A' ' 40' ' ' VAL . 30.8 m -123.97 127.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.527 0.679 . . . . 0.0 112.187 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.59 86.97 6.17 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.64 -57.15 6.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.2 t -125.62 153.44 43.76 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.81 60.9 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.41 -15.13 33.92 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -104.99 -40.06 6.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.286 0.565 . . . . 0.0 110.215 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.48 -175.87 46.11 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.29 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -62.39 108.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.176 0.991 . . . . 0.0 111.571 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 m -101.86 148.09 7.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -75.78 140.1 42.17 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -155.9 177.18 11.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -134.22 139.73 46.0 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.44 122.45 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.59 -44.43 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.678 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.483 HH21 ' CD ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER . . . . . 1 N--CA 1.342 -5.872 0 CA-C-O 122.194 0.997 . . . . 0.0 111.325 -175.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 49' ' ' THR . 2.4 m . . . . . 0 CA--C 1.493 -1.222 0 CA-C-O 121.259 0.552 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.446 HG13 ' CG ' ' A' ' 47' ' ' GLU . 2.3 t -107.19 124.01 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 33.7 m -129.07 152.65 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.73 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 18.9 tt0 -116.84 122.38 44.21 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 23.2 t -82.93 173.18 12.04 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 123.648 0.592 . . . . 0.0 109.637 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.03 -9.15 3.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.573 1.149 . . . . 0.0 113.312 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.746 ' N ' HE21 ' A' ' 44' ' ' GLN . 0.0 OUTLIER -91.58 5.68 48.66 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.89 19.56 79.87 Favored Glycine 0 C--O 1.216 -0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.339 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -108.44 118.32 36.47 Favored 'General case' 0 N--CA 1.403 -2.808 0 O-C-N 122.406 -0.467 . . . . 0.0 111.264 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.483 ' CD ' HH21 ' A' ' 31' ' ' ARG . 57.5 tt0 -88.6 133.8 34.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.6 174.28 14.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 38' ' ' VAL . 88.7 m -116.55 135.47 53.79 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.754 0.312 . . . . 0.0 111.149 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.73 174.48 7.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -82.83 156.66 23.51 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.15 -20.84 51.61 Favored Glycine 0 C--O 1.212 -1.241 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.56 -15.35 46.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.254 0.55 . . . . 0.0 110.343 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.0 -6.47 51.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.814 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 22.9 t -120.94 121.4 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 8.6 mmm180 -133.54 135.34 44.3 Favored 'General case' 1 N--CA 1.378 -4.031 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.23 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HA ' HG13 ' A' ' 14' ' ' VAL . 1.9 pp -56.11 161.93 2.18 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.729 0.643 . . . . 0.0 110.915 170.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.266 38.3 pt . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 11.2 Cg_exo . . . . . 0 N--CA 1.452 -0.968 0 N-CA-C 110.427 -0.644 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.41 9.24 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.36 159.66 32.09 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.802 0.441 . . . . 0.0 111.22 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.52 115.04 46.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 57' ' ' LEU . 27.5 m -130.46 177.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.432 0.634 . . . . 0.0 111.598 -173.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -110.85 124.75 52.66 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.5 t -129.69 133.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.58 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.41 91.22 8.71 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.08 -49.36 72.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.473 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 m -146.05 145.85 30.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.743 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.63 -22.41 66.88 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.66 5.02 45.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 -43.3 1.51 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.167 0.508 . . . . 0.0 109.79 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 -156.55 22.06 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.363 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.8 110.66 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.619 0.768 . . . . 0.0 110.322 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.41 167.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.443 ' HD2' ' CG ' ' A' ' 43' ' ' ASP . 35.5 ttm180 -73.82 129.78 38.6 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 166.84 22.52 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -127.0 140.65 52.15 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.0 t -82.04 109.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mp -90.19 -36.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.338 0.589 . . . . 0.0 110.346 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.45 ' NH2' HG11 ' A' ' 39' ' ' VAL . 2.0 ttp-105 . . . . . 1 N--CA 1.336 -6.164 0 CA-C-O 122.714 1.245 . . . . 0.0 111.683 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 HG11 ' NH2' ' A' ' 31' ' ' ARG . 25.6 t -114.43 123.55 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.29 155.83 40.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -171.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 51.6 tt0 -121.09 121.13 37.22 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.8 m -57.68 146.61 30.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.443 ' CG ' ' HD2' ' A' ' 26' ' ' ARG . 24.3 t70 -60.26 -18.95 52.54 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.959 0.885 . . . . 0.0 111.217 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -82.47 -2.32 52.94 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.1 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.75 -16.12 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -79.83 112.04 16.73 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.117 1.458 . . . . 0.0 113.756 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 25.6 tt0 -89.55 128.41 36.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.7 170.4 22.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -107.21 136.41 47.08 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.68 172.76 12.12 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -87.23 165.64 15.53 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.1 2.56 42.85 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-O 122.039 0.8 . . . . 0.0 111.55 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -90.97 -27.09 18.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.0 mt-30 -96.88 -14.79 21.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.56 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 29.7 t -122.16 122.28 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 28.1 mmm180 -130.54 133.74 46.47 Favored 'General case' 1 N--CA 1.377 -4.09 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.44 ' HA ' HG11 ' A' ' 14' ' ' VAL . 2.0 pp -62.61 176.35 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 123.837 0.71 . . . . 0.0 112.488 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 pt . . . . . 0 C--N 1.317 -0.814 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.581 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 38.3 Cg_exo . . . . . 0 N--CA 1.453 -0.909 0 CA-C-O 121.104 0.376 . . . . 0.0 111.471 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.61 -12.86 15.47 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.701 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -71.53 155.77 40.19 Favored 'General case' 0 C--O 1.25 1.103 0 C-N-CA 122.726 0.41 . . . . 0.0 111.102 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -112.62 107.71 23.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.9 m -125.5 171.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.913 0.864 . . . . 0.0 111.68 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -123.02 127.38 48.71 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -123.26 129.9 74.6 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.2 tt -85.09 100.7 11.88 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.6 -66.28 0.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.257 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.8 m -140.3 149.59 42.97 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.839 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.62 84.98 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.325 0.584 . . . . 0.0 109.806 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 177.12 -41.3 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 126.034 1.734 . . . . 0.0 106.351 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.7 -43.48 8.24 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.56 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 89.52 -151.27 21.76 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.648 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -75.99 106.21 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.442 0.697 . . . . 0.0 110.907 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.75 145.07 12.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -71.93 136.67 46.93 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -145.62 165.44 28.7 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -123.11 130.94 53.44 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.5 t -70.21 113.97 7.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 50.9 mm -91.43 -39.27 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.581 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 . . . . . 1 N--CA 1.342 -5.842 0 CA-C-O 122.603 1.192 . . . . 0.0 113.013 -176.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.427 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.471 HG11 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -136.11 128.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.014 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 29' ' ' VAL . 32.9 m -126.3 143.15 40.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 24.8 tt0 -107.24 126.92 53.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.5 t -92.29 175.68 6.76 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.56 -13.95 55.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.82 0.848 . . . . 0.0 111.63 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.44 -0.72 26.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.557 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.66 20.37 77.26 Favored Glycine 0 C--O 1.22 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.549 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -112.15 118.69 36.06 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HG2' HG11 ' A' ' 39' ' ' VAL . 22.1 tt0 -87.12 122.06 30.41 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.9 170.03 16.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.875 0.369 . . . . 0.0 111.495 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -85.99 134.64 33.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.154 0.502 . . . . 0.0 109.697 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.72 159.32 22.44 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.515 ' HD2' ' OE1' ' A' ' 54' ' ' GLN . 60.5 mtt180 -114.05 141.74 47.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.53 34.25 Favored Glycine 0 N--CA 1.474 1.173 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -85.73 1.62 48.73 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.75 0.786 . . . . 0.0 112.291 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.515 ' OE1' ' HD2' ' A' ' 51' ' ' ARG . 24.7 mt-30 -115.16 9.13 15.78 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.302 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.2 t -124.38 137.37 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.121 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.36 139.12 35.31 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.434 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.5 pt? -71.92 -161.22 0.07 Allowed 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 173.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 122.626 1.203 . . . . 0.0 112.086 171.788 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.522 ' H1 ' ' CD ' ' A' ' 59' ' ' GLU . 26.4 m . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -164.29 165.65 21.63 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.33 -66.76 0.88 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.8 mtt -136.64 -3.08 2.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.72 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 1.5 mp0 -55.35 133.13 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.256 1.422 . . . . 0.0 112.07 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -95.16 94.44 7.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.258 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -115.85 19.13 15.34 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 124.119 1.914 . . . . 0.0 106.819 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.96 119.01 18.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.506 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.35 155.14 47.39 Favored Pre-proline 0 C--N 1.287 -2.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.644 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 10.3 Cg_exo -63.66 124.45 13.71 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.001 1.801 . . . . 0.0 111.399 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.63 -8.59 22.02 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -72.4 155.75 39.8 Favored 'General case' 0 C--O 1.259 1.555 0 C-N-CA 123.124 0.57 . . . . 0.0 111.478 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.39 100.66 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.092 1.357 . . . . 0.0 110.212 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.28 169.22 21.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.946 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -100.48 128.89 46.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.8 m -128.58 141.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.0 93.56 9.39 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 38.0 tt0 -65.18 -53.6 42.41 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.942 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.9 m -148.84 149.29 31.05 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.27 -26.8 66.75 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 7.09 36.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 0.0 111.511 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.73 -44.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.0 110.142 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.44 -152.7 21.32 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.097 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.82 109.11 7.07 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 123.57 0.748 . . . . 0.0 111.062 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.69 176.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? -105.82 126.0 51.66 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.501 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.06 178.81 5.33 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.695 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -133.55 131.29 39.56 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 48.5 t -79.16 120.21 29.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.644 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.7 mp -95.43 -38.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.122 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HG3' ' N ' ' A' ' 32' ' ' VAL 0.276 9.5 tpp180 -163.83 162.34 23.65 Favored 'General case' 0 N--CA 1.392 -3.339 0 CA-C-O 121.629 0.728 . . . . 0.0 110.394 -174.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' N ' ' HG3' ' A' ' 31' ' ' ARG . 60.2 t -110.88 118.43 57.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 167.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.609 ' HD2' ' CG2' ' A' ' 39' ' ' VAL 0.257 34.1 tttt -103.01 -149.54 0.4 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 124.341 1.056 . . . . 0.0 109.687 -170.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 m -50.29 99.9 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 125.145 1.378 . . . . 0.0 114.533 -173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.59 -78.11 1.52 Allowed Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.951 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.41 29.71 1.89 Allowed Glycine 0 C--N 1.302 -1.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 1.5 tmt_? -91.09 97.46 11.17 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-O 122.891 1.329 . . . . 0.0 108.024 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.9 t -79.98 132.84 30.95 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.179 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.241 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.609 ' CG2' ' HD2' ' A' ' 33' ' ' LYS . 76.7 t -101.89 118.05 48.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.12 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.94 152.91 38.35 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 172.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -137.0 130.56 31.63 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -84.43 170.97 13.0 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -74.03 -4.14 33.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -10.15 59.39 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.53 -5.42 70.36 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.132 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.475 ' HD3' ' OE2' ' A' ' 18' ' ' GLU . 13.6 ptm180 -78.26 125.45 29.37 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 117.281 0.541 . . . . 0.0 111.262 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' CG ' HG11 ' A' ' 39' ' ' VAL . 8.6 tt0 -88.32 146.61 25.21 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.402 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 18.7 p90 -153.76 164.67 37.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 120.843 0.354 . . . . 0.0 110.589 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.9 t -86.9 116.25 24.84 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.213 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . . . -95.59 160.37 14.54 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.47 ' HD3' ' OE1' ' A' ' 54' ' ' GLN . 5.7 mpt_? -136.8 162.42 33.27 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.89 -3.87 38.02 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 121.343 -0.456 . . . . 0.0 113.757 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -96.77 -9.68 28.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.408 0.623 . . . . 0.0 109.63 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.481 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.9 mt-30 -113.73 -2.32 13.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.922 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 50' ' ' ALA . 35.1 t -130.79 135.36 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.962 -172.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -137.39 124.0 21.0 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.207 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.438 ' H ' HD21 ' A' ' 57' ' ' LEU . 1.8 pt? -101.85 115.15 29.91 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.292 35.3 pt 33.46 66.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.522 ' CD ' ' H1 ' ' A' ' 1' ' ' SER . 40.0 tt0 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.072 1.749 . . . . 0.0 106.373 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.583 ' H3 ' ' CG ' ' A' ' 7' ' ' ASP . 46.1 t . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -111.65 -4.82 14.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -170.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.5 -67.78 0.9 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.82 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.469 ' HG3' ' HG3' ' A' ' 5' ' ' GLU . 24.1 ptt? -168.46 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.469 ' HG3' ' HG3' ' A' ' 4' ' ' MET 0.294 0.0 OUTLIER -132.89 -114.39 0.22 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.44 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.23 41.36 1.57 Allowed 'General case' 0 C--N 1.255 -3.54 0 C-N-CA 125.34 1.456 . . . . 0.0 111.007 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' CG ' ' H3 ' ' A' ' 1' ' ' SER . 1.4 p30 -62.09 38.42 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 C-N-CA 128.347 2.659 . . . . 0.0 115.368 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.5 143.95 32.94 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -117.21 152.2 48.75 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 118.91 0.777 . . . . 0.0 111.338 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -73.38 131.55 16.5 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.179 1.92 . . . . 0.0 110.974 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.36 -9.99 39.03 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -73.32 159.03 33.99 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.87 95.37 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.89 178.33 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.468 -169.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.402 ' HZ1' ' C ' ' A' ' 59' ' ' GLU . 37.0 pttt -113.66 126.63 55.47 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 84.7 t -127.17 133.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.8 tt -84.89 91.85 8.13 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.02 -50.49 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.556 -1.657 . . . . 0.0 109.926 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 t -132.96 149.88 52.2 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -18.39 62.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.005 0.431 . . . . 0.0 110.145 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.34 -16.09 29.86 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -104.14 -33.21 8.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.0 110.841 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 86.1 -158.12 31.35 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -73.31 104.49 4.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.618 0.767 . . . . 0.0 110.532 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.66 163.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.633 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 34.6 ttm180 -79.82 126.46 31.0 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -133.31 160.77 36.34 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.563 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -125.68 124.46 41.18 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.8 t -70.94 118.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -90.37 -42.67 14.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.416 ' HB3' ' HB ' ' A' ' 39' ' ' VAL . 14.7 tpp180 -156.29 154.11 30.14 Favored 'General case' 1 N--CA 1.378 -4.041 0 CA-C-O 121.537 0.684 . . . . 0.0 109.655 -178.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.28 132.21 62.78 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 37' ' ' ARG 0.34 26.6 tttp -127.77 -170.06 2.17 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -112.7 178.67 4.21 Favored 'General case' 1 N--CA 1.376 -4.13 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.518 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 17.36 76.41 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.69 24.46 75.41 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.68 ' NH1' ' HA ' ' A' ' 39' ' ' VAL . 1.1 tmt_? -95.48 111.64 23.5 Favored 'General case' 0 CA--C 1.456 -2.643 0 CA-C-O 122.726 1.25 . . . . 0.0 108.994 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.23 129.33 61.19 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.63 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.68 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 49.1 t -98.41 111.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.986 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.2 m -135.02 147.1 29.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -129.3 121.47 27.58 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 67.6 m -65.59 157.14 30.6 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.954 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.633 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 45.6 m-20 -65.32 2.88 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.498 0.666 . . . . 0.0 112.62 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 42' ' ' SER . 41.9 mt-30 -87.12 -5.81 58.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.81 9.32 78.13 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 121.8 0.666 . . . . 0.0 111.479 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 27.5 mtp85 -95.28 111.81 23.61 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 123.823 0.849 . . . . 0.0 110.522 -177.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -94.95 153.27 17.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -170.9 144.86 2.27 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 123.795 0.684 . . . . 0.0 110.801 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -74.33 95.63 2.71 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.909 0.861 . . . . 0.0 111.535 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.94 159.13 19.12 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -107.02 160.61 15.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.82 2.33 12.83 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -102.69 -9.46 20.03 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.566 0.698 . . . . 0.0 109.14 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.413 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.7 mt-30 -100.5 -4.22 29.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.97 133.4 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -137.32 139.91 41.16 Favored 'General case' 0 N--CA 1.391 -3.421 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.85 -171.86 0.24 Allowed 'General case' 0 C--N 1.291 -1.939 0 O-C-N 123.493 0.496 . . . . 0.0 110.489 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.4 pt -73.75 76.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 122.547 1.165 . . . . 0.0 111.714 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' C ' ' HZ1' ' A' ' 15' ' ' LYS . 11.6 pt-20 . . . . . 0 C--N 1.29 -1.982 0 CA-C-N 113.199 -1.819 . . . . 0.0 107.012 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -82.75 148.35 27.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.531 0.682 . . . . 0.0 111.475 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.19 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 127.285 2.234 . . . . 0.0 105.133 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.29 31.4 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.214 -1.812 . . . . 0.0 107.207 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -87.94 157.3 18.98 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.71 148.31 52.48 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.96 12.9 20.22 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 122.461 1.124 . . . . 0.0 108.86 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.6 143.77 38.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.947 -1.933 . . . . 0.0 106.178 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.652 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 28.7 mm-40 -115.78 165.06 15.47 Favored Pre-proline 0 C--N 1.3 -1.556 0 CA-C-N 118.054 0.388 . . . . 0.0 111.828 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -78.86 120.76 4.78 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.38 1.386 . . . . 0.0 110.828 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.58 6.4 35.54 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.652 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 2.7 t0 -73.39 -175.04 1.81 Allowed 'General case' 0 C--O 1.25 1.1 0 C-N-CA 124.823 1.249 . . . . 0.0 110.932 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.55 106.44 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 32.7 m -132.58 176.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.789 0.804 . . . . 0.0 112.273 -168.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 9.7 pttm -113.73 132.96 55.63 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.202 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.34 125.86 71.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.604 0.716 . . . . 0.0 111.873 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' A' ' 23' ' ' GLY . 26.3 tp -88.86 92.83 9.37 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.52 -59.77 3.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.958 0.885 . . . . 0.0 109.814 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.3 m -146.27 156.08 43.11 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -14.91 63.35 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.59 0.71 56.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.737 0.303 . . . . 0.0 111.046 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -129.83 -53.46 1.14 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.26 0.553 . . . . 0.0 109.805 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' A' ' 17' ' ' LEU . . . 103.06 -172.6 21.69 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.068 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 85.3 m95 -62.31 114.51 3.52 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.273 1.029 . . . . 0.0 111.489 175.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.3 163.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.431 HH11 ' CG ' ' A' ' 43' ' ' ASP . 38.6 ttm105 -79.52 133.75 36.49 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -154.41 172.61 17.45 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.073 0.463 . . . . 0.0 110.845 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -130.73 130.47 43.84 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 9' ' ' GLN . 61.4 t -71.03 115.52 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -86.35 -42.57 15.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -153.14 142.41 21.54 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.135 0.969 . . . . 0.0 111.137 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.03 115.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.387 0 CA-C-N 113.066 -1.879 . . . . 0.0 108.144 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 10.0 mttt -106.58 143.21 35.02 Favored 'General case' 0 CA--C 1.453 -2.779 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.179 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -94.59 26.02 3.68 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.256 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.41 30.18 5.67 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.26 25.97 74.38 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 114.929 -0.635 . . . . 0.0 111.821 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.632 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -117.82 85.8 2.41 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 123.161 1.457 . . . . 0.0 111.577 -174.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 49' ' ' THR . 21.6 t -80.64 128.01 39.0 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.432 0 CA-C-N 112.968 -1.924 . . . . 0.0 107.267 178.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 58.8 t -107.78 115.94 50.07 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.06 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.5 m -135.29 143.62 36.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' ' 47' ' ' GLU . 36.2 tt0 -130.87 126.9 37.41 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.484 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 46.3 t -77.27 167.69 21.3 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.626 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' CG ' HH11 ' A' ' 26' ' ' ARG . 5.9 p-10 -76.29 -6.55 51.96 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.281 1.039 . . . . 0.0 110.477 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -84.62 6.79 22.56 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.099 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.49 16.13 75.57 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 122.139 0.855 . . . . 0.0 111.462 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -93.13 98.28 11.21 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.384 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.441 ' HB2' HE21 ' A' ' 41' ' ' GLN . 3.4 tm-20 -95.57 150.87 19.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -171.39 153.14 3.47 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.011 0.819 . . . . 0.0 111.285 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.2 t -78.76 112.47 15.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.903 0.858 . . . . 0.0 109.44 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.15 177.56 5.54 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.737 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.518 ' O ' HG23 ' A' ' 55' ' ' VAL . 54.6 mtp180 -123.58 146.49 48.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.22 -14.65 57.18 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.941 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.86 -6.2 58.87 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.498 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.0 mt-30 -120.98 14.21 11.47 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.158 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 51' ' ' ARG . 12.6 t -133.39 136.83 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.476 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 5.3 mmm180 -140.11 150.73 44.66 Favored 'General case' 1 N--CA 1.375 -4.205 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.08 178.033 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.436 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 91.4 mt -57.97 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 123.191 1.472 . . . . 0.0 111.427 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.423 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 13.3 pt -105.84 64.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.517 0 O-C-N 120.846 -1.159 . . . . 0.0 112.415 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.288 -2.093 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.52 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -167.18 153.25 7.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -170.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.26 31.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 124.304 1.003 . . . . 0.0 109.634 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -105.91 -13.21 15.57 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.071 0.939 . . . . 0.0 109.124 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.65 29.32 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.402 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.6 mt -128.29 110.57 12.51 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -81.64 84.08 6.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.629 1.204 . . . . 0.0 108.135 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -144.65 165.25 28.57 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 112.139 -2.3 . . . . 0.0 104.959 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 29.8 mm-40 -113.49 153.56 45.7 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.734 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.625 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.1 Cg_exo -62.71 112.45 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.242 1.961 . . . . 0.0 110.206 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.46 -6.97 9.12 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 3.8 t70 -70.7 158.81 35.61 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.72 0.808 . . . . 0.0 110.367 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -127.61 108.8 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 122.635 1.207 . . . . 0.0 111.982 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 28.6 m -134.81 -172.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.643 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 59' ' ' GLU . 37.8 pttt -127.66 140.54 52.02 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 27' ' ' ALA . 25.1 m -130.59 146.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.66 112.26 24.77 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -80.21 -71.6 0.45 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.34 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -116.24 139.54 50.25 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.912 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.62 66.01 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 112.325 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 5.5 41.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -127.34 -52.05 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.67 -154.25 18.36 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.45 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -78.21 118.54 20.53 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.206 1.002 . . . . 0.0 111.333 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 163.18 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 18.3 tpp180 -87.6 114.42 24.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -107.77 140.6 40.6 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.943 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 55.7 mtm180 -113.31 119.27 37.1 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 49.0 t -69.47 111.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.625 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.6 mm -94.3 -33.73 5.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.14 0.495 . . . . 0.0 110.827 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.537 ' NE ' HG22 ' A' ' 39' ' ' VAL . 8.8 ttp180 -158.98 137.4 10.77 Favored 'General case' 1 N--CA 1.347 -5.587 0 CA-C-O 122.095 0.95 . . . . 0.0 108.614 -175.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -102.01 102.66 13.85 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.722 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.449 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HD3' ' HB3' ' A' ' 37' ' ' ARG . 21.1 mttm -105.98 173.55 6.27 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 112.502 -2.136 . . . . 0.0 105.281 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -142.49 157.34 44.84 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.127 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.0 -92.07 1.34 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.499 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -18.97 60.97 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.126 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.603 ' NH1' HG21 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -143.93 152.49 41.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' THR . 60.2 t -155.16 147.93 12.77 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.915 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 174.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.603 HG21 ' NH1' ' A' ' 37' ' ' ARG . 63.1 t -125.05 116.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 119.509 1.049 . . . . 0.0 112.126 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.89 142.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 29.6 tt0 -127.18 108.28 10.76 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.915 0.864 . . . . 0.0 109.008 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 15.6 m -70.82 169.34 14.84 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.856 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -28.26 -58.83 0.12 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 128.552 2.741 . . . . 0.0 114.359 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -59.22 -19.45 45.62 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.173 1.789 . . . . 0.0 112.595 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.1 21.06 23.96 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -172.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -90.43 99.88 12.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.238 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.451 ' CD ' HG11 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -91.45 142.9 27.16 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -165.13 176.47 8.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.875 0.734 . . . . 0.0 110.755 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.5 t -96.71 117.51 31.17 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-O 121.638 0.732 . . . . 0.0 110.493 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.53 169.52 10.96 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.899 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.562 ' O ' HG21 ' A' ' 55' ' ' VAL . 24.4 mmt180 -131.41 145.45 51.81 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.35 -34.3 48.13 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 115.253 0.861 . . . . 0.0 115.253 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.2 -0.06 43.41 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 122.149 -0.618 . . . . 0.0 111.739 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -114.46 9.42 16.75 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 51' ' ' ARG . 45.8 t -124.83 139.89 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-O 121.128 0.489 . . . . 0.0 109.882 -174.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.441 HH21 ' C ' ' A' ' 59' ' ' GLU . 13.6 mmm180 -137.66 129.28 28.33 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.02 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 57' ' ' LEU . 4.0 pp -99.6 131.87 45.31 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.7 mt 75.32 150.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 54.4 mm-40 . . . . . 0 C--O 1.275 2.444 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.91 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -133.61 34.8 3.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -170.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.72 9.61 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 125.071 1.348 . . . . 0.0 113.1 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.8 ttp -96.42 -11.3 25.87 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.596 1.188 . . . . 0.0 108.017 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -87.92 130.99 34.75 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.1 mt -85.15 82.69 8.29 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.25 83.99 1.9 Allowed 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.462 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 mm? -106.44 129.01 54.49 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.505 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -76.29 154.41 84.21 Favored Pre-proline 0 N--CA 1.406 -2.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.092 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 13.8 Cg_exo -63.08 117.55 4.47 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 C-N-CA 121.886 1.724 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.12 -12.83 9.72 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.196 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.16 169.73 14.47 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 122.805 0.442 . . . . 0.0 110.094 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 90.5 t -129.82 111.57 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.42 0.628 . . . . 0.0 110.691 -173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -131.76 169.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.878 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -111.9 133.18 54.25 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.949 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 18.3 m -127.34 137.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.419 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.6 tt -89.01 93.68 9.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.0 -49.89 66.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.182 -1.826 . . . . 0.0 110.966 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.7 m -147.25 148.05 31.05 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.506 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.17 68.12 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.8 8.74 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.965 0.412 . . . . 0.0 111.211 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.98 -45.21 1.03 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.288 0.566 . . . . 0.0 109.51 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.06 -154.54 21.19 Favored Glycine 0 N--CA 1.423 -2.167 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -72.56 108.14 5.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.863 0.865 . . . . 0.0 110.833 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.58 146.4 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -73.52 134.64 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.07 166.39 24.93 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.699 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HD2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -119.21 142.19 48.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.17 121.5 26.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.9 mm -89.47 -38.99 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.157 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.05 155.75 33.18 Favored 'General case' 1 N--CA 1.343 -5.805 0 CA-C-O 121.943 0.877 . . . . 0.0 110.538 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 8' ' ' LEU . 7.5 p -117.6 124.61 73.29 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.543 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.694 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.621 ' CB ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -121.94 -71.63 0.72 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.312 170.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 38' ' ' VAL . 25.6 t -169.88 177.57 4.34 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.95 59.29 1.0 Allowed Glycine 0 N--CA 1.481 1.686 0 O-C-N 123.493 0.495 . . . . 0.0 114.185 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.81 -23.37 0.06 OUTLIER Glycine 0 C--N 1.296 -1.66 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.621 ' HB3' ' CB ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.8 15.64 10.14 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.982 0.896 . . . . 0.0 110.966 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 34' ' ' SER . 2.7 m -79.75 125.54 38.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.8 t -110.12 122.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.202 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 34.7 m -126.75 153.74 35.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.551 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 34.1 tt0 -123.52 123.93 41.71 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.4 t -78.08 170.24 16.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.75 1.86 13.66 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.062 0.934 . . . . 0.0 111.472 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -89.76 0.33 57.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.468 174.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 11.69 84.03 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 99.8 mtt180 -87.74 101.87 14.1 Favored 'General case' 0 N--CA 1.41 -2.427 0 C-N-CA 122.925 0.49 . . . . 0.0 110.24 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 38.0 tt0 -97.51 120.91 38.74 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.85 166.08 28.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.416 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 12.6 t -99.42 132.49 44.72 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.46 156.54 33.87 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.962 0.41 . . . . 0.0 111.005 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.455 ' O ' HG21 ' A' ' 55' ' ' VAL . 46.3 mtp180 -84.68 157.71 21.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.57 8.03 6.09 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-O 121.766 0.648 . . . . 0.0 112.882 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' H ' ' C ' ' A' ' 51' ' ' ARG . 14.2 m120 -103.86 -8.84 19.43 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -111.93 -0.54 15.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.697 -177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 51' ' ' ARG . 5.9 t -127.82 138.26 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -139.53 152.36 46.85 Favored 'General case' 1 N--CA 1.377 -4.112 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.89 -169.73 0.5 Allowed 'General case' 0 C--N 1.27 -2.85 0 O-C-N 123.934 0.771 . . . . 0.0 109.817 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 pt -73.9 78.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 122.518 1.152 . . . . 0.0 110.966 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 C--N 1.293 -1.854 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.215 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.428 ' H2 ' ' CD ' ' A' ' 5' ' ' GLU . 11.4 m . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.649 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.04 -168.35 1.41 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.04 0.69 5.61 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.8 ttt -103.14 -7.21 21.46 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.01 0.91 . . . . 0.0 109.085 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.428 ' CD ' ' H2 ' ' A' ' 1' ' ' SER . 33.6 mt-10 -116.89 -152.82 0.51 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.893 -175.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -107.05 150.3 26.67 Favored 'General case' 0 N--CA 1.397 -3.102 0 C-N-CA 124.427 1.091 . . . . 0.0 108.777 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.08 20.07 18.32 Favored 'General case' 0 C--N 1.254 -3.563 0 C-N-CA 126.445 1.898 . . . . 0.0 107.027 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.6 mt -132.15 174.99 9.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.506 -171.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -136.23 163.9 46.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 123.781 0.833 . . . . 0.0 109.624 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.7 Cg_exo -66.58 137.65 47.02 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.764 1.643 . . . . 0.0 110.673 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.39 0.25 50.3 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.9 159.11 23.74 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 123.064 0.546 . . . . 0.0 110.076 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.03 100.21 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 122.734 1.254 . . . . 0.0 108.603 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.44 177.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.428 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.461 ' HE2' ' HB3' ' A' ' 59' ' ' GLU . 47.9 pttt -117.94 134.07 55.31 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.446 HG23 HG22 ' A' ' 40' ' ' VAL . 65.7 t -131.64 130.34 62.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.0 tt -90.86 100.5 13.35 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -66.79 -57.68 6.56 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.698 0.761 . . . . 0.0 110.563 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -147.17 160.59 42.27 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.514 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -25.77 67.52 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.01 7.1 36.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.848 0.356 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.34 -46.4 1.34 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.092 0.473 . . . . 0.0 109.981 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 88.85 -160.87 30.27 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.304 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.45 111.03 10.32 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.474 0.71 . . . . 0.0 111.091 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.39 154.78 4.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 44.7 ttt180 -75.32 136.64 40.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.14 163.5 36.76 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.142 0.972 . . . . 0.0 112.87 -177.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -116.25 119.67 36.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.19 111.16 3.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 41.4 mt -80.36 -45.2 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.389 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.92 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.566 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 3.0 ptp180 -160.1 162.73 34.11 Favored 'General case' 1 N--CA 1.343 -5.808 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.961 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.427 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 7.3 mttm -86.99 -66.6 0.89 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.313 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t -171.95 99.92 0.17 Allowed 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.49 -82.37 0.01 OUTLIER Glycine 0 N--CA 1.47 0.936 0 O-C-N 124.623 1.202 . . . . 0.0 114.611 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.46 63.79 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 17.5 mmt180 -99.73 106.99 18.95 Favored 'General case' 1 N--CA 1.348 -5.569 0 CA-C-O 122.515 1.15 . . . . 0.0 109.195 176.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.29 144.64 37.53 Favored 'Isoleucine or valine' 1 C--N 1.225 -4.828 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.845 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.566 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 3.0 m -129.66 138.86 53.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.446 HG22 HG23 ' A' ' 16' ' ' VAL . 35.8 m -133.2 152.93 36.56 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.008 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 57.7 tt0 -116.92 124.45 49.45 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -83.05 173.76 11.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.416 ' OD1' ' HB3' ' A' ' 26' ' ' ARG . 3.1 m-20 -61.04 -16.64 45.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.428 1.091 . . . . 0.0 110.778 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -78.17 1.33 21.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.673 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.71 87.85 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 116.233 -0.44 . . . . 0.0 113.391 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 35.7 ttt-85 -101.24 120.11 39.76 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.542 0.337 . . . . 0.0 111.564 -174.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.9 136.52 34.56 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -145.1 155.94 43.62 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -95.73 137.23 35.1 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.211 0.529 . . . . 0.0 111.358 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 172.39 13.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.4 mtp180 -85.56 160.19 19.7 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.82 -19.44 69.52 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.238 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -86.94 -1.88 58.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.436 0.636 . . . . 0.0 109.819 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.27 2.26 17.61 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 HG13 HG22 ' A' ' 16' ' ' VAL . 38.4 t -125.22 133.02 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.443 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 5.9 mmm180 -138.91 140.86 38.48 Favored 'General case' 0 N--CA 1.385 -3.677 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.145 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -176.17 0.08 Allowed 'General case' 0 C--N 1.287 -2.112 0 O-C-N 123.901 0.75 . . . . 0.0 112.42 170.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 58' ' ' ILE . 2.5 pp -59.98 106.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 122.996 1.379 . . . . 0.0 110.157 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 26.5 tt0 . . . . . 0 C--N 1.261 -3.272 0 CA-C-N 112.614 -2.085 . . . . 0.0 105.631 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.546 ' O ' ' HG2' ' A' ' 4' ' ' MET . 3.3 m-20 72.14 109.01 0.07 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 124.991 1.432 . . . . 0.0 108.394 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.61 93.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.632 1.208 . . . . 0.0 113.762 -173.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.546 ' HG2' ' O ' ' A' ' 2' ' ' ASN . 25.2 ptt? -165.49 2.11 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.36 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -97.93 -168.57 1.69 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.146 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -133.27 138.89 46.63 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -85.22 -0.02 53.3 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.422 1.106 . . . . 0.0 110.855 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.9 150.43 20.37 Favored 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.588 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -115.95 167.21 10.64 Favored Pre-proline 0 C--N 1.287 -2.114 0 CA-C-O 120.447 0.165 . . . . 0.0 111.42 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.598 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 42.3 Cg_exo -56.61 110.89 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.094 1.862 . . . . 0.0 111.398 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.46 -24.37 3.94 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.813 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -73.42 169.77 16.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.26 132.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -145.28 177.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 124.333 1.053 . . . . 0.0 108.712 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.4 133.87 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -86.1 95.22 9.48 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.51 -59.92 4.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.799 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.2 m -139.1 149.0 44.04 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.25 66.89 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.56 8.03 38.55 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.996 0.427 . . . . 0.0 110.972 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.8 mt -130.02 -46.48 1.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.13 -158.26 20.05 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.346 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -72.41 112.22 8.29 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.965 0.906 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.91 152.28 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -78.19 135.24 37.58 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -143.97 159.24 42.92 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.85 0.833 . . . . 0.0 112.116 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -105.78 133.16 50.95 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.971 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 48.1 t -72.56 111.12 6.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.598 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 51.4 mm -91.02 -35.51 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.927 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.49 153.27 30.0 Favored 'General case' 1 N--CA 1.339 -6.006 0 CA-C-O 121.814 0.816 . . . . 0.0 108.925 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.55 112.72 41.52 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.831 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.487 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -110.75 -177.36 3.2 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 166.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 m -136.09 160.65 37.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.294 -1.762 . . . . 0.0 113.008 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.72 -88.42 0.11 Allowed Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.105 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.88 -21.72 49.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.77 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.621 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 2.7 mmp_? -121.06 147.51 45.42 Favored 'General case' 1 N--CA 1.376 -4.175 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.02 146.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 102.224 -3.25 . . . . 0.0 102.224 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.24 124.0 59.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 119.173 0.897 . . . . 0.0 108.848 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 29' ' ' VAL . 28.5 m -137.5 155.44 31.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.72 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 35.0 tt0 -121.77 124.22 43.68 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 22.3 t -75.65 171.98 13.38 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -10.99 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.402 1.096 . . . . 0.0 109.785 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -9.88 58.98 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.721 174.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.2 85.28 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.441 -0.409 . . . . 0.0 112.529 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -91.11 125.71 35.98 Favored 'General case' 0 N--CA 1.407 -2.623 0 O-C-N 122.283 -0.54 . . . . 0.0 111.296 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 42.2 tt0 -92.07 134.56 34.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.71 153.57 42.59 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.6 t -113.08 116.78 30.42 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.787 0.803 . . . . 0.0 110.838 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.35 -171.34 1.94 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.968 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -100.98 164.59 11.74 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.86 -8.75 69.2 Favored Glycine 0 C--O 1.216 -1.009 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -85.79 -1.82 57.61 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -118.8 11.2 12.59 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.495 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.26 136.28 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 121.418 0.627 . . . . 0.0 109.336 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 18.7 mmm180 -132.72 129.69 39.03 Favored 'General case' 0 N--CA 1.395 -3.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.324 178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.67 138.75 37.3 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.759 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.282 37.1 pt 38.13 78.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.415 1.886 . . . . 0.0 115.492 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 102.166 -3.272 . . . . 0.0 102.166 -176.412 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.5 -0.958 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -121.19 151.72 39.63 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.95 112.92 20.22 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.0 mmm -87.84 94.17 9.68 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -111.05 160.81 16.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 8' ' ' LEU . 83.6 mt -95.34 96.94 9.48 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.82 23.53 0.43 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.232 1.013 . . . . 0.0 112.604 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' H ' ' C ' ' A' ' 6' ' ' LEU . 91.7 mt -135.56 134.98 39.96 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 124.761 1.224 . . . . 0.0 108.092 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -126.51 152.46 74.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -72.04 134.46 23.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.03 1.82 . . . . 0.0 112.791 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.26 48.51 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.016 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.57 156.77 18.87 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-O 120.964 0.411 . . . . 0.0 110.985 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.5 106.94 21.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.1 m -123.03 173.31 9.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.97 -170.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -110.34 126.81 54.64 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.074 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.42 HG13 HG21 ' A' ' 55' ' ' VAL . 25.6 m -121.9 144.63 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.35 87.05 3.77 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 171.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -70.32 -42.12 72.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.072 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.7 m -144.44 142.43 30.3 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.681 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.08 67.15 Favored 'General case' 0 C--O 1.21 -0.994 0 C-N-CA 122.851 0.46 . . . . 0.0 112.164 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.02 3.79 47.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.917 0.389 . . . . 0.0 110.959 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -123.42 -44.79 2.11 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.27 -153.35 21.73 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -74.43 107.55 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 123.409 0.684 . . . . 0.0 110.722 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG23 HE22 ' A' ' 44' ' ' GLN . 28.3 m -111.83 171.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.773 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.44 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 41.1 ttm180 -82.35 140.81 33.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.05 170.49 16.56 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.894 176.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 4.4 ptp180 -131.77 129.39 40.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.1 t -77.81 112.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.0 mt -86.09 -47.31 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.289 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -160.94 155.79 23.91 Favored 'General case' 1 N--CA 1.328 -6.527 0 C-N-CA 117.023 -1.871 . . . . 0.0 114.442 -170.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.01 105.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.803 -2.453 . . . . 0.0 107.55 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HB3' ' CB ' ' A' ' 37' ' ' ARG . 20.7 mttt -95.98 171.3 8.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -100.36 167.4 10.42 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.271 -1.371 . . . . 0.0 109.932 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.24 20.86 56.38 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.19 30.46 50.48 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 12.0 mmp_? -97.49 85.86 3.72 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-O 122.431 1.11 . . . . 0.0 113.333 -177.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.48 106.5 18.2 Favored 'Isoleucine or valine' 1 C--N 1.229 -4.658 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.608 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 60.2 t -114.45 130.33 68.96 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 121.882 0.849 . . . . 0.0 112.672 -170.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 29.7 m -124.89 159.82 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.583 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.644 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 35.4 tt0 -124.88 116.51 22.34 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.9 m -70.68 163.78 26.39 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.44 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 3.8 m-20 -62.96 -15.12 54.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.969 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.427 HE22 HG23 ' A' ' 25' ' ' VAL . 1.7 mp0 -83.88 2.42 38.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.4 10.42 70.86 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 172.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.644 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 4.3 mpt_? -91.44 115.99 28.49 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 118.238 1.019 . . . . 0.0 110.29 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.608 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 31.2 tt0 -93.95 108.21 20.04 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -139.45 166.02 25.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.747 0.308 . . . . 0.0 110.633 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -82.06 136.79 35.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.33 -176.27 3.83 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.466 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' O ' HG23 ' A' ' 55' ' ' VAL . 62.4 mtm180 -146.09 154.55 41.95 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.46 2.6 5.57 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-O 121.666 0.592 . . . . 0.0 113.219 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -92.78 -20.04 21.15 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.81 -4.2 14.04 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.366 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 51' ' ' ARG . 15.3 t -139.23 140.64 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.433 -3.552 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 5.2 mmm180 -134.82 151.01 50.59 Favored 'General case' 1 N--CA 1.362 -4.866 0 O-C-N 125.301 1.626 . . . . 0.0 107.055 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 75.8 mt -69.19 -170.43 0.26 Allowed 'General case' 0 C--N 1.278 -2.511 0 O-C-N 124.088 0.867 . . . . 0.0 110.498 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.65 85.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.402 1.096 . . . . 0.0 110.336 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 8.9 pt-20 . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.5 -0.955 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -37.96 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 125.711 1.882 . . . . 0.0 115.057 -170.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 164.64 -20.03 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.369 1.868 . . . . 0.0 109.193 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ptm -105.76 -17.31 14.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.26 0.553 . . . . 0.0 111.535 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 144.84 48.09 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.476 1.111 . . . . 0.0 109.94 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 65.5 mt -128.76 110.86 12.54 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.501 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.02 91.88 6.13 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.73 133.12 56.07 Favored 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 112.474 -2.148 . . . . 0.0 105.483 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -83.32 152.56 64.7 Favored Pre-proline 0 C--N 1.283 -2.294 0 O-C-N 123.647 0.592 . . . . 0.0 112.511 -167.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.6 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 23.0 Cg_exo -61.16 123.13 12.25 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.441 2.094 . . . . 0.0 111.194 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.92 -15.32 12.43 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 156.58 38.76 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.34 109.07 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG13 ' HA ' ' A' ' 57' ' ' LEU . 28.3 m -132.54 -179.68 3.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' HZ1' ' C ' ' A' ' 59' ' ' GLU . 6.4 pttm -112.92 122.29 47.2 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.94 132.74 70.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.1 tt -80.12 98.24 7.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.02 -56.21 18.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.549 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 m -151.09 148.25 28.08 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.92 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 86.17 3.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.335 0.588 . . . . 0.0 109.748 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.43 -43.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.56 -47.16 5.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.337 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 103.38 -143.6 15.78 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.144 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -72.83 114.28 10.8 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.339 1.056 . . . . 0.0 111.061 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.83 164.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.454 HH11 ' CG ' ' A' ' 43' ' ' ASP . 42.6 ttm180 -77.06 131.01 38.17 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.31 136.7 33.51 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.365 0.602 . . . . 0.0 111.192 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HE ' HD11 ' A' ' 30' ' ' ILE . 49.2 ttp180 -108.66 123.95 49.76 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 41.7 t -66.22 125.17 22.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.6 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.7 mm -105.07 -35.93 3.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.289 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' HE ' HG22 ' A' ' 39' ' ' VAL . 2.1 ttp180 -156.17 155.71 32.94 Favored 'General case' 1 N--CA 1.354 -5.272 0 CA-C-O 122.043 0.925 . . . . 0.0 111.836 -173.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' N ' ' HG3' ' A' ' 31' ' ' ARG . 14.7 m -105.29 115.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.616 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 7.4 mttm -120.94 176.83 5.36 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.71 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -97.17 143.67 27.75 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -171.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 -89.02 0.55 Allowed Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.151 -1.386 . . . . 0.0 113.603 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.64 29.81 3.52 Favored Glycine 0 C--N 1.292 -1.911 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.507 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.615 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -125.85 31.44 5.48 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 122.08 0.943 . . . . 0.0 109.899 176.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.57 128.51 23.13 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG21 ' NH1' ' A' ' 37' ' ' ARG . 69.8 t -99.63 123.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.926 -170.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.7 m -134.97 149.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -132.34 126.95 34.49 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.1 m -67.91 159.78 29.85 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.454 ' CG ' HH11 ' A' ' 26' ' ' ARG . 6.1 p-10 -66.6 -15.54 63.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.167 0.508 . . . . 0.0 111.667 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -78.66 0.54 26.13 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.612 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.21 65.97 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 170.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -91.23 129.14 37.26 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 118.927 1.364 . . . . 0.0 112.519 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -85.81 141.36 29.7 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.03 171.14 17.32 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.615 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 15.2 t -97.48 141.73 30.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.804 -177.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.4 140.93 44.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.611 ' O ' HG21 ' A' ' 55' ' ' VAL . 56.2 mtp180 -113.9 145.83 40.92 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.58 -16.16 54.83 Favored Glycine 0 C--O 1.214 -1.116 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.37 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -88.56 -2.29 58.51 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.46 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.1 mt-30 -126.83 14.9 7.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.573 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 51' ' ' ARG . 31.5 t -129.52 139.73 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 121.724 0.773 . . . . 0.0 110.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -137.19 140.77 42.0 Favored 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 59' ' ' GLU . 2.3 pt? -75.92 -153.17 0.04 OUTLIER 'General case' 0 C--N 1.261 -3.252 0 CA-C-O 121.778 0.799 . . . . 0.0 111.505 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -76.19 8.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 122.656 1.217 . . . . 0.0 112.129 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 57' ' ' LEU . 1.9 tm-20 . . . . . 1 C--N 1.237 -4.322 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.491 -1.298 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.81 112.49 19.31 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -172.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.4 -3.69 25.13 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.706 0.765 . . . . 0.0 109.019 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.7 tpt -166.46 145.18 5.55 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -96.6 178.67 5.25 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.824 0.703 . . . . 0.0 110.042 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -93.72 101.83 13.97 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.52 20.3 0.32 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 125.464 1.506 . . . . 0.0 112.577 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.483 ' H ' ' C ' ' A' ' 6' ' ' LEU . 93.0 mt -61.87 122.25 14.95 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.86 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.6 mm-40 -93.26 150.03 38.4 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.605 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.0 Cg_exo -65.47 129.06 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.495 2.13 . . . . 0.0 110.624 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.39 29.35 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -67.43 150.74 48.51 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.324 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.19 98.2 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 122.842 1.306 . . . . 0.0 111.0 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.64 172.8 9.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.531 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 40.5 pttt -108.13 129.28 55.17 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 33.5 m -129.24 140.62 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.282 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.5 tt -101.31 102.9 13.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -72.17 -68.84 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.057 0.932 . . . . 0.0 109.579 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -128.69 153.67 47.08 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.01 -173.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -19.87 65.58 Favored 'General case' 0 C--O 1.209 -1.036 0 C-N-CA 122.856 0.462 . . . . 0.0 112.084 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.88 2.28 51.89 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.84 0.352 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.27 -44.12 1.9 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.968 0.413 . . . . 0.0 110.284 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 85.79 -156.78 30.44 Favored Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -81.12 112.15 18.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.38 164.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -82.15 137.02 35.06 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.0 146.27 48.89 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' NH1' ' HA ' ' A' ' 43' ' ' ASP . 15.9 mtm180 -113.77 123.59 50.22 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.22 118.31 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.605 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 53.2 mt -85.91 -44.23 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.547 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.025 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 5.4 ptp85 -162.45 165.13 26.67 Favored 'General case' 1 N--CA 1.347 -5.592 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.186 -173.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.8 m -99.63 128.79 51.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 CA-C-N 112.668 -2.06 . . . . 0.0 108.616 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -103.04 -49.16 3.84 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m 75.58 162.92 0.25 Allowed 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 111.858 -2.428 . . . . 0.0 110.747 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.22 30.4 16.9 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.77 -29.11 11.02 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.912 -0.644 . . . . 0.0 112.014 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.511 ' HE ' HG23 ' A' ' 39' ' ' VAL . 28.6 ttt180 -81.15 123.06 28.12 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 m -121.64 123.88 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.387 168.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.511 HG23 ' HE ' ' A' ' 37' ' ' ARG . 74.2 t -91.74 123.92 44.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.525 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.8 m -135.2 150.58 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.475 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -129.17 128.98 44.49 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.3 t -74.78 165.24 25.56 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.501 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 10.4 m-20 -65.6 -15.68 62.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -78.8 -2.08 37.85 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.981 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.47 73.17 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.801 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -81.78 104.01 11.86 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.605 0.762 . . . . 0.0 110.604 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -86.89 137.62 32.24 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.97 -177.97 7.02 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.439 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -101.87 119.17 38.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.16 169.85 9.95 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.568 ' O ' HG21 ' A' ' 55' ' ' VAL . 74.3 mtm180 -139.77 158.58 43.86 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.23 0.54 6.17 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.17 -8.46 22.2 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.676 0.751 . . . . 0.0 109.074 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.2 mt-30 -119.61 6.6 11.03 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.703 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG21 ' O ' ' A' ' 51' ' ' ARG . 23.1 t -127.43 134.99 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.997 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 -174.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 27.4 mmm180 -137.77 136.96 37.77 Favored 'General case' 0 N--CA 1.383 -3.791 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.422 ' H ' HD22 ' A' ' 57' ' ' LEU . 2.5 pt? -72.48 -175.54 1.64 Allowed 'General case' 0 C--N 1.28 -2.453 0 O-C-N 123.537 0.523 . . . . 0.0 110.524 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.06 107.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.244 1.018 . . . . 0.0 111.121 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.278 -2.526 0 CA-C-N 112.987 -1.915 . . . . 0.0 105.835 -174.962 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.644 ' HA ' ' CG ' ' A' ' 7' ' ' ASP . 19.6 m120 78.61 91.86 0.06 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.549 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.58 -51.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.168 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.3 tpp -165.65 30.27 0.05 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -112.31 -172.39 2.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.41 71.32 2.73 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 166.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.644 ' CG ' ' HA ' ' A' ' 2' ' ' ASN . 1.2 p30 -92.83 23.17 4.31 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 112.801 -2.0 . . . . 0.0 113.881 -169.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.58 148.64 26.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -119.09 161.84 34.59 Favored Pre-proline 0 C--N 1.291 -1.947 0 CA-C-N 117.878 0.308 . . . . 0.0 111.828 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.645 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 33.4 Cg_exo -62.41 71.9 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.366 2.711 . . . . 0.0 113.372 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' HA2' ' NE ' ' A' ' 28' ' ' ARG . . . -178.97 -22.32 0.03 OUTLIER Glycine 0 C--N 1.267 -3.256 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.427 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.88 123.55 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.63 123.55 52.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.1 169.32 6.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.927 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.599 ' NZ ' ' HA ' ' A' ' 59' ' ' GLU . 31.8 mttm -98.15 129.29 44.94 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 23.4 t -127.38 126.23 67.22 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.21 102.34 15.0 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.56 -59.46 2.7 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.88 0.847 . . . . 0.0 109.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -124.37 154.24 40.65 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.617 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.01 -21.13 63.23 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.89 -18.77 33.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.657 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.99 -36.95 9.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.073 0.463 . . . . 0.0 110.753 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.09 -162.17 40.31 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -74.51 112.99 11.25 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.341 0.591 . . . . 0.0 110.494 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.83 146.22 18.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.549 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -78.64 127.28 31.89 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-O 121.282 0.563 . . . . 0.0 110.009 -178.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.72 159.41 41.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.557 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' NE ' ' HA2' ' A' ' 11' ' ' GLY . 61.1 ttt180 -119.06 135.98 54.36 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 51.7 t -63.98 112.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 171.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.645 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.4 mm -97.22 -34.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -159.75 148.16 17.39 Favored 'General case' 1 N--CA 1.344 -5.736 0 CA-C-O 121.81 0.814 . . . . 0.0 110.141 -173.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -108.19 96.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.141 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 34.2 mttt -95.47 157.02 16.08 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 p -100.36 179.76 4.36 Favored 'General case' 0 C--N 1.265 -3.089 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.871 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.42 -75.04 2.27 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.48 51.28 0.17 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.596 ' HD3' ' OG1' ' A' ' 49' ' ' THR . 0.4 OUTLIER -140.22 34.99 1.89 Allowed 'General case' 0 N--CA 1.41 -2.445 0 O-C-N 122.585 -0.362 . . . . 0.0 111.778 -177.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 m -63.22 111.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 37' ' ' ARG . 2.7 t -94.48 132.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -164.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.96 140.47 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -124.88 125.47 44.01 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 m -87.04 173.83 9.05 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.78 -44.06 1.53 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.945 2.098 . . . . 0.0 115.647 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.35 -6.06 43.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.87 10.93 62.35 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.131 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.28 102.05 6.53 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.486 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' HG3' ' CG1' ' A' ' 39' ' ' VAL . 22.2 tt0 -84.77 115.19 22.58 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.338 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.74 170.47 15.93 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.878 -0.514 . . . . 0.0 111.527 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.596 ' OG1' ' HD3' ' A' ' 37' ' ' ARG . 52.0 m -86.33 137.68 32.4 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.145 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.81 163.37 12.77 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.845 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -140.94 153.74 45.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.95 -17.61 51.79 Favored Glycine 0 N--CA 1.477 1.431 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -87.23 -10.18 53.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.342 0.592 . . . . 0.0 110.219 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.66 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.1 mt-30 -110.83 5.99 21.03 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.912 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.2 129.88 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.545 -171.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -132.38 119.07 20.2 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.1 pt? -92.89 88.54 6.22 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 122.003 0.906 . . . . 0.0 112.828 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.487 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 4.4 pt -168.76 155.58 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.599 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 5.9 mm-40 . . . . . 0 C--N 1.292 -1.934 0 CA-C-O 117.201 -1.38 . . . . 0.0 109.072 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.617 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 3.6 t-20 -89.05 155.7 19.31 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.56 30.2 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.741 1.617 . . . . 0.0 110.569 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 ptp -156.97 6.34 0.16 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.804 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.617 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -105.64 160.63 15.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.16 81.12 3.0 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.474 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -93.72 82.18 4.31 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.43 121.1 43.92 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 112.729 -2.032 . . . . 0.0 107.265 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -84.58 155.6 62.26 Favored Pre-proline 0 N--CA 1.415 -2.178 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.191 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.618 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 21.3 Cg_exo -60.21 125.3 17.16 Favored 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.181 1.921 . . . . 0.0 111.755 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.79 -17.35 10.95 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.319 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 33.4 t0 -63.52 158.85 19.96 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.761 0.825 . . . . 0.0 111.712 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -116.31 107.58 22.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.176 0.59 . . . . 0.0 109.58 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.6 175.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -126.28 139.8 53.03 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 57.7 t -131.17 133.85 62.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.92 -66.29 0.57 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.96 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.8 m -126.63 146.15 50.29 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.898 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -21.43 66.45 Favored 'General case' 0 C--O 1.21 -0.998 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.27 48.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.859 0.362 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.68 -46.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 0.0 109.803 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.29 -158.15 23.59 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.311 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -78.85 112.21 15.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.1 0.56 . . . . 0.0 110.677 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.16 149.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -97.88 123.8 42.02 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.048 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.16 169.22 17.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.156 0.979 . . . . 0.0 113.614 -168.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 22.1 mmt180 -112.6 132.88 54.93 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.903 -1.499 . . . . 0.0 107.438 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 65.9 t -67.56 114.15 4.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 173.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.618 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 44.4 mm -87.17 -40.63 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.596 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.502 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.443 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 1.4 ptp180 -165.86 160.11 16.6 Favored 'General case' 1 N--CA 1.338 -6.036 0 CA-C-O 121.984 0.897 . . . . 0.0 110.563 -176.813 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.19 94.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.537 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.753 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 56.3 mttt -81.36 149.64 28.79 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.19 169.67 13.61 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -170.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.33 -82.38 1.56 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.66 35.02 0.21 Allowed Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -108.6 22.91 15.29 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.009 -175.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 49' ' ' THR . 31.0 m -61.73 136.44 25.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 124.345 1.028 . . . . 0.0 109.103 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.421 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 11.4 m -126.1 144.42 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.229 1.014 . . . . 0.0 113.523 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.93 141.11 47.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.247 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 34.7 tt0 -106.06 116.97 32.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 8.3 t -80.33 172.16 14.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.134 -175.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -44.39 -37.24 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 127.051 2.14 . . . . 0.0 112.55 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -76.81 0.97 18.74 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.27 -3.77 83.47 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 122.103 0.835 . . . . 0.0 112.125 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -77.61 107.72 10.29 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 124.135 0.974 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.7 tt0 -84.92 114.9 22.47 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -131.58 167.76 18.86 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.428 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.4 t -102.38 145.95 28.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.377 -175.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.85 156.11 48.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.461 -0.896 . . . . 0.0 113.028 -172.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 157.53 16.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.45 -23.26 62.34 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.134 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.79 1.09 54.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.155 0.502 . . . . 0.0 111.107 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.425 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.5 mt-30 -104.8 -2.75 24.4 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.37 138.18 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.434 0.635 . . . . 0.0 110.648 -170.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -137.73 126.23 23.51 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.571 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.471 ' H ' HD21 ' A' ' 57' ' ' LEU . 2.5 pt? -94.9 141.39 28.7 Favored 'General case' 0 C--N 1.262 -3.203 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.4 mt 75.25 145.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 124.163 0.915 . . . . 0.0 109.117 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.727 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -66.19 -24.77 66.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.694 0.759 . . . . 0.0 109.735 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.38 130.21 56.82 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 172.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.86 118.1 8.53 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 124.081 0.863 . . . . 0.0 112.037 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -81.45 144.16 31.58 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.7 mt -82.49 90.12 6.72 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.5 0.667 . . . . 0.0 111.328 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -96.05 10.21 38.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.816 1.769 . . . . 0.0 108.418 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.2 mt -143.54 143.93 31.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 112.664 -2.062 . . . . 0.0 108.376 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -139.26 154.79 72.34 Favored Pre-proline 0 C--O 1.213 -0.818 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -73.94 135.61 21.49 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.78 1.653 . . . . 0.0 111.669 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -2.84 56.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -83.82 154.95 23.22 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 122.667 0.387 . . . . 0.0 111.089 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.1 112.7 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 CA-C-O 122.111 0.958 . . . . 0.0 108.631 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG11 ' HA ' ' A' ' 57' ' ' LEU . 35.5 m -128.55 176.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.666 0.745 . . . . 0.0 111.819 -171.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -115.01 129.73 56.78 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 66.5 t -129.44 130.97 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -86.84 90.61 8.37 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.96 -54.51 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.526 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.1 m -144.22 149.25 36.06 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.477 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.48 -17.44 64.8 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.97 5.46 46.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.88 0.371 . . . . 0.0 110.673 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -130.97 -47.69 1.02 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.177 0.513 . . . . 0.0 109.887 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.84 -156.66 19.72 Favored Glycine 0 N--CA 1.428 -1.85 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.089 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.564 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 91.7 m95 -74.03 112.69 10.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.449 0.7 . . . . 0.0 110.765 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.28 152.14 8.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -71.13 131.49 43.65 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' HA ' HH21 ' A' ' 28' ' ' ARG . . . -140.31 169.27 17.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.477 HH22 ' CG ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -128.9 134.12 48.15 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.418 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.6 t -75.02 115.82 16.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.8 -43.79 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -156.78 155.42 31.56 Favored 'General case' 1 N--CA 1.347 -5.582 0 CA-C-O 121.868 0.842 . . . . 0.0 110.167 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -111.67 110.12 31.04 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.647 0 CA-C-N 113.623 -1.626 . . . . 0.0 113.25 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 64.0 mttt -113.16 166.61 11.27 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 t -99.85 164.96 11.8 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 118.541 -1.263 . . . . 0.0 112.667 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -90.58 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.673 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.507 ' HA2' ' HA ' ' A' ' 51' ' ' ARG . . . -146.73 35.02 1.32 Allowed Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 18.9 mmt-85 -109.24 16.79 22.17 Favored 'General case' 1 N--CA 1.374 -4.243 0 CA-C-N 114.775 -0.712 . . . . 0.0 111.64 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -72.61 122.41 25.15 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 CA-C-N 114.557 -1.201 . . . . 0.0 107.797 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 39.3 t -103.76 116.1 46.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.732 -175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 29' ' ' VAL . 31.2 m -127.85 148.76 32.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.027 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 34.4 tt0 -118.38 131.0 56.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.0 t -89.62 174.98 7.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.477 ' CG ' HH22 ' A' ' 28' ' ' ARG . 15.2 m-20 -72.19 -10.08 59.3 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.144 0.973 . . . . 0.0 109.779 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.66 2.43 48.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.074 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.59 0.79 85.32 Favored Glycine 0 CA--C 1.506 -0.474 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.719 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -80.89 111.83 17.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 118.149 0.974 . . . . 0.0 110.973 177.459 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 36.3 tt0 -96.36 114.22 25.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -139.22 161.81 36.51 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.179 0.514 . . . . 0.0 111.876 -173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.3 t -91.54 106.27 18.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.422 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.64 161.69 14.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.243 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 76.8 mtt85 -80.3 153.11 28.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.19 6.85 6.64 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.148 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.81 -21.94 15.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 46.5 mt-30 -90.8 -12.64 35.8 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.188 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 HG13 HG21 ' A' ' 16' ' ' VAL . 19.1 t -115.88 125.73 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.88 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.564 ' HG3' ' CH2' ' A' ' 24' ' ' TRP . 6.4 mmp_? -133.37 140.84 47.6 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.463 ' HA ' HG11 ' A' ' 14' ' ' VAL . 2.5 pt? -61.34 176.6 0.45 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 124.371 1.044 . . . . 0.0 111.17 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.72 79.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 122.121 0.962 . . . . 0.0 113.53 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.286 -2.163 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -34.17 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 125.804 1.94 . . . . 0.0 115.897 -168.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.14 -40.81 0.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.401 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.2 mtp -117.36 -25.63 6.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.255 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.1 103.58 13.44 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.898 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' C ' ' H ' ' A' ' 8' ' ' LEU . 95.6 mt -134.33 157.4 46.45 Favored 'General case' 0 CA--C 1.446 -3.035 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -176.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.421 ' OD1' ' HA ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -63.93 37.19 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 128.629 2.772 . . . . 0.0 111.057 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -164.28 40.85 0.09 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -167.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.623 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 27.9 mm-40 -113.25 146.99 36.39 Favored Pre-proline 0 C--N 1.256 -3.48 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.691 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.4 114.21 3.48 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.817 1.678 . . . . 0.0 110.148 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.94 1.39 31.91 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.22 153.56 38.01 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.431 0.692 . . . . 0.0 110.22 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 107.25 22.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -133.0 -179.94 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 122.159 0.981 . . . . 0.0 112.42 -168.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' NZ ' ' OXT' ' A' ' 59' ' ' GLU . 47.8 pttt -123.4 136.25 54.53 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.5 t -125.96 127.19 70.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.117 0.484 . . . . 0.0 110.112 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.406 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.5 tp -85.39 86.73 7.35 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.46 -58.54 4.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.257 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.3 t -129.81 156.4 44.4 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.312 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.61 -13.1 30.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.088 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -107.45 -38.78 5.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.406 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 85.35 -172.86 47.56 Favored Glycine 0 N--CA 1.424 -2.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.361 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . 0.416 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 93.0 m95 -62.23 106.9 0.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.45 1.1 . . . . 0.0 111.896 175.275 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -99.18 146.63 8.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.489 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 32.2 ttm180 -67.65 137.69 55.79 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.19 172.27 16.09 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.566 ' NH2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -136.22 127.68 28.58 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 9' ' ' GLN . 39.9 t -70.86 120.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.52 -42.8 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.439 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -152.48 145.18 24.27 Favored 'General case' 1 N--CA 1.343 -5.792 0 CA-C-O 122.564 1.174 . . . . 0.0 111.083 -174.534 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.0 112.7 29.58 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.091 0 CA-C-N 112.604 -2.089 . . . . 0.0 113.447 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 23.4 mttm -125.15 164.71 19.66 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 166.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 m -106.74 178.53 4.53 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.525 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.76 0.9 Allowed Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.66 24.44 1.82 Allowed Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 0.3 OUTLIER -110.33 23.2 14.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.262 -178.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.2 121.12 20.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 33.4 t -103.88 126.24 58.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.398 -172.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.4 146.81 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 32.3 tt0 -114.66 125.58 53.91 Favored 'General case' 0 C--N 1.254 -3.566 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -69.96 166.06 20.42 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 16.9 t70 -57.64 -30.88 65.74 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.854 0.862 . . . . 0.0 111.377 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.03 -5.31 30.29 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.754 1.622 . . . . 0.0 112.484 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.86 68.33 Favored Glycine 0 C--O 1.224 -0.519 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.093 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -82.84 110.35 17.78 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 122.654 0.381 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.0 tt0 -90.34 135.96 33.35 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.733 0.813 . . . . 0.0 109.412 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.57 -175.88 5.38 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 12.0 t -122.18 143.97 49.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.4 -178.14 6.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' ASN . 14.7 mtm180 -106.51 165.83 11.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.484 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.67 28.58 1.81 Allowed Glycine 0 N--CA 1.472 1.08 0 CA-C-O 121.789 0.66 . . . . 0.0 112.545 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.7 m120 -117.17 -16.09 10.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.1 mt-30 -104.56 -2.15 25.55 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.879 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 56' ' ' ARG . 6.4 t -118.0 140.58 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 11.8 mmm180 -150.43 141.69 23.23 Favored 'General case' 0 N--CA 1.403 -2.781 0 O-C-N 124.672 1.233 . . . . 0.0 110.15 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 97.0 mt -56.84 169.78 0.48 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 124.974 1.421 . . . . 0.0 110.434 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 pt -73.09 81.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.153 0.978 . . . . 0.0 111.929 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' HB3' ' NH2' ' A' ' 56' ' ' ARG . 9.5 tp10 . . . . . 0 C--O 1.29 3.201 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.221 -0.426 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -86.33 93.46 9.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.0 145.46 0.08 Allowed 'General case' 0 C--O 1.269 2.13 0 O-C-N 125.39 1.681 . . . . 0.0 108.521 -168.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.0 mmt -109.12 -158.66 0.66 Allowed 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.61 13.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.463 1.125 . . . . 0.0 110.592 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.97 86.14 1.5 Allowed 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.68 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.72 8.65 33.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.12 0.962 . . . . 0.0 112.878 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.47 117.95 35.4 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -110.54 146.55 34.55 Favored Pre-proline 0 C--N 1.289 -2.055 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.556 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.652 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.4 Cg_exo -61.44 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.237 2.625 . . . . 0.0 111.748 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.71 5.28 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.29 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.5 148.9 44.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.648 0.261 . . . . 0.0 111.35 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.62 116.36 52.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.64 166.68 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 112.598 -169.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' HZ3' ' C ' ' A' ' 59' ' ' GLU . 39.0 pttt -110.95 125.56 53.82 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 168.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.34 133.4 60.14 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.999 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.79 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -82.53 90.79 6.8 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.28 -50.64 67.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.791 -2.004 . . . . 0.0 111.733 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -147.18 144.96 29.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.42 66.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.56 8.07 35.94 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.835 0.35 . . . . 0.0 111.227 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -128.61 -44.77 1.35 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.225 0.535 . . . . 0.0 109.82 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 96.05 -153.69 20.63 Favored Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.01 113.02 9.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.74 0.816 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.6 161.07 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -80.02 131.2 35.74 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.98 173.52 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.152 0.501 . . . . 0.0 110.297 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.14 134.51 36.45 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 40.1 t -70.24 118.08 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.652 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 19.8 mt -107.95 -33.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.079 -172.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.512 ' HG3' ' N ' ' A' ' 32' ' ' VAL . 7.0 ttp180 -157.54 155.98 31.18 Favored 'General case' 1 N--CA 1.343 -5.788 0 CA-C-O 122.498 1.142 . . . . 0.0 112.443 -170.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.512 ' N ' ' HG3' ' A' ' 31' ' ' ARG . 14.3 m -109.33 121.48 62.43 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.57 0 CA-C-N 112.215 -2.266 . . . . 0.0 106.611 170.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 1.0 OUTLIER -98.86 -168.61 1.66 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 178.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 m -115.52 163.24 16.04 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.06 76.04 Favored Glycine 0 C--O 1.214 -1.151 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.778 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.58 55.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.418 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 11.9 ttt180 -76.59 110.65 11.34 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t -97.78 129.47 47.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 172.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG11 ' HG3' ' A' ' 47' ' ' GLU . 16.5 t -106.37 125.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.048 0 CA-C-O 121.723 0.773 . . . . 0.0 113.03 -174.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 35.8 m -132.62 141.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 170.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.44 HE21 ' HA2' ' A' ' 45' ' ' GLY . 53.8 tt0 -125.49 126.76 45.4 Favored 'General case' 0 C--N 1.26 -3.29 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 t -78.67 168.34 19.9 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.85 -4.5 35.22 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.557 0.694 . . . . 0.0 111.37 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -72.81 -17.12 61.59 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.643 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA2' HE21 ' A' ' 41' ' ' GLN . . . 92.55 9.87 61.05 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.749 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.6 104.55 16.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HG3' HG11 ' A' ' 39' ' ' VAL . 21.7 tt0 -80.51 118.53 22.19 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.55 175.42 9.6 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.785 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.9 m -100.08 119.32 38.12 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.97 136.61 48.97 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.334 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.516 ' C ' ' H ' ' A' ' 53' ' ' ASN . 51.8 mtp180 -90.79 154.03 19.81 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.65 29.19 0.88 Allowed Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.075 0.819 . . . . 0.0 112.744 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.8 m120 -125.08 -8.55 7.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -116.81 -1.55 12.02 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.133 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 51' ' ' ARG . 22.3 t -124.16 136.21 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 CA-C-O 121.237 0.541 . . . . 0.0 109.864 -171.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -139.14 134.94 33.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.58 -173.02 0.86 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.555 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.7 pt -63.84 93.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.893 0.854 . . . . 0.0 113.126 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' C ' ' HZ3' ' A' ' 15' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.507 -0.675 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -141.89 151.23 42.47 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.98 96.27 10.66 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -125.91 94.69 4.18 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.367 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.18 100.9 13.65 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.279 1.038 . . . . 0.0 111.064 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.2 mt -121.0 93.95 4.19 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.305 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -82.28 85.14 6.9 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.44 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt -148.46 138.11 22.15 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.425 -2.17 . . . . 0.0 106.559 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -121.58 155.9 59.05 Favored Pre-proline 0 C--N 1.292 -1.911 0 CA-C-O 121.082 0.468 . . . . 0.0 110.941 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.589 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 4.3 Cg_exo -69.14 111.01 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 121.819 1.679 . . . . 0.0 110.827 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.7 4.55 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.676 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 20.9 m-20 -60.03 125.16 22.57 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.15 103.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.439 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 30.1 m -131.32 176.88 7.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.797 -173.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.505 ' HZ2' ' C ' ' A' ' 59' ' ' GLU . 27.3 pttt -105.39 123.73 48.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.142 174.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.79 134.36 66.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -85.9 100.11 11.87 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -73.38 -66.03 0.74 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.6 m -121.41 140.3 52.32 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.219 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.67 66.4 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.33 2.73 53.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -124.74 -44.25 1.96 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 0.0 109.989 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.89 -151.35 20.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -73.38 108.27 6.15 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.663 0.785 . . . . 0.0 110.761 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.0 m -110.71 165.26 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.649 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -82.02 124.29 29.66 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.25 162.83 34.54 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.546 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 1.6 mpp_? -123.92 136.96 54.67 Favored 'General case' 0 CA--C 1.476 -1.88 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.028 176.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 46.5 t -71.49 115.08 10.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.589 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 57.5 mt -82.94 -41.03 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.384 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.467 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.8 ptp85 -160.48 157.89 28.36 Favored 'General case' 1 N--CA 1.345 -5.679 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.874 -177.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.49 116.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.774 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.686 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 14.1 mttm -120.31 164.71 15.89 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.742 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 p -95.37 174.35 7.07 Favored 'General case' 0 N--CA 1.388 -3.547 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.107 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.48 5.24 89.31 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.24 25.81 60.89 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.572 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 0.3 OUTLIER -95.91 41.15 1.11 Allowed 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.483 1.135 . . . . 0.0 109.222 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -67.48 117.61 9.31 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.217 -1.811 . . . . 0.0 108.754 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.549 HG23 ' NH1' ' A' ' 37' ' ' ARG . 88.1 t -92.25 128.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.217 -171.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.0 m -137.29 154.88 31.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -132.89 126.6 32.51 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -71.71 162.16 29.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 124.2 0.937 . . . . 0.0 109.632 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.92 -15.56 13.43 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -87.66 13.37 10.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.335 -0.228 . . . . 0.0 110.903 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.34 35.78 77.1 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-O 121.373 0.429 . . . . 0.0 113.107 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.0 mtp85 -113.94 109.22 18.15 Favored 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 122.851 0.46 . . . . 0.0 110.154 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -84.23 140.63 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -154.92 168.78 25.81 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.572 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 9.5 t -97.54 125.35 42.19 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.68 167.07 10.03 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.755 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -122.1 153.78 38.23 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.39 -20.24 43.85 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.194 0.838 . . . . 0.0 115.194 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.65 -7.36 52.87 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.027 -0.69 . . . . 0.0 110.939 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -104.6 1.21 29.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.37 133.41 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.914 0 CA-C-O 121.575 0.702 . . . . 0.0 109.403 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.439 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 21.5 mmm180 -137.87 135.12 35.86 Favored 'General case' 1 N--CA 1.379 -4.003 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.808 177.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.42 ' H ' HD21 ' A' ' 57' ' ' LEU . 2.5 pt? -70.16 -175.89 1.06 Allowed 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.44 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -71.5 73.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 122.524 1.154 . . . . 0.0 112.394 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.505 ' C ' ' HZ2' ' A' ' 15' ' ' LYS . 39.9 tt0 . . . . . 0 C--N 1.29 -1.996 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -172.01 -171.18 0.83 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.17 30.65 6.01 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 118.249 0.477 . . . . 0.0 109.75 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.1 ttt -109.89 -25.84 10.09 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.718 0.77 . . . . 0.0 110.964 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -88.67 141.53 28.44 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.06 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.04 93.66 8.86 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.851 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -95.47 87.9 4.91 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 167.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.45 126.5 46.87 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.423 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -85.08 153.69 60.02 Favored Pre-proline 0 N--CA 1.411 -2.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.093 -175.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.546 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 6.4 Cg_exo -66.43 103.2 0.64 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.299 1.999 . . . . 0.0 110.918 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.68 -16.56 2.64 Favored Glycine 0 N--CA 1.424 -2.138 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.144 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.4 159.23 34.56 Favored 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.235 0.609 . . . . 0.0 109.442 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.97 113.48 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.8 m -131.83 169.18 22.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.611 -173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -103.18 124.04 47.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 38.3 t -123.38 129.13 74.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -91.39 106.15 18.29 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.99 -69.97 0.41 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.226 1.012 . . . . 0.0 109.324 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.4 m -124.38 147.84 47.96 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 113.789 -1.551 . . . . 0.0 108.991 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.0 -23.36 66.38 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.5 -1.58 57.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.8 0.334 . . . . 0.0 111.518 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.37 -42.0 2.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.282 0.563 . . . . 0.0 109.658 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 -156.72 28.04 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -75.47 109.15 8.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.068 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -107.43 145.24 15.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.479 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -84.42 124.91 31.83 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -177.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.16 151.9 51.1 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.359 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -106.64 131.25 54.0 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 45.0 t -68.41 113.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.0 mt -91.26 -40.58 12.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 121.537 0.684 . . . . 0.0 109.886 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.42 ' CG ' ' HG3' ' A' ' 33' ' ' LYS . 10.7 tpp180 -155.39 143.1 19.76 Favored 'General case' 1 N--CA 1.368 -4.563 0 CA-C-O 122.14 0.972 . . . . 0.0 110.341 -176.097 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -95.79 89.26 2.22 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.029 0 CA-C-N 113.258 -1.792 . . . . 0.0 108.908 173.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 43.7 mttt -84.27 154.04 23.2 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 174.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t -100.31 -175.96 3.08 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.042 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.14 -62.16 4.28 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.11 46.53 0.02 OUTLIER Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -131.1 27.81 4.81 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.302 -174.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t -55.74 123.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 37' ' ' ARG . 1.7 t -109.58 131.47 60.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -166.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.64 149.22 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 113.014 -1.903 . . . . 0.0 106.073 174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.24 123.4 38.05 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 m -76.75 168.74 19.57 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.081 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -58.95 -17.41 24.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.831 1.652 . . . . 0.0 111.514 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -83.33 7.72 15.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.394 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.22 42.22 99.72 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -124.09 104.75 9.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.746 -171.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -82.67 132.08 35.19 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -151.87 175.6 12.3 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 121.32 -0.152 . . . . 0.0 110.614 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 11.7 t -91.62 143.76 26.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' A' ' 55' ' ' VAL . . . -118.7 146.84 44.41 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.298 0.571 . . . . 0.0 111.192 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.8 mtp-105 -125.24 150.58 46.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.48 -19.47 41.26 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 115.038 0.775 . . . . 0.0 115.038 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.53 -12.6 53.87 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.487 0.66 . . . . 0.0 110.146 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 37.8 mt-30 -114.65 0.18 13.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.092 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.557 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 t -127.12 124.52 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.566 0 CA-C-O 121.925 0.869 . . . . 0.0 111.114 -174.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.557 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 15.9 mmm180 -132.29 137.11 47.35 Favored 'General case' 1 N--CA 1.368 -4.561 0 CA-C-N 113.831 -1.531 . . . . 0.0 106.935 177.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.1 pp -57.0 168.15 0.7 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.548 0.53 . . . . 0.0 111.826 172.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt -72.16 115.25 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.601 0.715 . . . . 0.0 110.334 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--N 1.273 -2.728 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 -179.826 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 CA--C 1.505 -0.766 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -117.67 121.05 39.85 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.85 85.08 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.302 0.573 . . . . 0.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -110.79 -9.81 14.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.305 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -81.54 112.91 19.2 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.811 0.815 . . . . 0.0 110.558 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.26 117.27 6.78 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.9 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -99.6 25.96 6.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.892 0.853 . . . . 0.0 110.695 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -118.89 139.11 52.18 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.032 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -120.41 159.21 48.83 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.385 0.674 . . . . 0.0 109.652 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.67 94.11 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.798 1.665 . . . . 0.0 112.333 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.15 -19.0 0.83 Allowed Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.311 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.35 129.22 39.08 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -84.54 114.27 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 57' ' ' LEU . 34.9 m -125.29 173.44 11.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.298 -169.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -119.38 129.1 54.64 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.444 HG11 HG23 ' A' ' 40' ' ' VAL . 30.8 m -123.97 127.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.527 0.679 . . . . 0.0 112.187 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.3 tp -91.59 86.97 6.17 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.64 -57.15 6.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.2 t -125.62 153.44 43.76 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.81 60.9 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.41 -15.13 33.92 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -104.99 -40.06 6.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.286 0.565 . . . . 0.0 110.215 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.48 -175.87 46.11 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.29 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -62.39 108.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.176 0.991 . . . . 0.0 111.571 175.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 m -101.86 148.09 7.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -75.78 140.1 42.17 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -155.9 177.18 11.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -134.22 139.73 46.0 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 47.1 t -69.44 122.45 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -89.59 -44.43 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.678 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.483 HH21 ' CD ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -154.05 160.23 41.9 Favored 'General case' 1 N--CA 1.342 -5.872 0 CA-C-O 122.194 0.997 . . . . 0.0 111.325 -175.609 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.7 t -118.51 129.99 73.99 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.349 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.646 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -117.5 179.63 4.0 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 171.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -110.86 175.87 5.25 Favored 'General case' 0 N--CA 1.403 -2.806 0 C-N-CA 117.557 -1.657 . . . . 0.0 109.594 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.27 18.24 65.02 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.48 56.01 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.95 98.13 7.65 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 123.476 1.608 . . . . 0.0 110.827 -176.005 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 49' ' ' THR . 2.4 m -118.88 123.8 72.1 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 CA-C-N 112.94 -1.936 . . . . 0.0 110.698 -176.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.446 HG13 ' CG ' ' A' ' 47' ' ' GLU . 2.3 t -107.19 124.01 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 33.7 m -129.07 152.65 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.73 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 18.9 tt0 -116.84 122.38 44.21 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 23.2 t -82.93 173.18 12.04 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 123.648 0.592 . . . . 0.0 109.637 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.03 -9.15 3.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.573 1.149 . . . . 0.0 113.312 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.746 ' N ' HE21 ' A' ' 44' ' ' GLN . 0.0 OUTLIER -91.58 5.68 48.66 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.89 19.56 79.87 Favored Glycine 0 C--O 1.216 -0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.339 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -108.44 118.32 36.47 Favored 'General case' 0 N--CA 1.403 -2.808 0 O-C-N 122.406 -0.467 . . . . 0.0 111.264 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.483 ' CD ' HH21 ' A' ' 31' ' ' ARG . 57.5 tt0 -88.6 133.8 34.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.6 174.28 14.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 38' ' ' VAL . 88.7 m -116.55 135.47 53.79 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.754 0.312 . . . . 0.0 111.149 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.73 174.48 7.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -82.83 156.66 23.51 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.15 -20.84 51.61 Favored Glycine 0 C--O 1.212 -1.241 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.56 -15.35 46.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.254 0.55 . . . . 0.0 110.343 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.0 -6.47 51.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.814 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 22.9 t -120.94 121.4 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 8.6 mmm180 -133.54 135.34 44.3 Favored 'General case' 1 N--CA 1.378 -4.031 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.23 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.441 ' HA ' HG13 ' A' ' 14' ' ' VAL . 1.9 pp -56.11 161.93 2.18 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.729 0.643 . . . . 0.0 110.915 170.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.266 38.3 pt -73.06 82.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.268 2.052 0 N-CA-C 102.251 -3.24 . . . . 0.0 102.251 172.363 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.18 140.8 39.97 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.97 25.68 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 O-C-N 125.176 1.547 . . . . 0.0 109.72 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.406 ' C ' ' H ' ' A' ' 6' ' ' LEU . 51.5 ttm -143.01 9.98 1.73 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.716 0.769 . . . . 0.0 110.658 -173.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -76.68 30.19 0.13 Allowed 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.721 1.209 . . . . 0.0 113.081 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.406 ' H ' ' C ' ' A' ' 4' ' ' MET . 90.8 mt -91.67 85.0 5.54 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.66 83.92 7.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.506 1.146 . . . . 0.0 110.675 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -154.54 140.76 18.55 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.276 -2.238 . . . . 0.0 105.13 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -132.23 152.37 80.01 Favored Pre-proline 0 C--N 1.298 -1.658 0 CA-C-N 118.203 0.456 . . . . 0.0 110.612 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 11.2 Cg_exo -66.7 116.88 4.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.555 2.17 . . . . 0.0 110.427 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.41 9.24 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.36 159.66 32.09 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.802 0.441 . . . . 0.0 111.22 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.52 115.04 46.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 57' ' ' LEU . 27.5 m -130.46 177.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.432 0.634 . . . . 0.0 111.598 -173.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -110.85 124.75 52.66 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.5 t -129.69 133.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.58 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.41 91.22 8.71 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.08 -49.36 72.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.473 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 m -146.05 145.85 30.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.743 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.63 -22.41 66.88 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.66 5.02 45.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 -43.3 1.51 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.167 0.508 . . . . 0.0 109.79 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 94.61 -156.55 22.06 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.363 179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.8 110.66 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.619 0.768 . . . . 0.0 110.322 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.41 167.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.443 ' HD2' ' CG ' ' A' ' 43' ' ' ASP . 35.5 ttm180 -73.82 129.78 38.6 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 166.84 22.52 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -127.0 140.65 52.15 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.0 t -82.04 109.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mp -90.19 -36.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.338 0.589 . . . . 0.0 110.346 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.45 ' NH2' HG11 ' A' ' 39' ' ' VAL . 2.0 ttp-105 -148.37 142.26 25.78 Favored 'General case' 1 N--CA 1.336 -6.164 0 CA-C-O 122.714 1.245 . . . . 0.0 111.683 -174.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.92 130.63 65.21 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.292 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.849 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 3.4 tptp -99.82 -150.17 0.37 Allowed 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -134.89 167.09 21.53 Favored 'General case' 0 N--CA 1.39 -3.468 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.754 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.62 -88.76 1.57 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.01 36.31 0.77 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 47.0 ttt180 -121.76 133.71 54.92 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 m -135.9 135.46 50.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.646 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 HG11 ' NH2' ' A' ' 31' ' ' ARG . 25.6 t -114.43 123.55 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -128.29 155.83 40.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -171.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 51.6 tt0 -121.09 121.13 37.22 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.8 m -57.68 146.61 30.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.443 ' CG ' ' HD2' ' A' ' 26' ' ' ARG . 24.3 t70 -60.26 -18.95 52.54 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.959 0.885 . . . . 0.0 111.217 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -82.47 -2.32 52.94 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.1 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.75 -16.12 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -79.83 112.04 16.73 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.117 1.458 . . . . 0.0 113.756 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 25.6 tt0 -89.55 128.41 36.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.7 170.4 22.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -107.21 136.41 47.08 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.68 172.76 12.12 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -87.23 165.64 15.53 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.1 2.56 42.85 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-O 122.039 0.8 . . . . 0.0 111.55 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -90.97 -27.09 18.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.0 mt-30 -96.88 -14.79 21.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.56 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 29.7 t -122.16 122.28 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 28.1 mmm180 -130.54 133.74 46.47 Favored 'General case' 1 N--CA 1.377 -4.09 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.44 ' HA ' HG11 ' A' ' 14' ' ' VAL . 2.0 pp -62.61 176.35 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 123.837 0.71 . . . . 0.0 112.488 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 pt -68.93 89.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.271 2.229 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 176.114 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.214 -0.778 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 67.32 -168.0 0.2 Allowed 'General case' 0 C--N 1.351 0.663 0 O-C-N 124.194 0.933 . . . . 0.0 109.993 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.55 77.97 1.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -131.5 152.52 50.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.616 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -133.06 -152.15 0.48 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.61 75.15 9.74 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.685 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 9.99 30.35 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.58 118.48 27.08 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -115.73 160.26 35.63 Favored Pre-proline 0 C--N 1.286 -2.181 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.774 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.581 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 38.3 Cg_exo -57.61 128.23 28.46 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.61 -12.86 15.47 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.701 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -71.53 155.77 40.19 Favored 'General case' 0 C--O 1.25 1.103 0 C-N-CA 122.726 0.41 . . . . 0.0 111.102 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -112.62 107.71 23.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.9 m -125.5 171.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.913 0.864 . . . . 0.0 111.68 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -123.02 127.38 48.71 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -123.26 129.9 74.6 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.2 tt -85.09 100.7 11.88 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.6 -66.28 0.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.257 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.8 m -140.3 149.59 42.97 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.839 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.62 84.98 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.325 0.584 . . . . 0.0 109.806 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 177.12 -41.3 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 126.034 1.734 . . . . 0.0 106.351 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.7 -43.48 8.24 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.56 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 89.52 -151.27 21.76 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.648 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -75.99 106.21 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.442 0.697 . . . . 0.0 110.907 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.75 145.07 12.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -71.93 136.67 46.93 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -145.62 165.44 28.7 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -123.11 130.94 53.44 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.5 t -70.21 113.97 7.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 50.9 mm -91.43 -39.27 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.581 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -163.37 166.05 23.35 Favored 'General case' 1 N--CA 1.342 -5.842 0 CA-C-O 122.603 1.192 . . . . 0.0 113.013 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.63 133.39 56.25 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 CA-C-N 112.613 -2.085 . . . . 0.0 105.94 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.471 ' CB ' ' HD2' ' A' ' 37' ' ' ARG . 12.2 tptp -96.92 -60.42 1.59 Allowed 'General case' 0 CA--C 1.455 -2.71 0 CA-C-O 121.857 0.837 . . . . 0.0 109.749 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -148.19 -177.41 5.73 Favored 'General case' 1 N--CA 1.375 -4.218 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.589 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.3 78.25 0.83 Allowed Glycine 0 C--O 1.217 -0.967 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.68 -13.5 5.07 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.56 ' NH1' HG22 ' A' ' 39' ' ' VAL . 2.2 tmt_? -120.58 122.97 41.73 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.02 167.31 25.51 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.877 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.797 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.56 HG22 ' NH1' ' A' ' 37' ' ' ARG . 0.5 OUTLIER -136.11 128.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.014 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 29' ' ' VAL . 32.9 m -126.3 143.15 40.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 24.8 tt0 -107.24 126.92 53.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.5 t -92.29 175.68 6.76 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.56 -13.95 55.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.82 0.848 . . . . 0.0 111.63 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -77.44 -0.72 26.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.557 175.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.66 20.37 77.26 Favored Glycine 0 C--O 1.22 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.549 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -112.15 118.69 36.06 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.471 ' HG2' HG11 ' A' ' 39' ' ' VAL . 22.1 tt0 -87.12 122.06 30.41 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.9 170.03 16.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.875 0.369 . . . . 0.0 111.495 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.477 ' HB ' ' NH1' ' A' ' 37' ' ' ARG . 12.6 t -85.99 134.64 33.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.154 0.502 . . . . 0.0 109.697 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.72 159.32 22.44 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.515 ' HD2' ' OE1' ' A' ' 54' ' ' GLN . 60.5 mtt180 -114.05 141.74 47.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.53 34.25 Favored Glycine 0 N--CA 1.474 1.173 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -85.73 1.62 48.73 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.75 0.786 . . . . 0.0 112.291 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.515 ' OE1' ' HD2' ' A' ' 51' ' ' ARG . 24.7 mt-30 -115.16 9.13 15.78 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.302 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.2 t -124.38 137.37 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.121 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.461 HH21 ' C ' ' A' ' 59' ' ' GLU . 7.8 mmm180 -140.36 139.12 35.31 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.434 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.5 pt? -71.92 -161.22 0.07 Allowed 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 173.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -72.44 64.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.626 1.203 . . . . 0.0 112.086 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' C ' HH21 ' A' ' 56' ' ' ARG . 8.4 tp10 . . . . . 0 C--N 1.295 -1.793 0 C-N-CA 129.128 2.971 . . . . 0.0 104.587 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 10.3 Cg_exo . . . . . 0 N--CA 1.451 -1.004 0 CA-C-O 121.03 0.346 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.63 -8.59 22.02 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -72.4 155.75 39.8 Favored 'General case' 0 C--O 1.259 1.555 0 C-N-CA 123.124 0.57 . . . . 0.0 111.478 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 26' ' ' ARG . 8.4 p -126.39 100.66 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.092 1.357 . . . . 0.0 110.212 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.28 169.22 21.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.946 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -100.48 128.89 46.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 55' ' ' VAL . 21.8 m -128.58 141.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.0 93.56 9.39 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.504 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 38.0 tt0 -65.18 -53.6 42.41 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.942 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.9 m -148.84 149.29 31.05 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.27 -26.8 66.75 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 7.09 36.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 0.0 111.511 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.73 -44.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.0 110.142 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.44 -152.7 21.32 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.097 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.82 109.11 7.07 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 123.57 0.748 . . . . 0.0 111.062 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.69 176.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD3' HG23 ' A' ' 13' ' ' VAL . 3.5 tmm_? -105.82 126.0 51.66 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.501 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.06 178.81 5.33 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.695 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -133.55 131.29 39.56 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 40' ' ' VAL . 48.5 t -79.16 120.21 29.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.666 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.7 mp -95.43 -38.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.122 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 9.5 tpp180 . . . . . 0 N--CA 1.392 -3.339 0 CA-C-O 121.629 0.728 . . . . 0.0 110.394 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.9 t . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 121.533 0.683 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 47' ' ' GLU . 76.7 t -101.89 118.05 48.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.12 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 29' ' ' VAL . 26.8 m -130.94 152.91 38.35 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 172.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -137.0 130.56 31.63 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -84.43 170.97 13.0 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -74.03 -4.14 33.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -10.15 59.39 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.53 -5.42 70.36 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.132 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.504 ' HD3' ' OE2' ' A' ' 18' ' ' GLU . 13.6 ptm180 -78.26 125.45 29.37 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 117.281 0.541 . . . . 0.0 111.262 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.509 ' HG3' HG13 ' A' ' 39' ' ' VAL . 8.6 tt0 -88.32 146.61 25.21 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 18.7 p90 -153.76 164.67 37.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 120.843 0.354 . . . . 0.0 110.589 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.9 t -86.9 116.25 24.84 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.213 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -95.59 160.37 14.54 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HD3' ' OE1' ' A' ' 54' ' ' GLN . 5.7 mpt_? -136.8 162.42 33.27 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.89 -3.87 38.02 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 121.343 -0.456 . . . . 0.0 113.757 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -96.77 -9.68 28.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.408 0.623 . . . . 0.0 109.63 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.491 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 51.9 mt-30 -113.73 -2.32 13.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.922 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 16' ' ' VAL . 35.1 t -130.79 135.36 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.962 -172.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -137.39 124.0 21.0 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.207 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.8 pt? -101.85 115.15 29.91 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.292 35.3 pt . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.446 -1.293 0 N-CA-C 110.974 -0.433 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.36 -9.99 39.03 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -73.32 159.03 33.99 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.87 95.37 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.8 m -114.89 178.33 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.468 -169.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -113.66 126.63 55.47 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 84.7 t -127.17 133.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.8 tt -84.89 91.85 8.13 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.02 -50.49 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.556 -1.657 . . . . 0.0 109.926 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 t -132.96 149.88 52.2 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -18.39 62.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.005 0.431 . . . . 0.0 110.145 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.34 -16.09 29.86 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -104.14 -33.21 8.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.0 110.841 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 86.1 -158.12 31.35 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -73.31 104.49 4.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.618 0.767 . . . . 0.0 110.532 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.66 163.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 34.6 ttm180 -79.82 126.46 31.0 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -133.31 160.77 36.34 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.563 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -125.68 124.46 41.18 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.8 t -70.94 118.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -90.37 -42.67 14.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 . . . . . 1 N--CA 1.378 -4.041 0 CA-C-O 121.537 0.684 . . . . 0.0 109.655 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.42 -1.939 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.41 111.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.986 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 29' ' ' VAL . 34.2 m -135.02 147.1 29.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -129.3 121.47 27.58 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 67.6 m -65.59 157.14 30.6 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.954 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.64 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 45.6 m-20 -65.32 2.88 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.498 0.666 . . . . 0.0 112.62 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 41.9 mt-30 -87.12 -5.81 58.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.81 9.32 78.13 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 121.8 0.666 . . . . 0.0 111.479 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 27.5 mtp85 -95.28 111.81 23.61 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 123.823 0.849 . . . . 0.0 110.522 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -94.95 153.27 17.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -170.9 144.86 2.27 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 123.795 0.684 . . . . 0.0 110.801 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -74.33 95.63 2.71 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.909 0.861 . . . . 0.0 111.535 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.94 159.13 19.12 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -107.02 160.61 15.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.82 2.33 12.83 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -102.69 -9.46 20.03 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.566 0.698 . . . . 0.0 109.14 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.7 mt-30 -100.5 -4.22 29.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.97 133.4 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -137.32 139.91 41.16 Favored 'General case' 0 N--CA 1.391 -3.421 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . 82.5 mt -67.85 -171.86 0.24 Allowed 'General case' 0 C--N 1.291 -1.939 0 O-C-N 123.493 0.496 . . . . 0.0 110.489 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 C--N 1.315 -0.913 0 CA-C-O 122.547 1.165 . . . . 0.0 111.714 174.885 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 17.7 Cg_endo . . . . . 0 N--CA 1.439 -1.704 0 N-CA-C 110.828 -0.489 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.58 6.4 35.54 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -73.39 -175.04 1.81 Allowed 'General case' 0 C--O 1.25 1.1 0 C-N-CA 124.823 1.249 . . . . 0.0 110.932 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.55 106.44 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 32.7 m -132.58 176.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.789 0.804 . . . . 0.0 112.273 -168.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 9.7 pttm -113.73 132.96 55.63 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.202 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 m -124.34 125.86 71.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.604 0.716 . . . . 0.0 111.873 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.3 tp -88.86 92.83 9.37 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.52 -59.77 3.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.958 0.885 . . . . 0.0 109.814 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.3 m -146.27 156.08 43.11 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -14.91 63.35 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.59 0.71 56.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.737 0.303 . . . . 0.0 111.046 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -129.83 -53.46 1.14 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.26 0.553 . . . . 0.0 109.805 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 103.06 -172.6 21.69 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.068 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 85.3 m95 -62.31 114.51 3.52 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.273 1.029 . . . . 0.0 111.489 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.3 163.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.408 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 38.6 ttm105 -79.52 133.75 36.49 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -154.41 172.61 17.45 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.073 0.463 . . . . 0.0 110.845 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -130.73 130.47 43.84 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.4 t -71.03 115.52 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 39' ' ' VAL . 46.0 mm -86.35 -42.57 15.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 12.3 tpp180 . . . . . 0 N--CA 1.382 -3.868 0 CA-C-O 122.135 0.969 . . . . 0.0 111.137 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 49' ' ' THR . 21.6 t . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 30' ' ' ILE . 58.8 t -107.78 115.94 50.07 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.06 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.5 m -135.29 143.62 36.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 28.5 tt0 -130.87 126.9 37.41 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.484 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 46.3 t -77.27 167.69 21.3 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.626 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 5.9 p-10 -76.29 -6.55 51.96 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.281 1.039 . . . . 0.0 110.477 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -84.62 6.79 22.56 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.099 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.49 16.13 75.57 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 122.139 0.855 . . . . 0.0 111.462 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -93.13 98.28 11.21 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.384 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 3.4 tm-20 -95.57 150.87 19.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -171.39 153.14 3.47 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.011 0.819 . . . . 0.0 111.285 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.2 t -78.76 112.47 15.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.903 0.858 . . . . 0.0 109.44 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.15 177.56 5.54 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.737 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.531 ' O ' HG23 ' A' ' 55' ' ' VAL . 54.6 mtp180 -123.58 146.49 48.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.22 -14.65 57.18 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.941 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.86 -6.2 58.87 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.503 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.0 mt-30 -120.98 14.21 11.47 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.158 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 51' ' ' ARG . 12.6 t -133.39 136.83 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.476 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 5.3 mmm180 -140.11 150.73 44.66 Favored 'General case' 1 N--CA 1.375 -4.205 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.08 178.033 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 91.4 mt -57.97 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 123.191 1.472 . . . . 0.0 111.427 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 C--N 1.255 -3.517 0 O-C-N 120.846 -1.159 . . . . 0.0 112.415 175.055 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.622 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.1 Cg_exo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.46 -6.97 9.12 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 3.8 t70 -70.7 158.81 35.61 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.72 0.808 . . . . 0.0 110.367 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -127.61 108.8 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 122.635 1.207 . . . . 0.0 111.982 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 28.6 m -134.81 -172.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.643 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -127.66 140.54 52.02 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 55' ' ' VAL . 25.1 m -130.59 146.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.66 112.26 24.77 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -80.21 -71.6 0.45 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.34 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -116.24 139.54 50.25 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.912 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.62 66.01 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 112.325 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 5.5 41.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -127.34 -52.05 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.67 -154.25 18.36 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.45 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -78.21 118.54 20.53 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.206 1.002 . . . . 0.0 111.333 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 163.18 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 18.3 tpp180 -87.6 114.42 24.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -107.77 140.6 40.6 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.943 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 55.7 mtm180 -113.31 119.27 37.1 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 49.0 t -69.47 111.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.6 mm -94.3 -33.73 5.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.14 0.495 . . . . 0.0 110.827 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' NE ' HG21 ' A' ' 39' ' ' VAL . 8.8 ttp180 . . . . . 1 N--CA 1.347 -5.587 0 CA-C-O 122.095 0.95 . . . . 0.0 108.614 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 49' ' ' THR . 60.2 t . . . . . 0 CA--C 1.503 -0.838 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG21 ' NE ' ' A' ' 31' ' ' ARG . 63.1 t -125.05 116.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 119.509 1.049 . . . . 0.0 112.126 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.89 142.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 29.6 tt0 -127.18 108.28 10.76 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.915 0.864 . . . . 0.0 109.008 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 15.6 m -70.82 169.34 14.84 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.856 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -28.26 -58.83 0.12 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 128.552 2.741 . . . . 0.0 114.359 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -59.22 -19.45 45.62 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.173 1.789 . . . . 0.0 112.595 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.1 21.06 23.96 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -172.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -90.43 99.88 12.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.238 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -91.45 142.9 27.16 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -165.13 176.47 8.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.875 0.734 . . . . 0.0 110.755 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.5 t -96.71 117.51 31.17 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-O 121.638 0.732 . . . . 0.0 110.493 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.53 169.52 10.96 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.899 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 55' ' ' VAL . 24.4 mmt180 -131.41 145.45 51.81 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.35 -34.3 48.13 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 115.253 0.861 . . . . 0.0 115.253 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.2 -0.06 43.41 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 122.149 -0.618 . . . . 0.0 111.739 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -114.46 9.42 16.75 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.8 t -124.83 139.89 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-O 121.128 0.489 . . . . 0.0 109.882 -174.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -137.66 129.28 28.33 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.02 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -99.6 131.87 45.31 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--O 1.248 1.02 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -172.669 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 13.8 Cg_exo . . . . . 0 N--CA 1.438 -1.764 0 N-CA-C 111.044 -0.406 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.12 -12.83 9.72 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.196 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.16 169.73 14.47 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 122.805 0.442 . . . . 0.0 110.094 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.426 HG13 ' HE ' ' A' ' 26' ' ' ARG . 90.5 t -129.82 111.57 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.42 0.628 . . . . 0.0 110.691 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -131.76 169.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.878 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -111.9 133.18 54.25 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.949 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 40' ' ' VAL . 18.3 m -127.34 137.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.419 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.6 tt -89.01 93.68 9.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.0 -49.89 66.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.182 -1.826 . . . . 0.0 110.966 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.7 m -147.25 148.05 31.05 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.506 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.17 68.12 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.8 8.74 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.965 0.412 . . . . 0.0 111.211 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.98 -45.21 1.03 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.288 0.566 . . . . 0.0 109.51 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 95.06 -154.54 21.19 Favored Glycine 0 N--CA 1.423 -2.167 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -72.56 108.14 5.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.863 0.865 . . . . 0.0 110.833 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.58 146.4 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.426 ' HE ' HG13 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -73.52 134.64 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.07 166.39 24.93 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.699 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -119.21 142.19 48.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 40' ' ' VAL . 59.8 t -75.17 121.5 26.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.9 mm -89.47 -38.99 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.157 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 1 N--CA 1.343 -5.805 0 CA-C-O 121.943 0.877 . . . . 0.0 110.538 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 49' ' ' THR . 2.7 m . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 41.8 t -110.12 122.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.202 -174.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 16' ' ' VAL . 34.7 m -126.75 153.74 35.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.562 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 34.1 tt0 -123.52 123.93 41.71 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.4 t -78.08 170.24 16.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.75 1.86 13.66 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.062 0.934 . . . . 0.0 111.472 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -89.76 0.33 57.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.468 174.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 11.69 84.03 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 99.8 mtt180 -87.74 101.87 14.1 Favored 'General case' 0 N--CA 1.41 -2.427 0 C-N-CA 122.925 0.49 . . . . 0.0 110.24 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 38.0 tt0 -97.51 120.91 38.74 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.85 166.08 28.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.6 t -99.42 132.49 44.72 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.46 156.54 33.87 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.962 0.41 . . . . 0.0 111.005 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.3 mtp180 -84.68 157.71 21.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.57 8.03 6.09 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-O 121.766 0.648 . . . . 0.0 112.882 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -103.86 -8.84 19.43 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.0 mt-30 -111.93 -0.54 15.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.697 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 51' ' ' ARG . 5.9 t -127.82 138.26 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -139.53 152.36 46.85 Favored 'General case' 1 N--CA 1.377 -4.112 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.89 -169.73 0.5 Allowed 'General case' 0 C--N 1.27 -2.85 0 O-C-N 123.934 0.771 . . . . 0.0 109.817 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 pt . . . . . 0 C--N 1.306 -1.323 0 CA-C-O 122.518 1.152 . . . . 0.0 110.966 174.012 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.7 Cg_exo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.39 0.25 50.3 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.9 159.11 23.74 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 123.064 0.546 . . . . 0.0 110.076 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.03 100.21 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 122.734 1.254 . . . . 0.0 108.603 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 34.2 m -122.44 177.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.428 -166.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 47.9 pttt -117.94 134.07 55.31 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 40' ' ' VAL . 65.7 t -131.64 130.34 62.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.0 tt -90.86 100.5 13.35 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -66.79 -57.68 6.56 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.698 0.761 . . . . 0.0 110.563 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -147.17 160.59 42.27 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.514 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -25.77 67.52 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.01 7.1 36.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.848 0.356 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.34 -46.4 1.34 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.092 0.473 . . . . 0.0 109.981 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 88.85 -160.87 30.27 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.304 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.45 111.03 10.32 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.474 0.71 . . . . 0.0 111.091 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.39 154.78 4.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 44.7 ttt180 -75.32 136.64 40.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -148.14 163.5 36.76 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.142 0.972 . . . . 0.0 112.87 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -116.25 119.67 36.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 40' ' ' VAL . 60.7 t -70.19 111.16 3.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 41.4 mt -80.36 -45.2 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.389 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.92 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 3.0 ptp180 . . . . . 1 N--CA 1.343 -5.808 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.961 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.426 -1.668 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.558 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 3.0 m -129.66 138.86 53.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 16' ' ' VAL . 35.8 m -133.2 152.93 36.56 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.008 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 57.7 tt0 -116.92 124.45 49.45 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -83.05 173.76 11.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 26' ' ' ARG . 3.1 m-20 -61.04 -16.64 45.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.428 1.091 . . . . 0.0 110.778 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.17 1.33 21.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.673 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.71 87.85 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 116.233 -0.44 . . . . 0.0 113.391 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 35.7 ttt-85 -101.24 120.11 39.76 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.542 0.337 . . . . 0.0 111.564 -174.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.9 136.52 34.56 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -145.1 155.94 43.62 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -95.73 137.23 35.1 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.211 0.529 . . . . 0.0 111.358 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 172.39 13.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.4 mtp180 -85.56 160.19 19.7 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.82 -19.44 69.52 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.238 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -86.94 -1.88 58.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.436 0.636 . . . . 0.0 109.819 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.27 2.26 17.61 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 16' ' ' VAL . 38.4 t -125.22 133.02 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 5.9 mmm180 -138.91 140.86 38.48 Favored 'General case' 0 N--CA 1.385 -3.677 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.145 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -176.17 0.08 Allowed 'General case' 0 C--N 1.287 -2.112 0 O-C-N 123.901 0.75 . . . . 0.0 112.42 170.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.438 -1.026 0 CA-C-O 122.996 1.379 . . . . 0.0 110.157 171.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 42.3 Cg_exo . . . . . 0 N--CA 1.451 -1.024 0 CA-C-O 121.67 0.613 . . . . 0.0 111.398 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.46 -24.37 3.94 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.813 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -73.42 169.77 16.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.26 132.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -145.28 177.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 124.333 1.053 . . . . 0.0 108.712 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 39.8 pttt -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 40' ' ' VAL . 60.9 t -130.4 133.87 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -86.1 95.22 9.48 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.51 -59.92 4.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.799 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.2 m -139.1 149.0 44.04 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.25 66.89 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.56 8.03 38.55 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.996 0.427 . . . . 0.0 110.972 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.8 mt -130.02 -46.48 1.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.13 -158.26 20.05 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.346 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -72.41 112.22 8.29 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.965 0.906 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.91 152.28 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -78.19 135.24 37.58 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -143.97 159.24 42.92 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.85 0.833 . . . . 0.0 112.116 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -105.78 133.16 50.95 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.971 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 48.1 t -72.56 111.12 6.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 51.4 mm -91.02 -35.51 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.927 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.339 -6.006 0 CA-C-O 121.814 0.816 . . . . 0.0 108.925 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.244 0.772 0 N-CA-C 102.224 -3.25 . . . . 0.0 102.224 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.24 124.0 59.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 119.173 0.897 . . . . 0.0 108.848 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 16' ' ' VAL . 28.5 m -137.5 155.44 31.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.72 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 35.0 tt0 -121.77 124.22 43.68 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 22.3 t -75.65 171.98 13.38 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -10.99 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.402 1.096 . . . . 0.0 109.785 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -74.75 -9.88 58.98 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.721 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.2 85.28 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.441 -0.409 . . . . 0.0 112.529 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -91.11 125.71 35.98 Favored 'General case' 0 N--CA 1.407 -2.623 0 O-C-N 122.283 -0.54 . . . . 0.0 111.296 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 42.2 tt0 -92.07 134.56 34.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.71 153.57 42.59 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.6 t -113.08 116.78 30.42 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.787 0.803 . . . . 0.0 110.838 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.35 -171.34 1.94 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.968 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -100.98 164.59 11.74 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.86 -8.75 69.2 Favored Glycine 0 C--O 1.216 -1.009 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -85.79 -1.82 57.61 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -118.8 11.2 12.59 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.495 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.26 136.28 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 121.418 0.627 . . . . 0.0 109.336 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 18.7 mmm180 -132.72 129.69 39.03 Favored 'General case' 0 N--CA 1.395 -3.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.324 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.67 138.75 37.3 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.759 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.282 37.1 pt . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 126.415 1.886 . . . . 0.0 115.492 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 6.9 Cg_endo . . . . . 0 N--CA 1.45 -1.065 0 CA-C-O 121.152 0.397 . . . . 0.0 112.791 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.26 48.51 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.016 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.57 156.77 18.87 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-O 120.964 0.411 . . . . 0.0 110.985 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.5 106.94 21.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.1 m -123.03 173.31 9.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.97 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -110.34 126.81 54.64 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.074 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 55' ' ' VAL . 25.6 m -121.9 144.63 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -98.35 87.05 3.77 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 171.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -70.32 -42.12 72.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.072 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.7 m -144.44 142.43 30.3 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.681 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.08 67.15 Favored 'General case' 0 C--O 1.21 -0.994 0 C-N-CA 122.851 0.46 . . . . 0.0 112.164 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.02 3.79 47.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.917 0.389 . . . . 0.0 110.959 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -123.42 -44.79 2.11 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 92.27 -153.35 21.73 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.431 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 93.0 m95 -74.43 107.55 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 123.409 0.684 . . . . 0.0 110.722 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.83 171.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.773 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 41.1 ttm180 -82.35 140.81 33.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 16' ' ' VAL . . . -146.05 170.49 16.56 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.894 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 4.4 ptp180 -131.77 129.39 40.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 40' ' ' VAL . 33.1 t -77.81 112.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 31' ' ' ARG . 28.0 mt -86.09 -47.31 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.289 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 5.4 ptp180 . . . . . 1 N--CA 1.328 -6.527 0 C-N-CA 117.023 -1.871 . . . . 0.0 114.442 -170.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.478 -1.81 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.65 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 60.2 t -114.45 130.33 68.96 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 121.882 0.849 . . . . 0.0 112.672 -170.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 29' ' ' VAL . 29.7 m -124.89 159.82 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.583 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 35.4 tt0 -124.88 116.51 22.34 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 38.9 m -70.68 163.78 26.39 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 3.8 m-20 -62.96 -15.12 54.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.969 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -83.88 2.42 38.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.4 10.42 70.86 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 4.3 mpt_? -91.44 115.99 28.49 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 118.238 1.019 . . . . 0.0 110.29 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 31.2 tt0 -93.95 108.21 20.04 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -139.45 166.02 25.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.747 0.308 . . . . 0.0 110.633 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -82.06 136.79 35.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.33 -176.27 3.83 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.466 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 55' ' ' VAL . 62.4 mtm180 -146.09 154.55 41.95 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.46 2.6 5.57 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-O 121.666 0.592 . . . . 0.0 113.219 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -92.78 -20.04 21.15 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.81 -4.2 14.04 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.366 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 16' ' ' VAL . 15.3 t -139.23 140.64 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.433 -3.552 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 mmm180 -134.82 151.01 50.59 Favored 'General case' 1 N--CA 1.362 -4.866 0 O-C-N 125.301 1.626 . . . . 0.0 107.055 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' HA ' HG12 ' A' ' 14' ' ' VAL . 75.8 mt -69.19 -170.43 0.26 Allowed 'General case' 0 C--N 1.278 -2.511 0 O-C-N 124.088 0.867 . . . . 0.0 110.498 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.9 pt . . . . . 0 C--N 1.304 -1.395 0 CA-C-O 122.402 1.096 . . . . 0.0 110.336 171.494 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 23.0 Cg_exo . . . . . 0 N--CA 1.441 -1.576 0 N-CA-C 111.194 -0.349 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.92 -15.32 12.43 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 156.58 38.76 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.34 109.07 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 57' ' ' LEU . 28.3 m -132.54 -179.68 3.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -112.92 122.29 47.2 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.94 132.74 70.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.1 tt -80.12 98.24 7.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.02 -56.21 18.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.549 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 m -151.09 148.25 28.08 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.92 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 86.17 3.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.335 0.588 . . . . 0.0 109.748 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.43 -43.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.56 -47.16 5.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.337 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 103.38 -143.6 15.78 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.144 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -72.83 114.28 10.8 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.339 1.056 . . . . 0.0 111.061 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.83 164.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 42.6 ttm180 -77.06 131.01 38.17 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -140.31 136.7 33.51 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.365 0.602 . . . . 0.0 111.192 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.546 ' HE ' HD11 ' A' ' 30' ' ' ILE . 49.2 ttp180 -108.66 123.95 49.76 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 40' ' ' VAL . 41.7 t -66.22 125.17 22.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.7 mm -105.07 -35.93 3.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.289 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' HE ' HG21 ' A' ' 39' ' ' VAL . 2.1 ttp180 . . . . . 1 N--CA 1.354 -5.272 0 CA-C-O 122.043 0.925 . . . . 0.0 111.836 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.224 -0.263 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 30' ' ' ILE . 69.8 t -99.63 123.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.926 -170.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 28.7 m -134.97 149.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -132.34 126.95 34.49 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.1 m -67.91 159.78 29.85 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 26' ' ' ARG . 6.1 p-10 -66.6 -15.54 63.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.167 0.508 . . . . 0.0 111.667 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -78.66 0.54 26.13 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.612 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.21 65.97 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 170.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -91.23 129.14 37.26 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 118.927 1.364 . . . . 0.0 112.519 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' HG13 ' A' ' 39' ' ' VAL . 17.9 tt0 -85.81 141.36 29.7 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.03 171.14 17.32 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -97.48 141.73 30.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.804 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.4 140.93 44.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 55' ' ' VAL . 56.2 mtp180 -113.9 145.83 40.92 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.58 -16.16 54.83 Favored Glycine 0 C--O 1.214 -1.116 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.37 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -88.56 -2.29 58.51 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.1 mt-30 -126.83 14.9 7.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.573 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.5 t -129.52 139.73 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 121.724 0.773 . . . . 0.0 110.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -137.19 140.77 42.0 Favored 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.677 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.3 pt? -75.92 -153.17 0.04 OUTLIER 'General case' 0 C--N 1.261 -3.252 0 CA-C-O 121.778 0.799 . . . . 0.0 111.505 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt . . . . . 0 C--N 1.293 -1.885 0 CA-C-O 122.656 1.217 . . . . 0.0 112.129 177.604 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.0 Cg_exo . . . . . 0 N--CA 1.444 -1.415 0 N-CA-C 110.624 -0.568 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.39 29.35 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 t0 -67.43 150.74 48.51 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.19 98.2 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 122.842 1.306 . . . . 0.0 111.0 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.5 m -122.64 172.8 9.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.531 -174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 40.5 pttt -108.13 129.28 55.17 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 33.5 m -129.24 140.62 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.282 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.5 tt -101.31 102.9 13.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -72.17 -68.84 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.057 0.932 . . . . 0.0 109.579 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -128.69 153.67 47.08 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.01 -173.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -19.87 65.58 Favored 'General case' 0 C--O 1.209 -1.036 0 C-N-CA 122.856 0.462 . . . . 0.0 112.084 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.88 2.28 51.89 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.84 0.352 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.27 -44.12 1.9 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.968 0.413 . . . . 0.0 110.284 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 85.79 -156.78 30.44 Favored Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -81.12 112.15 18.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.38 164.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -82.15 137.02 35.06 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.0 146.27 48.89 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 43' ' ' ASP . 15.9 mtm180 -113.77 123.59 50.22 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 40' ' ' VAL . 49.0 t -68.22 118.31 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 53.2 mt -85.91 -44.23 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.547 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.025 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 5.4 ptp85 . . . . . 1 N--CA 1.347 -5.592 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.186 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.413 -2.293 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 74.2 t -91.74 123.92 44.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.525 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 29' ' ' VAL . 33.8 m -135.2 150.58 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.475 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' HD11 ' A' ' 30' ' ' ILE . 47.2 tt0 -129.17 128.98 44.49 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.3 t -74.78 165.24 25.56 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 10.4 m-20 -65.6 -15.68 62.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -78.8 -2.08 37.85 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.981 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.47 73.17 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.801 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -81.78 104.01 11.86 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.605 0.762 . . . . 0.0 110.604 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 37.0 tt0 -86.89 137.62 32.24 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.97 -177.97 7.02 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.439 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -101.87 119.17 38.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.16 169.85 9.95 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 55' ' ' VAL . 74.3 mtm180 -139.77 158.58 43.86 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.23 0.54 6.17 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -101.17 -8.46 22.2 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.676 0.751 . . . . 0.0 109.074 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.2 mt-30 -119.61 6.6 11.03 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.703 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 51' ' ' ARG . 23.1 t -127.43 134.99 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.997 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 -174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.523 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 27.4 mmm180 -137.77 136.96 37.77 Favored 'General case' 0 N--CA 1.383 -3.791 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -72.48 -175.54 1.64 Allowed 'General case' 0 C--N 1.28 -2.453 0 O-C-N 123.537 0.523 . . . . 0.0 110.524 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--N 1.325 -0.475 0 C-N-CA 124.244 1.018 . . . . 0.0 111.121 174.56 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 33.4 Cg_exo . . . . . 0 C--O 1.244 0.783 0 CA-C-O 122.536 0.974 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA2' ' NE ' ' A' ' 28' ' ' ARG . . . -178.97 -22.32 0.03 OUTLIER Glycine 0 C--N 1.267 -3.256 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.427 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' H ' ' H ' ' A' ' 11' ' ' GLY . 9.2 m-20 -69.88 123.55 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.63 123.55 52.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.1 169.32 6.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.927 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 58' ' ' ILE . 31.8 mttm -98.15 129.29 44.94 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 23.4 t -127.38 126.23 67.22 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.21 102.34 15.0 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.56 -59.46 2.7 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.88 0.847 . . . . 0.0 109.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -124.37 154.24 40.65 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.617 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.01 -21.13 63.23 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.89 -18.77 33.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.657 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.99 -36.95 9.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.073 0.463 . . . . 0.0 110.753 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.09 -162.17 40.31 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -74.51 112.99 11.25 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.341 0.591 . . . . 0.0 110.494 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.83 146.22 18.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.571 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -78.64 127.28 31.89 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-O 121.282 0.563 . . . . 0.0 110.009 -178.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.72 159.41 41.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.557 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' NE ' ' HA2' ' A' ' 11' ' ' GLY . 61.1 ttt180 -119.06 135.98 54.36 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 51.7 t -63.98 112.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 171.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.4 mm -97.22 -34.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 . . . . . 1 N--CA 1.344 -5.736 0 CA-C-O 121.81 0.814 . . . . 0.0 110.141 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.517 -0.325 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 30' ' ' ILE . 2.7 t -94.48 132.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -164.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.96 140.47 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HB3' HG13 ' A' ' 30' ' ' ILE . 26.7 tt0 -124.88 125.47 44.01 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 m -87.04 173.83 9.05 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.78 -44.06 1.53 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.945 2.098 . . . . 0.0 115.647 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.35 -6.06 43.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.87 10.93 62.35 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.131 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.28 102.05 6.53 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.486 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.2 tt0 -84.77 115.19 22.58 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.338 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.74 170.47 15.93 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.878 -0.514 . . . . 0.0 111.527 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.0 m -86.33 137.68 32.4 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.145 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.81 163.37 12.77 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.845 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -140.94 153.74 45.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.95 -17.61 51.79 Favored Glycine 0 N--CA 1.477 1.431 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -87.23 -10.18 53.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.342 0.592 . . . . 0.0 110.219 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.1 mt-30 -110.83 5.99 21.03 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.912 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.2 129.88 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.545 -171.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -132.38 119.07 20.2 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.665 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.1 pt? -92.89 88.54 6.22 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 122.003 0.906 . . . . 0.0 112.828 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 4.4 pt . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 21.3 Cg_exo . . . . . 0 N--CA 1.44 -1.659 0 CA-C-O 121.423 0.51 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.79 -17.35 10.95 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.319 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 33.4 t0 -63.52 158.85 19.96 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.761 0.825 . . . . 0.0 111.712 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -116.31 107.58 22.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.176 0.59 . . . . 0.0 109.58 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.6 175.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -126.28 139.8 53.03 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 40' ' ' VAL . 57.7 t -131.17 133.85 62.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.6 tt -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.92 -66.29 0.57 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.96 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.8 m -126.63 146.15 50.29 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.898 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -21.43 66.45 Favored 'General case' 0 C--O 1.21 -0.998 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.27 48.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.859 0.362 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.68 -46.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 0.0 109.803 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 93.29 -158.15 23.59 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.311 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -78.85 112.21 15.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.1 0.56 . . . . 0.0 110.677 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.16 149.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -97.88 123.8 42.02 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.048 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.16 169.22 17.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.156 0.979 . . . . 0.0 113.614 -168.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 22.1 mmt180 -112.6 132.88 54.93 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.903 -1.499 . . . . 0.0 107.438 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 65.9 t -67.56 114.15 4.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 173.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 44.4 mm -87.17 -40.63 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.596 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.502 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 1.4 ptp180 . . . . . 1 N--CA 1.338 -6.036 0 CA-C-O 121.984 0.897 . . . . 0.0 110.563 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' THR . 31.0 m . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 11.4 m -126.1 144.42 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.229 1.014 . . . . 0.0 113.523 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 16' ' ' VAL . 27.3 m -129.93 141.11 47.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.247 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 34.7 tt0 -106.06 116.97 32.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 8.3 t -80.33 172.16 14.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.134 -175.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -44.39 -37.24 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 127.051 2.14 . . . . 0.0 112.55 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -76.81 0.97 18.74 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.27 -3.77 83.47 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 122.103 0.835 . . . . 0.0 112.125 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -77.61 107.72 10.29 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 124.135 0.974 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.7 tt0 -84.92 114.9 22.47 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -131.58 167.76 18.86 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.428 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.4 t -102.38 145.95 28.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.377 -175.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.85 156.11 48.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.461 -0.896 . . . . 0.0 113.028 -172.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 157.53 16.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.45 -23.26 62.34 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.134 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -87.79 1.09 54.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.155 0.502 . . . . 0.0 111.107 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.5 mt-30 -104.8 -2.75 24.4 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.37 138.18 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.434 0.635 . . . . 0.0 110.648 -170.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -137.73 126.23 23.51 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.571 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -94.9 141.39 28.7 Favored 'General case' 0 C--N 1.262 -3.203 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.4 mt . . . . . 0 CA--C 1.547 0.864 0 O-C-N 124.163 0.915 . . . . 0.0 109.117 -174.007 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 CA-C-O 120.944 0.31 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -2.84 56.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -83.82 154.95 23.22 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 122.667 0.387 . . . . 0.0 111.089 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.1 112.7 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 CA-C-O 122.111 0.958 . . . . 0.0 108.631 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.5 m -128.55 176.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.666 0.745 . . . . 0.0 111.819 -171.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -115.01 129.73 56.78 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 40' ' ' VAL . 66.5 t -129.44 130.97 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -86.84 90.61 8.37 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.96 -54.51 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.526 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.1 m -144.22 149.25 36.06 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.477 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.48 -17.44 64.8 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.97 5.46 46.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.88 0.371 . . . . 0.0 110.673 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -130.97 -47.69 1.02 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.177 0.513 . . . . 0.0 109.887 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 99.84 -156.66 19.72 Favored Glycine 0 N--CA 1.428 -1.85 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.089 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.55 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 91.7 m95 -74.03 112.69 10.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.449 0.7 . . . . 0.0 110.765 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.28 152.14 8.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -71.13 131.49 43.65 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HH21 ' A' ' 28' ' ' ARG . . . -140.31 169.27 17.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.481 HH22 ' CG ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -128.9 134.12 48.15 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.6 t -75.02 115.82 16.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.8 -43.79 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.5 ptp180 . . . . . 1 N--CA 1.347 -5.582 0 CA-C-O 121.868 0.842 . . . . 0.0 110.167 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.499 -1.007 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 39.3 t -103.76 116.1 46.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.732 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 16' ' ' VAL . 31.2 m -127.85 148.76 32.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.027 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 34.4 tt0 -118.38 131.0 56.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 32.0 t -89.62 174.98 7.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.481 ' CG ' HH22 ' A' ' 28' ' ' ARG . 15.2 m-20 -72.19 -10.08 59.3 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.144 0.973 . . . . 0.0 109.779 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.66 2.43 48.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.074 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.59 0.79 85.32 Favored Glycine 0 CA--C 1.506 -0.474 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.719 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -80.89 111.83 17.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 118.149 0.974 . . . . 0.0 110.973 177.459 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 36.3 tt0 -96.36 114.22 25.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 38.2 p90 -139.22 161.81 36.51 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.179 0.514 . . . . 0.0 111.876 -173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.3 t -91.54 106.27 18.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.422 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.64 161.69 14.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.243 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -80.3 153.11 28.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.19 6.85 6.64 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.148 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -99.81 -21.94 15.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 46.5 mt-30 -90.8 -12.64 35.8 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.188 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 16' ' ' VAL . 19.1 t -115.88 125.73 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.88 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HG3' ' CH2' ' A' ' 24' ' ' TRP . 6.4 mmp_? -133.37 140.84 47.6 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.536 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.5 pt? -61.34 176.6 0.45 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 124.371 1.044 . . . . 0.0 111.17 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.3 pt . . . . . 0 C--N 1.316 -0.873 0 CA-C-O 122.121 0.962 . . . . 0.0 113.53 177.892 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.439 -1.691 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.94 1.39 31.91 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.22 153.56 38.01 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.431 0.692 . . . . 0.0 110.22 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 107.25 22.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -133.0 -179.94 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 122.159 0.981 . . . . 0.0 112.42 -168.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 47.8 pttt -123.4 136.25 54.53 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 40' ' ' VAL . 72.5 t -125.96 127.19 70.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.117 0.484 . . . . 0.0 110.112 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.5 tp -85.39 86.73 7.35 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.46 -58.54 4.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.257 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.3 t -129.81 156.4 44.4 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.312 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.61 -13.1 30.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.088 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -107.45 -38.78 5.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 85.35 -172.86 47.56 Favored Glycine 0 N--CA 1.424 -2.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.361 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -62.23 106.9 0.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.45 1.1 . . . . 0.0 111.896 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -99.18 146.63 8.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 32.2 ttm180 -67.65 137.69 55.79 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.19 172.27 16.09 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.583 ' NH2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -136.22 127.68 28.58 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 40' ' ' VAL . 39.9 t -70.86 120.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.52 -42.8 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER . . . . . 1 N--CA 1.343 -5.792 0 CA-C-O 122.564 1.174 . . . . 0.0 111.083 -174.534 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 33.4 t -103.88 126.24 58.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.398 -172.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 16' ' ' VAL . 27.0 m -134.4 146.81 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.643 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 32.3 tt0 -114.66 125.58 53.91 Favored 'General case' 0 C--N 1.254 -3.566 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -69.96 166.06 20.42 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 16.9 t70 -57.64 -30.88 65.74 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.854 0.862 . . . . 0.0 111.377 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.03 -5.31 30.29 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.754 1.622 . . . . 0.0 112.484 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.86 68.33 Favored Glycine 0 C--O 1.224 -0.519 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.093 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -82.84 110.35 17.78 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 122.654 0.381 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.0 tt0 -90.34 135.96 33.35 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.733 0.813 . . . . 0.0 109.412 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.57 -175.88 5.38 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -122.18 143.97 49.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.4 -178.14 6.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' C ' ' H ' ' A' ' 53' ' ' ASN . 14.7 mtm180 -106.51 165.83 11.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.484 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.67 28.58 1.81 Allowed Glycine 0 N--CA 1.472 1.08 0 CA-C-O 121.789 0.66 . . . . 0.0 112.545 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.7 m120 -117.17 -16.09 10.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.1 mt-30 -104.56 -2.15 25.55 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.879 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 t -118.0 140.58 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -150.43 141.69 23.23 Favored 'General case' 0 N--CA 1.403 -2.781 0 O-C-N 124.672 1.233 . . . . 0.0 110.15 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 97.0 mt -56.84 169.78 0.48 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 124.974 1.421 . . . . 0.0 110.434 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 pt . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 122.153 0.978 . . . . 0.0 111.929 176.053 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.4 Cg_exo . . . . . 0 N--CA 1.457 -0.652 0 CA-C-O 120.854 0.272 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.71 5.28 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.29 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.5 148.9 44.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.648 0.261 . . . . 0.0 111.35 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.62 116.36 52.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.64 166.68 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 112.598 -169.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 56' ' ' ARG . 39.0 pttt -110.95 125.56 53.82 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 168.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.34 133.4 60.14 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.999 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.79 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -82.53 90.79 6.8 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.28 -50.64 67.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.791 -2.004 . . . . 0.0 111.733 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -147.18 144.96 29.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.42 66.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.56 8.07 35.94 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.835 0.35 . . . . 0.0 111.227 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -128.61 -44.77 1.35 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.225 0.535 . . . . 0.0 109.82 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 96.05 -153.69 20.63 Favored Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.01 113.02 9.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.74 0.816 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.6 161.07 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -80.02 131.2 35.74 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.98 173.52 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.152 0.501 . . . . 0.0 110.297 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.14 134.51 36.45 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.1 t -70.24 118.08 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 19.8 mt -107.95 -33.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.079 -172.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 . . . . . 1 N--CA 1.343 -5.788 0 CA-C-O 122.498 1.142 . . . . 0.0 112.443 -170.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t . . . . . 0 CA--C 1.493 -1.248 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG13 ' HG3' ' A' ' 47' ' ' GLU . 16.5 t -106.37 125.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.048 0 CA-C-O 121.723 0.773 . . . . 0.0 113.03 -174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 29' ' ' VAL . 35.8 m -132.62 141.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 170.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB3' HD12 ' A' ' 30' ' ' ILE . 9.0 tt0 -125.49 126.76 45.4 Favored 'General case' 0 C--N 1.26 -3.29 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 t -78.67 168.34 19.9 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.85 -4.5 35.22 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.557 0.694 . . . . 0.0 111.37 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -72.81 -17.12 61.59 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.643 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.87 61.05 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.749 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.6 104.55 16.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HG3' HG13 ' A' ' 39' ' ' VAL . 21.7 tt0 -80.51 118.53 22.19 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.55 175.42 9.6 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.785 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.9 m -100.08 119.32 38.12 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.97 136.61 48.97 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.334 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' ASN . 51.8 mtp180 -90.79 154.03 19.81 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.65 29.19 0.88 Allowed Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.075 0.819 . . . . 0.0 112.744 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.8 m120 -125.08 -8.55 7.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -116.81 -1.55 12.02 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.133 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' ARG . 22.3 t -124.16 136.21 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 CA-C-O 121.237 0.541 . . . . 0.0 109.864 -171.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 13.0 mmm180 -139.14 134.94 33.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 174.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.58 -173.02 0.86 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.555 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 C--N 1.307 -1.278 0 CA-C-O 121.893 0.854 . . . . 0.0 113.126 178.355 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 4.3 Cg_exo . . . . . 0 N--CA 1.444 -1.413 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.7 4.55 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.676 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 20.9 m-20 -60.03 125.16 22.57 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.15 103.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 30.1 m -131.32 176.88 7.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.797 -173.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -105.39 123.73 48.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.142 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.79 134.36 66.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.3 tt -85.9 100.11 11.87 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -73.38 -66.03 0.74 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.6 m -121.41 140.3 52.32 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.219 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.67 66.4 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.33 2.73 53.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -124.74 -44.25 1.96 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 0.0 109.989 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.89 -151.35 20.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -73.38 108.27 6.15 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.663 0.785 . . . . 0.0 110.761 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.0 m -110.71 165.26 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.649 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -82.02 124.29 29.66 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.25 162.83 34.54 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.546 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 1.6 mpp_? -123.92 136.96 54.67 Favored 'General case' 0 CA--C 1.476 -1.88 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.028 176.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 40' ' ' VAL . 46.5 t -71.49 115.08 10.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 57.5 mt -82.94 -41.03 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.384 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.8 ptp85 . . . . . 1 N--CA 1.345 -5.679 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.874 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.424 -1.767 0 CA-C-O 122.048 0.928 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 88.1 t -92.25 128.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.217 -171.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 29' ' ' VAL . 31.0 m -137.29 154.88 31.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -132.89 126.6 32.51 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -71.71 162.16 29.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 124.2 0.937 . . . . 0.0 109.632 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.92 -15.56 13.43 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.44 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 21.7 mp0 -87.66 13.37 10.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.335 -0.228 . . . . 0.0 110.903 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.34 35.78 77.1 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-O 121.373 0.429 . . . . 0.0 113.107 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.44 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 40.0 mtp85 -113.94 109.22 18.15 Favored 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 122.851 0.46 . . . . 0.0 110.154 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -84.23 140.63 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -154.92 168.78 25.81 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -97.54 125.35 42.19 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.68 167.07 10.03 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.755 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -122.1 153.78 38.23 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.39 -20.24 43.85 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.194 0.838 . . . . 0.0 115.194 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -90.65 -7.36 52.87 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.027 -0.69 . . . . 0.0 110.939 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -104.6 1.21 29.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.37 133.41 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.914 0 CA-C-O 121.575 0.702 . . . . 0.0 109.403 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 21.5 mmm180 -137.87 135.12 35.86 Favored 'General case' 1 N--CA 1.379 -4.003 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.808 177.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -70.16 -175.89 1.06 Allowed 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.44 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt . . . . . 0 C--N 1.31 -1.11 0 CA-C-O 122.524 1.154 . . . . 0.0 112.394 175.276 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 6.4 Cg_exo . . . . . 0 N--CA 1.44 -1.626 0 CA-C-O 121.754 0.647 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.68 -16.56 2.64 Favored Glycine 0 N--CA 1.424 -2.138 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.144 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.4 159.23 34.56 Favored 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.235 0.609 . . . . 0.0 109.442 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.97 113.48 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 57' ' ' LEU . 18.8 m -131.83 169.18 22.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.611 -173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -103.18 124.04 47.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 38.3 t -123.38 129.13 74.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -91.39 106.15 18.29 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.99 -69.97 0.41 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.226 1.012 . . . . 0.0 109.324 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.4 m -124.38 147.84 47.96 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 113.789 -1.551 . . . . 0.0 108.991 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.0 -23.36 66.38 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.5 -1.58 57.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.8 0.334 . . . . 0.0 111.518 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.37 -42.0 2.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.282 0.563 . . . . 0.0 109.658 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 -156.72 28.04 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -75.47 109.15 8.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.068 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -107.43 145.24 15.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.528 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -84.42 124.91 31.83 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -177.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.16 151.9 51.1 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.359 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -106.64 131.25 54.0 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 40' ' ' VAL . 45.0 t -68.41 113.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.58 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.0 mt -91.26 -40.58 12.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 121.537 0.684 . . . . 0.0 109.886 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 . . . . . 1 N--CA 1.368 -4.563 0 CA-C-O 122.14 0.972 . . . . 0.0 110.341 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 47' ' ' GLU . 1.7 t -109.58 131.47 60.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -166.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.4 m -132.64 149.22 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 113.014 -1.903 . . . . 0.0 106.073 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.24 123.4 38.05 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 m -76.75 168.74 19.57 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.081 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -58.95 -17.41 24.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.831 1.652 . . . . 0.0 111.514 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -83.33 7.72 15.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.394 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.22 42.22 99.72 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -124.09 104.75 9.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.746 -171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.9 tt0 -82.67 132.08 35.19 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -151.87 175.6 12.3 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 121.32 -0.152 . . . . 0.0 110.614 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 11.7 t -91.62 143.76 26.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -118.7 146.84 44.41 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.298 0.571 . . . . 0.0 111.192 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.8 mtp-105 -125.24 150.58 46.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.48 -19.47 41.26 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 115.038 0.775 . . . . 0.0 115.038 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.53 -12.6 53.87 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.487 0.66 . . . . 0.0 110.146 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 37.8 mt-30 -114.65 0.18 13.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.092 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 t -127.12 124.52 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.566 0 CA-C-O 121.925 0.869 . . . . 0.0 111.114 -174.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 15.9 mmm180 -132.29 137.11 47.35 Favored 'General case' 1 N--CA 1.368 -4.561 0 CA-C-N 113.831 -1.531 . . . . 0.0 106.935 177.284 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.1 pp -57.0 168.15 0.7 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.548 0.53 . . . . 0.0 111.826 172.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.443 -0.789 0 CA-C-O 121.601 0.715 . . . . 0.0 110.334 -179.198 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 3.0 Cg_exo . . . . . 0 N--CA 1.446 -1.284 0 CA-C-O 121.977 0.741 . . . . 0.0 112.333 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.15 -19.0 0.83 Allowed Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.311 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.35 129.22 39.08 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -84.54 114.27 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 57' ' ' LEU . 34.9 m -125.29 173.44 11.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.298 -169.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -119.38 129.1 54.64 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' VAL . 30.8 m -123.97 127.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.527 0.679 . . . . 0.0 112.187 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 22.3 tp -91.59 86.97 6.17 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.64 -57.15 6.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.2 t -125.62 153.44 43.76 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.81 60.9 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.41 -15.13 33.92 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -104.99 -40.06 6.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.286 0.565 . . . . 0.0 110.215 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.48 -175.87 46.11 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.29 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . 0.401 ' CD2' ' HB2' ' A' ' 17' ' ' LEU . 90.6 m95 -62.39 108.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.176 0.991 . . . . 0.0 111.571 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 m -101.86 148.09 7.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -75.78 140.1 42.17 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.9 177.18 11.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -134.22 139.73 46.0 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 40' ' ' VAL . 47.1 t -69.44 122.45 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 49.8 mm -89.59 -44.43 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.678 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.48 HH21 ' CD ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER . . . . . 1 N--CA 1.342 -5.872 0 CA-C-O 122.194 0.997 . . . . 0.0 111.325 -175.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 49' ' ' THR . 2.4 m . . . . . 0 CA--C 1.493 -1.222 0 CA-C-O 121.259 0.552 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG12 ' CG ' ' A' ' 47' ' ' GLU . 2.3 t -107.19 124.01 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 16' ' ' VAL . 33.7 m -129.07 152.65 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.73 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 18.9 tt0 -116.84 122.38 44.21 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -82.93 173.18 12.04 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 123.648 0.592 . . . . 0.0 109.637 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.03 -9.15 3.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.573 1.149 . . . . 0.0 113.312 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -91.58 5.68 48.66 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.89 19.56 79.87 Favored Glycine 0 C--O 1.216 -0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.339 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -108.44 118.32 36.47 Favored 'General case' 0 N--CA 1.403 -2.808 0 O-C-N 122.406 -0.467 . . . . 0.0 111.264 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 57.5 tt0 -88.6 133.8 34.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.6 174.28 14.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.7 m -116.55 135.47 53.79 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.754 0.312 . . . . 0.0 111.149 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.73 174.48 7.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -82.83 156.66 23.51 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.15 -20.84 51.61 Favored Glycine 0 C--O 1.212 -1.241 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -84.56 -15.35 46.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.254 0.55 . . . . 0.0 110.343 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.0 -6.47 51.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.814 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 22.9 t -120.94 121.4 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 8.6 mmm180 -133.54 135.34 44.3 Favored 'General case' 1 N--CA 1.378 -4.031 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.23 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 14' ' ' VAL . 1.9 pp -56.11 161.93 2.18 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.729 0.643 . . . . 0.0 110.915 170.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.266 38.3 pt . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 11.2 Cg_exo . . . . . 0 N--CA 1.452 -0.968 0 N-CA-C 110.427 -0.644 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.41 9.24 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.36 159.66 32.09 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.802 0.441 . . . . 0.0 111.22 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.52 115.04 46.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 57' ' ' LEU . 27.5 m -130.46 177.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.432 0.634 . . . . 0.0 111.598 -173.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -110.85 124.75 52.66 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.5 t -129.69 133.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.58 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -88.41 91.22 8.71 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.08 -49.36 72.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.473 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 m -146.05 145.85 30.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.743 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.63 -22.41 66.88 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.66 5.02 45.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 -43.3 1.51 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.167 0.508 . . . . 0.0 109.79 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.61 -156.55 22.06 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.363 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.8 110.66 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.619 0.768 . . . . 0.0 110.322 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.41 167.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' CG ' ' A' ' 43' ' ' ASP . 35.5 ttm180 -73.82 129.78 38.6 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 166.84 22.52 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -127.0 140.65 52.15 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.0 t -82.04 109.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mp -90.19 -36.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.338 0.589 . . . . 0.0 110.346 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' NH2' HG11 ' A' ' 39' ' ' VAL . 2.0 ttp-105 . . . . . 1 N--CA 1.336 -6.164 0 CA-C-O 122.714 1.245 . . . . 0.0 111.683 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG11 ' NH2' ' A' ' 31' ' ' ARG . 25.6 t -114.43 123.55 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.7 m -128.29 155.83 40.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -171.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 51.6 tt0 -121.09 121.13 37.22 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.8 m -57.68 146.61 30.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.461 ' CG ' ' HD2' ' A' ' 26' ' ' ARG . 24.3 t70 -60.26 -18.95 52.54 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.959 0.885 . . . . 0.0 111.217 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -82.47 -2.32 52.94 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.1 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.75 -16.12 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -79.83 112.04 16.73 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.117 1.458 . . . . 0.0 113.756 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 25.6 tt0 -89.55 128.41 36.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.7 170.4 22.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -107.21 136.41 47.08 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.68 172.76 12.12 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -87.23 165.64 15.53 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.1 2.56 42.85 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-O 122.039 0.8 . . . . 0.0 111.55 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -90.97 -27.09 18.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.0 mt-30 -96.88 -14.79 21.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.56 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 29.7 t -122.16 122.28 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 28.1 mmm180 -130.54 133.74 46.47 Favored 'General case' 1 N--CA 1.377 -4.09 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.0 pp -62.61 176.35 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 123.837 0.71 . . . . 0.0 112.488 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 pt . . . . . 0 C--N 1.317 -0.814 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 38.3 Cg_exo . . . . . 0 N--CA 1.453 -0.909 0 CA-C-O 121.104 0.376 . . . . 0.0 111.471 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.61 -12.86 15.47 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.701 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -71.53 155.77 40.19 Favored 'General case' 0 C--O 1.25 1.103 0 C-N-CA 122.726 0.41 . . . . 0.0 111.102 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -112.62 107.71 23.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.9 m -125.5 171.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.913 0.864 . . . . 0.0 111.68 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -123.02 127.38 48.71 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 40' ' ' VAL . 63.8 t -123.26 129.9 74.6 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.2 tt -85.09 100.7 11.88 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.6 -66.28 0.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.257 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.8 m -140.3 149.59 42.97 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.839 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.62 84.98 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.325 0.584 . . . . 0.0 109.806 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 177.12 -41.3 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 126.034 1.734 . . . . 0.0 106.351 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.7 -43.48 8.24 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.56 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 89.52 -151.27 21.76 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.648 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -75.99 106.21 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.442 0.697 . . . . 0.0 110.907 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.75 145.07 12.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -71.93 136.67 46.93 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -145.62 165.44 28.7 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -123.11 130.94 53.44 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.5 t -70.21 113.97 7.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 50.9 mm -91.43 -39.27 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.581 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 2.2 ptp180 . . . . . 1 N--CA 1.342 -5.842 0 CA-C-O 122.603 1.192 . . . . 0.0 113.013 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.427 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -136.11 128.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.014 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 29' ' ' VAL . 32.9 m -126.3 143.15 40.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 24.8 tt0 -107.24 126.92 53.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.5 t -92.29 175.68 6.76 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.56 -13.95 55.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.82 0.848 . . . . 0.0 111.63 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 14.7 pt20 -77.44 -0.72 26.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.557 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.66 20.37 77.26 Favored Glycine 0 C--O 1.22 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.549 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -112.15 118.69 36.06 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HG2' HG12 ' A' ' 39' ' ' VAL . 22.1 tt0 -87.12 122.06 30.41 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.9 170.03 16.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.875 0.369 . . . . 0.0 111.495 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -85.99 134.64 33.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.154 0.502 . . . . 0.0 109.697 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.72 159.32 22.44 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 54' ' ' GLN . 60.5 mtt180 -114.05 141.74 47.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.53 34.25 Favored Glycine 0 N--CA 1.474 1.173 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -85.73 1.62 48.73 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.75 0.786 . . . . 0.0 112.291 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' OE1' ' HD2' ' A' ' 51' ' ' ARG . 24.7 mt-30 -115.16 9.13 15.78 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.302 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.2 t -124.38 137.37 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.121 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.36 139.12 35.31 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -71.92 -161.22 0.07 Allowed 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 173.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 122.626 1.203 . . . . 0.0 112.086 171.788 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -164.29 165.65 21.63 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.33 -66.76 0.88 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.8 mtt -136.64 -3.08 2.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.72 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 1.5 mp0 -55.35 133.13 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.256 1.422 . . . . 0.0 112.07 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -95.16 94.44 7.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.258 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -115.85 19.13 15.34 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 124.119 1.914 . . . . 0.0 106.819 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.96 119.01 18.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.506 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.35 155.14 47.39 Favored Pre-proline 0 C--N 1.287 -2.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 10.3 Cg_exo -63.66 124.45 13.71 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.001 1.801 . . . . 0.0 111.399 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.63 -8.59 22.02 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -72.4 155.75 39.8 Favored 'General case' 0 C--O 1.259 1.555 0 C-N-CA 123.124 0.57 . . . . 0.0 111.478 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 26' ' ' ARG . 8.4 p -126.39 100.66 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.092 1.357 . . . . 0.0 110.212 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.28 169.22 21.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.946 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -100.48 128.89 46.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 55' ' ' VAL . 21.8 m -128.58 141.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.0 93.56 9.39 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.504 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 38.0 tt0 -65.18 -53.6 42.41 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.942 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.9 m -148.84 149.29 31.05 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.27 -26.8 66.75 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 7.09 36.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 0.0 111.511 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.73 -44.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.0 110.142 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.44 -152.7 21.32 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.097 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.82 109.11 7.07 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 123.57 0.748 . . . . 0.0 111.062 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.69 176.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD3' HG23 ' A' ' 13' ' ' VAL . 3.5 tmm_? -105.82 126.0 51.66 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.501 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.06 178.81 5.33 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.695 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -133.55 131.29 39.56 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 40' ' ' VAL . 48.5 t -79.16 120.21 29.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.666 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.7 mp -95.43 -38.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.122 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 9.5 tpp180 -163.83 162.34 23.65 Favored 'General case' 0 N--CA 1.392 -3.339 0 CA-C-O 121.629 0.728 . . . . 0.0 110.394 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.88 118.43 57.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 167.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HD2' ' CG2' ' A' ' 39' ' ' VAL 0.257 34.1 tttt -103.01 -149.54 0.4 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 124.341 1.056 . . . . 0.0 109.687 -170.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 m -50.29 99.9 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 125.145 1.378 . . . . 0.0 114.533 -173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.59 -78.11 1.52 Allowed Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.951 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.41 29.71 1.89 Allowed Glycine 0 C--N 1.302 -1.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 1.5 tmt_? -91.09 97.46 11.17 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-O 122.891 1.329 . . . . 0.0 108.024 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.9 t -79.98 132.84 30.95 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.179 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.241 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.649 ' CG2' ' HD2' ' A' ' 33' ' ' LYS . 76.7 t -101.89 118.05 48.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.12 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 29' ' ' VAL . 26.8 m -130.94 152.91 38.35 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 172.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -137.0 130.56 31.63 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -84.43 170.97 13.0 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -74.03 -4.14 33.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -10.15 59.39 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.53 -5.42 70.36 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.132 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' HD3' ' OE2' ' A' ' 18' ' ' GLU . 13.6 ptm180 -78.26 125.45 29.37 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 117.281 0.541 . . . . 0.0 111.262 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.509 ' HG3' HG13 ' A' ' 39' ' ' VAL . 8.6 tt0 -88.32 146.61 25.21 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 18.7 p90 -153.76 164.67 37.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 120.843 0.354 . . . . 0.0 110.589 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.9 t -86.9 116.25 24.84 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.213 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -95.59 160.37 14.54 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HD3' ' OE1' ' A' ' 54' ' ' GLN . 5.7 mpt_? -136.8 162.42 33.27 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.89 -3.87 38.02 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 121.343 -0.456 . . . . 0.0 113.757 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -96.77 -9.68 28.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.408 0.623 . . . . 0.0 109.63 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 51.9 mt-30 -113.73 -2.32 13.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.922 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 16' ' ' VAL . 35.1 t -130.79 135.36 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.962 -172.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -137.39 124.0 21.0 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.207 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.8 pt? -101.85 115.15 29.91 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.292 35.3 pt 33.46 66.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.072 1.749 . . . . 0.0 106.373 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -111.65 -4.82 14.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -170.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.5 -67.78 0.9 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.82 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.506 ' HG3' ' HG3' ' A' ' 5' ' ' GLU . 24.1 ptt? -168.46 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' A' ' 4' ' ' MET 0.294 0.0 OUTLIER -132.89 -114.39 0.22 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.44 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.23 41.36 1.57 Allowed 'General case' 0 C--N 1.255 -3.54 0 C-N-CA 125.34 1.456 . . . . 0.0 111.007 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.09 38.42 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 C-N-CA 128.347 2.659 . . . . 0.0 115.368 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.5 143.95 32.94 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -117.21 152.2 48.75 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 118.91 0.777 . . . . 0.0 111.338 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -73.38 131.55 16.5 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.179 1.92 . . . . 0.0 110.974 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.36 -9.99 39.03 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -73.32 159.03 33.99 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.87 95.37 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.8 m -114.89 178.33 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.468 -169.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -113.66 126.63 55.47 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 84.7 t -127.17 133.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.8 tt -84.89 91.85 8.13 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.02 -50.49 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.556 -1.657 . . . . 0.0 109.926 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 t -132.96 149.88 52.2 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -18.39 62.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.005 0.431 . . . . 0.0 110.145 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.34 -16.09 29.86 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -104.14 -33.21 8.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.0 110.841 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 86.1 -158.12 31.35 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -73.31 104.49 4.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.618 0.767 . . . . 0.0 110.532 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.66 163.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 34.6 ttm180 -79.82 126.46 31.0 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -133.31 160.77 36.34 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.563 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -125.68 124.46 41.18 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.8 t -70.94 118.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -90.37 -42.67 14.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -156.29 154.11 30.14 Favored 'General case' 1 N--CA 1.378 -4.041 0 CA-C-O 121.537 0.684 . . . . 0.0 109.655 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.28 132.21 62.78 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 37' ' ' ARG 0.34 26.6 tttp -127.77 -170.06 2.17 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -112.7 178.67 4.21 Favored 'General case' 1 N--CA 1.376 -4.13 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.518 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 17.36 76.41 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.69 24.46 75.41 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.694 ' NH1' ' HA ' ' A' ' 39' ' ' VAL . 1.1 tmt_? -95.48 111.64 23.5 Favored 'General case' 0 CA--C 1.456 -2.643 0 CA-C-O 122.726 1.25 . . . . 0.0 108.994 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.23 129.33 61.19 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.63 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.694 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 49.1 t -98.41 111.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.986 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 29' ' ' VAL . 34.2 m -135.02 147.1 29.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -129.3 121.47 27.58 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 67.6 m -65.59 157.14 30.6 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.954 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.64 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 45.6 m-20 -65.32 2.88 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.498 0.666 . . . . 0.0 112.62 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 41.9 mt-30 -87.12 -5.81 58.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.81 9.32 78.13 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 121.8 0.666 . . . . 0.0 111.479 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 27.5 mtp85 -95.28 111.81 23.61 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 123.823 0.849 . . . . 0.0 110.522 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -94.95 153.27 17.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -170.9 144.86 2.27 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 123.795 0.684 . . . . 0.0 110.801 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -74.33 95.63 2.71 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.909 0.861 . . . . 0.0 111.535 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.94 159.13 19.12 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -107.02 160.61 15.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.82 2.33 12.83 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -102.69 -9.46 20.03 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.566 0.698 . . . . 0.0 109.14 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.7 mt-30 -100.5 -4.22 29.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.97 133.4 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -137.32 139.91 41.16 Favored 'General case' 0 N--CA 1.391 -3.421 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . 82.5 mt -67.85 -171.86 0.24 Allowed 'General case' 0 C--N 1.291 -1.939 0 O-C-N 123.493 0.496 . . . . 0.0 110.489 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.4 pt -73.75 76.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 122.547 1.165 . . . . 0.0 111.714 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--N 1.29 -1.982 0 CA-C-N 113.199 -1.819 . . . . 0.0 107.012 -179.177 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -82.75 148.35 27.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.531 0.682 . . . . 0.0 111.475 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.19 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 127.285 2.234 . . . . 0.0 105.133 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.29 31.4 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.214 -1.812 . . . . 0.0 107.207 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -87.94 157.3 18.98 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.71 148.31 52.48 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.96 12.9 20.22 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 122.461 1.124 . . . . 0.0 108.86 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 29' ' ' VAL . 1.4 mm? -109.6 143.77 38.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.947 -1.933 . . . . 0.0 106.178 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.67 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 28.7 mm-40 -115.78 165.06 15.47 Favored Pre-proline 0 C--N 1.3 -1.556 0 CA-C-N 118.054 0.388 . . . . 0.0 111.828 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 17.7 Cg_endo -78.86 120.76 4.78 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.38 1.386 . . . . 0.0 110.828 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.58 6.4 35.54 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 2.7 t0 -73.39 -175.04 1.81 Allowed 'General case' 0 C--O 1.25 1.1 0 C-N-CA 124.823 1.249 . . . . 0.0 110.932 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.55 106.44 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 32.7 m -132.58 176.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.789 0.804 . . . . 0.0 112.273 -168.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 9.7 pttm -113.73 132.96 55.63 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.202 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 m -124.34 125.86 71.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.604 0.716 . . . . 0.0 111.873 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.3 tp -88.86 92.83 9.37 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.52 -59.77 3.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.958 0.885 . . . . 0.0 109.814 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.3 m -146.27 156.08 43.11 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -14.91 63.35 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.59 0.71 56.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.737 0.303 . . . . 0.0 111.046 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -129.83 -53.46 1.14 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.26 0.553 . . . . 0.0 109.805 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 103.06 -172.6 21.69 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.068 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 85.3 m95 -62.31 114.51 3.52 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.273 1.029 . . . . 0.0 111.489 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.3 163.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.408 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 38.6 ttm105 -79.52 133.75 36.49 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -154.41 172.61 17.45 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.073 0.463 . . . . 0.0 110.845 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -130.73 130.47 43.84 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.4 t -71.03 115.52 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 39' ' ' VAL . 46.0 mm -86.35 -42.57 15.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 12.3 tpp180 -153.14 142.41 21.54 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.135 0.969 . . . . 0.0 111.137 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.03 115.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.387 0 CA-C-N 113.066 -1.879 . . . . 0.0 108.144 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.781 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 10.0 mttt -106.58 143.21 35.02 Favored 'General case' 0 CA--C 1.453 -2.779 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.179 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -94.59 26.02 3.68 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.256 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.41 30.18 5.67 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.26 25.97 74.38 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 114.929 -0.635 . . . . 0.0 111.821 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.781 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -117.82 85.8 2.41 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 123.161 1.457 . . . . 0.0 111.577 -174.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 49' ' ' THR . 21.6 t -80.64 128.01 39.0 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.432 0 CA-C-N 112.968 -1.924 . . . . 0.0 107.267 178.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 58.8 t -107.78 115.94 50.07 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.06 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.5 m -135.29 143.62 36.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 28.5 tt0 -130.87 126.9 37.41 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.484 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 46.3 t -77.27 167.69 21.3 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.626 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 5.9 p-10 -76.29 -6.55 51.96 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.281 1.039 . . . . 0.0 110.477 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -84.62 6.79 22.56 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.099 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.49 16.13 75.57 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 122.139 0.855 . . . . 0.0 111.462 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -93.13 98.28 11.21 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.384 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 3.4 tm-20 -95.57 150.87 19.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -171.39 153.14 3.47 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.011 0.819 . . . . 0.0 111.285 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.2 t -78.76 112.47 15.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.903 0.858 . . . . 0.0 109.44 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.15 177.56 5.54 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.737 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.531 ' O ' HG23 ' A' ' 55' ' ' VAL . 54.6 mtp180 -123.58 146.49 48.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.22 -14.65 57.18 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.941 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.86 -6.2 58.87 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.503 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.0 mt-30 -120.98 14.21 11.47 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.158 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 51' ' ' ARG . 12.6 t -133.39 136.83 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.476 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 5.3 mmm180 -140.11 150.73 44.66 Favored 'General case' 1 N--CA 1.375 -4.205 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.08 178.033 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 91.4 mt -57.97 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 123.191 1.472 . . . . 0.0 111.427 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.84 64.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.517 0 O-C-N 120.846 -1.159 . . . . 0.0 112.415 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.288 -2.093 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.52 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -167.18 153.25 7.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -170.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.26 31.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 124.304 1.003 . . . . 0.0 109.634 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -105.91 -13.21 15.57 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.071 0.939 . . . . 0.0 109.124 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.65 29.32 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.402 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 55' ' ' VAL . 90.6 mt -128.29 110.57 12.51 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -81.64 84.08 6.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.629 1.204 . . . . 0.0 108.135 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -144.65 165.25 28.57 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 112.139 -2.3 . . . . 0.0 104.959 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 29.8 mm-40 -113.49 153.56 45.7 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.734 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.622 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.1 Cg_exo -62.71 112.45 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.242 1.961 . . . . 0.0 110.206 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.46 -6.97 9.12 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 3.8 t70 -70.7 158.81 35.61 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.72 0.808 . . . . 0.0 110.367 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -127.61 108.8 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 122.635 1.207 . . . . 0.0 111.982 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 28.6 m -134.81 -172.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.643 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 59' ' ' GLU . 37.8 pttt -127.66 140.54 52.02 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 55' ' ' VAL . 25.1 m -130.59 146.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.66 112.26 24.77 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -80.21 -71.6 0.45 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.34 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -116.24 139.54 50.25 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.912 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.62 66.01 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 112.325 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 5.5 41.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -127.34 -52.05 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.67 -154.25 18.36 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.45 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -78.21 118.54 20.53 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.206 1.002 . . . . 0.0 111.333 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 163.18 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 18.3 tpp180 -87.6 114.42 24.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -107.77 140.6 40.6 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.943 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 55.7 mtm180 -113.31 119.27 37.1 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 49.0 t -69.47 111.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.6 mm -94.3 -33.73 5.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.14 0.495 . . . . 0.0 110.827 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' NE ' HG21 ' A' ' 39' ' ' VAL . 8.8 ttp180 -158.98 137.4 10.77 Favored 'General case' 1 N--CA 1.347 -5.587 0 CA-C-O 122.095 0.95 . . . . 0.0 108.614 -175.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -102.01 102.66 13.85 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.722 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.449 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 37' ' ' ARG . 21.1 mttm -105.98 173.55 6.27 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 112.502 -2.136 . . . . 0.0 105.281 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -142.49 157.34 44.84 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.127 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.0 -92.07 1.34 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.499 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -18.97 60.97 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.126 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.633 ' NH1' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -143.93 152.49 41.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 49' ' ' THR . 60.2 t -155.16 147.93 12.77 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.915 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 174.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.633 HG22 ' NH1' ' A' ' 37' ' ' ARG . 63.1 t -125.05 116.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 119.509 1.049 . . . . 0.0 112.126 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.89 142.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 29.6 tt0 -127.18 108.28 10.76 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.915 0.864 . . . . 0.0 109.008 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 15.6 m -70.82 169.34 14.84 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.856 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -28.26 -58.83 0.12 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 128.552 2.741 . . . . 0.0 114.359 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -59.22 -19.45 45.62 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.173 1.789 . . . . 0.0 112.595 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.1 21.06 23.96 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -172.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -90.43 99.88 12.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.238 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -91.45 142.9 27.16 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -165.13 176.47 8.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.875 0.734 . . . . 0.0 110.755 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.5 t -96.71 117.51 31.17 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-O 121.638 0.732 . . . . 0.0 110.493 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.53 169.52 10.96 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.899 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 55' ' ' VAL . 24.4 mmt180 -131.41 145.45 51.81 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.35 -34.3 48.13 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 115.253 0.861 . . . . 0.0 115.253 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -82.2 -0.06 43.41 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 122.149 -0.618 . . . . 0.0 111.739 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -114.46 9.42 16.75 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.8 t -124.83 139.89 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-O 121.128 0.489 . . . . 0.0 109.882 -174.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.424 HH21 ' C ' ' A' ' 59' ' ' GLU . 13.6 mmm180 -137.66 129.28 28.33 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.02 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -99.6 131.87 45.31 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.7 mt 75.32 150.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 54.4 mm-40 . . . . . 0 C--O 1.275 2.444 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.91 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -133.61 34.8 3.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -170.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.72 9.61 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 125.071 1.348 . . . . 0.0 113.1 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.8 ttp -96.42 -11.3 25.87 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.596 1.188 . . . . 0.0 108.017 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -87.92 130.99 34.75 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.1 mt -85.15 82.69 8.29 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.25 83.99 1.9 Allowed 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 mm? -106.44 129.01 54.49 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.505 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -76.29 154.41 84.21 Favored Pre-proline 0 N--CA 1.406 -2.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.092 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 13.8 Cg_exo -63.08 117.55 4.47 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 C-N-CA 121.886 1.724 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.12 -12.83 9.72 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.196 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.16 169.73 14.47 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 122.805 0.442 . . . . 0.0 110.094 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.426 HG13 ' HE ' ' A' ' 26' ' ' ARG . 90.5 t -129.82 111.57 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.42 0.628 . . . . 0.0 110.691 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -131.76 169.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.878 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -111.9 133.18 54.25 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.949 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 40' ' ' VAL . 18.3 m -127.34 137.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.419 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.6 tt -89.01 93.68 9.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.0 -49.89 66.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.182 -1.826 . . . . 0.0 110.966 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.7 m -147.25 148.05 31.05 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.506 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.17 68.12 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.8 8.74 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.965 0.412 . . . . 0.0 111.211 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.98 -45.21 1.03 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.288 0.566 . . . . 0.0 109.51 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 95.06 -154.54 21.19 Favored Glycine 0 N--CA 1.423 -2.167 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -72.56 108.14 5.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.863 0.865 . . . . 0.0 110.833 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.58 146.4 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.426 ' HE ' HG13 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -73.52 134.64 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.07 166.39 24.93 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.699 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -119.21 142.19 48.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 40' ' ' VAL . 59.8 t -75.17 121.5 26.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.9 mm -89.47 -38.99 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.157 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.05 155.75 33.18 Favored 'General case' 1 N--CA 1.343 -5.805 0 CA-C-O 121.943 0.877 . . . . 0.0 110.538 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 8' ' ' LEU . 7.5 p -117.6 124.61 73.29 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.543 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.694 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.662 ' CB ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -121.94 -71.63 0.72 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.312 170.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.482 ' O ' HG13 ' A' ' 38' ' ' VAL . 25.6 t -169.88 177.57 4.34 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.95 59.29 1.0 Allowed Glycine 0 N--CA 1.481 1.686 0 O-C-N 123.493 0.495 . . . . 0.0 114.185 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 51' ' ' ARG . . . 174.81 -23.37 0.06 OUTLIER Glycine 0 C--N 1.296 -1.66 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.662 ' HB3' ' CB ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.8 15.64 10.14 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.982 0.896 . . . . 0.0 110.966 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 34' ' ' SER . 2.7 m -79.75 125.54 38.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 41.8 t -110.12 122.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.202 -174.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 16' ' ' VAL . 34.7 m -126.75 153.74 35.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.562 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 34.1 tt0 -123.52 123.93 41.71 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.4 t -78.08 170.24 16.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.75 1.86 13.66 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.062 0.934 . . . . 0.0 111.472 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -89.76 0.33 57.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.468 174.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 11.69 84.03 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 99.8 mtt180 -87.74 101.87 14.1 Favored 'General case' 0 N--CA 1.41 -2.427 0 C-N-CA 122.925 0.49 . . . . 0.0 110.24 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 38.0 tt0 -97.51 120.91 38.74 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.85 166.08 28.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.6 t -99.42 132.49 44.72 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.46 156.54 33.87 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.962 0.41 . . . . 0.0 111.005 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.3 mtp180 -84.68 157.71 21.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.57 8.03 6.09 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-O 121.766 0.648 . . . . 0.0 112.882 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -103.86 -8.84 19.43 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.0 mt-30 -111.93 -0.54 15.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.697 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 51' ' ' ARG . 5.9 t -127.82 138.26 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -139.53 152.36 46.85 Favored 'General case' 1 N--CA 1.377 -4.112 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.89 -169.73 0.5 Allowed 'General case' 0 C--N 1.27 -2.85 0 O-C-N 123.934 0.771 . . . . 0.0 109.817 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 pt -73.9 78.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 122.518 1.152 . . . . 0.0 110.966 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 C--N 1.293 -1.854 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.215 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -116.04 -168.35 1.41 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.04 0.69 5.61 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.8 ttt -103.14 -7.21 21.46 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.01 0.91 . . . . 0.0 109.085 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -116.89 -152.82 0.51 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.893 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -107.05 150.3 26.67 Favored 'General case' 0 N--CA 1.397 -3.102 0 C-N-CA 124.427 1.091 . . . . 0.0 108.777 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.08 20.07 18.32 Favored 'General case' 0 C--N 1.254 -3.563 0 C-N-CA 126.445 1.898 . . . . 0.0 107.027 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.485 HD13 HG11 ' A' ' 14' ' ' VAL . 73.6 mt -132.15 174.99 9.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.506 -171.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -136.23 163.9 46.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 123.781 0.833 . . . . 0.0 109.624 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.7 Cg_exo -66.58 137.65 47.02 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.764 1.643 . . . . 0.0 110.673 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.39 0.25 50.3 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.9 159.11 23.74 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 123.064 0.546 . . . . 0.0 110.076 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.03 100.21 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 122.734 1.254 . . . . 0.0 108.603 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.485 HG11 HD13 ' A' ' 8' ' ' LEU . 34.2 m -122.44 177.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.428 -166.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 47.9 pttt -117.94 134.07 55.31 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 40' ' ' VAL . 65.7 t -131.64 130.34 62.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.0 tt -90.86 100.5 13.35 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -66.79 -57.68 6.56 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.698 0.761 . . . . 0.0 110.563 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -147.17 160.59 42.27 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.514 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -25.77 67.52 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.01 7.1 36.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.848 0.356 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.34 -46.4 1.34 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.092 0.473 . . . . 0.0 109.981 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 88.85 -160.87 30.27 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.304 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.45 111.03 10.32 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.474 0.71 . . . . 0.0 111.091 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.39 154.78 4.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 44.7 ttt180 -75.32 136.64 40.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -148.14 163.5 36.76 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.142 0.972 . . . . 0.0 112.87 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -116.25 119.67 36.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 40' ' ' VAL . 60.7 t -70.19 111.16 3.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 41.4 mt -80.36 -45.2 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.389 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.92 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 3.0 ptp180 -160.1 162.73 34.11 Favored 'General case' 1 N--CA 1.343 -5.808 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.961 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.427 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 7.3 mttm -86.99 -66.6 0.89 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.313 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t -171.95 99.92 0.17 Allowed 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.49 -82.37 0.01 OUTLIER Glycine 0 N--CA 1.47 0.936 0 O-C-N 124.623 1.202 . . . . 0.0 114.611 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.46 63.79 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 17.5 mmt180 -99.73 106.99 18.95 Favored 'General case' 1 N--CA 1.348 -5.569 0 CA-C-O 122.515 1.15 . . . . 0.0 109.195 176.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.29 144.64 37.53 Favored 'Isoleucine or valine' 1 C--N 1.225 -4.828 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.845 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.558 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 3.0 m -129.66 138.86 53.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 16' ' ' VAL . 35.8 m -133.2 152.93 36.56 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.008 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 57.7 tt0 -116.92 124.45 49.45 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -83.05 173.76 11.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 26' ' ' ARG . 3.1 m-20 -61.04 -16.64 45.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.428 1.091 . . . . 0.0 110.778 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -78.17 1.33 21.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.673 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.71 87.85 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 116.233 -0.44 . . . . 0.0 113.391 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 35.7 ttt-85 -101.24 120.11 39.76 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.542 0.337 . . . . 0.0 111.564 -174.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.9 136.52 34.56 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -145.1 155.94 43.62 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -95.73 137.23 35.1 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.211 0.529 . . . . 0.0 111.358 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 172.39 13.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.4 mtp180 -85.56 160.19 19.7 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.82 -19.44 69.52 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.238 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -86.94 -1.88 58.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.436 0.636 . . . . 0.0 109.819 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.27 2.26 17.61 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 16' ' ' VAL . 38.4 t -125.22 133.02 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 5.9 mmm180 -138.91 140.86 38.48 Favored 'General case' 0 N--CA 1.385 -3.677 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.145 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -176.17 0.08 Allowed 'General case' 0 C--N 1.287 -2.112 0 O-C-N 123.901 0.75 . . . . 0.0 112.42 170.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.5 pp -59.98 106.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 122.996 1.379 . . . . 0.0 110.157 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 26.5 tt0 . . . . . 0 C--N 1.261 -3.272 0 CA-C-N 112.614 -2.085 . . . . 0.0 105.631 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.56 ' O ' ' HG2' ' A' ' 4' ' ' MET . 3.3 m-20 72.14 109.01 0.07 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 124.991 1.432 . . . . 0.0 108.394 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.61 93.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.632 1.208 . . . . 0.0 113.762 -173.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 2' ' ' ASN . 25.2 ptt? -165.49 2.11 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.36 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -97.93 -168.57 1.69 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.146 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -133.27 138.89 46.63 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -85.22 -0.02 53.3 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.422 1.106 . . . . 0.0 110.855 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.9 150.43 20.37 Favored 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.588 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -115.95 167.21 10.64 Favored Pre-proline 0 C--N 1.287 -2.114 0 CA-C-O 120.447 0.165 . . . . 0.0 111.42 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 42.3 Cg_exo -56.61 110.89 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.094 1.862 . . . . 0.0 111.398 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.46 -24.37 3.94 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.813 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -73.42 169.77 16.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.26 132.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -145.28 177.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 124.333 1.053 . . . . 0.0 108.712 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 39.8 pttt -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 40' ' ' VAL . 60.9 t -130.4 133.87 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -86.1 95.22 9.48 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.51 -59.92 4.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.799 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.2 m -139.1 149.0 44.04 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.25 66.89 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.56 8.03 38.55 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.996 0.427 . . . . 0.0 110.972 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.8 mt -130.02 -46.48 1.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.13 -158.26 20.05 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.346 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -72.41 112.22 8.29 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.965 0.906 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.91 152.28 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -78.19 135.24 37.58 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -143.97 159.24 42.92 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.85 0.833 . . . . 0.0 112.116 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -105.78 133.16 50.95 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.971 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 48.1 t -72.56 111.12 6.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 51.4 mm -91.02 -35.51 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.927 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.49 153.27 30.0 Favored 'General case' 1 N--CA 1.339 -6.006 0 CA-C-O 121.814 0.816 . . . . 0.0 108.925 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.55 112.72 41.52 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.831 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.487 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 37' ' ' ARG . 18.7 mttm -110.75 -177.36 3.2 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 166.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 m -136.09 160.65 37.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.294 -1.762 . . . . 0.0 113.008 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.72 -88.42 0.11 Allowed Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.105 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.88 -21.72 49.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.77 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 2.7 mmp_? -121.06 147.51 45.42 Favored 'General case' 1 N--CA 1.376 -4.175 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.02 146.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 102.224 -3.25 . . . . 0.0 102.224 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HD2' ' A' ' 33' ' ' LYS . 11.8 t -129.24 124.0 59.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 119.173 0.897 . . . . 0.0 108.848 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 16' ' ' VAL . 28.5 m -137.5 155.44 31.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.72 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 35.0 tt0 -121.77 124.22 43.68 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 22.3 t -75.65 171.98 13.38 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -10.99 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.402 1.096 . . . . 0.0 109.785 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -74.75 -9.88 58.98 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.721 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.2 85.28 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.441 -0.409 . . . . 0.0 112.529 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -91.11 125.71 35.98 Favored 'General case' 0 N--CA 1.407 -2.623 0 O-C-N 122.283 -0.54 . . . . 0.0 111.296 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 42.2 tt0 -92.07 134.56 34.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.71 153.57 42.59 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.6 t -113.08 116.78 30.42 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.787 0.803 . . . . 0.0 110.838 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.35 -171.34 1.94 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.968 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -100.98 164.59 11.74 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.86 -8.75 69.2 Favored Glycine 0 C--O 1.216 -1.009 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -85.79 -1.82 57.61 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -118.8 11.2 12.59 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.495 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.26 136.28 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 121.418 0.627 . . . . 0.0 109.336 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 18.7 mmm180 -132.72 129.69 39.03 Favored 'General case' 0 N--CA 1.395 -3.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.324 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.67 138.75 37.3 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.759 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.282 37.1 pt 38.13 78.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.415 1.886 . . . . 0.0 115.492 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 102.166 -3.272 . . . . 0.0 102.166 -176.412 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.5 -0.958 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -121.19 151.72 39.63 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.95 112.92 20.22 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.0 mmm -87.84 94.17 9.68 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -111.05 160.81 16.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.34 96.94 9.48 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.82 23.53 0.43 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.232 1.013 . . . . 0.0 112.604 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -135.56 134.98 39.96 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 124.761 1.224 . . . . 0.0 108.092 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -126.51 152.46 74.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 6.9 Cg_endo -72.04 134.46 23.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.03 1.82 . . . . 0.0 112.791 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.26 48.51 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.016 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.57 156.77 18.87 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-O 120.964 0.411 . . . . 0.0 110.985 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.5 106.94 21.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.1 m -123.03 173.31 9.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.97 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -110.34 126.81 54.64 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.074 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 55' ' ' VAL . 25.6 m -121.9 144.63 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -98.35 87.05 3.77 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 171.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -70.32 -42.12 72.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.072 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.7 m -144.44 142.43 30.3 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.681 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.08 67.15 Favored 'General case' 0 C--O 1.21 -0.994 0 C-N-CA 122.851 0.46 . . . . 0.0 112.164 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.02 3.79 47.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.917 0.389 . . . . 0.0 110.959 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -123.42 -44.79 2.11 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 92.27 -153.35 21.73 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.431 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 93.0 m95 -74.43 107.55 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 123.409 0.684 . . . . 0.0 110.722 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -111.83 171.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.773 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 41.1 ttm180 -82.35 140.81 33.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 16' ' ' VAL . . . -146.05 170.49 16.56 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.894 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 4.4 ptp180 -131.77 129.39 40.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 40' ' ' VAL . 33.1 t -77.81 112.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 31' ' ' ARG . 28.0 mt -86.09 -47.31 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.289 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 5.4 ptp180 -160.94 155.79 23.91 Favored 'General case' 1 N--CA 1.328 -6.527 0 C-N-CA 117.023 -1.871 . . . . 0.0 114.442 -170.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.01 105.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.803 -2.453 . . . . 0.0 107.55 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 20.7 mttt -95.98 171.3 8.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -100.36 167.4 10.42 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.271 -1.371 . . . . 0.0 109.932 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.24 20.86 56.38 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.19 30.46 50.48 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 12.0 mmp_? -97.49 85.86 3.72 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-O 122.431 1.11 . . . . 0.0 113.333 -177.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.48 106.5 18.2 Favored 'Isoleucine or valine' 1 C--N 1.229 -4.658 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.65 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 60.2 t -114.45 130.33 68.96 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 121.882 0.849 . . . . 0.0 112.672 -170.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 29' ' ' VAL . 29.7 m -124.89 159.82 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.583 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 35.4 tt0 -124.88 116.51 22.34 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 38.9 m -70.68 163.78 26.39 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 3.8 m-20 -62.96 -15.12 54.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.969 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.5 mp0 -83.88 2.42 38.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.4 10.42 70.86 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 172.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 4.3 mpt_? -91.44 115.99 28.49 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 118.238 1.019 . . . . 0.0 110.29 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 31.2 tt0 -93.95 108.21 20.04 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -139.45 166.02 25.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.747 0.308 . . . . 0.0 110.633 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -82.06 136.79 35.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.33 -176.27 3.83 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.466 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 55' ' ' VAL . 62.4 mtm180 -146.09 154.55 41.95 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.46 2.6 5.57 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-O 121.666 0.592 . . . . 0.0 113.219 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -92.78 -20.04 21.15 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.81 -4.2 14.04 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.366 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 16' ' ' VAL . 15.3 t -139.23 140.64 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.433 -3.552 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 mmm180 -134.82 151.01 50.59 Favored 'General case' 1 N--CA 1.362 -4.866 0 O-C-N 125.301 1.626 . . . . 0.0 107.055 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 75.8 mt -69.19 -170.43 0.26 Allowed 'General case' 0 C--N 1.278 -2.511 0 O-C-N 124.088 0.867 . . . . 0.0 110.498 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.65 85.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.402 1.096 . . . . 0.0 110.336 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 8.9 pt-20 . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.5 -0.955 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -37.96 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 125.711 1.882 . . . . 0.0 115.057 -170.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 164.64 -20.03 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.369 1.868 . . . . 0.0 109.193 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ptm -105.76 -17.31 14.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.26 0.553 . . . . 0.0 111.535 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 144.84 48.09 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.476 1.111 . . . . 0.0 109.94 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.402 HD12 ' HB ' ' A' ' 55' ' ' VAL . 65.5 mt -128.76 110.86 12.54 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.501 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.02 91.88 6.13 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.73 133.12 56.07 Favored 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 112.474 -2.148 . . . . 0.0 105.483 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -83.32 152.56 64.7 Favored Pre-proline 0 C--N 1.283 -2.294 0 O-C-N 123.647 0.592 . . . . 0.0 112.511 -167.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 23.0 Cg_exo -61.16 123.13 12.25 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.441 2.094 . . . . 0.0 111.194 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.92 -15.32 12.43 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 156.58 38.76 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.34 109.07 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 57' ' ' LEU . 28.3 m -132.54 -179.68 3.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -112.92 122.29 47.2 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.94 132.74 70.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.1 tt -80.12 98.24 7.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.02 -56.21 18.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.549 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 m -151.09 148.25 28.08 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.92 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 86.17 3.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.335 0.588 . . . . 0.0 109.748 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.43 -43.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.56 -47.16 5.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.337 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 103.38 -143.6 15.78 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.144 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -72.83 114.28 10.8 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.339 1.056 . . . . 0.0 111.061 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.83 164.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 42.6 ttm180 -77.06 131.01 38.17 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -140.31 136.7 33.51 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.365 0.602 . . . . 0.0 111.192 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.546 ' HE ' HD11 ' A' ' 30' ' ' ILE . 49.2 ttp180 -108.66 123.95 49.76 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 40' ' ' VAL . 41.7 t -66.22 125.17 22.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.7 mm -105.07 -35.93 3.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.289 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' HE ' HG21 ' A' ' 39' ' ' VAL . 2.1 ttp180 -156.17 155.71 32.94 Favored 'General case' 1 N--CA 1.354 -5.272 0 CA-C-O 122.043 0.925 . . . . 0.0 111.836 -173.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.29 115.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.616 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 7.4 mttm -120.94 176.83 5.36 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.71 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -97.17 143.67 27.75 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -171.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 -89.02 0.55 Allowed Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.151 -1.386 . . . . 0.0 113.603 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.64 29.81 3.52 Favored Glycine 0 C--N 1.292 -1.911 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.507 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -125.85 31.44 5.48 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 122.08 0.943 . . . . 0.0 109.899 176.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.57 128.51 23.13 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 30' ' ' ILE . 69.8 t -99.63 123.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.926 -170.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 28.7 m -134.97 149.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -132.34 126.95 34.49 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.1 m -67.91 159.78 29.85 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 26' ' ' ARG . 6.1 p-10 -66.6 -15.54 63.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.167 0.508 . . . . 0.0 111.667 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -78.66 0.54 26.13 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.612 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.21 65.97 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 170.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -91.23 129.14 37.26 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 118.927 1.364 . . . . 0.0 112.519 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' HG13 ' A' ' 39' ' ' VAL . 17.9 tt0 -85.81 141.36 29.7 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.03 171.14 17.32 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.601 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 15.2 t -97.48 141.73 30.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.804 -177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.4 140.93 44.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 55' ' ' VAL . 56.2 mtp180 -113.9 145.83 40.92 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.58 -16.16 54.83 Favored Glycine 0 C--O 1.214 -1.116 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.37 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -88.56 -2.29 58.51 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.1 mt-30 -126.83 14.9 7.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.573 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.5 t -129.52 139.73 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 121.724 0.773 . . . . 0.0 110.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -137.19 140.77 42.0 Favored 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.3 pt? -75.92 -153.17 0.04 OUTLIER 'General case' 0 C--N 1.261 -3.252 0 CA-C-O 121.778 0.799 . . . . 0.0 111.505 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -76.19 8.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 122.656 1.217 . . . . 0.0 112.129 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 57' ' ' LEU . 1.9 tm-20 . . . . . 1 C--N 1.237 -4.322 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.491 -1.298 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.81 112.49 19.31 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -172.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.4 -3.69 25.13 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.706 0.765 . . . . 0.0 109.019 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.7 tpt -166.46 145.18 5.55 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -96.6 178.67 5.25 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.824 0.703 . . . . 0.0 110.042 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -93.72 101.83 13.97 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.52 20.3 0.32 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 125.464 1.506 . . . . 0.0 112.577 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 6' ' ' LEU . 93.0 mt -61.87 122.25 14.95 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.86 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.6 mm-40 -93.26 150.03 38.4 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.0 Cg_exo -65.47 129.06 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.495 2.13 . . . . 0.0 110.624 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.39 29.35 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 t0 -67.43 150.74 48.51 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.19 98.2 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 122.842 1.306 . . . . 0.0 111.0 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.5 m -122.64 172.8 9.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.531 -174.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 40.5 pttt -108.13 129.28 55.17 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 33.5 m -129.24 140.62 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.282 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.5 tt -101.31 102.9 13.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -72.17 -68.84 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.057 0.932 . . . . 0.0 109.579 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -128.69 153.67 47.08 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.01 -173.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -19.87 65.58 Favored 'General case' 0 C--O 1.209 -1.036 0 C-N-CA 122.856 0.462 . . . . 0.0 112.084 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.88 2.28 51.89 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.84 0.352 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.27 -44.12 1.9 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.968 0.413 . . . . 0.0 110.284 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 85.79 -156.78 30.44 Favored Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -81.12 112.15 18.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.38 164.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -82.15 137.02 35.06 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.0 146.27 48.89 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 43' ' ' ASP . 15.9 mtm180 -113.77 123.59 50.22 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 40' ' ' VAL . 49.0 t -68.22 118.31 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 53.2 mt -85.91 -44.23 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.547 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.025 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 5.4 ptp85 -162.45 165.13 26.67 Favored 'General case' 1 N--CA 1.347 -5.592 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.186 -173.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.8 m -99.63 128.79 51.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 CA-C-N 112.668 -2.06 . . . . 0.0 108.616 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 11.1 tptp -103.04 -49.16 3.84 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m 75.58 162.92 0.25 Allowed 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 111.858 -2.428 . . . . 0.0 110.747 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.22 30.4 16.9 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.77 -29.11 11.02 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.912 -0.644 . . . . 0.0 112.014 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.674 ' HE ' HG22 ' A' ' 39' ' ' VAL . 28.6 ttt180 -81.15 123.06 28.12 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 m -121.64 123.88 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.387 168.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.674 HG22 ' HE ' ' A' ' 37' ' ' ARG . 74.2 t -91.74 123.92 44.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.525 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 29' ' ' VAL . 33.8 m -135.2 150.58 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.475 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' HD11 ' A' ' 30' ' ' ILE . 47.2 tt0 -129.17 128.98 44.49 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.3 t -74.78 165.24 25.56 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 10.4 m-20 -65.6 -15.68 62.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -78.8 -2.08 37.85 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.981 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.47 73.17 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.801 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -81.78 104.01 11.86 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.605 0.762 . . . . 0.0 110.604 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 37.0 tt0 -86.89 137.62 32.24 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.97 -177.97 7.02 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.439 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -101.87 119.17 38.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.16 169.85 9.95 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 55' ' ' VAL . 74.3 mtm180 -139.77 158.58 43.86 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.23 0.54 6.17 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -101.17 -8.46 22.2 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.676 0.751 . . . . 0.0 109.074 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.2 mt-30 -119.61 6.6 11.03 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.703 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 51' ' ' ARG . 23.1 t -127.43 134.99 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.997 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 -174.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.523 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 27.4 mmm180 -137.77 136.96 37.77 Favored 'General case' 0 N--CA 1.383 -3.791 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -72.48 -175.54 1.64 Allowed 'General case' 0 C--N 1.28 -2.453 0 O-C-N 123.537 0.523 . . . . 0.0 110.524 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.06 107.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.244 1.018 . . . . 0.0 111.121 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.278 -2.526 0 CA-C-N 112.987 -1.915 . . . . 0.0 105.835 -174.962 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.663 ' HA ' ' CG ' ' A' ' 7' ' ' ASP . 19.6 m120 78.61 91.86 0.06 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.549 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.58 -51.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.168 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.3 tpp -165.65 30.27 0.05 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -112.31 -172.39 2.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.41 71.32 2.73 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 166.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.663 ' CG ' ' HA ' ' A' ' 2' ' ' ASN . 1.2 p30 -92.83 23.17 4.31 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 112.801 -2.0 . . . . 0.0 113.881 -169.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.58 148.64 26.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -119.09 161.84 34.59 Favored Pre-proline 0 C--N 1.291 -1.947 0 CA-C-N 117.878 0.308 . . . . 0.0 111.828 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 33.4 Cg_exo -62.41 71.9 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.366 2.711 . . . . 0.0 113.372 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA2' ' NE ' ' A' ' 28' ' ' ARG . . . -178.97 -22.32 0.03 OUTLIER Glycine 0 C--N 1.267 -3.256 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.427 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' H ' ' H ' ' A' ' 11' ' ' GLY . 9.2 m-20 -69.88 123.55 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.63 123.55 52.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.1 169.32 6.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.927 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.576 ' HZ3' ' HA ' ' A' ' 59' ' ' GLU . 31.8 mttm -98.15 129.29 44.94 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 23.4 t -127.38 126.23 67.22 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.21 102.34 15.0 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.56 -59.46 2.7 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.88 0.847 . . . . 0.0 109.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -124.37 154.24 40.65 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.617 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.01 -21.13 63.23 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.89 -18.77 33.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.657 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.99 -36.95 9.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.073 0.463 . . . . 0.0 110.753 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.09 -162.17 40.31 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -74.51 112.99 11.25 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.341 0.591 . . . . 0.0 110.494 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.83 146.22 18.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.571 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -78.64 127.28 31.89 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-O 121.282 0.563 . . . . 0.0 110.009 -178.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.72 159.41 41.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.557 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' NE ' ' HA2' ' A' ' 11' ' ' GLY . 61.1 ttt180 -119.06 135.98 54.36 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 51.7 t -63.98 112.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 171.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.4 mm -97.22 -34.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -159.75 148.16 17.39 Favored 'General case' 1 N--CA 1.344 -5.736 0 CA-C-O 121.81 0.814 . . . . 0.0 110.141 -173.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -108.19 96.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.141 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.688 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 34.2 mttt -95.47 157.02 16.08 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 p -100.36 179.76 4.36 Favored 'General case' 0 C--N 1.265 -3.089 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.871 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.42 -75.04 2.27 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.48 51.28 0.17 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.688 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -140.22 34.99 1.89 Allowed 'General case' 0 N--CA 1.41 -2.445 0 O-C-N 122.585 -0.362 . . . . 0.0 111.778 -177.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 m -63.22 111.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 37' ' ' ARG . 2.7 t -94.48 132.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -164.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.96 140.47 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HB3' HG13 ' A' ' 30' ' ' ILE . 26.7 tt0 -124.88 125.47 44.01 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 m -87.04 173.83 9.05 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.78 -44.06 1.53 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.945 2.098 . . . . 0.0 115.647 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.35 -6.06 43.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.87 10.93 62.35 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.131 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.28 102.05 6.53 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.486 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.2 tt0 -84.77 115.19 22.58 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.338 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.74 170.47 15.93 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.878 -0.514 . . . . 0.0 111.527 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.601 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 52.0 m -86.33 137.68 32.4 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.145 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.81 163.37 12.77 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.845 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -140.94 153.74 45.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.95 -17.61 51.79 Favored Glycine 0 N--CA 1.477 1.431 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -87.23 -10.18 53.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.342 0.592 . . . . 0.0 110.219 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.1 mt-30 -110.83 5.99 21.03 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.912 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.2 129.88 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.545 -171.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -132.38 119.07 20.2 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.1 pt? -92.89 88.54 6.22 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 122.003 0.906 . . . . 0.0 112.828 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 4.4 pt -168.76 155.58 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 5.9 mm-40 . . . . . 0 C--N 1.292 -1.934 0 CA-C-O 117.201 -1.38 . . . . 0.0 109.072 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.629 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 3.6 t-20 -89.05 155.7 19.31 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.56 30.2 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.741 1.617 . . . . 0.0 110.569 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 ptp -156.97 6.34 0.16 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.804 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.629 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -105.64 160.63 15.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.16 81.12 3.0 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.474 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -93.72 82.18 4.31 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.43 121.1 43.92 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 112.729 -2.032 . . . . 0.0 107.265 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -84.58 155.6 62.26 Favored Pre-proline 0 N--CA 1.415 -2.178 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.191 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 21.3 Cg_exo -60.21 125.3 17.16 Favored 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.181 1.921 . . . . 0.0 111.755 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.79 -17.35 10.95 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.319 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 33.4 t0 -63.52 158.85 19.96 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.761 0.825 . . . . 0.0 111.712 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -116.31 107.58 22.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.176 0.59 . . . . 0.0 109.58 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.6 175.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -126.28 139.8 53.03 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 40' ' ' VAL . 57.7 t -131.17 133.85 62.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.6 tt -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.92 -66.29 0.57 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.96 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.8 m -126.63 146.15 50.29 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.898 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -21.43 66.45 Favored 'General case' 0 C--O 1.21 -0.998 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.27 48.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.859 0.362 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.68 -46.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 0.0 109.803 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 93.29 -158.15 23.59 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.311 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -78.85 112.21 15.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.1 0.56 . . . . 0.0 110.677 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.16 149.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -97.88 123.8 42.02 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.048 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.16 169.22 17.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.156 0.979 . . . . 0.0 113.614 -168.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 22.1 mmt180 -112.6 132.88 54.93 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.903 -1.499 . . . . 0.0 107.438 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 65.9 t -67.56 114.15 4.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 173.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 44.4 mm -87.17 -40.63 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.596 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.502 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 1.4 ptp180 -165.86 160.11 16.6 Favored 'General case' 1 N--CA 1.338 -6.036 0 CA-C-O 121.984 0.897 . . . . 0.0 110.563 -176.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.19 94.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.537 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.753 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HE3' ' HD2' ' A' ' 31' ' ' ARG . 56.3 mttt -81.36 149.64 28.79 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.19 169.67 13.61 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -170.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.33 -82.38 1.56 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.66 35.02 0.21 Allowed Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -108.6 22.91 15.29 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.009 -175.23 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' THR . 31.0 m -61.73 136.44 25.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 124.345 1.028 . . . . 0.0 109.103 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 11.4 m -126.1 144.42 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.229 1.014 . . . . 0.0 113.523 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 16' ' ' VAL . 27.3 m -129.93 141.11 47.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.247 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 34.7 tt0 -106.06 116.97 32.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 8.3 t -80.33 172.16 14.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.134 -175.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -44.39 -37.24 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 127.051 2.14 . . . . 0.0 112.55 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 58.2 mm-40 -76.81 0.97 18.74 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.27 -3.77 83.47 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 122.103 0.835 . . . . 0.0 112.125 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -77.61 107.72 10.29 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 124.135 0.974 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.7 tt0 -84.92 114.9 22.47 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -131.58 167.76 18.86 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.428 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.4 t -102.38 145.95 28.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.377 -175.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.85 156.11 48.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.461 -0.896 . . . . 0.0 113.028 -172.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 157.53 16.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.45 -23.26 62.34 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.134 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -87.79 1.09 54.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.155 0.502 . . . . 0.0 111.107 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.5 mt-30 -104.8 -2.75 24.4 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.37 138.18 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.434 0.635 . . . . 0.0 110.648 -170.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -137.73 126.23 23.51 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.571 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -94.9 141.39 28.7 Favored 'General case' 0 C--N 1.262 -3.203 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.4 mt 75.25 145.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 124.163 0.915 . . . . 0.0 109.117 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.727 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -66.19 -24.77 66.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.694 0.759 . . . . 0.0 109.735 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.38 130.21 56.82 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 172.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.86 118.1 8.53 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 124.081 0.863 . . . . 0.0 112.037 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -81.45 144.16 31.58 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.7 mt -82.49 90.12 6.72 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.5 0.667 . . . . 0.0 111.328 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -96.05 10.21 38.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.816 1.769 . . . . 0.0 108.418 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.2 mt -143.54 143.93 31.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 112.664 -2.062 . . . . 0.0 108.376 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -139.26 154.79 72.34 Favored Pre-proline 0 C--O 1.213 -0.818 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -73.94 135.61 21.49 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.78 1.653 . . . . 0.0 111.669 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -2.84 56.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -83.82 154.95 23.22 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 122.667 0.387 . . . . 0.0 111.089 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.1 112.7 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 CA-C-O 122.111 0.958 . . . . 0.0 108.631 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.5 m -128.55 176.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.666 0.745 . . . . 0.0 111.819 -171.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -115.01 129.73 56.78 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 40' ' ' VAL . 66.5 t -129.44 130.97 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -86.84 90.61 8.37 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.96 -54.51 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.526 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.1 m -144.22 149.25 36.06 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.477 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.48 -17.44 64.8 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.97 5.46 46.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.88 0.371 . . . . 0.0 110.673 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -130.97 -47.69 1.02 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.177 0.513 . . . . 0.0 109.887 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 99.84 -156.66 19.72 Favored Glycine 0 N--CA 1.428 -1.85 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.089 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.55 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 91.7 m95 -74.03 112.69 10.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.449 0.7 . . . . 0.0 110.765 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.28 152.14 8.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -71.13 131.49 43.65 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HH21 ' A' ' 28' ' ' ARG . . . -140.31 169.27 17.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.481 HH22 ' CG ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -128.9 134.12 48.15 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.6 t -75.02 115.82 16.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.8 -43.79 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.5 ptp180 -156.78 155.42 31.56 Favored 'General case' 1 N--CA 1.347 -5.582 0 CA-C-O 121.868 0.842 . . . . 0.0 110.167 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -111.67 110.12 31.04 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.647 0 CA-C-N 113.623 -1.626 . . . . 0.0 113.25 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 64.0 mttt -113.16 166.61 11.27 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 t -99.85 164.96 11.8 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 118.541 -1.263 . . . . 0.0 112.667 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -90.58 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.673 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 51' ' ' ARG . . . -146.73 35.02 1.32 Allowed Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 18.9 mmt-85 -109.24 16.79 22.17 Favored 'General case' 1 N--CA 1.374 -4.243 0 CA-C-N 114.775 -0.712 . . . . 0.0 111.64 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -72.61 122.41 25.15 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 CA-C-N 114.557 -1.201 . . . . 0.0 107.797 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 39.3 t -103.76 116.1 46.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.732 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 16' ' ' VAL . 31.2 m -127.85 148.76 32.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.027 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 34.4 tt0 -118.38 131.0 56.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 32.0 t -89.62 174.98 7.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.481 ' CG ' HH22 ' A' ' 28' ' ' ARG . 15.2 m-20 -72.19 -10.08 59.3 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.144 0.973 . . . . 0.0 109.779 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.66 2.43 48.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.074 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.59 0.79 85.32 Favored Glycine 0 CA--C 1.506 -0.474 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.719 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -80.89 111.83 17.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 118.149 0.974 . . . . 0.0 110.973 177.459 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 36.3 tt0 -96.36 114.22 25.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 38.2 p90 -139.22 161.81 36.51 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.179 0.514 . . . . 0.0 111.876 -173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 2.3 t -91.54 106.27 18.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.422 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.64 161.69 14.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.243 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.633 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 76.8 mtt85 -80.3 153.11 28.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.19 6.85 6.64 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.148 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -99.81 -21.94 15.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 46.5 mt-30 -90.8 -12.64 35.8 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.188 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 16' ' ' VAL . 19.1 t -115.88 125.73 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.88 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HG3' ' CH2' ' A' ' 24' ' ' TRP . 6.4 mmp_? -133.37 140.84 47.6 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.536 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.5 pt? -61.34 176.6 0.45 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 124.371 1.044 . . . . 0.0 111.17 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.72 79.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 122.121 0.962 . . . . 0.0 113.53 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.286 -2.163 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -34.17 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 125.804 1.94 . . . . 0.0 115.897 -168.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.14 -40.81 0.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.401 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.2 mtp -117.36 -25.63 6.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.255 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.1 103.58 13.44 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.898 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.33 157.4 46.45 Favored 'General case' 0 CA--C 1.446 -3.035 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -63.93 37.19 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 128.629 2.772 . . . . 0.0 111.057 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.28 40.85 0.09 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -167.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 27.9 mm-40 -113.25 146.99 36.39 Favored Pre-proline 0 C--N 1.256 -3.48 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.691 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.4 114.21 3.48 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.817 1.678 . . . . 0.0 110.148 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.94 1.39 31.91 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.22 153.56 38.01 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.431 0.692 . . . . 0.0 110.22 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 107.25 22.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -133.0 -179.94 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 122.159 0.981 . . . . 0.0 112.42 -168.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 47.8 pttt -123.4 136.25 54.53 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 40' ' ' VAL . 72.5 t -125.96 127.19 70.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.117 0.484 . . . . 0.0 110.112 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.5 tp -85.39 86.73 7.35 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.46 -58.54 4.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.257 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.3 t -129.81 156.4 44.4 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.312 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.61 -13.1 30.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.088 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -107.45 -38.78 5.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 85.35 -172.86 47.56 Favored Glycine 0 N--CA 1.424 -2.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.361 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -62.23 106.9 0.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.45 1.1 . . . . 0.0 111.896 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -99.18 146.63 8.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 32.2 ttm180 -67.65 137.69 55.79 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.19 172.27 16.09 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.583 ' NH2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -136.22 127.68 28.58 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 9' ' ' GLN . 39.9 t -70.86 120.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.52 -42.8 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -152.48 145.18 24.27 Favored 'General case' 1 N--CA 1.343 -5.792 0 CA-C-O 122.564 1.174 . . . . 0.0 111.083 -174.534 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.0 112.7 29.58 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.091 0 CA-C-N 112.604 -2.089 . . . . 0.0 113.447 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 23.4 mttm -125.15 164.71 19.66 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 166.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 m -106.74 178.53 4.53 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.525 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.76 0.9 Allowed Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.66 24.44 1.82 Allowed Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -110.33 23.2 14.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.262 -178.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.2 121.12 20.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 33.4 t -103.88 126.24 58.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.398 -172.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 16' ' ' VAL . 27.0 m -134.4 146.81 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.643 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 32.3 tt0 -114.66 125.58 53.91 Favored 'General case' 0 C--N 1.254 -3.566 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -69.96 166.06 20.42 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 16.9 t70 -57.64 -30.88 65.74 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.854 0.862 . . . . 0.0 111.377 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.03 -5.31 30.29 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.754 1.622 . . . . 0.0 112.484 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.86 68.33 Favored Glycine 0 C--O 1.224 -0.519 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.093 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -82.84 110.35 17.78 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 122.654 0.381 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.0 tt0 -90.34 135.96 33.35 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.733 0.813 . . . . 0.0 109.412 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.57 -175.88 5.38 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 12.0 t -122.18 143.97 49.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.4 -178.14 6.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' C ' ' H ' ' A' ' 53' ' ' ASN . 14.7 mtm180 -106.51 165.83 11.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.484 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.67 28.58 1.81 Allowed Glycine 0 N--CA 1.472 1.08 0 CA-C-O 121.789 0.66 . . . . 0.0 112.545 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.7 m120 -117.17 -16.09 10.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.1 mt-30 -104.56 -2.15 25.55 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.879 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 t -118.0 140.58 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' NH2' ' HB3' ' A' ' 59' ' ' GLU . 11.8 mmm180 -150.43 141.69 23.23 Favored 'General case' 0 N--CA 1.403 -2.781 0 O-C-N 124.672 1.233 . . . . 0.0 110.15 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 97.0 mt -56.84 169.78 0.48 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 124.974 1.421 . . . . 0.0 110.434 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 pt -73.09 81.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.153 0.978 . . . . 0.0 111.929 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HB3' ' NH2' ' A' ' 56' ' ' ARG . 9.5 tp10 . . . . . 0 C--O 1.29 3.201 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.221 -0.426 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -86.33 93.46 9.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.0 145.46 0.08 Allowed 'General case' 0 C--O 1.269 2.13 0 O-C-N 125.39 1.681 . . . . 0.0 108.521 -168.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.0 mmt -109.12 -158.66 0.66 Allowed 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.61 13.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.463 1.125 . . . . 0.0 110.592 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.97 86.14 1.5 Allowed 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.68 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.72 8.65 33.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.12 0.962 . . . . 0.0 112.878 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.47 117.95 35.4 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -110.54 146.55 34.55 Favored Pre-proline 0 C--N 1.289 -2.055 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.556 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.4 Cg_exo -61.44 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.237 2.625 . . . . 0.0 111.748 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.71 5.28 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.29 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.5 148.9 44.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.648 0.261 . . . . 0.0 111.35 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.62 116.36 52.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.64 166.68 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 112.598 -169.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 56' ' ' ARG . 39.0 pttt -110.95 125.56 53.82 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 168.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.34 133.4 60.14 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.999 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.79 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -82.53 90.79 6.8 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.28 -50.64 67.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.791 -2.004 . . . . 0.0 111.733 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -147.18 144.96 29.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.42 66.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.56 8.07 35.94 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.835 0.35 . . . . 0.0 111.227 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -128.61 -44.77 1.35 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.225 0.535 . . . . 0.0 109.82 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 96.05 -153.69 20.63 Favored Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.01 113.02 9.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.74 0.816 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.6 161.07 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -80.02 131.2 35.74 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.98 173.52 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.152 0.501 . . . . 0.0 110.297 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.14 134.51 36.45 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.1 t -70.24 118.08 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 19.8 mt -107.95 -33.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.079 -172.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 32' ' ' VAL . 7.0 ttp180 -157.54 155.98 31.18 Favored 'General case' 1 N--CA 1.343 -5.788 0 CA-C-O 122.498 1.142 . . . . 0.0 112.443 -170.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 31' ' ' ARG . 14.3 m -109.33 121.48 62.43 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.57 0 CA-C-N 112.215 -2.266 . . . . 0.0 106.611 170.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' CB ' ' HB3' ' A' ' 37' ' ' ARG . 1.0 OUTLIER -98.86 -168.61 1.66 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 178.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 m -115.52 163.24 16.04 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.06 76.04 Favored Glycine 0 C--O 1.214 -1.151 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.778 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.58 55.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.418 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HB3' ' CB ' ' A' ' 33' ' ' LYS . 11.9 ttt180 -76.59 110.65 11.34 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t -97.78 129.47 47.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 172.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG13 ' HG3' ' A' ' 47' ' ' GLU . 16.5 t -106.37 125.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.048 0 CA-C-O 121.723 0.773 . . . . 0.0 113.03 -174.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 29' ' ' VAL . 35.8 m -132.62 141.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 170.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.402 ' HB3' HD12 ' A' ' 30' ' ' ILE . 9.0 tt0 -125.49 126.76 45.4 Favored 'General case' 0 C--N 1.26 -3.29 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 t -78.67 168.34 19.9 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.85 -4.5 35.22 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.557 0.694 . . . . 0.0 111.37 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -72.81 -17.12 61.59 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.643 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.55 9.87 61.05 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.749 -178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.6 104.55 16.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HG3' HG13 ' A' ' 39' ' ' VAL . 21.7 tt0 -80.51 118.53 22.19 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.55 175.42 9.6 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.785 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.9 m -100.08 119.32 38.12 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.97 136.61 48.97 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.334 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' ASN . 51.8 mtp180 -90.79 154.03 19.81 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.65 29.19 0.88 Allowed Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.075 0.819 . . . . 0.0 112.744 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.8 m120 -125.08 -8.55 7.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -116.81 -1.55 12.02 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.133 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' ARG . 22.3 t -124.16 136.21 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 CA-C-O 121.237 0.541 . . . . 0.0 109.864 -171.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 13.0 mmm180 -139.14 134.94 33.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 174.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.58 -173.02 0.86 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.555 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.7 pt -63.84 93.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.893 0.854 . . . . 0.0 113.126 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.507 -0.675 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -141.89 151.23 42.47 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.98 96.27 10.66 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -125.91 94.69 4.18 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.367 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.18 100.9 13.65 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.279 1.038 . . . . 0.0 111.064 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.2 mt -121.0 93.95 4.19 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.305 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -82.28 85.14 6.9 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.44 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt -148.46 138.11 22.15 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.425 -2.17 . . . . 0.0 106.559 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -121.58 155.9 59.05 Favored Pre-proline 0 C--N 1.292 -1.911 0 CA-C-O 121.082 0.468 . . . . 0.0 110.941 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 4.3 Cg_exo -69.14 111.01 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 121.819 1.679 . . . . 0.0 110.827 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.7 4.55 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.676 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 20.9 m-20 -60.03 125.16 22.57 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.15 103.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 30.1 m -131.32 176.88 7.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.797 -173.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -105.39 123.73 48.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.142 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.79 134.36 66.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.3 tt -85.9 100.11 11.87 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -73.38 -66.03 0.74 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.6 m -121.41 140.3 52.32 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.219 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.67 66.4 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.33 2.73 53.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -124.74 -44.25 1.96 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 0.0 109.989 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.89 -151.35 20.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -73.38 108.27 6.15 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.663 0.785 . . . . 0.0 110.761 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.0 m -110.71 165.26 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.649 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -82.02 124.29 29.66 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.25 162.83 34.54 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.546 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 1.6 mpp_? -123.92 136.96 54.67 Favored 'General case' 0 CA--C 1.476 -1.88 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.028 176.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 40' ' ' VAL . 46.5 t -71.49 115.08 10.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 57.5 mt -82.94 -41.03 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.384 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.8 ptp85 -160.48 157.89 28.36 Favored 'General case' 1 N--CA 1.345 -5.679 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.874 -177.053 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.49 116.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.774 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.686 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 14.1 mttm -120.31 164.71 15.89 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.742 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 p -95.37 174.35 7.07 Favored 'General case' 0 N--CA 1.388 -3.547 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.107 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.48 5.24 89.31 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.24 25.81 60.89 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.592 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 0.3 OUTLIER -95.91 41.15 1.11 Allowed 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.483 1.135 . . . . 0.0 109.222 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -67.48 117.61 9.31 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.217 -1.811 . . . . 0.0 108.754 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.555 HG22 ' NH1' ' A' ' 37' ' ' ARG . 88.1 t -92.25 128.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.217 -171.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 29' ' ' VAL . 31.0 m -137.29 154.88 31.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -132.89 126.6 32.51 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -71.71 162.16 29.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 124.2 0.937 . . . . 0.0 109.632 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.92 -15.56 13.43 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.44 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 21.7 mp0 -87.66 13.37 10.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.335 -0.228 . . . . 0.0 110.903 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.34 35.78 77.1 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-O 121.373 0.429 . . . . 0.0 113.107 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.44 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 40.0 mtp85 -113.94 109.22 18.15 Favored 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 122.851 0.46 . . . . 0.0 110.154 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -84.23 140.63 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -154.92 168.78 25.81 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.592 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 9.5 t -97.54 125.35 42.19 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.68 167.07 10.03 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.755 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -122.1 153.78 38.23 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.39 -20.24 43.85 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.194 0.838 . . . . 0.0 115.194 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -90.65 -7.36 52.87 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.027 -0.69 . . . . 0.0 110.939 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -104.6 1.21 29.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.37 133.41 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.914 0 CA-C-O 121.575 0.702 . . . . 0.0 109.403 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 21.5 mmm180 -137.87 135.12 35.86 Favored 'General case' 1 N--CA 1.379 -4.003 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.808 177.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -70.16 -175.89 1.06 Allowed 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.44 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -71.5 73.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 122.524 1.154 . . . . 0.0 112.394 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 C--N 1.29 -1.996 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -172.01 -171.18 0.83 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.17 30.65 6.01 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 118.249 0.477 . . . . 0.0 109.75 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.1 ttt -109.89 -25.84 10.09 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.718 0.77 . . . . 0.0 110.964 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -88.67 141.53 28.44 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.06 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.04 93.66 8.86 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.851 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -95.47 87.9 4.91 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 167.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.45 126.5 46.87 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.423 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -85.08 153.69 60.02 Favored Pre-proline 0 N--CA 1.411 -2.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.093 -175.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 6.4 Cg_exo -66.43 103.2 0.64 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.299 1.999 . . . . 0.0 110.918 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.68 -16.56 2.64 Favored Glycine 0 N--CA 1.424 -2.138 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.144 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.4 159.23 34.56 Favored 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.235 0.609 . . . . 0.0 109.442 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.97 113.48 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 57' ' ' LEU . 18.8 m -131.83 169.18 22.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.611 -173.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -103.18 124.04 47.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 38.3 t -123.38 129.13 74.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -91.39 106.15 18.29 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.99 -69.97 0.41 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.226 1.012 . . . . 0.0 109.324 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.4 m -124.38 147.84 47.96 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 113.789 -1.551 . . . . 0.0 108.991 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.0 -23.36 66.38 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.5 -1.58 57.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.8 0.334 . . . . 0.0 111.518 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.37 -42.0 2.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.282 0.563 . . . . 0.0 109.658 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 -156.72 28.04 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -75.47 109.15 8.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.068 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -107.43 145.24 15.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.528 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -84.42 124.91 31.83 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -177.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.16 151.9 51.1 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.359 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -106.64 131.25 54.0 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 40' ' ' VAL . 45.0 t -68.41 113.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.58 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.0 mt -91.26 -40.58 12.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 121.537 0.684 . . . . 0.0 109.886 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' CG ' ' HG3' ' A' ' 33' ' ' LYS . 10.7 tpp180 -155.39 143.1 19.76 Favored 'General case' 1 N--CA 1.368 -4.563 0 CA-C-O 122.14 0.972 . . . . 0.0 110.341 -176.097 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -95.79 89.26 2.22 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.029 0 CA-C-N 113.258 -1.792 . . . . 0.0 108.908 173.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 43.7 mttt -84.27 154.04 23.2 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 174.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t -100.31 -175.96 3.08 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.042 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.14 -62.16 4.28 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.11 46.53 0.02 OUTLIER Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -131.1 27.81 4.81 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.302 -174.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t -55.74 123.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 47' ' ' GLU . 1.7 t -109.58 131.47 60.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -166.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.4 m -132.64 149.22 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 113.014 -1.903 . . . . 0.0 106.073 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.24 123.4 38.05 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 m -76.75 168.74 19.57 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.081 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -58.95 -17.41 24.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.831 1.652 . . . . 0.0 111.514 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -83.33 7.72 15.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.394 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.22 42.22 99.72 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -124.09 104.75 9.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.746 -171.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.9 tt0 -82.67 132.08 35.19 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -151.87 175.6 12.3 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 121.32 -0.152 . . . . 0.0 110.614 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 11.7 t -91.62 143.76 26.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -118.7 146.84 44.41 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.298 0.571 . . . . 0.0 111.192 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.8 mtp-105 -125.24 150.58 46.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.48 -19.47 41.26 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 115.038 0.775 . . . . 0.0 115.038 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.53 -12.6 53.87 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.487 0.66 . . . . 0.0 110.146 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 37.8 mt-30 -114.65 0.18 13.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.092 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 t -127.12 124.52 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.566 0 CA-C-O 121.925 0.869 . . . . 0.0 111.114 -174.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 15.9 mmm180 -132.29 137.11 47.35 Favored 'General case' 1 N--CA 1.368 -4.561 0 CA-C-N 113.831 -1.531 . . . . 0.0 106.935 177.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.1 pp -57.0 168.15 0.7 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.548 0.53 . . . . 0.0 111.826 172.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt -72.16 115.25 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.601 0.715 . . . . 0.0 110.334 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--N 1.273 -2.728 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 -179.826 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 CA--C 1.505 -0.766 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -117.67 121.05 39.85 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.85 85.08 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.302 0.573 . . . . 0.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -110.79 -9.81 14.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.305 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -81.54 112.91 19.2 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.811 0.815 . . . . 0.0 110.558 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.26 117.27 6.78 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.9 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -99.6 25.96 6.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.892 0.853 . . . . 0.0 110.695 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB3' HG21 ' A' ' 29' ' ' VAL . 2.3 mm? -118.89 139.11 52.18 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.032 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -120.41 159.21 48.83 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.385 0.674 . . . . 0.0 109.652 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 3.0 Cg_exo -69.67 94.11 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.798 1.665 . . . . 0.0 112.333 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.15 -19.0 0.83 Allowed Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.311 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.35 129.22 39.08 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -84.54 114.27 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 57' ' ' LEU . 34.9 m -125.29 173.44 11.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.298 -169.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -119.38 129.1 54.64 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' VAL . 30.8 m -123.97 127.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.527 0.679 . . . . 0.0 112.187 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 22.3 tp -91.59 86.97 6.17 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.64 -57.15 6.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.2 t -125.62 153.44 43.76 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.81 60.9 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.41 -15.13 33.92 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -104.99 -40.06 6.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.286 0.565 . . . . 0.0 110.215 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.48 -175.87 46.11 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.29 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . 0.401 ' CD2' ' HB2' ' A' ' 17' ' ' LEU . 90.6 m95 -62.39 108.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.176 0.991 . . . . 0.0 111.571 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 m -101.86 148.09 7.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -75.78 140.1 42.17 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.9 177.18 11.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -134.22 139.73 46.0 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 40' ' ' VAL . 47.1 t -69.44 122.45 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 49.8 mm -89.59 -44.43 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.678 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.48 HH21 ' CD ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -154.05 160.23 41.9 Favored 'General case' 1 N--CA 1.342 -5.872 0 CA-C-O 122.194 0.997 . . . . 0.0 111.325 -175.609 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.7 t -118.51 129.99 73.99 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.349 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.646 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -117.5 179.63 4.0 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 171.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -110.86 175.87 5.25 Favored 'General case' 0 N--CA 1.403 -2.806 0 C-N-CA 117.557 -1.657 . . . . 0.0 109.594 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.27 18.24 65.02 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.48 56.01 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.95 98.13 7.65 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 123.476 1.608 . . . . 0.0 110.827 -176.005 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 49' ' ' THR . 2.4 m -118.88 123.8 72.1 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 CA-C-N 112.94 -1.936 . . . . 0.0 110.698 -176.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG12 ' CG ' ' A' ' 47' ' ' GLU . 2.3 t -107.19 124.01 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 16' ' ' VAL . 33.7 m -129.07 152.65 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.73 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 18.9 tt0 -116.84 122.38 44.21 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -82.93 173.18 12.04 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 123.648 0.592 . . . . 0.0 109.637 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.03 -9.15 3.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.573 1.149 . . . . 0.0 113.312 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -91.58 5.68 48.66 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.89 19.56 79.87 Favored Glycine 0 C--O 1.216 -0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.339 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -108.44 118.32 36.47 Favored 'General case' 0 N--CA 1.403 -2.808 0 O-C-N 122.406 -0.467 . . . . 0.0 111.264 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 57.5 tt0 -88.6 133.8 34.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.6 174.28 14.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.7 m -116.55 135.47 53.79 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.754 0.312 . . . . 0.0 111.149 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.73 174.48 7.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -82.83 156.66 23.51 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.15 -20.84 51.61 Favored Glycine 0 C--O 1.212 -1.241 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -84.56 -15.35 46.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.254 0.55 . . . . 0.0 110.343 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.0 -6.47 51.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.814 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 22.9 t -120.94 121.4 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 8.6 mmm180 -133.54 135.34 44.3 Favored 'General case' 1 N--CA 1.378 -4.031 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.23 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 14' ' ' VAL . 1.9 pp -56.11 161.93 2.18 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.729 0.643 . . . . 0.0 110.915 170.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.266 38.3 pt -73.06 82.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.268 2.052 0 N-CA-C 102.251 -3.24 . . . . 0.0 102.251 172.363 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.18 140.8 39.97 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.97 25.68 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 O-C-N 125.176 1.547 . . . . 0.0 109.72 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.5 ttm -143.01 9.98 1.73 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.716 0.769 . . . . 0.0 110.658 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -76.68 30.19 0.13 Allowed 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.721 1.209 . . . . 0.0 113.081 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.67 85.0 5.54 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.66 83.92 7.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.506 1.146 . . . . 0.0 110.675 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -154.54 140.76 18.55 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.276 -2.238 . . . . 0.0 105.13 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -132.23 152.37 80.01 Favored Pre-proline 0 C--N 1.298 -1.658 0 CA-C-N 118.203 0.456 . . . . 0.0 110.612 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 11.2 Cg_exo -66.7 116.88 4.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.555 2.17 . . . . 0.0 110.427 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.41 9.24 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.36 159.66 32.09 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.802 0.441 . . . . 0.0 111.22 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.52 115.04 46.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 57' ' ' LEU . 27.5 m -130.46 177.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.432 0.634 . . . . 0.0 111.598 -173.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -110.85 124.75 52.66 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.5 t -129.69 133.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.58 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -88.41 91.22 8.71 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.08 -49.36 72.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.473 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 m -146.05 145.85 30.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.743 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.63 -22.41 66.88 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.66 5.02 45.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 -43.3 1.51 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.167 0.508 . . . . 0.0 109.79 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.61 -156.55 22.06 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.363 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.8 110.66 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.619 0.768 . . . . 0.0 110.322 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.41 167.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' CG ' ' A' ' 43' ' ' ASP . 35.5 ttm180 -73.82 129.78 38.6 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 166.84 22.52 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -127.0 140.65 52.15 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.0 t -82.04 109.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mp -90.19 -36.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.338 0.589 . . . . 0.0 110.346 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' NH2' HG11 ' A' ' 39' ' ' VAL . 2.0 ttp-105 -148.37 142.26 25.78 Favored 'General case' 1 N--CA 1.336 -6.164 0 CA-C-O 122.714 1.245 . . . . 0.0 111.683 -174.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.92 130.63 65.21 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.292 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.849 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 3.4 tptp -99.82 -150.17 0.37 Allowed 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -134.89 167.09 21.53 Favored 'General case' 0 N--CA 1.39 -3.468 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.754 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.62 -88.76 1.57 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.01 36.31 0.77 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 47.0 ttt180 -121.76 133.71 54.92 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 m -135.9 135.46 50.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.646 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG11 ' NH2' ' A' ' 31' ' ' ARG . 25.6 t -114.43 123.55 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.7 m -128.29 155.83 40.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -171.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 51.6 tt0 -121.09 121.13 37.22 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.8 m -57.68 146.61 30.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.461 ' CG ' ' HD2' ' A' ' 26' ' ' ARG . 24.3 t70 -60.26 -18.95 52.54 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.959 0.885 . . . . 0.0 111.217 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -82.47 -2.32 52.94 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.1 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.75 -16.12 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -79.83 112.04 16.73 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.117 1.458 . . . . 0.0 113.756 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 25.6 tt0 -89.55 128.41 36.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.7 170.4 22.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -107.21 136.41 47.08 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.68 172.76 12.12 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -87.23 165.64 15.53 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.1 2.56 42.85 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-O 122.039 0.8 . . . . 0.0 111.55 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -90.97 -27.09 18.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.0 mt-30 -96.88 -14.79 21.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.56 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 29.7 t -122.16 122.28 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 28.1 mmm180 -130.54 133.74 46.47 Favored 'General case' 1 N--CA 1.377 -4.09 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.0 pp -62.61 176.35 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 123.837 0.71 . . . . 0.0 112.488 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 pt -68.93 89.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.271 2.229 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 176.114 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.214 -0.778 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 67.32 -168.0 0.2 Allowed 'General case' 0 C--N 1.351 0.663 0 O-C-N 124.194 0.933 . . . . 0.0 109.993 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.55 77.97 1.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -131.5 152.52 50.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.616 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -133.06 -152.15 0.48 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.61 75.15 9.74 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.685 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 9.99 30.35 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.58 118.48 27.08 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -115.73 160.26 35.63 Favored Pre-proline 0 C--N 1.286 -2.181 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.774 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 38.3 Cg_exo -57.61 128.23 28.46 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.61 -12.86 15.47 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.701 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -71.53 155.77 40.19 Favored 'General case' 0 C--O 1.25 1.103 0 C-N-CA 122.726 0.41 . . . . 0.0 111.102 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -112.62 107.71 23.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.9 m -125.5 171.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.913 0.864 . . . . 0.0 111.68 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -123.02 127.38 48.71 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 40' ' ' VAL . 63.8 t -123.26 129.9 74.6 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.2 tt -85.09 100.7 11.88 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.6 -66.28 0.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.257 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.8 m -140.3 149.59 42.97 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.839 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.62 84.98 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.325 0.584 . . . . 0.0 109.806 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 177.12 -41.3 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 126.034 1.734 . . . . 0.0 106.351 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.7 -43.48 8.24 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.56 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 89.52 -151.27 21.76 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.648 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -75.99 106.21 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.442 0.697 . . . . 0.0 110.907 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.75 145.07 12.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -71.93 136.67 46.93 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -145.62 165.44 28.7 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -123.11 130.94 53.44 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.5 t -70.21 113.97 7.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 50.9 mm -91.43 -39.27 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.581 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 2.2 ptp180 -163.37 166.05 23.35 Favored 'General case' 1 N--CA 1.342 -5.842 0 CA-C-O 122.603 1.192 . . . . 0.0 113.013 -176.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.63 133.39 56.25 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 CA-C-N 112.613 -2.085 . . . . 0.0 105.94 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' CB ' ' HD2' ' A' ' 37' ' ' ARG . 12.2 tptp -96.92 -60.42 1.59 Allowed 'General case' 0 CA--C 1.455 -2.71 0 CA-C-O 121.857 0.837 . . . . 0.0 109.749 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -148.19 -177.41 5.73 Favored 'General case' 1 N--CA 1.375 -4.218 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.589 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.3 78.25 0.83 Allowed Glycine 0 C--O 1.217 -0.967 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.68 -13.5 5.07 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.557 ' NH1' HG22 ' A' ' 39' ' ' VAL . 2.2 tmt_? -120.58 122.97 41.73 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.02 167.31 25.51 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.877 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.797 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -136.11 128.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.014 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 29' ' ' VAL . 32.9 m -126.3 143.15 40.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 24.8 tt0 -107.24 126.92 53.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.5 t -92.29 175.68 6.76 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.56 -13.95 55.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.82 0.848 . . . . 0.0 111.63 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 14.7 pt20 -77.44 -0.72 26.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.557 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.66 20.37 77.26 Favored Glycine 0 C--O 1.22 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.549 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -112.15 118.69 36.06 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HG2' HG12 ' A' ' 39' ' ' VAL . 22.1 tt0 -87.12 122.06 30.41 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.9 170.03 16.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.875 0.369 . . . . 0.0 111.495 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.459 ' HB ' ' NH1' ' A' ' 37' ' ' ARG . 12.6 t -85.99 134.64 33.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.154 0.502 . . . . 0.0 109.697 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.72 159.32 22.44 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 54' ' ' GLN . 60.5 mtt180 -114.05 141.74 47.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.53 34.25 Favored Glycine 0 N--CA 1.474 1.173 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -85.73 1.62 48.73 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.75 0.786 . . . . 0.0 112.291 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' OE1' ' HD2' ' A' ' 51' ' ' ARG . 24.7 mt-30 -115.16 9.13 15.78 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.302 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.2 t -124.38 137.37 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.121 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 HH21 ' C ' ' A' ' 59' ' ' GLU . 7.8 mmm180 -140.36 139.12 35.31 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -71.92 -161.22 0.07 Allowed 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 173.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -72.44 64.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.626 1.203 . . . . 0.0 112.086 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' C ' HH21 ' A' ' 56' ' ' ARG . 8.4 tp10 . . . . . 0 C--N 1.295 -1.793 0 C-N-CA 129.128 2.971 . . . . 0.0 104.587 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 10.3 Cg_exo . . . . . 0 N--CA 1.451 -1.004 0 CA-C-O 121.03 0.346 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.63 -8.59 22.02 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -72.4 155.75 39.8 Favored 'General case' 0 C--O 1.259 1.555 0 C-N-CA 123.124 0.57 . . . . 0.0 111.478 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 26' ' ' ARG . 8.4 p -126.39 100.66 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.092 1.357 . . . . 0.0 110.212 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.28 169.22 21.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.946 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -100.48 128.89 46.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 55' ' ' VAL . 21.8 m -128.58 141.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.0 93.56 9.39 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.504 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 38.0 tt0 -65.18 -53.6 42.41 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.942 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.9 m -148.84 149.29 31.05 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.27 -26.8 66.75 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 7.09 36.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 0.0 111.511 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.73 -44.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.0 110.142 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.44 -152.7 21.32 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.097 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.82 109.11 7.07 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 123.57 0.748 . . . . 0.0 111.062 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.69 176.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD3' HG23 ' A' ' 13' ' ' VAL . 3.5 tmm_? -105.82 126.0 51.66 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.501 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.06 178.81 5.33 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.695 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -133.55 131.29 39.56 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 40' ' ' VAL . 48.5 t -79.16 120.21 29.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.666 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.7 mp -95.43 -38.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.122 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 9.5 tpp180 . . . . . 0 N--CA 1.392 -3.339 0 CA-C-O 121.629 0.728 . . . . 0.0 110.394 -174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.9 t . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 121.533 0.683 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.509 HG13 ' HG3' ' A' ' 47' ' ' GLU . 76.7 t -101.89 118.05 48.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.12 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 29' ' ' VAL . 26.8 m -130.94 152.91 38.35 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 172.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -137.0 130.56 31.63 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -84.43 170.97 13.0 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -74.03 -4.14 33.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -10.15 59.39 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.53 -5.42 70.36 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.132 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.504 ' HD3' ' OE2' ' A' ' 18' ' ' GLU . 13.6 ptm180 -78.26 125.45 29.37 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 117.281 0.541 . . . . 0.0 111.262 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.509 ' HG3' HG13 ' A' ' 39' ' ' VAL . 8.6 tt0 -88.32 146.61 25.21 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 18.7 p90 -153.76 164.67 37.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 120.843 0.354 . . . . 0.0 110.589 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.9 t -86.9 116.25 24.84 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.213 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -95.59 160.37 14.54 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HD3' ' OE1' ' A' ' 54' ' ' GLN . 5.7 mpt_? -136.8 162.42 33.27 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.89 -3.87 38.02 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 121.343 -0.456 . . . . 0.0 113.757 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -96.77 -9.68 28.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.408 0.623 . . . . 0.0 109.63 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.491 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 51.9 mt-30 -113.73 -2.32 13.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.922 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 16' ' ' VAL . 35.1 t -130.79 135.36 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.962 -172.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -137.39 124.0 21.0 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.207 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.8 pt? -101.85 115.15 29.91 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.292 35.3 pt . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.446 -1.293 0 N-CA-C 110.974 -0.433 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.36 -9.99 39.03 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -73.32 159.03 33.99 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.87 95.37 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.8 m -114.89 178.33 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.468 -169.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -113.66 126.63 55.47 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 84.7 t -127.17 133.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.8 tt -84.89 91.85 8.13 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.02 -50.49 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.556 -1.657 . . . . 0.0 109.926 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 t -132.96 149.88 52.2 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -18.39 62.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.005 0.431 . . . . 0.0 110.145 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.34 -16.09 29.86 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -104.14 -33.21 8.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.0 110.841 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 86.1 -158.12 31.35 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -73.31 104.49 4.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.618 0.767 . . . . 0.0 110.532 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.66 163.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 34.6 ttm180 -79.82 126.46 31.0 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -133.31 160.77 36.34 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.563 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -125.68 124.46 41.18 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.8 t -70.94 118.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -90.37 -42.67 14.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 . . . . . 1 N--CA 1.378 -4.041 0 CA-C-O 121.537 0.684 . . . . 0.0 109.655 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t . . . . . 0 N--CA 1.42 -1.939 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.1 t -98.41 111.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.986 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 29' ' ' VAL . 34.2 m -135.02 147.1 29.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -129.3 121.47 27.58 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 67.6 m -65.59 157.14 30.6 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.954 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.64 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 45.6 m-20 -65.32 2.88 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.498 0.666 . . . . 0.0 112.62 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 41.9 mt-30 -87.12 -5.81 58.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.81 9.32 78.13 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 121.8 0.666 . . . . 0.0 111.479 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 27.5 mtp85 -95.28 111.81 23.61 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 123.823 0.849 . . . . 0.0 110.522 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -94.95 153.27 17.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -170.9 144.86 2.27 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 123.795 0.684 . . . . 0.0 110.801 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -74.33 95.63 2.71 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.909 0.861 . . . . 0.0 111.535 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.94 159.13 19.12 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -107.02 160.61 15.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.82 2.33 12.83 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -102.69 -9.46 20.03 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.566 0.698 . . . . 0.0 109.14 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.7 mt-30 -100.5 -4.22 29.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.97 133.4 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -137.32 139.91 41.16 Favored 'General case' 0 N--CA 1.391 -3.421 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . 82.5 mt -67.85 -171.86 0.24 Allowed 'General case' 0 C--N 1.291 -1.939 0 O-C-N 123.493 0.496 . . . . 0.0 110.489 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.4 pt . . . . . 0 C--N 1.315 -0.913 0 CA-C-O 122.547 1.165 . . . . 0.0 111.714 174.885 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 17.7 Cg_endo . . . . . 0 N--CA 1.439 -1.704 0 N-CA-C 110.828 -0.489 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.58 6.4 35.54 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -73.39 -175.04 1.81 Allowed 'General case' 0 C--O 1.25 1.1 0 C-N-CA 124.823 1.249 . . . . 0.0 110.932 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.55 106.44 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 32.7 m -132.58 176.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.789 0.804 . . . . 0.0 112.273 -168.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 9.7 pttm -113.73 132.96 55.63 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.202 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 m -124.34 125.86 71.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.604 0.716 . . . . 0.0 111.873 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.3 tp -88.86 92.83 9.37 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.52 -59.77 3.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.958 0.885 . . . . 0.0 109.814 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.3 m -146.27 156.08 43.11 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -14.91 63.35 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.59 0.71 56.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.737 0.303 . . . . 0.0 111.046 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -129.83 -53.46 1.14 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.26 0.553 . . . . 0.0 109.805 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 103.06 -172.6 21.69 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.068 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 85.3 m95 -62.31 114.51 3.52 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.273 1.029 . . . . 0.0 111.489 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.3 163.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.408 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 38.6 ttm105 -79.52 133.75 36.49 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -154.41 172.61 17.45 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.073 0.463 . . . . 0.0 110.845 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -130.73 130.47 43.84 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.4 t -71.03 115.52 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 39' ' ' VAL . 46.0 mm -86.35 -42.57 15.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 12.3 tpp180 . . . . . 0 N--CA 1.382 -3.868 0 CA-C-O 122.135 0.969 . . . . 0.0 111.137 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 49' ' ' THR . 21.6 t . . . . . 0 N--CA 1.436 -1.136 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 30' ' ' ILE . 58.8 t -107.78 115.94 50.07 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.06 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.5 m -135.29 143.62 36.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.489 HE21 ' HB2' ' A' ' 47' ' ' GLU . 36.2 tt0 -130.87 126.9 37.41 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.484 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 46.3 t -77.27 167.69 21.3 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.626 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 5.9 p-10 -76.29 -6.55 51.96 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.281 1.039 . . . . 0.0 110.477 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -84.62 6.79 22.56 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.099 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.49 16.13 75.57 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 122.139 0.855 . . . . 0.0 111.462 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -93.13 98.28 11.21 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.384 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HB2' HE21 ' A' ' 41' ' ' GLN . 3.4 tm-20 -95.57 150.87 19.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -171.39 153.14 3.47 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.011 0.819 . . . . 0.0 111.285 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.2 t -78.76 112.47 15.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.903 0.858 . . . . 0.0 109.44 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.15 177.56 5.54 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.737 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.531 ' O ' HG23 ' A' ' 55' ' ' VAL . 54.6 mtp180 -123.58 146.49 48.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.22 -14.65 57.18 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.941 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.86 -6.2 58.87 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.503 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.0 mt-30 -120.98 14.21 11.47 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.158 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 51' ' ' ARG . 12.6 t -133.39 136.83 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.476 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 5.3 mmm180 -140.11 150.73 44.66 Favored 'General case' 1 N--CA 1.375 -4.205 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.08 178.033 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 91.4 mt -57.97 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 123.191 1.472 . . . . 0.0 111.427 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 C--N 1.255 -3.517 0 O-C-N 120.846 -1.159 . . . . 0.0 112.415 175.055 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.622 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.1 Cg_exo . . . . . 0 N--CA 1.45 -1.03 0 N-CA-C 110.206 -0.728 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.46 -6.97 9.12 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 3.8 t70 -70.7 158.81 35.61 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.72 0.808 . . . . 0.0 110.367 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -127.61 108.8 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 122.635 1.207 . . . . 0.0 111.982 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 28.6 m -134.81 -172.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.643 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.8 pttt -127.66 140.54 52.02 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 55' ' ' VAL . 25.1 m -130.59 146.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.66 112.26 24.77 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -80.21 -71.6 0.45 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.34 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -116.24 139.54 50.25 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.912 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.62 66.01 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 112.325 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 5.5 41.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -127.34 -52.05 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.67 -154.25 18.36 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.45 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -78.21 118.54 20.53 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.206 1.002 . . . . 0.0 111.333 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 163.18 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 18.3 tpp180 -87.6 114.42 24.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -107.77 140.6 40.6 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.943 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 55.7 mtm180 -113.31 119.27 37.1 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 49.0 t -69.47 111.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.6 mm -94.3 -33.73 5.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.14 0.495 . . . . 0.0 110.827 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.556 ' NE ' HG21 ' A' ' 39' ' ' VAL . 8.8 ttp180 . . . . . 1 N--CA 1.347 -5.587 0 CA-C-O 122.095 0.95 . . . . 0.0 108.614 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 49' ' ' THR . 60.2 t . . . . . 0 CA--C 1.503 -0.838 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.556 HG21 ' NE ' ' A' ' 31' ' ' ARG . 63.1 t -125.05 116.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 119.509 1.049 . . . . 0.0 112.126 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.89 142.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 29.6 tt0 -127.18 108.28 10.76 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.915 0.864 . . . . 0.0 109.008 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 15.6 m -70.82 169.34 14.84 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.856 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -28.26 -58.83 0.12 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 128.552 2.741 . . . . 0.0 114.359 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -59.22 -19.45 45.62 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.173 1.789 . . . . 0.0 112.595 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.1 21.06 23.96 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -172.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -90.43 99.88 12.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.238 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -91.45 142.9 27.16 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -165.13 176.47 8.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.875 0.734 . . . . 0.0 110.755 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.5 t -96.71 117.51 31.17 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-O 121.638 0.732 . . . . 0.0 110.493 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.53 169.52 10.96 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.899 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 55' ' ' VAL . 24.4 mmt180 -131.41 145.45 51.81 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.35 -34.3 48.13 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 115.253 0.861 . . . . 0.0 115.253 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.2 -0.06 43.41 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 122.149 -0.618 . . . . 0.0 111.739 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -114.46 9.42 16.75 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.8 t -124.83 139.89 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-O 121.128 0.489 . . . . 0.0 109.882 -174.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.6 mmm180 -137.66 129.28 28.33 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.02 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -99.6 131.87 45.31 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--O 1.248 1.02 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -172.669 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 13.8 Cg_exo . . . . . 0 N--CA 1.438 -1.764 0 N-CA-C 111.044 -0.406 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.12 -12.83 9.72 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.196 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.16 169.73 14.47 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 122.805 0.442 . . . . 0.0 110.094 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.426 HG13 ' HE ' ' A' ' 26' ' ' ARG . 90.5 t -129.82 111.57 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.42 0.628 . . . . 0.0 110.691 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -131.76 169.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.878 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -111.9 133.18 54.25 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.949 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 40' ' ' VAL . 18.3 m -127.34 137.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.419 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.6 tt -89.01 93.68 9.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.0 -49.89 66.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.182 -1.826 . . . . 0.0 110.966 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.7 m -147.25 148.05 31.05 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.506 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.17 68.12 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.8 8.74 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.965 0.412 . . . . 0.0 111.211 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.98 -45.21 1.03 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.288 0.566 . . . . 0.0 109.51 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 95.06 -154.54 21.19 Favored Glycine 0 N--CA 1.423 -2.167 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -72.56 108.14 5.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.863 0.865 . . . . 0.0 110.833 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.58 146.4 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.426 ' HE ' HG13 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -73.52 134.64 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.07 166.39 24.93 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.699 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -119.21 142.19 48.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 40' ' ' VAL . 59.8 t -75.17 121.5 26.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.9 mm -89.47 -38.99 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.157 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 1 N--CA 1.343 -5.805 0 CA-C-O 121.943 0.877 . . . . 0.0 110.538 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 49' ' ' THR . 2.7 m . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 41.8 t -110.12 122.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.202 -174.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 16' ' ' VAL . 34.7 m -126.75 153.74 35.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.562 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 34.1 tt0 -123.52 123.93 41.71 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.4 t -78.08 170.24 16.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.75 1.86 13.66 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.062 0.934 . . . . 0.0 111.472 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -89.76 0.33 57.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.468 174.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 11.69 84.03 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 99.8 mtt180 -87.74 101.87 14.1 Favored 'General case' 0 N--CA 1.41 -2.427 0 C-N-CA 122.925 0.49 . . . . 0.0 110.24 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 38.0 tt0 -97.51 120.91 38.74 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.85 166.08 28.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.6 t -99.42 132.49 44.72 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.46 156.54 33.87 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.962 0.41 . . . . 0.0 111.005 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.3 mtp180 -84.68 157.71 21.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.57 8.03 6.09 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-O 121.766 0.648 . . . . 0.0 112.882 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -103.86 -8.84 19.43 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.0 mt-30 -111.93 -0.54 15.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.697 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 51' ' ' ARG . 5.9 t -127.82 138.26 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -139.53 152.36 46.85 Favored 'General case' 1 N--CA 1.377 -4.112 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.89 -169.73 0.5 Allowed 'General case' 0 C--N 1.27 -2.85 0 O-C-N 123.934 0.771 . . . . 0.0 109.817 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 pt . . . . . 0 C--N 1.306 -1.323 0 CA-C-O 122.518 1.152 . . . . 0.0 110.966 174.012 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.7 Cg_exo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.39 0.25 50.3 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.9 159.11 23.74 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 123.064 0.546 . . . . 0.0 110.076 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.03 100.21 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 122.734 1.254 . . . . 0.0 108.603 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.4 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 34.2 m -122.44 177.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.428 -166.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 47.9 pttt -117.94 134.07 55.31 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 40' ' ' VAL . 65.7 t -131.64 130.34 62.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.0 tt -90.86 100.5 13.35 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -66.79 -57.68 6.56 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.698 0.761 . . . . 0.0 110.563 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -147.17 160.59 42.27 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.514 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -25.77 67.52 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.01 7.1 36.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.848 0.356 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.34 -46.4 1.34 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.092 0.473 . . . . 0.0 109.981 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 88.85 -160.87 30.27 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.304 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.45 111.03 10.32 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.474 0.71 . . . . 0.0 111.091 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.39 154.78 4.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 44.7 ttt180 -75.32 136.64 40.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -148.14 163.5 36.76 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.142 0.972 . . . . 0.0 112.87 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -116.25 119.67 36.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 40' ' ' VAL . 60.7 t -70.19 111.16 3.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 41.4 mt -80.36 -45.2 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.389 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.92 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 3.0 ptp180 . . . . . 1 N--CA 1.343 -5.808 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.961 -175.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.6 t . . . . . 0 N--CA 1.426 -1.668 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.558 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 3.0 m -129.66 138.86 53.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 16' ' ' VAL . 35.8 m -133.2 152.93 36.56 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.008 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 57.7 tt0 -116.92 124.45 49.45 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -83.05 173.76 11.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 26' ' ' ARG . 3.1 m-20 -61.04 -16.64 45.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.428 1.091 . . . . 0.0 110.778 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -78.17 1.33 21.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.673 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.71 87.85 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 116.233 -0.44 . . . . 0.0 113.391 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 35.7 ttt-85 -101.24 120.11 39.76 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.542 0.337 . . . . 0.0 111.564 -174.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.9 136.52 34.56 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -145.1 155.94 43.62 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -95.73 137.23 35.1 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.211 0.529 . . . . 0.0 111.358 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 172.39 13.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.4 mtp180 -85.56 160.19 19.7 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.82 -19.44 69.52 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.238 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -86.94 -1.88 58.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.436 0.636 . . . . 0.0 109.819 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.27 2.26 17.61 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 16' ' ' VAL . 38.4 t -125.22 133.02 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 5.9 mmm180 -138.91 140.86 38.48 Favored 'General case' 0 N--CA 1.385 -3.677 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.145 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -176.17 0.08 Allowed 'General case' 0 C--N 1.287 -2.112 0 O-C-N 123.901 0.75 . . . . 0.0 112.42 170.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.5 pp . . . . . 0 N--CA 1.438 -1.026 0 CA-C-O 122.996 1.379 . . . . 0.0 110.157 171.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 42.3 Cg_exo . . . . . 0 N--CA 1.451 -1.024 0 CA-C-O 121.67 0.613 . . . . 0.0 111.398 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.46 -24.37 3.94 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.813 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -73.42 169.77 16.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.26 132.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -145.28 177.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 124.333 1.053 . . . . 0.0 108.712 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 39.8 pttt -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 40' ' ' VAL . 60.9 t -130.4 133.87 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -86.1 95.22 9.48 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.51 -59.92 4.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.799 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.2 m -139.1 149.0 44.04 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.25 66.89 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.56 8.03 38.55 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.996 0.427 . . . . 0.0 110.972 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.8 mt -130.02 -46.48 1.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.13 -158.26 20.05 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.346 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -72.41 112.22 8.29 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.965 0.906 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.91 152.28 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -78.19 135.24 37.58 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -143.97 159.24 42.92 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.85 0.833 . . . . 0.0 112.116 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -105.78 133.16 50.95 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.971 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 48.1 t -72.56 111.12 6.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 51.4 mm -91.02 -35.51 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.927 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 1 N--CA 1.339 -6.006 0 CA-C-O 121.814 0.816 . . . . 0.0 108.925 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t . . . . . 0 C--O 1.244 0.772 0 N-CA-C 102.224 -3.25 . . . . 0.0 102.224 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 t -129.24 124.0 59.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 119.173 0.897 . . . . 0.0 108.848 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 16' ' ' VAL . 28.5 m -137.5 155.44 31.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.72 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 35.0 tt0 -121.77 124.22 43.68 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 22.3 t -75.65 171.98 13.38 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -10.99 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.402 1.096 . . . . 0.0 109.785 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -9.88 58.98 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.721 174.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.2 85.28 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.441 -0.409 . . . . 0.0 112.529 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -91.11 125.71 35.98 Favored 'General case' 0 N--CA 1.407 -2.623 0 O-C-N 122.283 -0.54 . . . . 0.0 111.296 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 42.2 tt0 -92.07 134.56 34.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.71 153.57 42.59 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.6 t -113.08 116.78 30.42 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.787 0.803 . . . . 0.0 110.838 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.35 -171.34 1.94 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.968 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -100.98 164.59 11.74 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.86 -8.75 69.2 Favored Glycine 0 C--O 1.216 -1.009 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -85.79 -1.82 57.61 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -118.8 11.2 12.59 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.495 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.26 136.28 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 121.418 0.627 . . . . 0.0 109.336 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 18.7 mmm180 -132.72 129.69 39.03 Favored 'General case' 0 N--CA 1.395 -3.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.324 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.67 138.75 37.3 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.759 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.282 37.1 pt . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 126.415 1.886 . . . . 0.0 115.492 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 6.9 Cg_endo . . . . . 0 N--CA 1.45 -1.065 0 CA-C-O 121.152 0.397 . . . . 0.0 112.791 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.26 48.51 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.016 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.57 156.77 18.87 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-O 120.964 0.411 . . . . 0.0 110.985 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.5 106.94 21.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.1 m -123.03 173.31 9.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.97 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -110.34 126.81 54.64 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.074 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 55' ' ' VAL . 25.6 m -121.9 144.63 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -98.35 87.05 3.77 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 171.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -70.32 -42.12 72.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.072 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.7 m -144.44 142.43 30.3 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.681 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.08 67.15 Favored 'General case' 0 C--O 1.21 -0.994 0 C-N-CA 122.851 0.46 . . . . 0.0 112.164 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.02 3.79 47.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.917 0.389 . . . . 0.0 110.959 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -123.42 -44.79 2.11 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 92.27 -153.35 21.73 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.431 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 93.0 m95 -74.43 107.55 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 123.409 0.684 . . . . 0.0 110.722 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.599 HG21 HE22 ' A' ' 44' ' ' GLN . 28.3 m -111.83 171.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.773 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 41.1 ttm180 -82.35 140.81 33.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 16' ' ' VAL . . . -146.05 170.49 16.56 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.894 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 4.4 ptp180 -131.77 129.39 40.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 40' ' ' VAL . 33.1 t -77.81 112.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 31' ' ' ARG . 28.0 mt -86.09 -47.31 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.289 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 5.4 ptp180 . . . . . 1 N--CA 1.328 -6.527 0 C-N-CA 117.023 -1.871 . . . . 0.0 114.442 -170.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.478 -1.81 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.65 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 60.2 t -114.45 130.33 68.96 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 121.882 0.849 . . . . 0.0 112.672 -170.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 29' ' ' VAL . 29.7 m -124.89 159.82 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.583 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 35.4 tt0 -124.88 116.51 22.34 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 38.9 m -70.68 163.78 26.39 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 3.8 m-20 -62.96 -15.12 54.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.969 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.599 HE22 HG21 ' A' ' 25' ' ' VAL . 1.7 mp0 -83.88 2.42 38.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.4 10.42 70.86 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 4.3 mpt_? -91.44 115.99 28.49 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 118.238 1.019 . . . . 0.0 110.29 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 31.2 tt0 -93.95 108.21 20.04 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -139.45 166.02 25.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.747 0.308 . . . . 0.0 110.633 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -82.06 136.79 35.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.33 -176.27 3.83 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.466 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 55' ' ' VAL . 62.4 mtm180 -146.09 154.55 41.95 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.46 2.6 5.57 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-O 121.666 0.592 . . . . 0.0 113.219 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -92.78 -20.04 21.15 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.81 -4.2 14.04 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.366 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 16' ' ' VAL . 15.3 t -139.23 140.64 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.433 -3.552 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 mmm180 -134.82 151.01 50.59 Favored 'General case' 1 N--CA 1.362 -4.866 0 O-C-N 125.301 1.626 . . . . 0.0 107.055 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.409 ' HA ' HG12 ' A' ' 14' ' ' VAL . 75.8 mt -69.19 -170.43 0.26 Allowed 'General case' 0 C--N 1.278 -2.511 0 O-C-N 124.088 0.867 . . . . 0.0 110.498 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.9 pt . . . . . 0 C--N 1.304 -1.395 0 CA-C-O 122.402 1.096 . . . . 0.0 110.336 171.494 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 23.0 Cg_exo . . . . . 0 N--CA 1.441 -1.576 0 N-CA-C 111.194 -0.349 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.92 -15.32 12.43 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 156.58 38.76 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.34 109.07 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 57' ' ' LEU . 28.3 m -132.54 -179.68 3.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -112.92 122.29 47.2 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.94 132.74 70.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.1 tt -80.12 98.24 7.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.02 -56.21 18.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.549 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 m -151.09 148.25 28.08 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.92 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 86.17 3.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.335 0.588 . . . . 0.0 109.748 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.43 -43.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.56 -47.16 5.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.337 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 103.38 -143.6 15.78 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.144 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -72.83 114.28 10.8 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.339 1.056 . . . . 0.0 111.061 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.83 164.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 42.6 ttm180 -77.06 131.01 38.17 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -140.31 136.7 33.51 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.365 0.602 . . . . 0.0 111.192 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.546 ' HE ' HD11 ' A' ' 30' ' ' ILE . 49.2 ttp180 -108.66 123.95 49.76 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 40' ' ' VAL . 41.7 t -66.22 125.17 22.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.7 mm -105.07 -35.93 3.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.289 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.483 ' HE ' HG21 ' A' ' 39' ' ' VAL . 2.1 ttp180 . . . . . 1 N--CA 1.354 -5.272 0 CA-C-O 122.043 0.925 . . . . 0.0 111.836 -173.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.224 -0.263 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 30' ' ' ILE . 69.8 t -99.63 123.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.926 -170.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 28.7 m -134.97 149.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -132.34 126.95 34.49 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.1 m -67.91 159.78 29.85 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 26' ' ' ARG . 6.1 p-10 -66.6 -15.54 63.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.167 0.508 . . . . 0.0 111.667 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -78.66 0.54 26.13 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.612 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.21 65.97 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 170.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -91.23 129.14 37.26 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 118.927 1.364 . . . . 0.0 112.519 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' HG13 ' A' ' 39' ' ' VAL . 17.9 tt0 -85.81 141.36 29.7 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.03 171.14 17.32 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.2 t -97.48 141.73 30.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.804 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.4 140.93 44.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 55' ' ' VAL . 56.2 mtp180 -113.9 145.83 40.92 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.58 -16.16 54.83 Favored Glycine 0 C--O 1.214 -1.116 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.37 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -88.56 -2.29 58.51 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.1 mt-30 -126.83 14.9 7.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.573 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.5 t -129.52 139.73 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 121.724 0.773 . . . . 0.0 110.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -137.19 140.77 42.0 Favored 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.677 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.3 pt? -75.92 -153.17 0.04 OUTLIER 'General case' 0 C--N 1.261 -3.252 0 CA-C-O 121.778 0.799 . . . . 0.0 111.505 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt . . . . . 0 C--N 1.293 -1.885 0 CA-C-O 122.656 1.217 . . . . 0.0 112.129 177.604 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.0 Cg_exo . . . . . 0 N--CA 1.444 -1.415 0 N-CA-C 110.624 -0.568 . . . . 0.0 110.624 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.39 29.35 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 t0 -67.43 150.74 48.51 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.19 98.2 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 122.842 1.306 . . . . 0.0 111.0 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.5 m -122.64 172.8 9.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.531 -174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 40.5 pttt -108.13 129.28 55.17 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 33.5 m -129.24 140.62 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.282 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.5 tt -101.31 102.9 13.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -72.17 -68.84 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.057 0.932 . . . . 0.0 109.579 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -128.69 153.67 47.08 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.01 -173.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -19.87 65.58 Favored 'General case' 0 C--O 1.209 -1.036 0 C-N-CA 122.856 0.462 . . . . 0.0 112.084 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.88 2.28 51.89 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.84 0.352 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.27 -44.12 1.9 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.968 0.413 . . . . 0.0 110.284 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 85.79 -156.78 30.44 Favored Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -81.12 112.15 18.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.38 164.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -82.15 137.02 35.06 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.0 146.27 48.89 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 43' ' ' ASP . 15.9 mtm180 -113.77 123.59 50.22 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 40' ' ' VAL . 49.0 t -68.22 118.31 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 53.2 mt -85.91 -44.23 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.547 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.025 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 5.4 ptp85 . . . . . 1 N--CA 1.347 -5.592 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.186 -173.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 m . . . . . 0 N--CA 1.413 -2.293 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 74.2 t -91.74 123.92 44.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.525 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 29' ' ' VAL . 33.8 m -135.2 150.58 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.475 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' HD11 ' A' ' 30' ' ' ILE . 47.2 tt0 -129.17 128.98 44.49 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.3 t -74.78 165.24 25.56 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 10.4 m-20 -65.6 -15.68 62.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -78.8 -2.08 37.85 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.981 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.47 73.17 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.801 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -81.78 104.01 11.86 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.605 0.762 . . . . 0.0 110.604 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 37.0 tt0 -86.89 137.62 32.24 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.97 -177.97 7.02 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.439 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -101.87 119.17 38.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.16 169.85 9.95 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 55' ' ' VAL . 74.3 mtm180 -139.77 158.58 43.86 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.23 0.54 6.17 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.17 -8.46 22.2 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.676 0.751 . . . . 0.0 109.074 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.2 mt-30 -119.61 6.6 11.03 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.703 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 51' ' ' ARG . 23.1 t -127.43 134.99 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.997 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 -174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.523 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 27.4 mmm180 -137.77 136.96 37.77 Favored 'General case' 0 N--CA 1.383 -3.791 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -72.48 -175.54 1.64 Allowed 'General case' 0 C--N 1.28 -2.453 0 O-C-N 123.537 0.523 . . . . 0.0 110.524 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt . . . . . 0 C--N 1.325 -0.475 0 C-N-CA 124.244 1.018 . . . . 0.0 111.121 174.56 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 33.4 Cg_exo . . . . . 0 C--O 1.244 0.783 0 CA-C-O 122.536 0.974 . . . . 0.0 113.372 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA2' ' NE ' ' A' ' 28' ' ' ARG . . . -178.97 -22.32 0.03 OUTLIER Glycine 0 C--N 1.267 -3.256 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.427 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' H ' ' H ' ' A' ' 11' ' ' GLY . 9.2 m-20 -69.88 123.55 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.63 123.55 52.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.1 169.32 6.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.927 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 58' ' ' ILE . 31.8 mttm -98.15 129.29 44.94 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 23.4 t -127.38 126.23 67.22 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.21 102.34 15.0 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.56 -59.46 2.7 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.88 0.847 . . . . 0.0 109.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -124.37 154.24 40.65 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.617 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.01 -21.13 63.23 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.89 -18.77 33.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.657 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.99 -36.95 9.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.073 0.463 . . . . 0.0 110.753 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.09 -162.17 40.31 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -74.51 112.99 11.25 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.341 0.591 . . . . 0.0 110.494 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.83 146.22 18.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.571 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -78.64 127.28 31.89 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-O 121.282 0.563 . . . . 0.0 110.009 -178.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.72 159.41 41.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.557 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.466 ' NE ' ' HA2' ' A' ' 11' ' ' GLY . 61.1 ttt180 -119.06 135.98 54.36 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 51.7 t -63.98 112.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 171.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.4 mm -97.22 -34.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 . . . . . 1 N--CA 1.344 -5.736 0 CA-C-O 121.81 0.814 . . . . 0.0 110.141 -173.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 m . . . . . 0 CA--C 1.517 -0.325 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG12 ' HB ' ' A' ' 30' ' ' ILE . 2.7 t -94.48 132.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -164.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.96 140.47 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HB3' HG13 ' A' ' 30' ' ' ILE . 26.7 tt0 -124.88 125.47 44.01 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 m -87.04 173.83 9.05 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.78 -44.06 1.53 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.945 2.098 . . . . 0.0 115.647 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.35 -6.06 43.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.87 10.93 62.35 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.131 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.28 102.05 6.53 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.486 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.2 tt0 -84.77 115.19 22.58 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.338 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.74 170.47 15.93 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.878 -0.514 . . . . 0.0 111.527 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.0 m -86.33 137.68 32.4 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.145 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.81 163.37 12.77 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.845 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -140.94 153.74 45.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.95 -17.61 51.79 Favored Glycine 0 N--CA 1.477 1.431 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -87.23 -10.18 53.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.342 0.592 . . . . 0.0 110.219 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.1 mt-30 -110.83 5.99 21.03 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.912 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.2 129.88 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.545 -171.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -132.38 119.07 20.2 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.665 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.1 pt? -92.89 88.54 6.22 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 122.003 0.906 . . . . 0.0 112.828 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 4.4 pt . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 21.3 Cg_exo . . . . . 0 N--CA 1.44 -1.659 0 CA-C-O 121.423 0.51 . . . . 0.0 111.755 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.79 -17.35 10.95 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.319 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 33.4 t0 -63.52 158.85 19.96 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.761 0.825 . . . . 0.0 111.712 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -116.31 107.58 22.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.176 0.59 . . . . 0.0 109.58 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.6 175.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -126.28 139.8 53.03 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 40' ' ' VAL . 57.7 t -131.17 133.85 62.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.6 tt -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.92 -66.29 0.57 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.96 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.8 m -126.63 146.15 50.29 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.898 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -21.43 66.45 Favored 'General case' 0 C--O 1.21 -0.998 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.27 48.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.859 0.362 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.68 -46.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 0.0 109.803 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 93.29 -158.15 23.59 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.311 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -78.85 112.21 15.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.1 0.56 . . . . 0.0 110.677 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.16 149.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -97.88 123.8 42.02 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.048 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.16 169.22 17.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.156 0.979 . . . . 0.0 113.614 -168.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 22.1 mmt180 -112.6 132.88 54.93 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.903 -1.499 . . . . 0.0 107.438 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 65.9 t -67.56 114.15 4.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 173.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 44.4 mm -87.17 -40.63 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.596 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.502 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.413 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 1.4 ptp180 . . . . . 1 N--CA 1.338 -6.036 0 CA-C-O 121.984 0.897 . . . . 0.0 110.563 -176.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' THR . 31.0 m . . . . . 0 CA--C 1.503 -0.854 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 11.4 m -126.1 144.42 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.229 1.014 . . . . 0.0 113.523 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 16' ' ' VAL . 27.3 m -129.93 141.11 47.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.247 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 34.7 tt0 -106.06 116.97 32.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 8.3 t -80.33 172.16 14.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.134 -175.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -44.39 -37.24 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 127.051 2.14 . . . . 0.0 112.55 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -76.81 0.97 18.74 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.27 -3.77 83.47 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 122.103 0.835 . . . . 0.0 112.125 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -77.61 107.72 10.29 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 124.135 0.974 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.7 tt0 -84.92 114.9 22.47 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -131.58 167.76 18.86 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.428 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.4 t -102.38 145.95 28.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.377 -175.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.85 156.11 48.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.461 -0.896 . . . . 0.0 113.028 -172.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 157.53 16.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.45 -23.26 62.34 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.134 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.79 1.09 54.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.155 0.502 . . . . 0.0 111.107 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.5 mt-30 -104.8 -2.75 24.4 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.37 138.18 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.434 0.635 . . . . 0.0 110.648 -170.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -137.73 126.23 23.51 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.571 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -94.9 141.39 28.7 Favored 'General case' 0 C--N 1.262 -3.203 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.4 mt . . . . . 0 CA--C 1.547 0.864 0 O-C-N 124.163 0.915 . . . . 0.0 109.117 -174.007 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo . . . . . 0 N--CA 1.451 -1.009 0 CA-C-O 120.944 0.31 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -2.84 56.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -83.82 154.95 23.22 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 122.667 0.387 . . . . 0.0 111.089 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.1 112.7 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 CA-C-O 122.111 0.958 . . . . 0.0 108.631 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.5 m -128.55 176.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.666 0.745 . . . . 0.0 111.819 -171.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -115.01 129.73 56.78 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 40' ' ' VAL . 66.5 t -129.44 130.97 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -86.84 90.61 8.37 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.96 -54.51 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.526 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.1 m -144.22 149.25 36.06 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.477 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.48 -17.44 64.8 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.97 5.46 46.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.88 0.371 . . . . 0.0 110.673 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -130.97 -47.69 1.02 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.177 0.513 . . . . 0.0 109.887 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 99.84 -156.66 19.72 Favored Glycine 0 N--CA 1.428 -1.85 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.089 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.55 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 91.7 m95 -74.03 112.69 10.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.449 0.7 . . . . 0.0 110.765 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.28 152.14 8.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -71.13 131.49 43.65 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HH21 ' A' ' 28' ' ' ARG . . . -140.31 169.27 17.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.481 HH22 ' CG ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -128.9 134.12 48.15 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.6 t -75.02 115.82 16.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.8 -43.79 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.5 ptp180 . . . . . 1 N--CA 1.347 -5.582 0 CA-C-O 121.868 0.842 . . . . 0.0 110.167 -177.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t . . . . . 0 CA--C 1.499 -1.007 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 39.3 t -103.76 116.1 46.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.732 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 16' ' ' VAL . 31.2 m -127.85 148.76 32.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.027 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 34.4 tt0 -118.38 131.0 56.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 32.0 t -89.62 174.98 7.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.481 ' CG ' HH22 ' A' ' 28' ' ' ARG . 15.2 m-20 -72.19 -10.08 59.3 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.144 0.973 . . . . 0.0 109.779 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.66 2.43 48.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.074 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.59 0.79 85.32 Favored Glycine 0 CA--C 1.506 -0.474 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.719 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -80.89 111.83 17.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 118.149 0.974 . . . . 0.0 110.973 177.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 36.3 tt0 -96.36 114.22 25.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 38.2 p90 -139.22 161.81 36.51 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.179 0.514 . . . . 0.0 111.876 -173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.3 t -91.54 106.27 18.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.422 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.64 161.69 14.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.243 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -80.3 153.11 28.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.19 6.85 6.64 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.148 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.81 -21.94 15.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 46.5 mt-30 -90.8 -12.64 35.8 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.188 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 16' ' ' VAL . 19.1 t -115.88 125.73 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.88 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HG3' ' CH2' ' A' ' 24' ' ' TRP . 6.4 mmp_? -133.37 140.84 47.6 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.536 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.5 pt? -61.34 176.6 0.45 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 124.371 1.044 . . . . 0.0 111.17 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.3 pt . . . . . 0 C--N 1.316 -0.873 0 CA-C-O 122.121 0.962 . . . . 0.0 113.53 177.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.439 -1.691 0 N-CA-C 110.148 -0.751 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.94 1.39 31.91 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.22 153.56 38.01 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.431 0.692 . . . . 0.0 110.22 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 107.25 22.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -133.0 -179.94 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 122.159 0.981 . . . . 0.0 112.42 -168.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 47.8 pttt -123.4 136.25 54.53 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 40' ' ' VAL . 72.5 t -125.96 127.19 70.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.117 0.484 . . . . 0.0 110.112 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.5 tp -85.39 86.73 7.35 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.46 -58.54 4.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.257 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.3 t -129.81 156.4 44.4 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.312 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.61 -13.1 30.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.088 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -107.45 -38.78 5.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 85.35 -172.86 47.56 Favored Glycine 0 N--CA 1.424 -2.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.361 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -62.23 106.9 0.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.45 1.1 . . . . 0.0 111.896 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -99.18 146.63 8.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 32.2 ttm180 -67.65 137.69 55.79 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.19 172.27 16.09 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.583 ' NH2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -136.22 127.68 28.58 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.453 ' HA ' HG12 ' A' ' 40' ' ' VAL . 39.9 t -70.86 120.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.52 -42.8 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER . . . . . 1 N--CA 1.343 -5.792 0 CA-C-O 122.564 1.174 . . . . 0.0 111.083 -174.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 CA--C 1.499 -1.016 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 33.4 t -103.88 126.24 58.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.398 -172.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 16' ' ' VAL . 27.0 m -134.4 146.81 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.643 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 32.3 tt0 -114.66 125.58 53.91 Favored 'General case' 0 C--N 1.254 -3.566 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -69.96 166.06 20.42 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 16.9 t70 -57.64 -30.88 65.74 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.854 0.862 . . . . 0.0 111.377 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.03 -5.31 30.29 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.754 1.622 . . . . 0.0 112.484 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.86 68.33 Favored Glycine 0 C--O 1.224 -0.519 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.093 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -82.84 110.35 17.78 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 122.654 0.381 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.0 tt0 -90.34 135.96 33.35 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.733 0.813 . . . . 0.0 109.412 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.57 -175.88 5.38 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.0 t -122.18 143.97 49.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.4 -178.14 6.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' C ' ' H ' ' A' ' 53' ' ' ASN . 14.7 mtm180 -106.51 165.83 11.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.484 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.67 28.58 1.81 Allowed Glycine 0 N--CA 1.472 1.08 0 CA-C-O 121.789 0.66 . . . . 0.0 112.545 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.7 m120 -117.17 -16.09 10.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.1 mt-30 -104.56 -2.15 25.55 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.879 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 t -118.0 140.58 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -150.43 141.69 23.23 Favored 'General case' 0 N--CA 1.403 -2.781 0 O-C-N 124.672 1.233 . . . . 0.0 110.15 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 97.0 mt -56.84 169.78 0.48 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 124.974 1.421 . . . . 0.0 110.434 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 pt . . . . . 0 C--N 1.308 -1.235 0 CA-C-O 122.153 0.978 . . . . 0.0 111.929 176.053 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.4 Cg_exo . . . . . 0 N--CA 1.457 -0.652 0 CA-C-O 120.854 0.272 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.71 5.28 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.29 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.5 148.9 44.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.648 0.261 . . . . 0.0 111.35 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.62 116.36 52.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.64 166.68 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 112.598 -169.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 56' ' ' ARG . 39.0 pttt -110.95 125.56 53.82 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 168.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.34 133.4 60.14 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.999 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.79 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -82.53 90.79 6.8 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.28 -50.64 67.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.791 -2.004 . . . . 0.0 111.733 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -147.18 144.96 29.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.42 66.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.56 8.07 35.94 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.835 0.35 . . . . 0.0 111.227 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -128.61 -44.77 1.35 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.225 0.535 . . . . 0.0 109.82 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 96.05 -153.69 20.63 Favored Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.01 113.02 9.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.74 0.816 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.6 161.07 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -80.02 131.2 35.74 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.98 173.52 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.152 0.501 . . . . 0.0 110.297 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.14 134.51 36.45 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.1 t -70.24 118.08 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 19.8 mt -107.95 -33.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.079 -172.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 . . . . . 1 N--CA 1.343 -5.788 0 CA-C-O 122.498 1.142 . . . . 0.0 112.443 -170.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t . . . . . 0 CA--C 1.493 -1.248 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG13 ' HG3' ' A' ' 47' ' ' GLU . 16.5 t -106.37 125.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.048 0 CA-C-O 121.723 0.773 . . . . 0.0 113.03 -174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 29' ' ' VAL . 35.8 m -132.62 141.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 170.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.501 HE21 ' HA2' ' A' ' 45' ' ' GLY . 53.8 tt0 -125.49 126.76 45.4 Favored 'General case' 0 C--N 1.26 -3.29 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 t -78.67 168.34 19.9 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.85 -4.5 35.22 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.557 0.694 . . . . 0.0 111.37 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -72.81 -17.12 61.59 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.643 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.501 ' HA2' HE21 ' A' ' 41' ' ' GLN . . . 92.55 9.87 61.05 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.749 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.6 104.55 16.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HG3' HG13 ' A' ' 39' ' ' VAL . 21.7 tt0 -80.51 118.53 22.19 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.55 175.42 9.6 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.785 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.9 m -100.08 119.32 38.12 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.97 136.61 48.97 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.334 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' ASN . 51.8 mtp180 -90.79 154.03 19.81 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.65 29.19 0.88 Allowed Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.075 0.819 . . . . 0.0 112.744 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.8 m120 -125.08 -8.55 7.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -116.81 -1.55 12.02 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.133 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' ARG . 22.3 t -124.16 136.21 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 CA-C-O 121.237 0.541 . . . . 0.0 109.864 -171.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 13.0 mmm180 -139.14 134.94 33.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 174.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.58 -173.02 0.86 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.555 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 C--N 1.307 -1.278 0 CA-C-O 121.893 0.854 . . . . 0.0 113.126 178.355 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 4.3 Cg_exo . . . . . 0 N--CA 1.444 -1.413 0 N-CA-C 110.827 -0.49 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.7 4.55 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.676 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 20.9 m-20 -60.03 125.16 22.57 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.15 103.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 30.1 m -131.32 176.88 7.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.797 -173.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -105.39 123.73 48.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.142 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.79 134.36 66.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.3 tt -85.9 100.11 11.87 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -73.38 -66.03 0.74 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.6 m -121.41 140.3 52.32 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.219 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.67 66.4 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.33 2.73 53.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -124.74 -44.25 1.96 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 0.0 109.989 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.89 -151.35 20.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -73.38 108.27 6.15 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.663 0.785 . . . . 0.0 110.761 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.0 m -110.71 165.26 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.649 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -82.02 124.29 29.66 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.25 162.83 34.54 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.546 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 1.6 mpp_? -123.92 136.96 54.67 Favored 'General case' 0 CA--C 1.476 -1.88 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.028 176.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 40' ' ' VAL . 46.5 t -71.49 115.08 10.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 57.5 mt -82.94 -41.03 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.384 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.8 ptp85 . . . . . 1 N--CA 1.345 -5.679 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.874 -177.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.424 -1.767 0 CA-C-O 122.048 0.928 . . . . 0.0 108.754 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.481 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 88.1 t -92.25 128.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.217 -171.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 29' ' ' VAL . 31.0 m -137.29 154.88 31.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -132.89 126.6 32.51 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -71.71 162.16 29.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 124.2 0.937 . . . . 0.0 109.632 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.92 -15.56 13.43 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.44 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 1.2 mp0 -87.66 13.37 10.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.335 -0.228 . . . . 0.0 110.903 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.34 35.78 77.1 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-O 121.373 0.429 . . . . 0.0 113.107 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.44 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 40.0 mtp85 -113.94 109.22 18.15 Favored 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 122.851 0.46 . . . . 0.0 110.154 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -84.23 140.63 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -154.92 168.78 25.81 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 t -97.54 125.35 42.19 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.68 167.07 10.03 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.755 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -122.1 153.78 38.23 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.39 -20.24 43.85 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.194 0.838 . . . . 0.0 115.194 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.65 -7.36 52.87 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.027 -0.69 . . . . 0.0 110.939 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -104.6 1.21 29.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.37 133.41 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.914 0 CA-C-O 121.575 0.702 . . . . 0.0 109.403 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 21.5 mmm180 -137.87 135.12 35.86 Favored 'General case' 1 N--CA 1.379 -4.003 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.808 177.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -70.16 -175.89 1.06 Allowed 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.44 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt . . . . . 0 C--N 1.31 -1.11 0 CA-C-O 122.524 1.154 . . . . 0.0 112.394 175.276 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 6.4 Cg_exo . . . . . 0 N--CA 1.44 -1.626 0 CA-C-O 121.754 0.647 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.68 -16.56 2.64 Favored Glycine 0 N--CA 1.424 -2.138 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.144 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.4 159.23 34.56 Favored 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.235 0.609 . . . . 0.0 109.442 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.97 113.48 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 57' ' ' LEU . 18.8 m -131.83 169.18 22.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.611 -173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -103.18 124.04 47.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 38.3 t -123.38 129.13 74.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -91.39 106.15 18.29 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.99 -69.97 0.41 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.226 1.012 . . . . 0.0 109.324 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.4 m -124.38 147.84 47.96 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 113.789 -1.551 . . . . 0.0 108.991 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.0 -23.36 66.38 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.5 -1.58 57.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.8 0.334 . . . . 0.0 111.518 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.37 -42.0 2.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.282 0.563 . . . . 0.0 109.658 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 -156.72 28.04 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -75.47 109.15 8.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.068 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -107.43 145.24 15.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.528 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -84.42 124.91 31.83 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -177.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.16 151.9 51.1 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.359 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -106.64 131.25 54.0 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 40' ' ' VAL . 45.0 t -68.41 113.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.58 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.0 mt -91.26 -40.58 12.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 121.537 0.684 . . . . 0.0 109.886 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 . . . . . 1 N--CA 1.368 -4.563 0 CA-C-O 122.14 0.972 . . . . 0.0 110.341 -176.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 47' ' ' GLU . 1.7 t -109.58 131.47 60.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -166.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.4 m -132.64 149.22 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 113.014 -1.903 . . . . 0.0 106.073 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.24 123.4 38.05 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 m -76.75 168.74 19.57 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.081 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -58.95 -17.41 24.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.831 1.652 . . . . 0.0 111.514 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -83.33 7.72 15.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.394 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.22 42.22 99.72 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -124.09 104.75 9.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.746 -171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.9 tt0 -82.67 132.08 35.19 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -151.87 175.6 12.3 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 121.32 -0.152 . . . . 0.0 110.614 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 11.7 t -91.62 143.76 26.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -118.7 146.84 44.41 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.298 0.571 . . . . 0.0 111.192 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.8 mtp-105 -125.24 150.58 46.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.48 -19.47 41.26 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 115.038 0.775 . . . . 0.0 115.038 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.53 -12.6 53.87 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.487 0.66 . . . . 0.0 110.146 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 37.8 mt-30 -114.65 0.18 13.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.092 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 t -127.12 124.52 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.566 0 CA-C-O 121.925 0.869 . . . . 0.0 111.114 -174.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 15.9 mmm180 -132.29 137.11 47.35 Favored 'General case' 1 N--CA 1.368 -4.561 0 CA-C-N 113.831 -1.531 . . . . 0.0 106.935 177.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.1 pp -57.0 168.15 0.7 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.548 0.53 . . . . 0.0 111.826 172.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.443 -0.789 0 CA-C-O 121.601 0.715 . . . . 0.0 110.334 -179.198 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 3.0 Cg_exo . . . . . 0 N--CA 1.446 -1.284 0 CA-C-O 121.977 0.741 . . . . 0.0 112.333 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.15 -19.0 0.83 Allowed Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.311 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.35 129.22 39.08 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -84.54 114.27 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 57' ' ' LEU . 34.9 m -125.29 173.44 11.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.298 -169.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -119.38 129.1 54.64 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' VAL . 30.8 m -123.97 127.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.527 0.679 . . . . 0.0 112.187 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 22.3 tp -91.59 86.97 6.17 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.64 -57.15 6.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.2 t -125.62 153.44 43.76 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.81 60.9 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.41 -15.13 33.92 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -104.99 -40.06 6.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.286 0.565 . . . . 0.0 110.215 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.48 -175.87 46.11 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.29 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . 0.401 ' CD2' ' HB2' ' A' ' 17' ' ' LEU . 90.6 m95 -62.39 108.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.176 0.991 . . . . 0.0 111.571 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 m -101.86 148.09 7.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -75.78 140.1 42.17 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.9 177.18 11.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -134.22 139.73 46.0 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 40' ' ' VAL . 47.1 t -69.44 122.45 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 49.8 mm -89.59 -44.43 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.678 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.48 HH21 ' CD ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER . . . . . 1 N--CA 1.342 -5.872 0 CA-C-O 122.194 0.997 . . . . 0.0 111.325 -175.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 49' ' ' THR . 2.4 m . . . . . 0 CA--C 1.493 -1.222 0 CA-C-O 121.259 0.552 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG12 ' CG ' ' A' ' 47' ' ' GLU . 2.3 t -107.19 124.01 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 16' ' ' VAL . 33.7 m -129.07 152.65 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.73 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 18.9 tt0 -116.84 122.38 44.21 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -82.93 173.18 12.04 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 123.648 0.592 . . . . 0.0 109.637 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.03 -9.15 3.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.573 1.149 . . . . 0.0 113.312 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.789 ' N ' HE21 ' A' ' 44' ' ' GLN . 0.0 OUTLIER -91.58 5.68 48.66 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.89 19.56 79.87 Favored Glycine 0 C--O 1.216 -0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.339 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -108.44 118.32 36.47 Favored 'General case' 0 N--CA 1.403 -2.808 0 O-C-N 122.406 -0.467 . . . . 0.0 111.264 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 57.5 tt0 -88.6 133.8 34.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.6 174.28 14.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.7 m -116.55 135.47 53.79 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.754 0.312 . . . . 0.0 111.149 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.73 174.48 7.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -82.83 156.66 23.51 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.15 -20.84 51.61 Favored Glycine 0 C--O 1.212 -1.241 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.56 -15.35 46.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.254 0.55 . . . . 0.0 110.343 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.0 -6.47 51.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.814 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 22.9 t -120.94 121.4 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 8.6 mmm180 -133.54 135.34 44.3 Favored 'General case' 1 N--CA 1.378 -4.031 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.23 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 14' ' ' VAL . 1.9 pp -56.11 161.93 2.18 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.729 0.643 . . . . 0.0 110.915 170.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.266 38.3 pt . . . . . 0 C--N 1.323 -0.574 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 11.2 Cg_exo . . . . . 0 N--CA 1.452 -0.968 0 N-CA-C 110.427 -0.644 . . . . 0.0 110.427 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.41 9.24 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.36 159.66 32.09 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.802 0.441 . . . . 0.0 111.22 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.52 115.04 46.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 57' ' ' LEU . 27.5 m -130.46 177.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.432 0.634 . . . . 0.0 111.598 -173.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -110.85 124.75 52.66 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.5 t -129.69 133.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.58 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -88.41 91.22 8.71 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.08 -49.36 72.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.473 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 m -146.05 145.85 30.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.743 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.63 -22.41 66.88 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.66 5.02 45.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 -43.3 1.51 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.167 0.508 . . . . 0.0 109.79 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.61 -156.55 22.06 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.363 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.8 110.66 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.619 0.768 . . . . 0.0 110.322 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.41 167.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' CG ' ' A' ' 43' ' ' ASP . 35.5 ttm180 -73.82 129.78 38.6 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 166.84 22.52 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -127.0 140.65 52.15 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.0 t -82.04 109.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mp -90.19 -36.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.338 0.589 . . . . 0.0 110.346 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.459 ' NH2' HG11 ' A' ' 39' ' ' VAL . 2.0 ttp-105 . . . . . 1 N--CA 1.336 -6.164 0 CA-C-O 122.714 1.245 . . . . 0.0 111.683 -174.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 m . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG11 ' NH2' ' A' ' 31' ' ' ARG . 25.6 t -114.43 123.55 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.7 m -128.29 155.83 40.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -171.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 51.6 tt0 -121.09 121.13 37.22 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.8 m -57.68 146.61 30.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.461 ' CG ' ' HD2' ' A' ' 26' ' ' ARG . 24.3 t70 -60.26 -18.95 52.54 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.959 0.885 . . . . 0.0 111.217 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -82.47 -2.32 52.94 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.1 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.75 -16.12 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -79.83 112.04 16.73 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.117 1.458 . . . . 0.0 113.756 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 25.6 tt0 -89.55 128.41 36.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.7 170.4 22.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -107.21 136.41 47.08 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.68 172.76 12.12 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -87.23 165.64 15.53 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.1 2.56 42.85 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-O 122.039 0.8 . . . . 0.0 111.55 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -90.97 -27.09 18.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.0 mt-30 -96.88 -14.79 21.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.56 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 29.7 t -122.16 122.28 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 28.1 mmm180 -130.54 133.74 46.47 Favored 'General case' 1 N--CA 1.377 -4.09 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.0 pp -62.61 176.35 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 123.837 0.71 . . . . 0.0 112.488 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 pt . . . . . 0 C--N 1.317 -0.814 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.66 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 38.3 Cg_exo . . . . . 0 N--CA 1.453 -0.909 0 CA-C-O 121.104 0.376 . . . . 0.0 111.471 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.61 -12.86 15.47 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.701 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -71.53 155.77 40.19 Favored 'General case' 0 C--O 1.25 1.103 0 C-N-CA 122.726 0.41 . . . . 0.0 111.102 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -112.62 107.71 23.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.9 m -125.5 171.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.913 0.864 . . . . 0.0 111.68 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -123.02 127.38 48.71 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 40' ' ' VAL . 63.8 t -123.26 129.9 74.6 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.2 tt -85.09 100.7 11.88 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.6 -66.28 0.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.257 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.8 m -140.3 149.59 42.97 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.839 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.62 84.98 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.325 0.584 . . . . 0.0 109.806 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 177.12 -41.3 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 126.034 1.734 . . . . 0.0 106.351 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.7 -43.48 8.24 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.56 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 89.52 -151.27 21.76 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.648 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -75.99 106.21 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.442 0.697 . . . . 0.0 110.907 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.75 145.07 12.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -71.93 136.67 46.93 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -145.62 165.44 28.7 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -123.11 130.94 53.44 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.5 t -70.21 113.97 7.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 50.9 mm -91.43 -39.27 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.581 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 2.2 ptp180 . . . . . 1 N--CA 1.342 -5.842 0 CA-C-O 122.603 1.192 . . . . 0.0 113.013 -176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.427 -1.624 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -136.11 128.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.014 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 29' ' ' VAL . 32.9 m -126.3 143.15 40.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 24.8 tt0 -107.24 126.92 53.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.5 t -92.29 175.68 6.76 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.56 -13.95 55.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.82 0.848 . . . . 0.0 111.63 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 14.7 pt20 -77.44 -0.72 26.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.557 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.66 20.37 77.26 Favored Glycine 0 C--O 1.22 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.549 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -112.15 118.69 36.06 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HG2' HG12 ' A' ' 39' ' ' VAL . 22.1 tt0 -87.12 122.06 30.41 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.9 170.03 16.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.875 0.369 . . . . 0.0 111.495 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.6 t -85.99 134.64 33.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.154 0.502 . . . . 0.0 109.697 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.72 159.32 22.44 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 54' ' ' GLN . 60.5 mtt180 -114.05 141.74 47.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.53 34.25 Favored Glycine 0 N--CA 1.474 1.173 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -85.73 1.62 48.73 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.75 0.786 . . . . 0.0 112.291 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.52 ' OE1' ' HD2' ' A' ' 51' ' ' ARG . 24.7 mt-30 -115.16 9.13 15.78 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.302 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.2 t -124.38 137.37 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.121 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -140.36 139.12 35.31 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.585 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -71.92 -161.22 0.07 Allowed 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 173.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt . . . . . 0 C--N 1.302 -1.465 0 CA-C-O 122.626 1.203 . . . . 0.0 112.086 171.788 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 26.4 m . . . . . 0 N--CA 1.43 -1.464 0 CA-C-O 119.409 -0.329 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -164.29 165.65 21.63 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.33 -66.76 0.88 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.8 mtt -136.64 -3.08 2.11 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.72 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 5' ' ' GLU . 1.5 mp0 -55.35 133.13 49.47 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 125.256 1.422 . . . . 0.0 112.07 -176.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.3 mt -95.16 94.44 7.92 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.258 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -115.85 19.13 15.34 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 124.119 1.914 . . . . 0.0 106.819 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.96 119.01 18.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 112.493 -2.14 . . . . 0.0 109.506 -174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -115.35 155.14 47.39 Favored Pre-proline 0 C--N 1.287 -2.112 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.666 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 10.3 Cg_exo -63.66 124.45 13.71 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.001 1.801 . . . . 0.0 111.399 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.63 -8.59 22.02 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 -177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -72.4 155.75 39.8 Favored 'General case' 0 C--O 1.259 1.555 0 C-N-CA 123.124 0.57 . . . . 0.0 111.478 -177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 26' ' ' ARG . 8.4 p -126.39 100.66 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.092 1.357 . . . . 0.0 110.212 -174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.28 169.22 21.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.946 -170.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -100.48 128.89 46.41 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 171.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.521 HG12 HG22 ' A' ' 55' ' ' VAL . 21.8 m -128.58 141.49 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.556 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.0 93.56 9.39 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.504 ' OE2' ' HD3' ' A' ' 46' ' ' ARG . 38.0 tt0 -65.18 -53.6 42.41 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.942 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.9 m -148.84 149.29 31.05 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.27 -26.8 66.75 Favored 'General case' 0 C--O 1.21 -0.999 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 7.09 36.11 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.778 0.323 . . . . 0.0 111.511 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.3 mt -129.73 -44.78 1.19 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.089 0.471 . . . . 0.0 110.142 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 92.44 -152.7 21.32 Favored Glycine 0 N--CA 1.426 -1.991 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.097 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.82 109.11 7.07 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 123.57 0.748 . . . . 0.0 111.062 177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.2 m -109.69 176.2 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD3' HG23 ' A' ' 13' ' ' VAL . 3.5 tmm_? -105.82 126.0 51.66 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 119.238 -0.985 . . . . 0.0 108.501 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.06 178.81 5.33 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.695 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 ttp-105 -133.55 131.29 39.56 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 -177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.412 ' HA ' HG12 ' A' ' 40' ' ' VAL . 48.5 t -79.16 120.21 29.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.666 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.7 mp -95.43 -38.65 8.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.122 -178.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.276 9.5 tpp180 -163.83 162.34 23.65 Favored 'General case' 0 N--CA 1.392 -3.339 0 CA-C-O 121.629 0.728 . . . . 0.0 110.394 -174.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.2 t -110.88 118.43 57.28 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.642 0 N-CA-C 104.8 -2.296 . . . . 0.0 104.8 167.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.649 ' HD2' ' CG2' ' A' ' 39' ' ' VAL 0.257 34.1 tttt -103.01 -149.54 0.4 Allowed 'General case' 0 C--N 1.286 -2.194 0 C-N-CA 124.341 1.056 . . . . 0.0 109.687 -170.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.0 m -50.29 99.9 0.02 OUTLIER 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 125.145 1.378 . . . . 0.0 114.533 -173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.59 -78.11 1.52 Allowed Glycine 0 C--O 1.22 -0.743 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.951 174.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -144.41 29.71 1.89 Allowed Glycine 0 C--N 1.302 -1.334 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 1.5 tmt_? -91.09 97.46 11.17 Favored 'General case' 0 N--CA 1.409 -2.478 0 CA-C-O 122.891 1.329 . . . . 0.0 108.024 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.9 t -79.98 132.84 30.95 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.179 0 CA-C-N 113.301 -1.772 . . . . 0.0 109.241 -177.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.649 ' CG2' ' HD2' ' A' ' 33' ' ' LYS . 76.7 t -101.89 118.05 48.13 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.809 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.12 177.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.412 HG12 ' HA ' ' A' ' 29' ' ' VAL . 26.8 m -130.94 152.91 38.35 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 172.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -137.0 130.56 31.63 Favored 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -84.43 170.97 13.0 Favored 'General case' 0 C--N 1.273 -2.729 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -74.03 -4.14 33.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -10.15 59.39 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 172.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.53 -5.42 70.36 Favored Glycine 0 N--CA 1.439 -1.131 0 CA-C-N 115.548 -0.751 . . . . 0.0 113.132 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.504 ' HD3' ' OE2' ' A' ' 18' ' ' GLU . 13.6 ptm180 -78.26 125.45 29.37 Favored 'General case' 0 N--CA 1.413 -2.296 0 CA-C-N 117.281 0.541 . . . . 0.0 111.262 -178.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.509 ' HG3' HG13 ' A' ' 39' ' ' VAL . 8.6 tt0 -88.32 146.61 25.21 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 106.114 -1.809 . . . . 0.0 106.114 173.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.411 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 18.7 p90 -153.76 164.67 37.95 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-O 120.843 0.354 . . . . 0.0 110.589 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 6.9 t -86.9 116.25 24.84 Favored 'General case' 0 N--CA 1.417 -2.107 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.213 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -95.59 160.37 14.54 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.248 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.491 ' HD3' ' OE1' ' A' ' 54' ' ' GLN . 5.7 mpt_? -136.8 162.42 33.27 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 177.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.89 -3.87 38.02 Favored Glycine 0 N--CA 1.477 1.378 0 C-N-CA 121.343 -0.456 . . . . 0.0 113.757 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -96.77 -9.68 28.33 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.408 0.623 . . . . 0.0 109.63 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.491 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 51.9 mt-30 -113.73 -2.32 13.75 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.922 -178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.521 HG22 HG12 ' A' ' 16' ' ' VAL . 35.1 t -130.79 135.36 60.37 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.468 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.962 -172.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 25.6 mmm180 -137.39 124.0 21.0 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.207 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.8 pt? -101.85 115.15 29.91 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.292 35.3 pt 33.46 66.69 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -176.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 . . . . . 0 C--O 1.255 1.364 0 C-N-CA 126.072 1.749 . . . . 0.0 106.373 179.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 N--CA 1.439 -0.993 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -111.65 -4.82 14.6 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -170.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.5 -67.78 0.9 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 119.292 -0.963 . . . . 0.0 109.82 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.506 ' HG3' ' HG3' ' A' ' 5' ' ' GLU . 24.1 ptt? -168.46 -26.02 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.506 ' HG3' ' HG3' ' A' ' 4' ' ' MET 0.294 0.0 OUTLIER -132.89 -114.39 0.22 Allowed 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 115.648 1.722 . . . . 0.0 115.648 -178.44 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.23 41.36 1.57 Allowed 'General case' 0 C--N 1.255 -3.54 0 C-N-CA 125.34 1.456 . . . . 0.0 111.007 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -62.09 38.42 0.01 OUTLIER 'General case' 0 C--N 1.275 -2.665 0 C-N-CA 128.347 2.659 . . . . 0.0 115.368 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -105.5 143.95 32.94 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -117.21 152.2 48.75 Favored Pre-proline 0 C--N 1.3 -1.562 0 CA-C-N 118.91 0.777 . . . . 0.0 111.338 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -73.38 131.55 16.5 Favored 'Trans proline' 0 N--CA 1.446 -1.293 0 C-N-CA 122.179 1.92 . . . . 0.0 110.974 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.36 -9.99 39.03 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -73.32 159.03 33.99 Favored 'General case' 0 C--O 1.256 1.43 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.87 95.37 3.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.8 m -114.89 178.33 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.468 -169.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.0 pttt -113.66 126.63 55.47 Favored 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 84.7 t -127.17 133.55 67.95 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.8 tt -84.89 91.85 8.13 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.02 -50.49 61.94 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 113.556 -1.657 . . . . 0.0 109.926 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 t -132.96 149.88 52.2 Favored 'General case' 0 N--CA 1.418 -2.039 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -71.24 -18.39 62.45 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.005 0.431 . . . . 0.0 110.145 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.34 -16.09 29.86 Favored 'General case' 0 C--O 1.219 -0.502 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.758 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.7 mt -104.14 -33.21 8.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.0 110.841 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 86.1 -158.12 31.35 Favored Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -73.31 104.49 4.35 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 123.618 0.767 . . . . 0.0 110.532 177.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -104.66 163.09 4.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 34.6 ttm180 -79.82 126.46 31.0 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -133.31 160.77 36.34 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.563 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 34.5 ttm105 -125.68 124.46 41.18 Favored 'General case' 0 C--N 1.273 -2.74 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.484 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.8 t -70.94 118.36 15.47 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.266 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -90.37 -42.67 14.22 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -156.29 154.11 30.14 Favored 'General case' 1 N--CA 1.378 -4.041 0 CA-C-O 121.537 0.684 . . . . 0.0 109.655 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.9 t -113.28 132.21 62.78 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 37' ' ' ARG 0.34 26.6 tttp -127.77 -170.06 2.17 Favored 'General case' 0 N--CA 1.403 -2.797 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -112.7 178.67 4.21 Favored 'General case' 1 N--CA 1.376 -4.13 0 C-N-CA 117.18 -1.808 . . . . 0.0 109.518 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.32 17.36 76.41 Favored Glycine 0 C--O 1.243 0.68 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.69 24.46 75.41 Favored Glycine 0 N--CA 1.44 -1.052 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.694 ' NH1' ' HA ' ' A' ' 39' ' ' VAL . 1.1 tmt_? -95.48 111.64 23.5 Favored 'General case' 0 CA--C 1.456 -2.643 0 CA-C-O 122.726 1.25 . . . . 0.0 108.994 -177.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 t -107.23 129.33 61.19 Favored 'Isoleucine or valine' 1 C--N 1.23 -4.63 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.694 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 49.1 t -98.41 111.28 27.7 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.986 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 29' ' ' VAL . 34.2 m -135.02 147.1 29.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -129.3 121.47 27.58 Favored 'General case' 0 C--N 1.277 -2.571 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 67.6 m -65.59 157.14 30.6 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.441 -0.8 . . . . 0.0 108.954 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.64 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 45.6 m-20 -65.32 2.88 0.75 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.498 0.666 . . . . 0.0 112.62 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 41.9 mt-30 -87.12 -5.81 58.89 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.81 9.32 78.13 Favored Glycine 0 C--N 1.335 0.506 0 CA-C-O 121.8 0.666 . . . . 0.0 111.479 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 27.5 mtp85 -95.28 111.81 23.61 Favored 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 123.823 0.849 . . . . 0.0 110.522 -177.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -94.95 153.27 17.74 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.5 p90 -170.9 144.86 2.27 Favored 'General case' 0 C--N 1.289 -2.031 0 O-C-N 123.795 0.684 . . . . 0.0 110.801 -175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 t -74.33 95.63 2.71 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-O 121.909 0.861 . . . . 0.0 111.535 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.94 159.13 19.12 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.498 179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -107.02 160.61 15.42 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 175.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.82 2.33 12.83 Favored Glycine 0 N--CA 1.474 1.219 0 N-CA-C 114.807 0.683 . . . . 0.0 114.807 -175.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -102.69 -9.46 20.03 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.566 0.698 . . . . 0.0 109.14 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.419 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.7 mt-30 -100.5 -4.22 29.2 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.959 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.5 t -119.97 133.4 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.831 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -175.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -137.32 139.91 41.16 Favored 'General case' 0 N--CA 1.391 -3.421 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . 82.5 mt -67.85 -171.86 0.24 Allowed 'General case' 0 C--N 1.291 -1.939 0 O-C-N 123.493 0.496 . . . . 0.0 110.489 177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.4 pt -73.75 76.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-O 122.547 1.165 . . . . 0.0 111.714 174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 C--N 1.29 -1.982 0 CA-C-N 113.199 -1.819 . . . . 0.0 107.012 -179.177 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -82.75 148.35 27.9 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.531 0.682 . . . . 0.0 111.475 -171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -176.19 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 127.285 2.234 . . . . 0.0 105.133 -177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.9 ptp -161.29 31.4 0.14 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 113.214 -1.812 . . . . 0.0 107.207 175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -87.94 157.3 18.98 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -174.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.9 mt -130.71 148.31 52.48 Favored 'General case' 0 N--CA 1.397 -3.082 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -170.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -91.96 12.9 20.22 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-O 122.461 1.124 . . . . 0.0 108.86 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HB3' HG21 ' A' ' 29' ' ' VAL . 1.4 mm? -109.6 143.77 38.84 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 112.947 -1.933 . . . . 0.0 106.178 179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.67 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 28.7 mm-40 -115.78 165.06 15.47 Favored Pre-proline 0 C--N 1.3 -1.556 0 CA-C-N 118.054 0.388 . . . . 0.0 111.828 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 17.7 Cg_endo -78.86 120.76 4.78 Favored 'Trans proline' 0 N--CA 1.439 -1.704 0 C-N-CA 121.38 1.386 . . . . 0.0 110.828 175.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.58 6.4 35.54 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 2.7 t0 -73.39 -175.04 1.81 Allowed 'General case' 0 C--O 1.25 1.1 0 C-N-CA 124.823 1.249 . . . . 0.0 110.932 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 59.0 t -141.55 106.44 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 32.7 m -132.58 176.47 8.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-O 121.789 0.804 . . . . 0.0 112.273 -168.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 9.7 pttm -113.73 132.96 55.63 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 114.564 -1.198 . . . . 0.0 108.202 170.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.443 HG12 HG13 ' A' ' 55' ' ' VAL . 21.1 m -124.34 125.86 71.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-O 121.604 0.716 . . . . 0.0 111.873 -176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.3 tp -88.86 92.83 9.37 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.52 -59.77 3.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.958 0.885 . . . . 0.0 109.814 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.3 m -146.27 156.08 43.11 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.972 -1.013 . . . . 0.0 108.882 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.1 -14.91 63.35 Favored 'General case' 0 C--O 1.21 -1.005 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -176.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.59 0.71 56.08 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.737 0.303 . . . . 0.0 111.046 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.1 mt -129.83 -53.46 1.14 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.26 0.553 . . . . 0.0 109.805 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.439 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 103.06 -172.6 21.69 Favored Glycine 0 N--CA 1.427 -1.913 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.068 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.436 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 85.3 m95 -62.31 114.51 3.52 Favored 'General case' 0 C--N 1.312 -1.044 0 C-N-CA 124.273 1.029 . . . . 0.0 111.489 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.3 163.5 4.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 176.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.408 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 38.6 ttm105 -79.52 133.75 36.49 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -154.41 172.61 17.45 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.073 0.463 . . . . 0.0 110.845 -179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -130.73 130.47 43.84 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.514 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.4 t -71.03 115.52 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 175.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 39' ' ' VAL . 46.0 mm -86.35 -42.57 15.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.468 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 12.3 tpp180 -153.14 142.41 21.54 Favored 'General case' 0 N--CA 1.382 -3.868 0 CA-C-O 122.135 0.969 . . . . 0.0 111.137 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.2 p -102.03 115.6 44.15 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.387 0 CA-C-N 113.066 -1.879 . . . . 0.0 108.144 171.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.781 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 10.0 mttt -106.58 143.21 35.02 Favored 'General case' 0 CA--C 1.453 -2.779 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.179 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.1 m -94.59 26.02 3.68 Favored 'General case' 0 C--N 1.256 -3.468 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.256 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -120.41 30.18 5.67 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 68.26 25.97 74.38 Favored Glycine 0 C--O 1.225 -0.449 0 CA-C-N 114.929 -0.635 . . . . 0.0 111.821 -177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.781 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.5 OUTLIER -117.82 85.8 2.41 Favored 'General case' 0 CA--C 1.471 -2.094 0 CA-C-O 123.161 1.457 . . . . 0.0 111.577 -174.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 49' ' ' THR . 21.6 t -80.64 128.01 39.0 Favored 'Isoleucine or valine' 1 C--N 1.234 -4.432 0 CA-C-N 112.968 -1.924 . . . . 0.0 107.267 178.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.469 ' HA ' ' NH1' ' A' ' 37' ' ' ARG . 58.8 t -107.78 115.94 50.07 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.018 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.06 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.5 m -135.29 143.62 36.49 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.109 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.489 HE21 ' HB2' ' A' ' 47' ' ' GLU . 36.2 tt0 -130.87 126.9 37.41 Favored 'General case' 0 C--N 1.281 -2.376 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.484 177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 46.3 t -77.27 167.69 21.3 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.626 176.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.408 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 5.9 p-10 -76.29 -6.55 51.96 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.281 1.039 . . . . 0.0 110.477 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -84.62 6.79 22.56 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.099 173.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.49 16.13 75.57 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-O 122.139 0.855 . . . . 0.0 111.462 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -93.13 98.28 11.21 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.49 -0.855 . . . . 0.0 109.384 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HB2' HE21 ' A' ' 41' ' ' GLN . 3.4 tm-20 -95.57 150.87 19.86 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 176.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -171.39 153.14 3.47 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.011 0.819 . . . . 0.0 111.285 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 10.2 t -78.76 112.47 15.92 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.903 0.858 . . . . 0.0 109.44 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -97.15 177.56 5.54 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.737 -177.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.531 ' O ' HG23 ' A' ' 55' ' ' VAL . 54.6 mtp180 -123.58 146.49 48.11 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.22 -14.65 57.18 Favored Glycine 0 N--CA 1.476 1.311 0 C-N-CA 120.976 -0.631 . . . . 0.0 113.941 -178.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -86.86 -6.2 58.87 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.503 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.0 mt-30 -120.98 14.21 11.47 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.158 -176.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 51' ' ' ARG . 12.6 t -133.39 136.83 54.21 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.476 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.517 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 5.3 mmm180 -140.11 150.73 44.66 Favored 'General case' 1 N--CA 1.375 -4.205 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.08 178.033 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 91.4 mt -57.97 -163.92 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 123.191 1.472 . . . . 0.0 111.427 171.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 13.3 pt -105.84 64.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.255 -3.517 0 O-C-N 120.846 -1.159 . . . . 0.0 112.415 175.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.288 -2.093 0 CA-C-N 114.069 -1.423 . . . . 0.0 107.52 172.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -167.18 153.25 7.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -170.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.26 31.69 0.24 Allowed 'General case' 0 C--N 1.316 -0.883 0 O-C-N 124.304 1.003 . . . . 0.0 109.634 -176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -105.91 -13.21 15.57 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 122.071 0.939 . . . . 0.0 109.124 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.85 157.65 29.32 Favored 'General case' 0 N--CA 1.411 -2.395 0 CA-C-N 113.919 -1.491 . . . . 0.0 108.402 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.494 HD11 HG21 ' A' ' 55' ' ' VAL . 90.6 mt -128.29 110.57 12.51 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -81.64 84.08 6.89 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 122.629 1.204 . . . . 0.0 108.135 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.8 mt -144.65 165.25 28.57 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 112.139 -2.3 . . . . 0.0 104.959 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 12' ' ' ASP . 29.8 mm-40 -113.49 153.56 45.7 Favored Pre-proline 0 C--N 1.29 -1.987 0 C-N-CA 119.671 -0.812 . . . . 0.0 111.734 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.622 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.1 Cg_exo -62.71 112.45 1.63 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.242 1.961 . . . . 0.0 110.206 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 123.46 -6.97 9.12 Favored Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 3.8 t70 -70.7 158.81 35.61 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 123.72 0.808 . . . . 0.0 110.367 -177.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.5 p -127.61 108.8 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 CA-C-O 122.635 1.207 . . . . 0.0 111.982 -175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.434 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 28.6 m -134.81 -172.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.115 -0.948 . . . . 0.0 108.643 -176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 59' ' ' GLU . 37.8 pttt -127.66 140.54 52.02 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 173.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.533 HG12 HG22 ' A' ' 55' ' ' VAL . 25.1 m -130.59 146.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.257 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -101.66 112.26 24.77 Favored 'General case' 0 C--N 1.279 -2.458 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -80.21 -71.6 0.45 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.34 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.4 m -116.24 139.54 50.25 Favored 'General case' 0 N--CA 1.402 -2.863 0 CA-C-N 114.02 -1.445 . . . . 0.0 108.912 -175.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.97 -20.62 66.01 Favored 'General case' 0 C--O 1.212 -0.915 0 C-N-CA 122.962 0.505 . . . . 0.0 112.325 -177.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.28 5.5 41.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -127.34 -52.05 1.39 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.67 -154.25 18.36 Favored Glycine 0 N--CA 1.424 -2.143 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.45 178.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -78.21 118.54 20.53 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 124.206 1.002 . . . . 0.0 111.333 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 m -108.98 163.18 6.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 14' ' ' VAL . 18.3 tpp180 -87.6 114.42 24.19 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -107.77 140.6 40.6 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.943 -170.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 55.7 mtm180 -113.31 119.27 37.1 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 106.846 -1.539 . . . . 0.0 106.846 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 49.0 t -69.47 111.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.622 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.6 mm -94.3 -33.73 5.22 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 CA-C-O 121.14 0.495 . . . . 0.0 110.827 -174.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.556 ' NE ' HG21 ' A' ' 39' ' ' VAL . 8.8 ttp180 -158.98 137.4 10.77 Favored 'General case' 1 N--CA 1.347 -5.587 0 CA-C-O 122.095 0.95 . . . . 0.0 108.614 -175.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 9.5 m -102.01 102.66 13.85 Favored 'Isoleucine or valine' 1 C--N 1.227 -4.722 0 CA-C-N 113.67 -1.605 . . . . 0.0 113.449 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.502 ' HD3' ' HB3' ' A' ' 37' ' ' ARG . 21.1 mttm -105.98 173.55 6.27 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 112.502 -2.136 . . . . 0.0 105.281 166.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.6 m -142.49 157.34 44.84 Favored 'General case' 0 C--N 1.287 -2.133 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.127 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.0 -92.07 1.34 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.499 176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.54 -18.97 60.97 Favored Glycine 0 N--CA 1.439 -1.107 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.126 -175.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.633 ' NH1' HG22 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -143.93 152.49 41.17 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 49' ' ' THR . 60.2 t -155.16 147.93 12.77 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.915 0 N-CA-C 101.438 -3.541 . . . . 0.0 101.438 174.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.633 HG22 ' NH1' ' A' ' 37' ' ' ARG . 63.1 t -125.05 116.48 47.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 CA-C-N 119.509 1.049 . . . . 0.0 112.126 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 36.0 m -130.89 142.13 44.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 29.6 tt0 -127.18 108.28 10.76 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-O 121.915 0.864 . . . . 0.0 109.008 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.55 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 15.6 m -70.82 169.34 14.84 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.856 -176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -28.26 -58.83 0.12 Allowed 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 128.552 2.741 . . . . 0.0 114.359 176.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -59.22 -19.45 45.62 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 126.173 1.789 . . . . 0.0 112.595 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.1 21.06 23.96 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 108.609 -1.796 . . . . 0.0 108.609 -172.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.3 ttt180 -90.43 99.88 12.82 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.402 -1.399 . . . . 0.0 109.238 -176.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -91.45 142.9 27.16 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 177.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -165.13 176.47 8.46 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 123.875 0.734 . . . . 0.0 110.755 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.5 t -96.71 117.51 31.17 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-O 121.638 0.732 . . . . 0.0 110.493 -177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.53 169.52 10.96 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.899 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.566 ' O ' HG23 ' A' ' 55' ' ' VAL . 24.4 mmt180 -131.41 145.45 51.81 Favored 'General case' 0 C--O 1.212 -0.887 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 175.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -53.35 -34.3 48.13 Favored Glycine 0 N--CA 1.478 1.441 0 N-CA-C 115.253 0.861 . . . . 0.0 115.253 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.2 -0.06 43.41 Favored 'General case' 0 C--N 1.311 -1.1 0 O-C-N 122.149 -0.618 . . . . 0.0 111.739 -178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -114.46 9.42 16.75 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 51' ' ' ARG . 45.8 t -124.83 139.89 49.63 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 CA-C-O 121.128 0.489 . . . . 0.0 109.882 -174.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.424 HH21 ' C ' ' A' ' 59' ' ' GLU . 13.6 mmm180 -137.66 129.28 28.33 Favored 'General case' 0 N--CA 1.407 -2.608 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.02 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -99.6 131.87 45.31 Favored 'General case' 0 C--N 1.268 -2.965 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 170.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 72.7 mt 75.32 150.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.248 1.02 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -172.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 15' ' ' LYS . 54.4 mm-40 . . . . . 0 C--O 1.275 2.444 0 CA-C-O 117.882 -1.056 . . . . 0.0 112.91 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -133.61 34.8 3.42 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.589 -170.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.72 9.61 2.38 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 125.071 1.348 . . . . 0.0 113.1 172.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.8 ttp -96.42 -11.3 25.87 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.596 1.188 . . . . 0.0 108.017 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -87.92 130.99 34.75 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 69.1 mt -85.15 82.69 8.29 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -107.25 83.99 1.9 Allowed 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 169.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 32' ' ' VAL . 3.5 mm? -106.44 129.01 54.49 Favored 'General case' 0 C--N 1.268 -2.946 0 CA-C-N 113.25 -1.796 . . . . 0.0 107.505 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -76.29 154.41 84.21 Favored Pre-proline 0 N--CA 1.406 -2.635 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.092 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 13.8 Cg_exo -63.08 117.55 4.47 Favored 'Trans proline' 0 N--CA 1.438 -1.764 0 C-N-CA 121.886 1.724 . . . . 0.0 111.044 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.12 -12.83 9.72 Favored Glycine 0 N--CA 1.434 -1.448 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.196 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -71.16 169.73 14.47 Favored 'General case' 0 C--O 1.25 1.11 0 C-N-CA 122.805 0.442 . . . . 0.0 110.094 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.426 HG13 ' HE ' ' A' ' 26' ' ' ARG . 90.5 t -129.82 111.57 22.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-O 121.42 0.628 . . . . 0.0 110.691 -173.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.9 m -131.76 169.42 21.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.878 -178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.6 pttt -111.9 133.18 54.25 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.949 175.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG11 HG21 ' A' ' 40' ' ' VAL . 18.3 m -127.34 137.99 56.13 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.419 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.6 tt -89.01 93.68 9.69 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 177.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.0 -49.89 66.18 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.182 -1.826 . . . . 0.0 110.966 -177.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 62.7 m -147.25 148.05 31.05 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.506 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.56 -25.17 68.12 Favored 'General case' 0 C--O 1.21 -1.011 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -177.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.8 8.74 27.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.965 0.412 . . . . 0.0 111.211 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.98 -45.21 1.03 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.288 0.566 . . . . 0.0 109.51 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 95.06 -154.54 21.19 Favored Glycine 0 N--CA 1.423 -2.167 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.8 m95 -72.56 108.14 5.45 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 123.863 0.865 . . . . 0.0 110.833 177.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.7 m -101.58 146.4 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.426 ' HE ' HG13 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -73.52 134.64 43.88 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.07 166.39 24.93 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.699 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.562 ' HD2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -119.21 142.19 48.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 174.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HA ' HG12 ' A' ' 40' ' ' VAL . 59.8 t -75.17 121.5 26.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.9 mm -89.47 -38.99 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.157 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -156.05 155.75 33.18 Favored 'General case' 1 N--CA 1.343 -5.805 0 CA-C-O 121.943 0.877 . . . . 0.0 110.538 -178.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' HB ' ' O ' ' A' ' 8' ' ' LEU . 7.5 p -117.6 124.61 73.29 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.543 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.694 -178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.662 ' CB ' ' HB3' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -121.94 -71.63 0.72 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.312 170.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.482 ' O ' HG13 ' A' ' 38' ' ' VAL . 25.6 t -169.88 177.57 4.34 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 177.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -70.95 59.29 1.0 Allowed Glycine 0 N--CA 1.481 1.686 0 O-C-N 123.493 0.495 . . . . 0.0 114.185 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 51' ' ' ARG . . . 174.81 -23.37 0.06 OUTLIER Glycine 0 C--N 1.296 -1.66 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.662 ' HB3' ' CB ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -122.8 15.64 10.14 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-O 121.982 0.896 . . . . 0.0 110.966 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 34' ' ' SER . 2.7 m -79.75 125.54 38.84 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 41.8 t -110.12 122.93 65.52 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.273 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.202 -174.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.502 HG21 HG11 ' A' ' 16' ' ' VAL . 34.7 m -126.75 153.74 35.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 -175.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.562 ' O ' ' HD2' ' A' ' 28' ' ' ARG . 34.1 tt0 -123.52 123.93 41.71 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 27.4 t -78.08 170.24 16.94 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -75.75 1.86 13.66 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.062 0.934 . . . . 0.0 111.472 -177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -89.76 0.33 57.07 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 114.626 -1.17 . . . . 0.0 108.468 174.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.23 11.69 84.03 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.675 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 99.8 mtt180 -87.74 101.87 14.1 Favored 'General case' 0 N--CA 1.41 -2.427 0 C-N-CA 122.925 0.49 . . . . 0.0 110.24 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 38.0 tt0 -97.51 120.91 38.74 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -147.85 166.08 28.67 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.822 0.344 . . . . 0.0 110.527 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 12.6 t -99.42 132.49 44.72 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.46 156.54 33.87 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 120.962 0.41 . . . . 0.0 111.005 -176.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 55' ' ' VAL . 46.3 mtp180 -84.68 157.71 21.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.57 8.03 6.09 Favored Glycine 0 N--CA 1.476 1.308 0 CA-C-O 121.766 0.648 . . . . 0.0 112.882 178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -103.86 -8.84 19.43 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.0 mt-30 -111.93 -0.54 15.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.697 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 51' ' ' ARG . 5.9 t -127.82 138.26 55.23 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.691 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -139.53 152.36 46.85 Favored 'General case' 1 N--CA 1.377 -4.112 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.7 mt -71.89 -169.73 0.5 Allowed 'General case' 0 C--N 1.27 -2.85 0 O-C-N 123.934 0.771 . . . . 0.0 109.817 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.4 pt -73.9 78.19 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 CA-C-O 122.518 1.152 . . . . 0.0 110.966 174.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 C--N 1.293 -1.854 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -179.215 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 N--CA 1.448 -0.544 0 CA-C-O 121.434 0.635 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -116.04 -168.35 1.41 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.04 0.69 5.61 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.8 ttt -103.14 -7.21 21.46 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 122.01 0.91 . . . . 0.0 109.085 177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -116.89 -152.82 0.51 Allowed 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.893 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -107.05 150.3 26.67 Favored 'General case' 0 N--CA 1.397 -3.102 0 C-N-CA 124.427 1.091 . . . . 0.0 108.777 177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.9 p-10 -103.08 20.07 18.32 Favored 'General case' 0 C--N 1.254 -3.563 0 C-N-CA 126.445 1.898 . . . . 0.0 107.027 171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.485 HD13 HG11 ' A' ' 14' ' ' VAL . 73.6 mt -132.15 174.99 9.64 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.012 -1.904 . . . . 0.0 109.506 -171.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -136.23 163.9 46.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 C-N-CA 123.781 0.833 . . . . 0.0 109.624 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.7 Cg_exo -66.58 137.65 47.02 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.764 1.643 . . . . 0.0 110.673 175.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.39 0.25 50.3 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -81.9 159.11 23.74 Favored 'General case' 0 C--O 1.259 1.567 0 C-N-CA 123.064 0.546 . . . . 0.0 110.076 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.03 100.21 10.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 122.734 1.254 . . . . 0.0 108.603 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.485 HG11 HD13 ' A' ' 8' ' ' LEU . 34.2 m -122.44 177.44 3.76 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 CA-C-N 114.806 -1.088 . . . . 0.0 112.428 -166.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.533 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 47.9 pttt -117.94 134.07 55.31 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 171.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 40' ' ' VAL . 65.7 t -131.64 130.34 62.12 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.0 tt -90.86 100.5 13.35 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -66.79 -57.68 6.56 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.698 0.761 . . . . 0.0 110.563 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.3 m -147.17 160.59 42.27 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.514 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.56 -25.77 67.52 Favored 'General case' 0 C--O 1.21 -1.0 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -176.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.01 7.1 36.52 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.848 0.356 . . . . 0.0 111.312 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.9 mt -128.34 -46.4 1.34 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.092 0.473 . . . . 0.0 109.981 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 88.85 -160.87 30.27 Favored Glycine 0 N--CA 1.431 -1.677 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.304 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -75.45 111.03 10.32 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 123.474 0.71 . . . . 0.0 111.091 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -99.39 154.78 4.11 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 176.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB3' ' OD1' ' A' ' 43' ' ' ASP . 44.7 ttt180 -75.32 136.64 40.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -148.14 163.5 36.76 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 122.142 0.972 . . . . 0.0 112.87 -177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -116.25 119.67 36.5 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.487 ' HA ' HG12 ' A' ' 40' ' ' VAL . 60.7 t -70.19 111.16 3.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 41.4 mt -80.36 -45.2 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.389 0 C-N-CA 119.85 -0.74 . . . . 0.0 109.92 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.558 ' HG2' ' CG2' ' A' ' 39' ' ' VAL . 3.0 ptp180 -160.1 162.73 34.11 Favored 'General case' 1 N--CA 1.343 -5.808 0 C-N-CA 118.72 -1.192 . . . . 0.0 111.961 -175.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.0 120.78 61.02 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.427 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 173.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 7.3 mttm -86.99 -66.6 0.89 Allowed 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.313 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.9 t -171.95 99.92 0.17 Allowed 'General case' 0 N--CA 1.415 -2.205 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.805 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 56.49 -82.37 0.01 OUTLIER Glycine 0 N--CA 1.47 0.936 0 O-C-N 124.623 1.202 . . . . 0.0 114.611 175.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.24 -13.46 63.79 Favored Glycine 0 N--CA 1.426 -2.029 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 -176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.565 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 17.5 mmt180 -99.73 106.99 18.95 Favored 'General case' 1 N--CA 1.348 -5.569 0 CA-C-O 122.515 1.15 . . . . 0.0 109.195 176.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 45.6 t -129.29 144.64 37.53 Favored 'Isoleucine or valine' 1 C--N 1.225 -4.828 0 CA-C-N 112.481 -2.145 . . . . 0.0 105.845 175.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.558 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 3.0 m -129.66 138.86 53.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-O 121.66 0.743 . . . . 0.0 110.857 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.622 HG21 HG21 ' A' ' 16' ' ' VAL . 35.8 m -133.2 152.93 36.56 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.008 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 57.7 tt0 -116.92 124.45 49.45 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -83.05 173.76 11.46 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.42 ' OD1' ' HB3' ' A' ' 26' ' ' ARG . 3.1 m-20 -61.04 -16.64 45.88 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.428 1.091 . . . . 0.0 110.778 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -78.17 1.33 21.72 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.673 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 78.28 6.71 87.85 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 116.233 -0.44 . . . . 0.0 113.391 176.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 35.7 ttt-85 -101.24 120.11 39.76 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 122.542 0.337 . . . . 0.0 111.564 -174.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -82.9 136.52 34.56 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 173.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -145.1 155.94 43.62 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 10.2 t -95.73 137.23 35.1 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.211 0.529 . . . . 0.0 111.358 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -144.94 172.39 13.11 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' O ' HG23 ' A' ' 55' ' ' VAL . 58.4 mtp180 -85.56 160.19 19.7 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.82 -19.44 69.52 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.238 177.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -86.94 -1.88 58.19 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.436 0.636 . . . . 0.0 109.819 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -111.27 2.26 17.61 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG13 HG22 ' A' ' 16' ' ' VAL . 38.4 t -125.22 133.02 70.4 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.067 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -177.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.533 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 5.9 mmm180 -138.91 140.86 38.48 Favored 'General case' 0 N--CA 1.385 -3.677 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.145 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.83 -176.17 0.08 Allowed 'General case' 0 C--N 1.287 -2.112 0 O-C-N 123.901 0.75 . . . . 0.0 112.42 170.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.517 ' O ' HD12 ' A' ' 58' ' ' ILE . 2.5 pp -59.98 106.95 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 122.996 1.379 . . . . 0.0 110.157 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 26.5 tt0 . . . . . 0 C--N 1.261 -3.272 0 CA-C-N 112.614 -2.085 . . . . 0.0 105.631 -170.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.56 ' O ' ' HG2' ' A' ' 4' ' ' MET . 3.3 m-20 72.14 109.01 0.07 Allowed 'General case' 0 C--O 1.207 -1.135 0 O-C-N 124.991 1.432 . . . . 0.0 108.394 -173.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -50.61 93.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 124.632 1.208 . . . . 0.0 113.762 -173.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.56 ' HG2' ' O ' ' A' ' 2' ' ' ASN . 25.2 ptt? -165.49 2.11 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.36 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -97.93 -168.57 1.69 Allowed 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.146 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.0 mt -133.27 138.89 46.63 Favored 'General case' 0 N--CA 1.413 -2.303 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -85.22 -0.02 53.3 Favored 'General case' 0 C--N 1.286 -2.17 0 CA-C-O 122.422 1.106 . . . . 0.0 110.855 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -93.9 150.43 20.37 Favored 'General case' 0 C--N 1.271 -2.844 0 CA-C-N 113.046 -1.888 . . . . 0.0 107.588 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -115.95 167.21 10.64 Favored Pre-proline 0 C--N 1.287 -2.114 0 CA-C-O 120.447 0.165 . . . . 0.0 111.42 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 42.3 Cg_exo -56.61 110.89 0.64 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.094 1.862 . . . . 0.0 111.398 175.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.46 -24.37 3.94 Favored Glycine 0 N--CA 1.431 -1.69 0 CA-C-N 114.539 -1.21 . . . . 0.0 110.813 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -73.42 169.77 16.48 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.26 132.65 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.356 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 17.3 m -145.28 177.11 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 C-N-CA 124.333 1.053 . . . . 0.0 108.712 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 39.8 pttt -112.59 131.52 55.58 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 40' ' ' VAL . 60.9 t -130.4 133.87 63.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 tt -86.1 95.22 9.48 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.51 -59.92 4.5 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.221 -1.809 . . . . 0.0 110.799 -177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.2 m -139.1 149.0 44.04 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.499 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.37 -22.25 66.89 Favored 'General case' 0 C--O 1.211 -0.937 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -91.56 8.03 38.55 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.996 0.427 . . . . 0.0 110.972 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.8 mt -130.02 -46.48 1.13 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.659 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.13 -158.26 20.05 Favored Glycine 0 N--CA 1.428 -1.881 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.346 177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -72.41 112.22 8.29 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 123.965 0.906 . . . . 0.0 110.968 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.5 m -105.91 152.28 7.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -78.19 135.24 37.58 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -143.97 159.24 42.92 Favored 'General case' 0 N--CA 1.421 -1.892 0 CA-C-O 121.85 0.833 . . . . 0.0 112.116 -176.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -105.78 133.16 50.95 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.353 -1.294 . . . . 0.0 107.971 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 48.1 t -72.56 111.12 6.39 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 51.4 mm -91.02 -35.51 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.927 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.49 153.27 30.0 Favored 'General case' 1 N--CA 1.339 -6.006 0 CA-C-O 121.814 0.816 . . . . 0.0 108.925 -179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.5 t -113.55 112.72 41.52 Favored 'Isoleucine or valine' 0 C--N 1.248 -3.831 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.487 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HD3' ' HB3' ' A' ' 37' ' ' ARG . 18.7 mttm -110.75 -177.36 3.2 Favored 'General case' 0 N--CA 1.401 -2.885 0 N-CA-C 104.509 -2.404 . . . . 0.0 104.509 166.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.6 m -136.09 160.65 37.99 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 117.294 -1.762 . . . . 0.0 113.008 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.72 -88.42 0.11 Allowed Glycine 0 CA--C 1.5 -0.85 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.105 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.88 -21.72 49.04 Favored Glycine 0 N--CA 1.419 -2.437 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.77 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.534 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 2.7 mmp_? -121.06 147.51 45.42 Favored 'General case' 1 N--CA 1.376 -4.175 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -178.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.02 146.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.288 0 N-CA-C 102.224 -3.25 . . . . 0.0 102.224 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HD2' ' A' ' 33' ' ' LYS . 11.8 t -129.24 124.0 59.4 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 119.173 0.897 . . . . 0.0 108.848 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.542 HG21 HG21 ' A' ' 16' ' ' VAL . 28.5 m -137.5 155.44 31.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.72 -172.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 35.0 tt0 -121.77 124.22 43.68 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 22.3 t -75.65 171.98 13.38 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -65.94 -10.99 44.1 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 122.402 1.096 . . . . 0.0 109.785 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.75 -9.88 58.98 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.721 174.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.62 -5.2 85.28 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 121.441 -0.409 . . . . 0.0 112.529 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -91.11 125.71 35.98 Favored 'General case' 0 N--CA 1.407 -2.623 0 O-C-N 122.283 -0.54 . . . . 0.0 111.296 -178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 42.2 tt0 -92.07 134.56 34.72 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -143.71 153.57 42.59 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.6 t -113.08 116.78 30.42 Favored 'General case' 0 N--CA 1.412 -2.374 0 CA-C-O 121.787 0.803 . . . . 0.0 110.838 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -115.35 -171.34 1.94 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.968 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 64.5 mtm180 -100.98 164.59 11.74 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.86 -8.75 69.2 Favored Glycine 0 C--O 1.216 -1.009 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -85.79 -1.82 57.61 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -118.8 11.2 12.59 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.495 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.6 t -129.26 136.28 59.84 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.411 0 CA-C-O 121.418 0.627 . . . . 0.0 109.336 -174.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 18.7 mmm180 -132.72 129.69 39.03 Favored 'General case' 0 N--CA 1.395 -3.205 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.324 178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.4 pp -100.67 138.75 37.3 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 114.156 -1.384 . . . . 0.0 109.759 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.282 37.1 pt 38.13 78.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.415 1.886 . . . . 0.0 115.492 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.425 -1.719 0 N-CA-C 102.166 -3.272 . . . . 0.0 102.166 -176.412 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.3 m . . . . . 0 CA--C 1.5 -0.958 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -121.19 151.72 39.63 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -118.95 112.92 20.22 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 94.0 mmm -87.84 94.17 9.68 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -111.05 160.81 16.51 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.6 mt -95.34 96.94 9.48 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -79.82 23.53 0.43 Allowed 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.232 1.013 . . . . 0.0 112.604 -175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt -135.56 134.98 39.96 Favored 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 124.761 1.224 . . . . 0.0 108.092 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -126.51 152.46 74.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.458 ' HB3' ' HA ' ' A' ' 31' ' ' ARG . 6.9 Cg_endo -72.04 134.46 23.37 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.03 1.82 . . . . 0.0 112.791 -177.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.87 -0.26 48.51 Favored Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.016 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -88.57 156.77 18.87 Favored 'General case' 0 C--O 1.254 1.327 0 CA-C-O 120.964 0.411 . . . . 0.0 110.985 -176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.2 t -115.5 106.94 21.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.1 m -123.03 173.31 9.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.97 -170.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 38.4 pttt -110.34 126.81 54.64 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.074 173.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 55' ' ' VAL . 25.6 m -121.9 144.63 30.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -98.35 87.05 3.77 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 171.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -70.32 -42.12 72.37 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 113.258 -1.792 . . . . 0.0 111.072 -176.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.7 m -144.44 142.43 30.3 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.681 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.56 -23.08 67.15 Favored 'General case' 0 C--O 1.21 -0.994 0 C-N-CA 122.851 0.46 . . . . 0.0 112.164 -177.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.02 3.79 47.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.917 0.389 . . . . 0.0 110.959 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.4 mt -123.42 -44.79 2.11 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 92.27 -153.35 21.73 Favored Glycine 0 N--CA 1.423 -2.192 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.431 ' CH2' ' HG2' ' A' ' 56' ' ' ARG . 93.0 m95 -74.43 107.55 6.65 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 123.409 0.684 . . . . 0.0 110.722 176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.599 HG21 HE22 ' A' ' 44' ' ' GLN . 28.3 m -111.83 171.55 3.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.773 179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.445 ' HD2' ' OD2' ' A' ' 43' ' ' ASP . 41.1 ttm180 -82.35 140.81 33.31 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.422 ' HB3' HG13 ' A' ' 16' ' ' VAL . . . -146.05 170.49 16.56 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.894 176.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 41' ' ' GLN . 4.4 ptp180 -131.77 129.39 40.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.507 ' HA ' HG12 ' A' ' 40' ' ' VAL . 33.1 t -77.81 112.91 16.32 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG22 ' HB3' ' A' ' 31' ' ' ARG . 28.0 mt -86.09 -47.31 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.44 -3.272 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.289 -175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.458 ' HA ' ' HB3' ' A' ' 10' ' ' PRO . 5.4 ptp180 -160.94 155.79 23.91 Favored 'General case' 1 N--CA 1.328 -6.527 0 C-N-CA 117.023 -1.871 . . . . 0.0 114.442 -170.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 93.5 t -101.01 105.04 17.11 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.076 0 CA-C-N 111.803 -2.453 . . . . 0.0 107.55 173.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 37' ' ' ARG . 20.7 mttt -95.98 171.3 8.71 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.9 t -100.36 167.4 10.42 Favored 'General case' 0 N--CA 1.409 -2.495 0 C-N-CA 118.271 -1.371 . . . . 0.0 109.932 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.24 20.86 56.38 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.19 30.46 50.48 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 110.577 -1.009 . . . . 0.0 110.577 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.498 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 12.0 mmp_? -97.49 85.86 3.72 Favored 'General case' 1 N--CA 1.366 -4.64 0 CA-C-O 122.431 1.11 . . . . 0.0 113.333 -177.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.48 106.5 18.2 Favored 'Isoleucine or valine' 1 C--N 1.229 -4.658 0 N-CA-C 103.484 -2.784 . . . . 0.0 103.484 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.65 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 60.2 t -114.45 130.33 68.96 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.245 0 CA-C-O 121.882 0.849 . . . . 0.0 112.672 -170.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 29' ' ' VAL . 29.7 m -124.89 159.82 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.583 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.654 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 35.4 tt0 -124.88 116.51 22.34 Favored 'General case' 0 C--N 1.278 -2.501 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 38.9 m -70.68 163.78 26.39 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.031 177.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.445 ' OD2' ' HD2' ' A' ' 26' ' ' ARG . 3.8 m-20 -62.96 -15.12 54.75 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.969 176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.599 HE22 HG21 ' A' ' 25' ' ' VAL . 1.7 mp0 -83.88 2.42 38.59 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.4 10.42 70.86 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 115.745 1.058 . . . . 0.0 115.745 172.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 4.3 mpt_? -91.44 115.99 28.49 Favored 'General case' 0 N--CA 1.415 -2.221 0 CA-C-N 118.238 1.019 . . . . 0.0 110.29 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.65 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 31.2 tt0 -93.95 108.21 20.04 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 172.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -139.45 166.02 25.66 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 120.747 0.308 . . . . 0.0 110.633 -174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 t -82.06 136.79 35.17 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.33 -176.27 3.83 Favored 'General case' 0 N--CA 1.411 -2.396 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.466 -177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.45 ' O ' HG23 ' A' ' 55' ' ' VAL . 62.4 mtm180 -146.09 154.55 41.95 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.46 2.6 5.57 Favored Glycine 0 N--CA 1.485 1.96 0 CA-C-O 121.666 0.592 . . . . 0.0 113.219 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -92.78 -20.04 21.15 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -112.81 -4.2 14.04 Favored 'General case' 0 CA--C 1.49 -1.355 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.366 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 HG13 HG12 ' A' ' 16' ' ' VAL . 15.3 t -139.23 140.64 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.433 -3.552 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.431 ' HG2' ' CH2' ' A' ' 24' ' ' TRP . 5.2 mmm180 -134.82 151.01 50.59 Favored 'General case' 1 N--CA 1.362 -4.866 0 O-C-N 125.301 1.626 . . . . 0.0 107.055 177.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 75.8 mt -69.19 -170.43 0.26 Allowed 'General case' 0 C--N 1.278 -2.511 0 O-C-N 124.088 0.867 . . . . 0.0 110.498 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.9 pt -72.65 85.56 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 122.402 1.096 . . . . 0.0 110.336 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 57' ' ' LEU . 8.9 pt-20 . . . . . 0 C--N 1.294 -1.843 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.5 -0.955 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -37.96 89.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 O-C-N 125.711 1.882 . . . . 0.0 115.057 -170.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 164.64 -20.03 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.369 1.868 . . . . 0.0 109.193 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ptm -105.76 -17.31 14.42 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.26 0.553 . . . . 0.0 111.535 -175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -120.79 144.84 48.09 Favored 'General case' 0 C--N 1.288 -2.1 0 C-N-CA 124.476 1.111 . . . . 0.0 109.94 -177.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.402 HD12 ' HB ' ' A' ' 55' ' ' VAL . 65.5 mt -128.76 110.86 12.54 Favored 'General case' 0 CA--C 1.472 -2.03 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.501 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -81.02 91.88 6.13 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.7 mt -118.73 133.12 56.07 Favored 'General case' 0 C--N 1.247 -3.86 0 CA-C-N 112.474 -2.148 . . . . 0.0 105.483 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 35.0 mm-40 -83.32 152.56 64.7 Favored Pre-proline 0 C--N 1.283 -2.294 0 O-C-N 123.647 0.592 . . . . 0.0 112.511 -167.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.603 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 23.0 Cg_exo -61.16 123.13 12.25 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 122.441 2.094 . . . . 0.0 111.194 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.92 -15.32 12.43 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -69.69 156.58 38.76 Favored 'General case' 0 C--O 1.251 1.159 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.1 t -128.34 109.07 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 57' ' ' LEU . 28.3 m -132.54 -179.68 3.61 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-O 121.289 0.566 . . . . 0.0 110.908 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -112.92 122.29 47.2 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 61.2 t -123.94 132.74 70.88 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -178.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.1 tt -80.12 98.24 7.2 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -63.02 -56.21 18.97 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.812 -1.54 . . . . 0.0 110.549 -176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.2 m -151.09 148.25 28.08 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.92 -178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.43 86.17 3.81 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.335 0.588 . . . . 0.0 109.748 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -178.43 -43.52 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.1 mt -99.56 -47.16 5.21 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.337 175.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 103.38 -143.6 15.78 Favored Glycine 0 N--CA 1.423 -2.233 0 C-N-CA 119.781 -1.2 . . . . 0.0 111.144 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -72.83 114.28 10.8 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 124.339 1.056 . . . . 0.0 111.061 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.83 164.8 9.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 42.6 ttm180 -77.06 131.01 38.17 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HB1' ' HB ' ' A' ' 40' ' ' VAL . . . -140.31 136.7 33.51 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-O 121.365 0.602 . . . . 0.0 111.192 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.546 ' HE ' HD11 ' A' ' 30' ' ' ILE . 49.2 ttp180 -108.66 123.95 49.76 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' HG12 ' A' ' 40' ' ' VAL . 41.7 t -66.22 125.17 22.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.603 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 46.7 mm -105.07 -35.93 3.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.289 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.483 ' HE ' HG21 ' A' ' 39' ' ' VAL . 2.1 ttp180 -156.17 155.71 32.94 Favored 'General case' 1 N--CA 1.354 -5.272 0 CA-C-O 122.043 0.925 . . . . 0.0 111.836 -173.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -105.29 115.56 47.35 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.97 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.616 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 7.4 mttm -120.94 176.83 5.36 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.71 168.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 p -97.17 143.67 27.75 Favored 'General case' 0 N--CA 1.39 -3.438 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -171.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.84 -89.02 0.55 Allowed Glycine 0 N--CA 1.436 -1.334 0 CA-C-N 114.151 -1.386 . . . . 0.0 113.603 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.64 29.81 3.52 Favored Glycine 0 C--N 1.292 -1.911 0 C-N-CA 120.213 -0.994 . . . . 0.0 112.507 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.601 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 0.1 OUTLIER -125.85 31.44 5.48 Favored 'General case' 0 CA--C 1.487 -1.474 0 CA-C-O 122.08 0.943 . . . . 0.0 109.899 176.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -61.57 128.51 23.13 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.682 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 30' ' ' ILE . 69.8 t -99.63 123.5 52.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.926 -170.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' HB ' ' HB1' ' A' ' 27' ' ' ALA . 28.7 m -134.97 149.36 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.892 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -132.34 126.95 34.49 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.1 m -67.91 159.78 29.85 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' OD1' ' HD2' ' A' ' 26' ' ' ARG . 6.1 p-10 -66.6 -15.54 63.52 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 121.167 0.508 . . . . 0.0 111.667 -178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -78.66 0.54 26.13 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.612 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.46 -7.21 65.97 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 116.435 1.334 . . . . 0.0 116.435 170.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -91.23 129.14 37.26 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-N 118.927 1.364 . . . . 0.0 112.519 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.428 ' HG3' HG13 ' A' ' 39' ' ' VAL . 17.9 tt0 -85.81 141.36 29.7 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.03 171.14 17.32 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 173.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.601 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 15.2 t -97.48 141.73 30.19 Favored 'General case' 0 N--CA 1.415 -2.221 0 C-N-CA 120.358 -0.537 . . . . 0.0 109.804 -177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -110.4 140.93 44.13 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.885 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.62 ' O ' HG23 ' A' ' 55' ' ' VAL . 56.2 mtp180 -113.9 145.83 40.92 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -62.58 -16.16 54.83 Favored Glycine 0 C--O 1.214 -1.116 0 C-N-CA 121.26 -0.495 . . . . 0.0 113.37 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -88.56 -2.29 58.51 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.173 0.511 . . . . 0.0 109.857 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.471 ' OE1' ' HD3' ' A' ' 51' ' ' ARG . 28.1 mt-30 -126.83 14.9 7.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.573 -176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.62 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.5 t -129.52 139.73 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.476 0 CA-C-O 121.724 0.773 . . . . 0.0 110.446 -176.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mmm180 -137.19 140.77 42.0 Favored 'General case' 0 N--CA 1.388 -3.552 0 N-CA-C 105.39 -2.078 . . . . 0.0 105.39 173.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.677 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.3 pt? -75.92 -153.17 0.04 OUTLIER 'General case' 0 C--N 1.261 -3.252 0 CA-C-O 121.778 0.799 . . . . 0.0 111.505 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.6 pt -76.19 8.39 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-O 122.656 1.217 . . . . 0.0 112.129 177.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 57' ' ' LEU . 1.9 tm-20 . . . . . 1 C--N 1.237 -4.322 0 N-CA-C 101.566 -3.494 . . . . 0.0 101.566 176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 CA--C 1.491 -1.298 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -119.81 112.49 19.31 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -172.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.4 -3.69 25.13 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.706 0.765 . . . . 0.0 109.019 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.7 tpt -166.46 145.18 5.55 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -96.6 178.67 5.25 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 123.824 0.703 . . . . 0.0 110.042 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -93.72 101.83 13.97 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.52 20.3 0.32 Allowed 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 125.464 1.506 . . . . 0.0 112.577 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 6' ' ' LEU . 93.0 mt -61.87 122.25 14.95 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.495 -1.229 . . . . 0.0 107.86 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 31.6 mm-40 -93.26 150.03 38.4 Favored Pre-proline 0 C--N 1.293 -1.884 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.63 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 7.0 Cg_exo -65.47 129.06 21.56 Favored 'Trans proline' 0 N--CA 1.444 -1.415 0 C-N-CA 122.495 2.13 . . . . 0.0 110.624 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 110.9 -13.39 29.35 Favored Glycine 0 N--CA 1.429 -1.77 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 45.7 t0 -67.43 150.74 48.51 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 120.928 0.394 . . . . 0.0 110.324 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.2 p -124.19 98.2 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.761 0 CA-C-O 122.842 1.306 . . . . 0.0 111.0 -175.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 57' ' ' LEU . 26.5 m -122.64 172.8 9.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.531 -174.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 56' ' ' ARG . 40.5 pttt -108.13 129.28 55.17 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 33.5 m -129.24 140.62 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.008 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.282 -178.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.5 tt -101.31 102.9 13.84 Favored 'General case' 0 N--CA 1.416 -2.163 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 173.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -72.17 -68.84 0.44 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.057 0.932 . . . . 0.0 109.579 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.7 m -128.69 153.67 47.08 Favored 'General case' 0 N--CA 1.409 -2.524 0 CA-C-N 113.963 -1.471 . . . . 0.0 109.01 -173.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.13 -19.87 65.58 Favored 'General case' 0 C--O 1.209 -1.036 0 C-N-CA 122.856 0.462 . . . . 0.0 112.084 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.88 2.28 51.89 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 120.84 0.352 . . . . 0.0 111.074 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.0 mt -125.27 -44.12 1.9 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.968 0.413 . . . . 0.0 110.284 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.478 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 85.79 -156.78 30.44 Favored Glycine 0 N--CA 1.434 -1.488 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -81.12 112.15 18.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 178.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.38 164.09 13.01 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 177.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -82.15 137.02 35.06 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.0 146.27 48.89 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-O 121.384 0.611 . . . . 0.0 110.77 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.517 ' NH1' ' HA ' ' A' ' 43' ' ' ASP . 15.9 mtm180 -113.77 123.59 50.22 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -178.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.45 HG22 HG12 ' A' ' 40' ' ' VAL . 49.0 t -68.22 118.31 11.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.63 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 53.2 mt -85.91 -44.23 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.547 0 C-N-CA 120.38 -0.528 . . . . 0.0 110.025 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 5.4 ptp85 -162.45 165.13 26.67 Favored 'General case' 1 N--CA 1.347 -5.592 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.186 -173.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.8 m -99.63 128.79 51.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.204 0 CA-C-N 112.668 -2.06 . . . . 0.0 108.616 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 37' ' ' ARG . 11.1 tptp -103.04 -49.16 3.84 Favored 'General case' 0 N--CA 1.406 -2.669 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 58.1 m 75.58 162.92 0.25 Allowed 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 111.858 -2.428 . . . . 0.0 110.747 -173.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.22 30.4 16.9 Favored Glycine 0 N--CA 1.425 -2.06 0 N-CA-C 107.987 -2.045 . . . . 0.0 107.987 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.77 -29.11 11.02 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.912 -0.644 . . . . 0.0 112.014 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.674 ' HE ' HG22 ' A' ' 39' ' ' VAL . 28.6 ttt180 -81.15 123.06 28.12 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 m -121.64 123.88 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.293 0 CA-C-N 113.794 -1.548 . . . . 0.0 107.387 168.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.674 HG22 ' HE ' ' A' ' 37' ' ' ARG . 74.2 t -91.74 123.92 44.05 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.34 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.525 -175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.45 HG12 HG22 ' A' ' 29' ' ' VAL . 33.8 m -135.2 150.58 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.475 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB2' HD11 ' A' ' 30' ' ' ILE . 47.2 tt0 -129.17 128.98 44.49 Favored 'General case' 0 C--N 1.264 -3.109 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 177.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.3 t -74.78 165.24 25.56 Favored 'General case' 0 N--CA 1.411 -2.421 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 10.4 m-20 -65.6 -15.68 62.97 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -175.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -78.8 -2.08 37.85 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.981 176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.3 -1.47 73.17 Favored Glycine 0 CA--C 1.509 -0.284 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.801 176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -81.78 104.01 11.86 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.605 0.762 . . . . 0.0 110.604 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 37.0 tt0 -86.89 137.62 32.24 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -156.97 -177.97 7.02 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.824 0.345 . . . . 0.0 110.439 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -101.87 119.17 38.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.16 169.85 9.95 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 55' ' ' VAL . 74.3 mtm180 -139.77 158.58 43.86 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 177.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.23 0.54 6.17 Favored Glycine 0 N--CA 1.482 1.701 0 N-CA-C 114.546 0.578 . . . . 0.0 114.546 -176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -101.17 -8.46 22.2 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.676 0.751 . . . . 0.0 109.074 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.2 mt-30 -119.61 6.6 11.03 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.703 -175.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 51' ' ' ARG . 23.1 t -127.43 134.99 64.54 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.997 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 -174.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.523 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . 27.4 mmm180 -137.77 136.96 37.77 Favored 'General case' 0 N--CA 1.383 -3.791 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 175.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.583 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -72.48 -175.54 1.64 Allowed 'General case' 0 C--N 1.28 -2.453 0 O-C-N 123.537 0.523 . . . . 0.0 110.524 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 pt -50.06 107.41 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 124.244 1.018 . . . . 0.0 111.121 174.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.278 -2.526 0 CA-C-N 112.987 -1.915 . . . . 0.0 105.835 -174.962 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 3.3 m . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.663 ' HA ' ' CG ' ' A' ' 7' ' ' ASP . 19.6 m120 78.61 91.86 0.06 Allowed 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.549 176.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.58 -51.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.168 -176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 45.3 tpp -165.65 30.27 0.05 Allowed 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -112.31 -172.39 2.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -96.41 71.32 2.73 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.969 -2.234 . . . . 0.0 104.969 166.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.663 ' CG ' ' HA ' ' A' ' 2' ' ' ASN . 1.2 p30 -92.83 23.17 4.31 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 112.801 -2.0 . . . . 0.0 113.881 -169.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.2 mt -84.58 148.64 26.37 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -119.09 161.84 34.59 Favored Pre-proline 0 C--N 1.291 -1.947 0 CA-C-N 117.878 0.308 . . . . 0.0 111.828 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 33.4 Cg_exo -62.41 71.9 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.366 2.711 . . . . 0.0 113.372 176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.466 ' HA2' ' NE ' ' A' ' 28' ' ' ARG . . . -178.97 -22.32 0.03 OUTLIER Glycine 0 C--N 1.267 -3.256 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.427 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' H ' ' H ' ' A' ' 11' ' ' GLY . 9.2 m-20 -69.88 123.55 21.77 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.63 123.55 52.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.3 m -146.1 169.32 6.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.927 -173.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.576 ' HZ3' ' HA ' ' A' ' 59' ' ' GLU . 31.8 mttm -98.15 129.29 44.94 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 23.4 t -127.38 126.23 67.22 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tt -89.21 102.34 15.0 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -73.56 -59.46 2.7 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.88 0.847 . . . . 0.0 109.097 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -124.37 154.24 40.65 Favored 'General case' 0 N--CA 1.417 -2.082 0 CA-C-N 114.92 -1.037 . . . . 0.0 108.617 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.01 -21.13 63.23 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-O 120.997 0.427 . . . . 0.0 109.992 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.89 -18.77 33.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.657 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.7 mt -97.99 -36.95 9.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.073 0.463 . . . . 0.0 110.753 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.09 -162.17 40.31 Favored Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -178.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -74.51 112.99 11.25 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.341 0.591 . . . . 0.0 110.494 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.83 146.22 18.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.571 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -78.64 127.28 31.89 Favored 'General case' 0 N--CA 1.391 -3.376 0 CA-C-O 121.282 0.563 . . . . 0.0 110.009 -178.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.72 159.41 41.91 Favored 'General case' 0 N--CA 1.415 -2.191 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.557 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.466 ' NE ' ' HA2' ' A' ' 11' ' ' GLY . 61.1 ttt180 -119.06 135.98 54.36 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 51.7 t -63.98 112.85 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 171.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.4 mm -97.22 -34.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.324 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.444 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -159.75 148.16 17.39 Favored 'General case' 1 N--CA 1.344 -5.736 0 CA-C-O 121.81 0.814 . . . . 0.0 110.141 -173.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.8 t -108.19 96.97 5.09 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.777 0 CA-C-N 113.97 -1.468 . . . . 0.0 109.141 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.688 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 34.2 mttt -95.47 157.02 16.08 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 174.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 p -100.36 179.76 4.36 Favored 'General case' 0 C--N 1.265 -3.089 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.871 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.42 -75.04 2.27 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.48 51.28 0.17 Allowed Glycine 0 N--CA 1.428 -1.848 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.688 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -140.22 34.99 1.89 Allowed 'General case' 0 N--CA 1.41 -2.445 0 O-C-N 122.585 -0.362 . . . . 0.0 111.778 -177.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.2 m -63.22 111.94 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.019 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 37' ' ' ARG . 2.7 t -94.48 132.42 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.78 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 -164.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -130.96 140.47 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.435 ' HB3' HG13 ' A' ' 30' ' ' ILE . 26.7 tt0 -124.88 125.47 44.01 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.3 m -87.04 173.83 9.05 Favored 'General case' 0 C--N 1.279 -2.471 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.771 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.78 -44.06 1.53 Allowed 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 126.945 2.098 . . . . 0.0 115.647 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -73.35 -6.06 43.74 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.87 10.93 62.35 Favored Glycine 0 N--CA 1.434 -1.439 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.131 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -77.28 102.05 6.53 Favored 'General case' 0 N--CA 1.414 -2.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.486 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.489 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.2 tt0 -84.77 115.19 22.58 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.338 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -135.74 170.47 15.93 Favored 'General case' 0 C--N 1.289 -2.026 0 O-C-N 121.878 -0.514 . . . . 0.0 111.527 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.601 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 52.0 m -86.33 137.68 32.4 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.145 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -105.81 163.37 12.77 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-O 121.165 0.507 . . . . 0.0 110.845 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 -140.94 153.74 45.77 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -60.95 -17.61 51.79 Favored Glycine 0 N--CA 1.477 1.431 0 N-CA-C 114.612 0.605 . . . . 0.0 114.612 -176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -87.23 -10.18 53.16 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.342 0.592 . . . . 0.0 110.219 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.658 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 51.1 mt-30 -110.83 5.99 21.03 Favored 'General case' 0 C--O 1.207 -1.161 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.912 -177.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -128.2 129.88 69.41 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.061 0 C-N-CA 119.732 -0.787 . . . . 0.0 111.545 -171.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -132.38 119.07 20.2 Favored 'General case' 0 N--CA 1.406 -2.65 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.665 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.1 pt? -92.89 88.54 6.22 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-O 122.003 0.906 . . . . 0.0 112.828 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.435 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 4.4 pt -168.76 155.58 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.508 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.576 ' HA ' ' HZ3' ' A' ' 15' ' ' LYS . 5.9 mm-40 . . . . . 0 C--N 1.292 -1.934 0 CA-C-O 117.201 -1.38 . . . . 0.0 109.072 174.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 CA--C 1.508 -0.644 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.629 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 3.6 t-20 -89.05 155.7 19.31 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 77.56 30.2 0.5 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.741 1.617 . . . . 0.0 110.569 177.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 18.1 ptp -156.97 6.34 0.16 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.804 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.629 ' OE1' ' HA ' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -105.64 160.63 15.04 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.16 81.12 3.0 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.474 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -93.72 82.18 4.31 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 171.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.4 mt -107.43 121.1 43.92 Favored 'General case' 0 C--N 1.266 -3.044 0 CA-C-N 112.729 -2.032 . . . . 0.0 107.265 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -84.58 155.6 62.26 Favored Pre-proline 0 N--CA 1.415 -2.178 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.191 -172.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.62 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 21.3 Cg_exo -60.21 125.3 17.16 Favored 'Trans proline' 0 N--CA 1.44 -1.659 0 C-N-CA 122.181 1.921 . . . . 0.0 111.755 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.79 -17.35 10.95 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.319 -177.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 33.4 t0 -63.52 158.85 19.96 Favored 'General case' 0 C--O 1.248 1.011 0 C-N-CA 123.761 0.825 . . . . 0.0 111.712 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.0 t -116.31 107.58 22.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.176 0.59 . . . . 0.0 109.58 -175.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.6 175.3 11.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 CA-C-O 121.284 0.564 . . . . 0.0 110.253 -177.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 pttt -126.28 139.8 53.03 Favored 'General case' 0 C--N 1.28 -2.446 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 170.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 40' ' ' VAL . 57.7 t -131.17 133.85 62.04 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -177.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.6 tt -92.9 97.4 10.72 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -66.92 -66.29 0.57 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.96 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.8 m -126.63 146.15 50.29 Favored 'General case' 0 N--CA 1.403 -2.793 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.898 -173.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.86 -21.43 66.45 Favored 'General case' 0 C--O 1.21 -0.998 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.05 4.27 48.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.859 0.362 . . . . 0.0 111.074 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -123.68 -46.55 1.99 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.15 0.5 . . . . 0.0 109.803 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 93.29 -158.15 23.59 Favored Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.311 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -78.85 112.21 15.78 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 123.1 0.56 . . . . 0.0 110.677 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.3 m -104.16 149.24 8.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 36.6 ttm105 -97.88 123.8 42.02 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.438 0.637 . . . . 0.0 110.048 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -135.16 169.22 17.78 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.156 0.979 . . . . 0.0 113.614 -168.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 22.1 mmt180 -112.6 132.88 54.93 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.903 -1.499 . . . . 0.0 107.438 174.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 65.9 t -67.56 114.15 4.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 173.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.62 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 44.4 mm -87.17 -40.63 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.596 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.502 -176.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.472 ' HD2' ' HE3' ' A' ' 33' ' ' LYS . 1.4 ptp180 -165.86 160.11 16.6 Favored 'General case' 1 N--CA 1.338 -6.036 0 CA-C-O 121.984 0.897 . . . . 0.0 110.563 -176.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.19 94.12 2.94 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.537 0 CA-C-N 113.241 -1.799 . . . . 0.0 109.753 178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.472 ' HE3' ' HD2' ' A' ' 31' ' ' ARG . 56.3 mttt -81.36 149.64 28.79 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.8 m -85.19 169.67 13.61 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -170.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.33 -82.38 1.56 Allowed Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.66 35.02 0.21 Allowed Glycine 0 C--N 1.292 -1.864 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.6 OUTLIER -108.6 22.91 15.29 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-N 114.716 -0.742 . . . . 0.0 111.009 -175.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' THR . 31.0 m -61.73 136.44 25.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 O-C-N 124.345 1.028 . . . . 0.0 109.103 -176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' CG2' ' HG2' ' A' ' 31' ' ' ARG . 11.4 m -126.1 144.42 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 CA-C-O 122.229 1.014 . . . . 0.0 113.523 -172.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.525 HG21 HG21 ' A' ' 16' ' ' VAL . 27.3 m -129.93 141.11 47.26 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.453 0 CA-C-N 113.37 -1.741 . . . . 0.0 107.247 177.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 34.7 tt0 -106.06 116.97 32.84 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 176.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 8.3 t -80.33 172.16 14.12 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.134 -175.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -44.39 -37.24 3.26 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 127.051 2.14 . . . . 0.0 112.55 173.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -76.81 0.97 18.74 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 83.27 -3.77 83.47 Favored Glycine 0 CA--C 1.522 0.472 0 CA-C-O 122.103 0.835 . . . . 0.0 112.125 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -77.61 107.72 10.29 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 124.135 0.974 . . . . 0.0 111.115 -178.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.7 tt0 -84.92 114.9 22.47 Favored 'General case' 0 C--N 1.345 0.395 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -131.58 167.76 18.86 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.428 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 9.4 t -102.38 145.95 28.76 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.377 -175.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -137.85 156.11 48.27 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 119.461 -0.896 . . . . 0.0 113.028 -172.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.0 157.53 16.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 172.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -61.45 -23.26 62.34 Favored Glycine 0 C--O 1.214 -1.119 0 C-N-CA 120.981 -0.628 . . . . 0.0 114.134 -177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.79 1.09 54.78 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 121.155 0.502 . . . . 0.0 111.107 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 54.5 mt-30 -104.8 -2.75 24.4 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.758 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -119.37 138.18 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.434 0.635 . . . . 0.0 110.648 -170.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -137.73 126.23 23.51 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.571 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -94.9 141.39 28.7 Favored 'General case' 0 C--N 1.262 -3.203 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 75.4 mt 75.25 145.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 O-C-N 124.163 0.915 . . . . 0.0 109.117 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--N 1.299 -1.6 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -178.727 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 54.0 m . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -66.19 -24.77 66.69 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.694 0.759 . . . . 0.0 109.735 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -115.38 130.21 56.82 Favored 'General case' 0 N--CA 1.391 -3.392 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 172.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.86 118.1 8.53 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 124.081 0.863 . . . . 0.0 112.037 -177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -81.45 144.16 31.58 Favored 'General case' 0 N--CA 1.406 -2.663 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.7 mt -82.49 90.12 6.72 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 121.5 0.667 . . . . 0.0 111.328 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -96.05 10.21 38.25 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 123.816 1.769 . . . . 0.0 108.418 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.2 mt -143.54 143.93 31.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 112.664 -2.062 . . . . 0.0 108.376 -175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -139.26 154.79 72.34 Favored Pre-proline 0 C--O 1.213 -0.818 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -73.94 135.61 21.49 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.78 1.653 . . . . 0.0 111.669 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -2.84 56.6 Favored Glycine 0 N--CA 1.44 -1.096 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -83.82 154.95 23.22 Favored 'General case' 0 C--O 1.251 1.174 0 C-N-CA 122.667 0.387 . . . . 0.0 111.089 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.1 112.7 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 CA-C-O 122.111 0.958 . . . . 0.0 108.631 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.5 m -128.55 176.36 8.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 CA-C-O 121.666 0.745 . . . . 0.0 111.819 -171.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -115.01 129.73 56.78 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 40' ' ' VAL . 66.5 t -129.44 130.97 67.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -86.84 90.61 8.37 Favored 'General case' 0 C--N 1.284 -2.273 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -60.96 -54.51 44.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.526 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 72.1 m -144.22 149.25 36.06 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.477 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.48 -17.44 64.8 Favored 'General case' 0 C--O 1.21 -0.992 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.97 5.46 46.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.88 0.371 . . . . 0.0 110.673 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 97.6 mt -130.97 -47.69 1.02 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.177 0.513 . . . . 0.0 109.887 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 99.84 -156.66 19.72 Favored Glycine 0 N--CA 1.428 -1.85 0 C-N-CA 120.428 -0.891 . . . . 0.0 111.089 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.55 ' CH2' ' HG3' ' A' ' 56' ' ' ARG . 91.7 m95 -74.03 112.69 10.41 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 123.449 0.7 . . . . 0.0 110.765 178.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.7 m -106.28 152.14 8.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -71.13 131.49 43.65 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' HA ' HH21 ' A' ' 28' ' ' ARG . . . -140.31 169.27 17.98 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-O 120.963 0.411 . . . . 0.0 110.415 -178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.481 HH22 ' CG ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -128.9 134.12 48.15 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.252 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.503 ' HA ' HG12 ' A' ' 40' ' ' VAL . 61.6 t -75.02 115.82 16.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.4 mm -82.8 -43.79 18.82 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.5 ptp180 -156.78 155.42 31.56 Favored 'General case' 1 N--CA 1.347 -5.582 0 CA-C-O 121.868 0.842 . . . . 0.0 110.167 -177.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 m -111.67 110.12 31.04 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.647 0 CA-C-N 113.623 -1.626 . . . . 0.0 113.25 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 64.0 mttt -113.16 166.61 11.27 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 169.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.4 t -99.85 164.96 11.8 Favored 'General case' 0 C--N 1.286 -2.18 0 C-N-CA 118.541 -1.263 . . . . 0.0 112.667 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.48 -90.58 0.94 Allowed Glycine 0 N--CA 1.438 -1.178 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.673 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 51' ' ' ARG . . . -146.73 35.02 1.32 Allowed Glycine 0 N--CA 1.414 -2.788 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 18.9 mmt-85 -109.24 16.79 22.17 Favored 'General case' 1 N--CA 1.374 -4.243 0 CA-C-N 114.775 -0.712 . . . . 0.0 111.64 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 t -72.61 122.41 25.15 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 CA-C-N 114.557 -1.201 . . . . 0.0 107.797 -175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.417 ' CG1' ' HG2' ' A' ' 47' ' ' GLU . 39.3 t -103.76 116.1 46.92 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.632 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.732 -175.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.582 HG21 HG21 ' A' ' 16' ' ' VAL . 31.2 m -127.85 148.76 32.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.027 -175.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 34.4 tt0 -118.38 131.0 56.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 32.0 t -89.62 174.98 7.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.481 ' CG ' HH22 ' A' ' 28' ' ' ARG . 15.2 m-20 -72.19 -10.08 59.3 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 122.144 0.973 . . . . 0.0 109.779 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -86.66 2.43 48.5 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.305 -1.316 . . . . 0.0 109.074 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.59 0.79 85.32 Favored Glycine 0 CA--C 1.506 -0.474 0 CA-C-N 115.354 -0.839 . . . . 0.0 114.719 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -80.89 111.83 17.72 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 118.149 0.974 . . . . 0.0 110.973 177.459 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 36.3 tt0 -96.36 114.22 25.88 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 171.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 38.2 p90 -139.22 161.81 36.51 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 121.179 0.514 . . . . 0.0 111.876 -173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.439 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 2.3 t -91.54 106.27 18.36 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.422 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -106.64 161.69 14.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.243 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.633 ' HA ' ' HA2' ' A' ' 36' ' ' GLY . 76.8 mtt85 -80.3 153.11 28.64 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.19 6.85 6.64 Favored Glycine 0 N--CA 1.475 1.239 0 C-N-CA 120.547 -0.835 . . . . 0.0 113.148 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -99.81 -21.94 15.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 46.5 mt-30 -90.8 -12.64 35.8 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.188 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.505 HG13 HG22 ' A' ' 16' ' ' VAL . 19.1 t -115.88 125.73 73.13 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.88 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -178.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.55 ' HG3' ' CH2' ' A' ' 24' ' ' TRP . 6.4 mmp_? -133.37 140.84 47.6 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.536 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.5 pt? -61.34 176.6 0.45 Allowed 'General case' 0 C--N 1.285 -2.2 0 O-C-N 124.371 1.044 . . . . 0.0 111.17 175.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.3 pt -74.72 79.94 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 122.121 0.962 . . . . 0.0 113.53 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.286 -2.163 0 N-CA-C 101.635 -3.468 . . . . 0.0 101.635 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.494 -1.203 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -34.17 92.51 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 125.804 1.94 . . . . 0.0 115.897 -168.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -143.14 -40.81 0.31 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 113.634 -1.621 . . . . 0.0 108.401 175.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.2 mtp -117.36 -25.63 6.97 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.255 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -84.1 103.58 13.44 Favored 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.898 176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.6 mt -134.33 157.4 46.45 Favored 'General case' 0 CA--C 1.446 -3.035 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 56' ' ' ARG . 0.7 OUTLIER -63.93 37.19 0.01 OUTLIER 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 128.629 2.772 . . . . 0.0 111.057 -178.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -164.28 40.85 0.09 Allowed 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -167.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.636 ' O ' ' HB ' ' A' ' 29' ' ' VAL . 27.9 mm-40 -113.25 146.99 36.39 Favored Pre-proline 0 C--N 1.256 -3.48 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.691 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -78.4 114.21 3.48 Favored 'Trans proline' 0 N--CA 1.439 -1.691 0 C-N-CA 121.817 1.678 . . . . 0.0 110.148 177.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 108.94 1.39 31.91 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -174.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -75.22 153.56 38.01 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.431 0.692 . . . . 0.0 110.22 -178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 55.9 t -112.97 107.25 22.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.3 m -133.0 -179.94 3.86 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-O 122.159 0.981 . . . . 0.0 112.42 -168.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 57' ' ' LEU . 47.8 pttt -123.4 136.25 54.53 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 170.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 40' ' ' VAL . 72.5 t -125.96 127.19 70.9 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-O 121.117 0.484 . . . . 0.0 110.112 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.424 HD12 ' HA2' ' A' ' 23' ' ' GLY . 26.5 tp -85.39 86.73 7.35 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.46 -58.54 4.56 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.257 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.3 t -129.81 156.4 44.4 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.312 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.28 61.64 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.61 -13.1 30.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.088 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.1 mt -107.45 -38.78 5.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 17' ' ' LEU . . . 85.35 -172.86 47.56 Favored Glycine 0 N--CA 1.424 -2.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.361 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -62.23 106.9 0.8 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 124.45 1.1 . . . . 0.0 111.896 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.6 m -99.18 146.63 8.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.508 ' HD2' ' OD1' ' A' ' 43' ' ' ASP . 32.2 ttm180 -67.65 137.69 55.79 Favored 'General case' 0 C--O 1.246 0.906 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -151.19 172.27 16.09 Favored 'General case' 0 N--CA 1.42 -1.929 0 CA-C-O 121.032 0.444 . . . . 0.0 110.04 -177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.583 ' NH2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -136.22 127.68 28.58 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 173.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.636 ' HB ' ' O ' ' A' ' 9' ' ' GLN . 39.9 t -70.86 120.42 18.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mm -86.52 -42.8 15.88 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.208 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -177.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 0.6 OUTLIER -152.48 145.18 24.27 Favored 'General case' 1 N--CA 1.343 -5.792 0 CA-C-O 122.564 1.174 . . . . 0.0 111.083 -174.534 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 88.8 t -97.0 112.7 29.58 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.091 0 CA-C-N 112.604 -2.089 . . . . 0.0 113.447 -179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 23.4 mttm -125.15 164.71 19.66 Favored 'General case' 0 N--CA 1.402 -2.864 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 166.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 m -106.74 178.53 4.53 Favored 'General case' 0 C--N 1.275 -2.662 0 C-N-CA 118.765 -1.174 . . . . 0.0 112.525 -174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 -92.76 0.9 Allowed Glycine 0 N--CA 1.441 -0.991 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.66 24.44 1.82 Allowed Glycine 0 N--CA 1.427 -1.917 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -110.33 23.2 14.59 Favored 'General case' 0 N--CA 1.41 -2.447 0 CA-C-O 121.206 0.527 . . . . 0.0 111.262 -178.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 16.9 t -71.2 121.12 20.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HB ' ' HG2' ' A' ' 31' ' ' ARG . 33.4 t -103.88 126.24 58.47 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.398 -172.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG21 HG21 ' A' ' 16' ' ' VAL . 27.0 m -134.4 146.81 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -175.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.643 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 32.3 tt0 -114.66 125.58 53.91 Favored 'General case' 0 C--N 1.254 -3.566 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 177.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 22.7 t -69.96 166.06 20.42 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.583 ' HA ' ' NH2' ' A' ' 28' ' ' ARG . 16.9 t70 -57.64 -30.88 65.74 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.854 0.862 . . . . 0.0 111.377 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -71.03 -5.31 30.29 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.754 1.622 . . . . 0.0 112.484 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.86 68.33 Favored Glycine 0 C--O 1.224 -0.519 0 C-N-CA 120.288 -0.958 . . . . 0.0 113.093 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.8 ttt-85 -82.84 110.35 17.78 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 122.654 0.381 . . . . 0.0 110.581 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 30.0 tt0 -90.34 135.96 33.35 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 123.733 0.813 . . . . 0.0 109.412 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -151.57 -175.88 5.38 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.504 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 12.0 t -122.18 143.97 49.24 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -177.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.4 -178.14 6.0 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 -179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' C ' ' H ' ' A' ' 53' ' ' ASN . 14.7 mtm180 -106.51 165.83 11.0 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.484 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.67 28.58 1.81 Allowed Glycine 0 N--CA 1.472 1.08 0 CA-C-O 121.789 0.66 . . . . 0.0 112.545 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.7 m120 -117.17 -16.09 10.42 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 174.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.1 mt-30 -104.56 -2.15 25.55 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.879 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.4 t -118.0 140.58 40.74 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -175.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.429 ' NH2' ' HB3' ' A' ' 59' ' ' GLU . 11.8 mmm180 -150.43 141.69 23.23 Favored 'General case' 0 N--CA 1.403 -2.781 0 O-C-N 124.672 1.233 . . . . 0.0 110.15 179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' O ' ' HE2' ' A' ' 15' ' ' LYS . 97.0 mt -56.84 169.78 0.48 Allowed 'General case' 0 C--N 1.282 -2.342 0 O-C-N 124.974 1.421 . . . . 0.0 110.434 170.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.3 pt -73.09 81.25 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-O 122.153 0.978 . . . . 0.0 111.929 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.429 ' HB3' ' NH2' ' A' ' 56' ' ' ARG . 9.5 tp10 . . . . . 0 C--O 1.29 3.201 0 N-CA-C 104.144 -2.539 . . . . 0.0 104.144 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.8 m . . . . . 0 C--O 1.221 -0.426 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -86.33 93.46 9.1 Favored 'General case' 0 CA--C 1.49 -1.343 0 N-CA-C 103.322 -2.844 . . . . 0.0 103.322 169.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 76.0 145.46 0.08 Allowed 'General case' 0 C--O 1.269 2.13 0 O-C-N 125.39 1.681 . . . . 0.0 108.521 -168.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 21.0 mmt -109.12 -158.66 0.66 Allowed 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.78 -40.61 13.92 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.463 1.125 . . . . 0.0 110.592 176.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 93.4 mt -148.97 86.14 1.5 Allowed 'General case' 0 C--N 1.246 -3.926 0 CA-C-N 112.525 -2.125 . . . . 0.0 109.68 176.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.72 8.65 33.42 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 122.12 0.962 . . . . 0.0 112.878 -177.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -104.47 117.95 35.4 Favored 'General case' 0 C--N 1.273 -2.744 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -110.54 146.55 34.55 Favored Pre-proline 0 C--N 1.289 -2.055 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.556 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.651 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 22.4 Cg_exo -61.44 120.74 8.55 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.237 2.625 . . . . 0.0 111.748 -179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 128.78 -21.71 5.28 Favored Glycine 0 N--CA 1.433 -1.56 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.29 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -72.5 148.9 44.6 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.648 0.261 . . . . 0.0 111.35 -175.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.62 116.36 52.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.64 166.68 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 CA-C-O 122.019 0.914 . . . . 0.0 112.598 -169.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 56' ' ' ARG . 39.0 pttt -110.95 125.56 53.82 Favored 'General case' 0 N--CA 1.414 -2.241 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 168.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.1 p -132.34 133.4 60.14 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.999 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.79 -176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.5 tt -82.53 90.79 6.8 Favored 'General case' 0 N--CA 1.414 -2.234 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -64.28 -50.64 67.1 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 112.791 -2.004 . . . . 0.0 111.733 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -147.18 144.96 29.33 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.98 -25.42 66.86 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -176.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.56 8.07 35.94 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.835 0.35 . . . . 0.0 111.227 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.4 mt -128.61 -44.77 1.35 Allowed 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.225 0.535 . . . . 0.0 109.82 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 96.05 -153.69 20.63 Favored Glycine 0 N--CA 1.428 -1.845 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.251 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -73.01 113.02 9.57 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 123.74 0.816 . . . . 0.0 110.436 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -106.6 161.07 5.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -80.02 131.2 35.74 Favored 'General case' 0 C--N 1.294 -1.821 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -154.98 173.52 16.44 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.152 0.501 . . . . 0.0 110.297 -178.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.14 134.51 36.45 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.536 ' HA ' HG12 ' A' ' 40' ' ' VAL . 40.1 t -70.24 118.08 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.609 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.651 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 19.8 mt -107.95 -33.12 2.54 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.872 0 C-N-CA 119.711 -0.796 . . . . 0.0 112.079 -172.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 32' ' ' VAL . 7.0 ttp180 -157.54 155.98 31.18 Favored 'General case' 1 N--CA 1.343 -5.788 0 CA-C-O 122.498 1.142 . . . . 0.0 112.443 -170.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.417 ' N ' ' HG3' ' A' ' 31' ' ' ARG . 14.3 m -109.33 121.48 62.43 Favored 'Isoleucine or valine' 0 C--N 1.254 -3.57 0 CA-C-N 112.215 -2.266 . . . . 0.0 106.611 170.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' CB ' ' HB3' ' A' ' 37' ' ' ARG . 1.0 OUTLIER -98.86 -168.61 1.66 Allowed 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 178.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 m -115.52 163.24 16.04 Favored 'General case' 0 N--CA 1.39 -3.432 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 171.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.61 7.06 76.04 Favored Glycine 0 C--O 1.214 -1.151 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.778 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.35 -0.58 55.82 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.418 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.454 ' HB3' ' CB ' ' A' ' 33' ' ' LYS . 11.9 ttt180 -76.59 110.65 11.34 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t -97.78 129.47 47.9 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.497 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 172.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG13 ' HG3' ' A' ' 47' ' ' GLU . 16.5 t -106.37 125.47 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.048 0 CA-C-O 121.723 0.773 . . . . 0.0 113.03 -174.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 29' ' ' VAL . 35.8 m -132.62 141.99 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.844 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 170.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.501 HE21 ' HA2' ' A' ' 45' ' ' GLY . 53.8 tt0 -125.49 126.76 45.4 Favored 'General case' 0 C--N 1.26 -3.29 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.7 t -78.67 168.34 19.9 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -73.85 -4.5 35.22 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.557 0.694 . . . . 0.0 111.37 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -72.81 -17.12 61.59 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 108.643 171.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.501 ' HA2' HE21 ' A' ' 41' ' ' GLN . . . 92.55 9.87 61.05 Favored Glycine 0 C--N 1.336 0.578 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.749 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -87.6 104.55 16.61 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.649 ' HG3' HG13 ' A' ' 39' ' ' VAL . 21.7 tt0 -80.51 118.53 22.19 Favored 'General case' 0 C--O 1.252 1.195 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 172.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -135.55 175.42 9.6 Favored 'General case' 0 C--N 1.281 -2.412 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.785 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 24.9 m -100.08 119.32 38.12 Favored 'General case' 0 N--CA 1.422 -1.872 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.97 136.61 48.97 Favored 'General case' 0 C--N 1.287 -2.128 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.334 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.465 ' C ' ' H ' ' A' ' 53' ' ' ASN . 51.8 mtp180 -90.79 154.03 19.81 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.65 29.19 0.88 Allowed Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.075 0.819 . . . . 0.0 112.744 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 51' ' ' ARG . 13.8 m120 -125.08 -8.55 7.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -116.81 -1.55 12.02 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-N 114.164 -1.38 . . . . 0.0 110.133 -175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 51' ' ' ARG . 22.3 t -124.16 136.21 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.786 0 CA-C-O 121.237 0.541 . . . . 0.0 109.864 -171.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.437 ' HB2' ' HG3' ' A' ' 15' ' ' LYS . 13.0 mmm180 -139.14 134.94 33.53 Favored 'General case' 0 N--CA 1.389 -3.496 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 174.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -71.58 -173.02 0.86 Allowed 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 120.86 -0.336 . . . . 0.0 111.555 176.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.7 pt -63.84 93.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-O 121.893 0.854 . . . . 0.0 113.126 178.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 177.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 CA--C 1.507 -0.675 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -141.89 151.23 42.47 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.98 96.27 10.66 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.1 mtt -125.91 94.69 4.18 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.367 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -91.18 100.9 13.65 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 122.279 1.038 . . . . 0.0 111.064 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.2 mt -121.0 93.95 4.19 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.305 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -82.28 85.14 6.9 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.44 -178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.8 mt -148.46 138.11 22.15 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 112.425 -2.17 . . . . 0.0 106.559 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -121.58 155.9 59.05 Favored Pre-proline 0 C--N 1.292 -1.911 0 CA-C-O 121.082 0.468 . . . . 0.0 110.941 -177.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.602 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 4.3 Cg_exo -69.14 111.01 2.56 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 121.819 1.679 . . . . 0.0 110.827 177.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 132.26 -19.7 4.55 Favored Glycine 0 N--CA 1.426 -2.007 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.676 -177.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' ARG . 20.9 m-20 -60.03 125.16 22.57 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 44.5 t -95.15 103.78 15.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.977 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 56' ' ' ARG . 30.1 m -131.32 176.88 7.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.797 -173.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -105.39 123.73 48.36 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.142 174.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.4 t -126.79 134.36 66.4 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.098 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.3 tt -85.9 100.11 11.87 Favored 'General case' 0 N--CA 1.418 -2.063 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 174.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -73.38 -66.03 0.74 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.833 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 70.6 m -121.41 140.3 52.32 Favored 'General case' 0 N--CA 1.405 -2.723 0 CA-C-N 113.896 -1.502 . . . . 0.0 109.219 -173.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -64.6 -20.67 66.4 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.33 2.73 53.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.827 0.346 . . . . 0.0 110.982 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.2 mt -124.74 -44.25 1.96 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 0.0 109.989 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.89 -151.35 20.05 Favored Glycine 0 N--CA 1.424 -2.153 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.0 m95 -73.38 108.27 6.15 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 123.663 0.785 . . . . 0.0 110.761 178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.0 m -110.71 165.26 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.649 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.9 ttt-85 -82.02 124.29 29.66 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -141.25 162.83 34.54 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.546 -177.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 1.6 mpp_? -123.92 136.96 54.67 Favored 'General case' 0 CA--C 1.476 -1.88 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.028 176.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.539 ' HA ' HG12 ' A' ' 40' ' ' VAL . 46.5 t -71.49 115.08 10.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 175.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 57.5 mt -82.94 -41.03 16.92 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.384 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.481 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 1.8 ptp85 -160.48 157.89 28.36 Favored 'General case' 1 N--CA 1.345 -5.679 0 C-N-CA 119.866 -0.734 . . . . 0.0 109.874 -177.053 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.4 p -110.49 116.48 52.49 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.774 0 CA-C-N 113.68 -1.6 . . . . 0.0 110.686 -178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 14.1 mttm -120.31 164.71 15.89 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.742 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 p -95.37 174.35 7.07 Favored 'General case' 0 N--CA 1.388 -3.547 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.107 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.48 5.24 89.31 Favored Glycine 0 C--O 1.241 0.554 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 78.24 25.81 60.89 Favored Glycine 0 N--CA 1.423 -2.231 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.592 ' HA ' ' OG1' ' A' ' 49' ' ' THR . 0.3 OUTLIER -95.91 41.15 1.11 Allowed 'General case' 0 CA--C 1.485 -1.528 0 CA-C-O 122.483 1.135 . . . . 0.0 109.222 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 m -67.48 117.61 9.31 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.113 0 CA-C-N 113.217 -1.811 . . . . 0.0 108.754 175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.555 HG22 ' NH1' ' A' ' 37' ' ' ARG . 88.1 t -92.25 128.3 43.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.606 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.217 -171.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 29' ' ' VAL . 31.0 m -137.29 154.88 31.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -132.89 126.6 32.51 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.0 m -71.71 162.16 29.87 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 124.2 0.937 . . . . 0.0 109.632 176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.92 -15.56 13.43 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.44 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 1.2 mp0 -87.66 13.37 10.54 Favored 'General case' 0 C--N 1.319 -0.721 0 O-C-N 122.335 -0.228 . . . . 0.0 110.903 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.34 35.78 77.1 Favored Glycine 0 C--O 1.221 -0.657 0 CA-C-O 121.373 0.429 . . . . 0.0 113.107 175.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.44 ' HD3' ' HB2' ' A' ' 44' ' ' GLN . 40.0 mtp85 -113.94 109.22 18.15 Favored 'General case' 0 N--CA 1.405 -2.697 0 C-N-CA 122.851 0.46 . . . . 0.0 110.154 -178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -84.23 140.63 31.56 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -154.92 168.78 25.81 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.592 ' OG1' ' HA ' ' A' ' 37' ' ' ARG . 9.5 t -97.54 125.35 42.19 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -103.68 167.07 10.03 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.251 -0.58 . . . . 0.0 110.755 -176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -122.1 153.78 38.23 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.39 -20.24 43.85 Favored Glycine 0 N--CA 1.478 1.49 0 N-CA-C 115.194 0.838 . . . . 0.0 115.194 -174.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.65 -7.36 52.87 Favored 'General case' 0 C--N 1.31 -1.135 0 O-C-N 122.027 -0.69 . . . . 0.0 110.939 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -104.6 1.21 29.4 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.37 133.41 68.7 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.914 0 CA-C-O 121.575 0.702 . . . . 0.0 109.403 -177.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.454 ' O ' ' HB ' ' A' ' 14' ' ' VAL . 21.5 mmm180 -137.87 135.12 35.86 Favored 'General case' 1 N--CA 1.379 -4.003 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.808 177.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 57' ' ' LEU . 2.5 pt? -70.16 -175.89 1.06 Allowed 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.44 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.6 pt -71.5 73.58 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-O 122.524 1.154 . . . . 0.0 112.394 175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 . . . . . 0 C--N 1.29 -1.996 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 179.415 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.1 t . . . . . 0 N--CA 1.448 -0.569 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -172.01 -171.18 0.83 Allowed 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.17 30.65 6.01 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 118.249 0.477 . . . . 0.0 109.75 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.1 ttt -109.89 -25.84 10.09 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-O 121.718 0.77 . . . . 0.0 110.964 -176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -88.67 141.53 28.44 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.06 176.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.4 mt -92.04 93.66 8.86 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.851 -176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -95.47 87.9 4.91 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 167.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.9 mt -123.45 126.5 46.87 Favored 'General case' 0 N--CA 1.406 -2.64 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.423 -178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -85.08 153.69 60.02 Favored Pre-proline 0 N--CA 1.411 -2.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.093 -175.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 6.4 Cg_exo -66.43 103.2 0.64 Allowed 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 122.299 1.999 . . . . 0.0 110.918 179.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 141.68 -16.56 2.64 Favored Glycine 0 N--CA 1.424 -2.138 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.144 -175.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -70.4 159.23 34.56 Favored 'General case' 0 C--O 1.246 0.891 0 O-C-N 124.235 0.609 . . . . 0.0 109.442 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.8 t -131.97 113.48 22.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.423 HG12 ' HA ' ' A' ' 57' ' ' LEU . 18.8 m -131.83 169.18 22.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.611 -173.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -103.18 124.04 47.85 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 174.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 38.3 t -123.38 129.13 74.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -177.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -91.39 106.15 18.29 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 174.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -73.99 -69.97 0.41 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 122.226 1.012 . . . . 0.0 109.324 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.4 m -124.38 147.84 47.96 Favored 'General case' 0 N--CA 1.408 -2.532 0 CA-C-N 113.789 -1.551 . . . . 0.0 108.991 -173.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.0 -23.36 66.38 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -85.5 -1.58 57.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.8 0.334 . . . . 0.0 111.518 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.7 mt -119.37 -42.0 2.69 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.282 0.563 . . . . 0.0 109.658 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.68 -156.72 28.04 Favored Glycine 0 N--CA 1.423 -2.173 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -75.47 109.15 8.78 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.068 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 m -107.43 145.24 15.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.528 ' H ' ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -84.42 124.91 31.83 Favored 'General case' 0 N--CA 1.398 -3.048 0 CA-C-O 121.13 0.491 . . . . 0.0 110.307 -177.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.16 151.9 51.1 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.359 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -106.64 131.25 54.0 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.438 ' HA ' HG12 ' A' ' 40' ' ' VAL . 45.0 t -68.41 113.91 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.58 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 37.0 mt -91.26 -40.58 12.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 CA-C-O 121.537 0.684 . . . . 0.0 109.886 -178.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.429 ' CG ' ' HG3' ' A' ' 33' ' ' LYS . 10.7 tpp180 -155.39 143.1 19.76 Favored 'General case' 1 N--CA 1.368 -4.563 0 CA-C-O 122.14 0.972 . . . . 0.0 110.341 -176.097 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 p -95.79 89.26 2.22 Favored 'Isoleucine or valine' 1 C--N 1.243 -4.029 0 CA-C-N 113.258 -1.792 . . . . 0.0 108.908 173.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 37' ' ' ARG . 43.7 mttt -84.27 154.04 23.2 Favored 'General case' 0 CA--C 1.491 -1.307 0 N-CA-C 107.084 -1.451 . . . . 0.0 107.084 174.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.1 t -100.31 -175.96 3.08 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.042 -172.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.14 -62.16 4.28 Favored Glycine 0 C--O 1.22 -0.77 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -177.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 166.11 46.53 0.02 OUTLIER Glycine 0 C--N 1.294 -1.755 0 N-CA-C 108.18 -1.968 . . . . 0.0 108.18 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.568 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -131.1 27.81 4.81 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 115.059 -0.571 . . . . 0.0 110.302 -174.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 49' ' ' THR . 16.2 t -55.74 123.69 7.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.514 HG13 ' HG3' ' A' ' 47' ' ' GLU . 1.7 t -109.58 131.47 60.39 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.688 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -166.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.4 m -132.64 149.22 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.574 0 CA-C-N 113.014 -1.903 . . . . 0.0 106.073 174.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -126.24 123.4 38.05 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.6 m -76.75 168.74 19.57 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.081 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -58.95 -17.41 24.28 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.831 1.652 . . . . 0.0 111.514 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -83.33 7.72 15.71 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.394 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.22 42.22 99.72 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -124.09 104.75 9.05 Favored 'General case' 0 N--CA 1.413 -2.282 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.746 -171.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' HG3' HG13 ' A' ' 39' ' ' VAL . 22.9 tt0 -82.67 132.08 35.19 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -151.87 175.6 12.3 Favored 'General case' 0 C--N 1.299 -1.595 0 C-N-CA 121.32 -0.152 . . . . 0.0 110.614 174.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 11.7 t -91.62 143.76 26.24 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' HB1' ' CG2' ' A' ' 55' ' ' VAL . . . -118.7 146.84 44.41 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.298 0.571 . . . . 0.0 111.192 -176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 55' ' ' VAL . 37.8 mtp-105 -125.24 150.58 46.9 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -58.48 -19.47 41.26 Favored Glycine 0 N--CA 1.484 1.871 0 N-CA-C 115.038 0.775 . . . . 0.0 115.038 -176.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -84.53 -12.6 53.87 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.487 0.66 . . . . 0.0 110.146 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 37.8 mt-30 -114.65 0.18 13.82 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.092 -175.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.561 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 36.7 t -127.12 124.52 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.458 -2.566 0 CA-C-O 121.925 0.869 . . . . 0.0 111.114 -174.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.561 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 15.9 mmm180 -132.29 137.11 47.35 Favored 'General case' 1 N--CA 1.368 -4.561 0 CA-C-N 113.831 -1.531 . . . . 0.0 106.935 177.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.423 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.1 pp -57.0 168.15 0.7 Allowed 'General case' 0 C--N 1.289 -2.027 0 O-C-N 123.548 0.53 . . . . 0.0 111.826 172.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.6 mt -72.16 115.25 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 CA-C-O 121.601 0.715 . . . . 0.0 110.334 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--N 1.273 -2.728 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 -179.826 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 CA--C 1.505 -0.766 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -117.67 121.05 39.85 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -173.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -85.85 85.08 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.302 0.573 . . . . 0.0 109.964 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.0 ttt -110.79 -9.81 14.47 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.305 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -81.54 112.91 19.2 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.811 0.815 . . . . 0.0 110.558 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.26 117.27 6.78 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 113.478 -1.692 . . . . 0.0 107.9 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -99.6 25.96 6.61 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.892 0.853 . . . . 0.0 110.695 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.415 ' HB3' HG21 ' A' ' 29' ' ' VAL . 2.3 mm? -118.89 139.11 52.18 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.032 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -120.41 159.21 48.83 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 123.385 0.674 . . . . 0.0 109.652 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 3.0 Cg_exo -69.67 94.11 0.52 Allowed 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 121.798 1.665 . . . . 0.0 112.333 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.15 -19.0 0.83 Allowed Glycine 0 N--CA 1.428 -1.894 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.311 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -64.35 129.22 39.08 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.1 p -84.54 114.27 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.686 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 172.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 57' ' ' LEU . 34.9 m -125.29 173.44 11.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.298 -169.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -119.38 129.1 54.64 Favored 'General case' 0 N--CA 1.412 -2.366 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 171.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.536 HG11 HG21 ' A' ' 40' ' ' VAL . 30.8 m -123.97 127.75 73.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.527 0.679 . . . . 0.0 112.187 -178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 ' HB2' ' CD2' ' A' ' 24' ' ' TRP . 22.3 tp -91.59 86.97 6.17 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -68.64 -57.15 6.12 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.744 0.783 . . . . 0.0 110.154 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.2 t -125.62 153.44 43.76 Favored 'General case' 0 N--CA 1.417 -2.098 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -73.83 -18.81 60.9 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.41 -15.13 33.92 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.834 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 95.6 mt -104.99 -40.06 6.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.286 0.565 . . . . 0.0 110.215 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 87.48 -175.87 46.11 Favored Glycine 0 N--CA 1.424 -2.146 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.29 179.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . 0.401 ' CD2' ' HB2' ' A' ' 17' ' ' LEU . 90.6 m95 -62.39 108.72 1.16 Allowed 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 124.176 0.991 . . . . 0.0 111.571 175.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.8 m -101.86 148.09 7.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 176.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -75.78 140.1 42.17 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.9 177.18 11.7 Favored 'General case' 0 N--CA 1.428 -1.56 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -134.22 139.73 46.0 Favored 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.464 ' HA ' HG12 ' A' ' 40' ' ' VAL . 47.1 t -69.44 122.45 20.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 49.8 mm -89.59 -44.43 15.11 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.678 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.48 HH21 ' CD ' ' A' ' 47' ' ' GLU . 1.0 OUTLIER -154.05 160.23 41.9 Favored 'General case' 1 N--CA 1.342 -5.872 0 CA-C-O 122.194 0.997 . . . . 0.0 111.325 -175.609 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 97.7 t -118.51 129.99 73.99 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.349 0 CA-C-N 112.904 -1.953 . . . . 0.0 109.646 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -117.5 179.63 4.0 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 171.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 t -110.86 175.87 5.25 Favored 'General case' 0 N--CA 1.403 -2.806 0 C-N-CA 117.557 -1.657 . . . . 0.0 109.594 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.27 18.24 65.02 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -175.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 75.16 32.48 56.01 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 -176.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -108.95 98.13 7.65 Favored 'General case' 0 N--CA 1.409 -2.49 0 CA-C-O 123.476 1.608 . . . . 0.0 110.827 -176.005 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' O ' HG23 ' A' ' 49' ' ' THR . 2.4 m -118.88 123.8 72.1 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 CA-C-N 112.94 -1.936 . . . . 0.0 110.698 -176.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG12 ' CG ' ' A' ' 47' ' ' GLU . 2.3 t -107.19 124.01 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.787 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -174.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.536 HG21 HG11 ' A' ' 16' ' ' VAL . 33.7 m -129.07 152.65 37.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.73 -172.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 18.9 tt0 -116.84 122.38 44.21 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 175.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.2 t -82.93 173.18 12.04 Favored 'General case' 0 C--N 1.313 -1.021 0 O-C-N 123.648 0.592 . . . . 0.0 109.637 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.03 -9.15 3.95 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.573 1.149 . . . . 0.0 113.312 -178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.789 ' N ' HE21 ' A' ' 44' ' ' GLN . 0.0 OUTLIER -91.58 5.68 48.66 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.89 19.56 79.87 Favored Glycine 0 C--O 1.216 -0.981 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.339 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -108.44 118.32 36.47 Favored 'General case' 0 N--CA 1.403 -2.808 0 O-C-N 122.406 -0.467 . . . . 0.0 111.264 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 57.5 tt0 -88.6 133.8 34.07 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 174.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -153.6 174.28 14.66 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 38' ' ' VAL . 88.7 m -116.55 135.47 53.79 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 120.754 0.312 . . . . 0.0 111.149 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.73 174.48 7.09 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 175.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 31.6 mmm180 -82.83 156.66 23.51 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -59.15 -20.84 51.61 Favored Glycine 0 C--O 1.212 -1.241 0 N-CA-C 114.151 0.42 . . . . 0.0 114.151 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -84.56 -15.35 46.01 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.254 0.55 . . . . 0.0 110.343 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -92.0 -6.47 51.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.814 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 22.9 t -120.94 121.4 65.01 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 8.6 mmm180 -133.54 135.34 44.3 Favored 'General case' 1 N--CA 1.378 -4.031 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.23 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 14' ' ' VAL . 1.9 pp -56.11 161.93 2.18 Favored 'General case' 0 C--N 1.293 -1.87 0 O-C-N 123.729 0.643 . . . . 0.0 110.915 170.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . 0.266 38.3 pt -73.06 82.46 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -176.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--O 1.268 2.052 0 N-CA-C 102.251 -3.24 . . . . 0.0 102.251 172.363 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -138.18 140.8 39.97 Favored 'General case' 0 CA--C 1.48 -1.727 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -171.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -178.97 25.68 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 O-C-N 125.176 1.547 . . . . 0.0 109.72 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.5 ttm -143.01 9.98 1.73 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.716 0.769 . . . . 0.0 110.658 -173.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -76.68 30.19 0.13 Allowed 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 124.721 1.209 . . . . 0.0 113.081 -175.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.8 mt -91.67 85.0 5.54 Favored 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -86.66 83.92 7.5 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 122.506 1.146 . . . . 0.0 110.675 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -154.54 140.76 18.55 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 112.276 -2.238 . . . . 0.0 105.13 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -132.23 152.37 80.01 Favored Pre-proline 0 C--N 1.298 -1.658 0 CA-C-N 118.203 0.456 . . . . 0.0 110.612 -178.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.588 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 11.2 Cg_exo -66.7 116.88 4.34 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.555 2.17 . . . . 0.0 110.427 176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.66 -9.41 9.24 Favored Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -74.36 159.66 32.09 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.802 0.441 . . . . 0.0 111.22 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.52 115.04 46.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.566 HG12 ' HA ' ' A' ' 57' ' ' LEU . 27.5 m -130.46 177.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.432 0.634 . . . . 0.0 111.598 -173.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -110.85 124.75 52.66 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.5 t -129.69 133.06 65.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.58 -178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 6.9 tt -88.41 91.22 8.71 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 176.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -64.08 -49.36 72.57 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.473 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.0 m -146.05 145.85 30.73 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.743 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.63 -22.41 66.88 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -176.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.66 5.02 45.11 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 98.7 mt -128.0 -43.3 1.51 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.167 0.508 . . . . 0.0 109.79 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 94.61 -156.55 22.06 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.363 179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -73.8 110.66 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 123.619 0.768 . . . . 0.0 110.322 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.41 167.39 4.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HD2' ' CG ' ' A' ' 43' ' ' ASP . 35.5 ttm180 -73.82 129.78 38.6 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.34 166.84 22.52 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -127.0 140.65 52.15 Favored 'General case' 0 C--N 1.274 -2.703 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 60.0 t -82.04 109.77 16.52 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.588 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 1.4 mp -90.19 -36.52 8.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.338 0.589 . . . . 0.0 110.346 -178.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.459 ' NH2' HG11 ' A' ' 39' ' ' VAL . 2.0 ttp-105 -148.37 142.26 25.78 Favored 'General case' 1 N--CA 1.336 -6.164 0 CA-C-O 122.714 1.245 . . . . 0.0 111.683 -174.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.9 m -111.92 130.63 65.21 Favored 'Isoleucine or valine' 1 C--N 1.237 -4.292 0 CA-C-N 111.987 -2.37 . . . . 0.0 107.849 174.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' ARG . 3.4 tptp -99.82 -150.17 0.37 Allowed 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 173.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.3 m -134.89 167.09 21.53 Favored 'General case' 0 N--CA 1.39 -3.468 0 C-N-CA 119.058 -1.057 . . . . 0.0 108.754 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.62 -88.76 1.57 Allowed Glycine 0 N--CA 1.435 -1.429 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.01 36.31 0.77 Allowed Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 33' ' ' LYS . 47.0 ttt180 -121.76 133.71 54.92 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 m -135.9 135.46 50.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.209 0 CA-C-N 114.855 -1.066 . . . . 0.0 108.646 177.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG11 ' NH2' ' A' ' 31' ' ' ARG . 25.6 t -114.43 123.55 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.924 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 29' ' ' VAL . 27.7 m -128.29 155.83 40.16 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -171.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ARG . 51.6 tt0 -121.09 121.13 37.22 Favored 'General case' 0 C--N 1.271 -2.843 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.8 m -57.68 146.61 30.28 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 171.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.461 ' CG ' ' HD2' ' A' ' 26' ' ' ARG . 24.3 t70 -60.26 -18.95 52.54 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.959 0.885 . . . . 0.0 111.217 -174.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -82.47 -2.32 52.94 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.1 177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.75 -16.12 16.45 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 117.015 1.566 . . . . 0.0 117.015 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -79.83 112.04 16.73 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-N 119.117 1.458 . . . . 0.0 113.756 -176.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 41' ' ' GLN . 25.6 tt0 -89.55 128.41 36.0 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -155.7 170.4 22.12 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.2 t -107.21 136.41 47.08 Favored 'General case' 0 N--CA 1.411 -2.403 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -132.68 172.76 12.12 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -87.23 165.64 15.53 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.1 2.56 42.85 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-O 122.039 0.8 . . . . 0.0 111.55 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -90.97 -27.09 18.91 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 53.0 mt-30 -96.88 -14.79 21.57 Favored 'General case' 0 CA--C 1.493 -1.24 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.56 -176.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HD2' ' A' ' 56' ' ' ARG . 29.7 t -122.16 122.28 66.09 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.254 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 55' ' ' VAL . 28.1 mmm180 -130.54 133.74 46.47 Favored 'General case' 1 N--CA 1.377 -4.09 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.566 ' HA ' HG12 ' A' ' 14' ' ' VAL . 2.0 pp -62.61 176.35 0.67 Allowed 'General case' 0 C--N 1.291 -1.947 0 O-C-N 123.837 0.71 . . . . 0.0 112.488 175.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.8 pt -68.93 89.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.271 2.229 0 N-CA-C 103.055 -2.943 . . . . 0.0 103.055 176.114 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.214 -0.778 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 67.32 -168.0 0.2 Allowed 'General case' 0 C--N 1.351 0.663 0 O-C-N 124.194 0.933 . . . . 0.0 109.993 175.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.55 77.97 1.81 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 120.901 0.381 . . . . 0.0 110.49 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -131.5 152.52 50.65 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 115.035 -0.984 . . . . 0.0 108.616 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -133.06 -152.15 0.48 Allowed 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 97.1 mt -86.61 75.15 9.74 Favored 'General case' 0 C--N 1.298 -1.642 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.685 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.79 9.99 30.35 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 114.18 -1.373 . . . . 0.0 111.662 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.58 118.48 27.08 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -115.73 160.26 35.63 Favored Pre-proline 0 C--N 1.286 -2.181 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.774 -173.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HB3' ' O ' ' A' ' 30' ' ' ILE . 38.3 Cg_exo -57.61 128.23 28.46 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 C-N-CA 122.745 2.297 . . . . 0.0 111.471 178.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 116.61 -12.86 15.47 Favored Glycine 0 N--CA 1.428 -1.897 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.701 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -71.53 155.77 40.19 Favored 'General case' 0 C--O 1.25 1.103 0 C-N-CA 122.726 0.41 . . . . 0.0 111.102 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.4 t -112.62 107.71 23.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 57' ' ' LEU . 35.9 m -125.5 171.68 13.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 CA-C-O 121.913 0.864 . . . . 0.0 111.68 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 41.9 pttt -123.02 127.38 48.71 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 169.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.441 HG21 HG21 ' A' ' 40' ' ' VAL . 63.8 t -123.26 129.9 74.6 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.52 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 7.2 tt -85.09 100.7 11.88 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -67.6 -66.28 0.58 Allowed 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.257 -177.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.8 m -140.3 149.59 42.97 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.839 -174.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.62 84.98 2.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.325 0.584 . . . . 0.0 109.806 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 177.12 -41.3 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.889 0 C-N-CA 126.034 1.734 . . . . 0.0 106.351 -177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.7 -43.48 8.24 Favored 'General case' 0 C--O 1.217 -0.655 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.56 177.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 17' ' ' LEU . . . 89.52 -151.27 21.76 Favored Glycine 0 N--CA 1.432 -1.585 0 C-N-CA 119.838 -1.173 . . . . 0.0 110.648 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -75.99 106.21 7.46 Favored 'General case' 0 C--N 1.299 -1.603 0 C-N-CA 123.442 0.697 . . . . 0.0 110.907 178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 m -102.75 145.07 12.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -71.93 136.67 46.93 Favored 'General case' 0 C--N 1.311 -1.109 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' SER . . . -145.62 165.44 28.7 Favored 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 121.352 0.596 . . . . 0.0 110.315 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -123.11 130.94 53.44 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.485 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.5 t -70.21 113.97 7.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 176.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 50.9 mm -91.43 -39.27 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.527 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.581 -178.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' HA ' ' HG3' ' A' ' 10' ' ' PRO . 2.2 ptp180 -163.37 166.05 23.35 Favored 'General case' 1 N--CA 1.342 -5.842 0 CA-C-O 122.603 1.192 . . . . 0.0 113.013 -176.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.1 t -110.63 133.39 56.25 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.709 0 CA-C-N 112.613 -2.085 . . . . 0.0 105.94 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' CB ' ' HD2' ' A' ' 37' ' ' ARG . 12.2 tptp -96.92 -60.42 1.59 Allowed 'General case' 0 CA--C 1.455 -2.71 0 CA-C-O 121.857 0.837 . . . . 0.0 109.749 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.8 m -148.19 -177.41 5.73 Favored 'General case' 1 N--CA 1.375 -4.218 0 CA-C-N 113.792 -1.549 . . . . 0.0 108.589 -174.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -73.3 78.25 0.83 Allowed Glycine 0 C--O 1.217 -0.967 0 N-CA-C 111.589 -0.605 . . . . 0.0 111.589 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 132.68 -13.5 5.07 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.557 ' NH1' HG22 ' A' ' 39' ' ' VAL . 2.2 tmt_? -120.58 122.97 41.73 Favored 'General case' 0 CA--C 1.459 -2.529 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.02 167.31 25.51 Favored 'Isoleucine or valine' 0 C--N 1.247 -3.877 0 CA-C-N 113.375 -1.739 . . . . 0.0 108.797 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.696 HG12 ' HG2' ' A' ' 47' ' ' GLU . 0.5 OUTLIER -136.11 128.52 45.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 176.014 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.485 HG12 ' HA ' ' A' ' 29' ' ' VAL . 32.9 m -126.3 143.15 40.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -177.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.514 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 24.8 tt0 -107.24 126.92 53.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 30.5 t -92.29 175.68 6.76 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.535 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.56 -13.95 55.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.82 0.848 . . . . 0.0 111.63 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 42' ' ' SER . 14.7 pt20 -77.44 -0.72 26.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.557 175.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.66 20.37 77.26 Favored Glycine 0 C--O 1.22 -0.764 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.549 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttt180 -112.15 118.69 36.06 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -178.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HG2' HG12 ' A' ' 39' ' ' VAL . 22.1 tt0 -87.12 122.06 30.41 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 175.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.9 170.03 16.77 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.875 0.369 . . . . 0.0 111.495 -176.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.459 ' HB ' ' NH1' ' A' ' 37' ' ' ARG . 12.6 t -85.99 134.64 33.85 Favored 'General case' 0 N--CA 1.428 -1.567 0 CA-C-O 121.154 0.502 . . . . 0.0 109.697 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.72 159.32 22.44 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.52 ' HD2' ' OE1' ' A' ' 54' ' ' GLN . 60.5 mtt180 -114.05 141.74 47.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 177.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -52.19 -31.53 34.25 Favored Glycine 0 N--CA 1.474 1.173 0 N-CA-C 115.33 0.892 . . . . 0.0 115.33 -174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -85.73 1.62 48.73 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 121.75 0.786 . . . . 0.0 112.291 -177.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.52 ' OE1' ' HD2' ' A' ' 51' ' ' ARG . 24.7 mt-30 -115.16 9.13 15.78 Favored 'General case' 0 C--N 1.278 -2.522 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.302 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 51' ' ' ARG . 31.2 t -124.38 137.37 57.48 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.564 0 CA-C-O 121.714 0.768 . . . . 0.0 110.121 -175.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 HH21 ' C ' ' A' ' 59' ' ' GLU . 7.8 mmm180 -140.36 139.12 35.31 Favored 'General case' 0 N--CA 1.389 -3.505 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 173.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.585 ' H ' HD23 ' A' ' 57' ' ' LEU . 2.5 pt? -71.92 -161.22 0.07 Allowed 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 173.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 19.2 pt -72.44 64.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 122.626 1.203 . . . . 0.0 112.086 171.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' C ' HH21 ' A' ' 56' ' ' ARG . 8.4 tp10 . . . . . 0 C--N 1.295 -1.793 0 C-N-CA 129.128 2.971 . . . . 0.0 104.587 -178.672 . . . . . . . . 1 1 . 1 stop_ save_